WO2018158365A1 - Microbiocidal oxadiazole derivatives - Google Patents

Microbiocidal oxadiazole derivatives Download PDF

Info

Publication number
WO2018158365A1
WO2018158365A1 PCT/EP2018/055042 EP2018055042W WO2018158365A1 WO 2018158365 A1 WO2018158365 A1 WO 2018158365A1 EP 2018055042 W EP2018055042 W EP 2018055042W WO 2018158365 A1 WO2018158365 A1 WO 2018158365A1
Authority
WO
WIPO (PCT)
Prior art keywords
methyl
carboxamide
heterocyclyl
ethyl
triazole
Prior art date
Application number
PCT/EP2018/055042
Other languages
French (fr)
Inventor
Thomas James HOFFMAN
Daniel Stierli
Thomas Pitterna
Ramya Rajan
Original Assignee
Syngenta Participations Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syngenta Participations Ag filed Critical Syngenta Participations Ag
Priority to MX2019010261A priority Critical patent/MX2019010261A/en
Priority to EP18708404.1A priority patent/EP3589629A1/en
Priority to US16/489,805 priority patent/US11358957B2/en
Priority to JP2019547632A priority patent/JP2020510670A/en
Priority to CN201880014967.1A priority patent/CN110382492B/en
Priority to BR112019018238-1A priority patent/BR112019018238B1/en
Publication of WO2018158365A1 publication Critical patent/WO2018158365A1/en
Priority to CONC2019/0009262A priority patent/CO2019009262A2/en
Priority to IL269023A priority patent/IL269023B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/82—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with three ring hetero atoms
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/84—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms six-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,4
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Definitions

  • A is selected from A-1 , A-2 or A-3;
  • Z is selected from Z Z 2 or Z 3 ; wherein Z represents a 4- to 6-membered non-aromatic heterocyclyl ring containing 1 ring nitrogen, wherein the heterocyclyl optionally comprises 1 or 2 additional ring members independently selected from N, O, S, C(O) and S(0)2 with the proviso that the heterocyclyl ring cannot contain 2 contiguous atoms selected from O and S, or the heterocyclyl optionally comprises 1 additional ring member NR 3 , wherein the heterocyclyl is optionally substituted by 1 or 2 substituents, which may be the same or different, selected from R 4 , and wherein further the heterocyclyl is bound to the rest of the molecule through a ring nitrogen;
  • R 3 represents hydrogen, hydroxy, amino, formyl, d salkyl, d salkoxy, d salkylcarbonyl, Ci- 3alkoxycarbonyl, N-Ci salkylaminocarbonyl, N,N-diCi-3alkylaminocarbonyl, N-Ci-3alkoxyaminocarbonyl, N-Ci-3alkyl-N-Ci-3alkoxy-aminocarbonyl, Ci-2alkylsulfonyl, N-Ci-2alkylaminosulfonyl, N,N-diCi- 2alkylaminosulfonyl, Ci-2alkyldicarbonyl, Ci-2alkoxydicarbonyl, N-Ci-2alkylaminodicarbonyl or N,N-diCi- 2alkylaminodicarbonyl; R 4 represents cyano, halogen, hydroxy, amino, methyl, ethyl, difluoromethyl
  • Z 2 represents a 5- or 6-membered heteroaryl ring containing 1 ring nitrogen, wherein the heteroaryl optionally comprises 1 , 2 or 3 additional ring members independently selected from O, S, or N, and wherein the heteroaryl is optionally substituted by: 1 or 2 substituents selected from R 5 , 1 substituent selected from R 6 , or 1 substituent selected from R 5 and 1 substituent selected from R 6 , and wherein further the heteroaryl is bound to the rest of the molecule through a ring nitrogen;
  • R 5 represents hydroxyl, amino, cyano, halogen, formyl, nitro, Ci-4alkyl, Ci-4alkoxy, C3-4alkenyl, C3-4alkynyl, C3-4alkenyloxy, C3-4alkynyloxy, cyanoCi-2alkyl, Ci-2haloalkyl, hydroxyCi-2alkyl, Ci-2alkoxyCi- 2alkyl, Ci-2alkoxyCi-2alkoxyCi-2alkyl, ⁇ , ⁇ -dimethylamino, Ci-3alkoxycarbonylCi-2alkyl, Ci- 3alkylcarbonyloxyCi-2alkyl, N-Ci-3alkylaminocarbonylCi-2alkyl, N,N-diCi-3alkylaminocarbonylCi-2alkyl, Ci-2alkylsulfonyl, d salkylcarbonyl, Ci salkyldicarbonyl, Ci salkoxyd
  • R b represents hydrogen, methyl, ethyl, propyl, prop-2-enyl, prop-2-ynyl, cyclopropyl, or cyclopropylmethyl; or R a and R b , together with the nitrogen atom they share, form an azetidinyl, pyrrolidinyl, isooxazolidinyl, morpholino, piperazin-4-yl, or piperidinyl ring optionally substituted by 1 or 2 groups selected from halogen, methyl, ethyl or methoxy; or R 5 represents -C(0)0-R c , wherein:
  • R c represents hydrogen, Ci-ealkyl, C3-salkenyl, C3-salkynyl, Ci shaloalkyl, C3-4haloalkenyl, N,N- diCi-3alkylaminoCi-3alkyl, C3-6cycloalkyl, C3-4cycloalkylCi-2alkyl, phenyl, heterocyclyl, wherein the heterocyclyl moiety is a 4- to 6-membered non-aromatic ring which comprises 1 or 2 heteroatoms independently selected from O, S and N, with the proviso that the heterocyclyl cannot contain 2 contiguous atoms selected from O and S, heteroaryl, wherein the heteroaryl moiety is a 5- or 6- membered aromatic ring which comprises 1 , 2 or 3 heteroatoms individually selected from N, O and S; and wherein the cycloalkyi, phenyl, heterocyclyl or heteroaryl is optionally substituted by 1 or 2 substituents, which
  • R 5 represents -N(R d )(R e ) or -Ci- 2 alkyl-N(R d )(R e ), wherein
  • R d represents d salkyl, C3-4alkenyl, C3-4alkynyl, methylcarbonyl, methoxycarbonyl, N- methylaminocarbonyl, ⁇ , ⁇ -dimethylaminocarbonyl, N-methoxyaminocarbonyl, N-methyl-N-methoxy- aminocarbonyl, methylsulfonyl, N-methylaminosulfonyl, ⁇ , ⁇ -dimethylaminosulfonyl, methyldicarbonyl, N-methylaminodicarbonyl, or ⁇ , ⁇ -dimethylaminodicarbonyl; and
  • R d and R e together with the nitrogen atom they share, form an azetidinyl, pyrrolidinyl, isooxazolidinyl, morpholino, piperazin-4-yl, or piperidinyl ring optionally substituted by 1 or 2 groups selected from halogen, methyl, ethyl or methoxy; or
  • R 7 is cyano, fluoro, chloro, amino, hydroxy, methyl, difluoromethyl, trifluoromethyl, methoxy, N,N- dimethylamino, formyl, methylcarbonyl, methoxycarbonyl, N-methylaminocarbonyl, or N,N- dimethylaminocarbonyl; or a salt or N-oxide thereof.
  • novel compounds of Formula (I) have, for practical purposes, a very advantageous level of biological activity for protecting plants against diseases that are caused by fungi.
  • an agrochemical composition comprising a fungicidally effective amount of a compound of Formula (I).
  • Such an agricultural composition may further comprise at least one additional active ingredient and/or an agrochemically- acceptable diluent or carrier.
  • halogen refers to fluorine (fluoro), chlorine (chloro), bromine (bromo) or iodine (iodo), preferably fluorine, chlorine or bromine.
  • cyano means a -CN group.
  • hydroxyl or "hydroxy” means an -OH group.
  • amino means an -NH2 group.
  • Ci- C2alkylene refers to the corresponding definition of Ci-2alkyl, except that such radical is attached to the rest of the molecule by two single bonds.
  • d-6alkynyl refers to a straight or branched hydrocarbon chain radical group consisting solely of carbon and hydrogen atoms, containing at least one triple bond, having from two to six carbon atoms, and which is attached to the rest of the molecule by a single bond.
  • d-salkynyl and C2-4alkynyl are to be construed accordingly.
  • Examples of d ealkynyl include, but are not limited to, prop-1-ynyl, propargyl (prop-2-ynyl).
  • cyanoCi-2alkyl refers to refers to a Cisalkyl radical as generally defined above substituted by one or more cyano groups.
  • Ci-3alkoxyaminocarbonyl refers to a radical of the formula RxONHC(O)-, where R x is a Ci salkyl radical as generally defined above.
  • Rx is a Ci salkyl radical as generally defined above.
  • N-Ci salkylamino refers to a radical of the formula R X NH- where R x is a Ci salkyl radical as generally defined above.
  • N,N-diCi-2alkylaminosulfonyl refers to a radical of the formula Rx(Rx)NS(0)2- where each R x is independently a Cisalkyl radical as generally defined above.
  • Ci-3alkylaminocarbonyl refers to a radical of the formula RxNHC(O)- where R x is a Ci salkyl radical as generally defined above.
  • N,N-diCi-3alkylaminocarbonyl refers to a radical of the formula (Rx)RxNHC(O)- where each R x is independently a d salkyl radical as generally defined above.
  • d-6cycloalkyl refers to a stable, monocyclic ring radical which is saturated or partially unsaturated and contains 3 to 6 carbon atoms.
  • d-scycloalkyl and Cscycloalkyl are to be construed accordingly.
  • Examples of d ecycloalkyl include, but are not limited to cyclopropyl, cyclobutyl, cyclopentyl, cyclopenten-1-yl, cyclopenten-3-yl, and cyclohexen-3-yl.
  • phenyld-2alkyl refers to a phenyl ring attached to the rest of the molecule by a d-2alkylene radical as defined above.
  • phenyld-2alkyl include, but are not limited to, benzyl.
  • heterocyclyl or “heterocyclic” generally refers to a stable, saturated or partially saturated, 4- to 6-membered, non-aromatic monocyclic ring, which comprises 1 , 2 or 3 heteroatoms individually selected from nitrogen, oxygen and sulfur.
  • the heterocyclyl radical may be bonded to the rest of the molecule via a carbon atom or heteroatom.
  • heterocyclyl examples include, but are not limited to, azetidinyl, oxetanyl, pyrrolidyl, tetrahydrofuryl, tetrahydrothienyl, tetrahydrothiopyranyl, piperidinyl, piperazinyl, tetrahydropyranyl, dioxolanyl, and morpholinyl.
  • heterocyclyl refers to a stable, 7- to 9-membered saturated, partially saturated or aromatic fused ring or saturated spirocyclic ring radical containing 1 nitrogen, which comprises 1 or 2 additional ring members individually selected from nitrogen, oxygen and sulfur.
  • the heterobicyclyl radical is bonded to the rest of the molecule via a nitrogen atom.
  • heterobicyclyl include, but are not limited to, pyrrolopyridine, benzimidazole.
  • the compounds of Formula (I) according to the invention are in free form, in oxidized form as an N-oxide, in covalently hydrated form, or in salt form, e.g., an agronomically usable or agrochemically acceptable salt form.
  • A is selected from A-1 , A-2, and A-3.
  • A-1 represents a 2,5-thienyl group
  • A-2 represents a 2,4- thienyl group
  • A-3 represents a 3,5-thienyl group.
  • A is A-1.
  • R and R 2 independently represent hydrogen, methyl, ethyl, fluoro, cyano, difluoromethyl or trifluoromethyl.
  • R and R 2 independently represent hydrogen or methyl, more preferably R and R 2 both represent hydrogen.
  • Z is selected from Z , Z 2 , and Z 3 .
  • Z represents a 4-, 5- or 6-membered non-aromatic heterocyclyl ring containing 1 ring nitrogen, wherein the heterocyclyl optionally comprises 1 or 2 additional ring members independently selected from N, O, S, C(O) and S(0)2 with the proviso that the heterocyclyl cannot contain 2 contiguous atoms selected from O and S, or the heterocyclyl optionally comprises 1 additional ring member NR 3 , wherein the heterocyclyl is optionally substituted by 1 or 2 substituents, which may be the same or different, selected from R 4 , and wherein further the heterocyclyl is bound to the rest of the molecule through a ring nitrogen.
  • Z represents a 4-, 5- or 6-membered non-aromatic heterocyclyl containing 1 ring nitrogen, wherein the heterocyclyl optionally comprises 1 additional ring member independently selected from N, O, S, C(O) or S(0)2 (in particular, O or C(O)), wherein the heterocyclyl is optionally substituted by 1 or 2 substituents, which may be the same or different, selected from R 4 , and wherein further the heterocyclyl is bound to the rest of the molecule through a ring nitrogen.
  • the heterocyclyl optionally comprises 1 additional ring member independently selected from N, O, S, C(O) or S(0)2 (in particular, O or C(O)), wherein the heterocyclyl is optionally substituted by 1 or 2 substituents, which may be the same or different, selected from R 4 , and wherein further the heterocyclyl is bound to the rest of the molecule through a ring nitrogen.
  • R 4 represents cyano, halogen, hydroxy, amino, methyl, ethyl, difluoromethyl, trifluoromethyl, methoxy, N-methylamino or ⁇ , ⁇ -dimethylamino.
  • R 4 is selected from methyl or ethyl.
  • Z 2 represents a 5- or 6-membered heteroaryl ring containing 1 ring nitrogen, wherein the heteroaryl optionally comprises 1 , 2 or 3 additional ring members independently selected from O, S, or N, and wherein the heteroaryl is optionally substituted by: 1 or 2 substituents selected from R 5 , 1 substituent selected from R 6 , or 1 substituent selected from R 5 and 1 substituent selected from R 6 , and wherein further the heteroaryl is bound to the rest of the molecule through a ring nitrogen;
  • Z 2 is optionally substituted by 1 or 2 substituents selected from R 5 , and most preferably is optionally substituted by a single substituent selected from R 5 .
  • Z 2 is selected from:
  • Z 2 is selected from:
  • R a represents hydrogen, Ci-ealkyl, C3-4alkenyl, C3-4alkynyl, C-i shaloalkyl, C3-4haloalkenyl, Ci- 4alkoxy, Ci-2alkoxyCi-3alkyl, C2-3haloalkoxy, C3-4alkenyloxy, C3-4alkynyloxy, N-Ci salkylamino, or N,N- diCi-2alkylamino; or
  • R a and R b together with the nitrogen atom they share, form an azetidinyl, pyrrolidinyl or piperidinyl ring optionally substituted by 1 or 2 groups selected from halogen, methyl, ethyl or methoxy; or
  • R 5 represents -C(0)0-R c , wherein:
  • R c represents hydrogen, Ci-ealkyl, C3-salkenyl, C3-salkynyl, Ci shaloalkyl, C3-4haloalkenyl, N,N- diCi-3alkylaminoCi-3alkyl, C3-6cycloalkyl, C3-4cycloalkylCi-2alkyl, phenyl, heterocyclyl, wherein the heterocyclyl moiety is a 4- to 6-membered non-aromatic ring which comprises 1 or 2 heteroatoms independently selected from O, S and N, with the proviso that the heterocyclyl cannot contain 2 contiguous atoms selected from O and S, heteroaryl, wherein the heteroaryl moiety is a 5- or 6- membered aromatic ring which comprises 1 , 2 or 3 heteroatoms individually selected from N, O and S; and wherein the cycloalkyi, phenyl, heterocyclyl or heteroaryl is optionally substituted by 1 or 2 substituents, which
  • R d represents d salkyl, C3-4alkenyl, C3-4alkynyl, methylcarbonyl, methoxycarbonyl, N- methylaminocarbonyl, ⁇ , ⁇ -dimethylaminocarbonyl, N-methoxyaminocarbonyl, N-methyl-N-methoxy- aminocarbonyl, methylsulfonyl, N-methylaminosulfonyl, ⁇ , ⁇ -dimethylaminosulfonyl, methyldicarbonyl, N-methylaminodicarbonyl, or ⁇ , ⁇ -dimethylaminodicarbonyl; and
  • R e represents hydrogen, methyl, ethyl, or propyl
  • R 6 represents C3-6cycloalkyl, phenyl, heteroaryl, wherein the heteroaryl moiety is a 5- or 6- membered aromatic ring which comprises 1 , 2, 3 or 4 heteroatoms individually selected from N, O and S, heterocyclyl, wherein the heterocyclyl moiety is a 4- to 6-membered non-aromatic ring which comprises 1 or 2 heteroatoms individually selected from N, O and S, and wherein the cycloalkyi, phenyl, heteroaryl and heterocyclyl is optionally substituted by 1 or 2 substituents, which may be the same or different, selected from hydroxyl, amino, formyl, acyl, cyano, halogen, methyl, trifluoromethyl, methoxy, ⁇ , ⁇ -dimethylamino, and wherein when R 6 represents cycloalkyl or heterocyclyl, these cycles optionally contain 1 group selected from C(O) or S(0)2.
  • R 5 is selected from amino, cyano, chloro, fluoro, formyl, nitro, methyl, ethyl, difluoromethyl, methoxymethyl, ⁇ , ⁇ -dimethylamino, methoxycarbonyl, ethoxycarbonyl or n- propoxycarbonyl; or -C(0)N(R a )(R b ) wherein R a is selected from hydrogen, methyl or methoxy and R b is selected from hydrogen or methyl, and R 6 is phenyl optionally substituted by 1 or 2 substituents, which may be the same or different, selected from fluoro, chloro or bromo.
  • Z 3 represents a heterobicyclyl which is a 7- to 9-membered saturated , partially saturated, or aromatic fused ring or saturated spirocyclic ring system containing 1 nitrogen, wherein the heterobicyclyl optionally comprises 1 or 2 additional ring members independently selected from N, O, S, C(O) and S(0)2 with the proviso that the heterobicyclyl cannot contain 2 contiguous atoms selected from O and S, wherein the heterobicyclyl is optionally substituted by 1 substituent selected from R 7 , and wherein further the heterobicyclyl is bound to the rest of the molecule through a ring nitrogen; and
  • Z 3 represents a heterobicyclyl which is a 9-membered saturated, partially saturated, or aromatic fused ring system containing 1 nitrogen, wherein the heterobicyclyl optionally comprises 1 additional ring member independently selected from N, O and S, wherein the heterobicyclyl is optionally substituted by 1 substituent selected from R
  • Z 3 is optionally substituted by 1 substituent selected from R 7 .
  • R 7 is cyano, fluoro, chloro, amino, hydroxy, methyl, difluoromethyl, trifluoromethyl, methoxy, N,N dimethylamino, formyl, methylcarbonyl, methoxycarbonyl, N-methylaminocarbonyl, or N,N dimethylanninocarbonyl.
  • R 7 is selected from hydroxyl, methoxy, methyl cyano, fluoro or chloro.
  • the compound according to Formula (I) is selected from a compound 1.1 to 1.190 listed in Table T1 (below).
  • A is A-1 ;
  • R is hydrogen and R 2 is hydrogen or methyl
  • Z is Z , wherein Z represents a 4-, 5- or 6-membered non-aromatic heterocyclyl containing 1 ring nitrogen, wherein the heterocyclyl optionally comprises 1 additional ring member independently selected from N, O, S, C(O) or S(0)2 (in particular, O or C(O)), wherein the heterocyclyl is optionally substituted by 1 or 2 substituents, which may be the same or different, selected from R 4 , and wherein further the heterocyclyl is bound to the rest of the molecule through a ring nitrogen; and
  • R 4 represents cyano, halogen, hydroxy, amino, methyl, ethyl, difluoromethyl, trifluoromethyl, methoxy, N-methylamino or N,N-dimethylamino.
  • R and R 2 are hydrogen
  • Z is Z , wherein Z represents a 4-, 5- or 6-membered non-aromatic heterocyclyl containing 1 ring nitrogen, wherein the heterocyclyl optionally comprises 1 additional ring member independently selected from N, O, S, C(O) or S(0)2 (in particular, O or C(O)), wherein the heterocyclyl is optionally substituted by 1 or 2 substituents, which may be the same or different, selected from R 4 , and wherein further the heterocyclyl is bound to the rest of the molecule through a ring nitrogen; and
  • R 4 represents methyl or ethyl.
  • A is A-1 ;
  • R is hydrogen and R 2 is hydrogen or methyl
  • Z is Z 2 , wherein Z 2 is selected from:
  • Z 2 is optionally substituted by: 1 or 2 substituents selected from R 5 , 1 substituent selected from R 6 , or 1 substituent selected from R 5 and 1 substituent selected from R 6 .
  • A is A-1 ;
  • R and R 2 are hydrogen
  • Z 2 is optionally substituted by: 1 or 2 substituents selected from R 5 or 1 substituent selected from R 6 .
  • A is A-1 ;
  • R and R 2 are hydrogen
  • Z is Z 3 , wherein Z 3 represents a heterobicyclyl which is a 9-membered saturated, partially saturated, or aromatic fused ring system containing 1 nitrogen, wherein the heterobicyclyl optionally comprises 1 additional ring member independently selected from N, O and S, wherein the heterobicyclyl is optionally substituted by 1 substituent selected from R 7 , and wherein further the heterobicyclyl is bound to the rest of the molecule through a ring nitrogen; and
  • R 7 is selected from hydroxyl, methoxy, methyl cyano, fluoro or chloro.
  • the compounds of the present invention may be enantiomers of the compound of Formula (I) as represented by a Formula (la) or a Formula (lb), wherein R and R 2 are different substituents.
  • compounds of formula (I) can optionally be obtained via a coupling transformation with compounds of formula (III) and compounds of formula (II), wherein X is OH, via a process that converts the -OH into an improved leaving group, such as a -OSO2CH3 group, for example by using methanesulfonyl chloride (CIS02Me), prior to treatment with the compounds of formula (III).
  • a catalyst e.g., BU4NHSO4, Bu4NBr, BU4NI , Nal, or 4- dimethylaminopyridine
  • X is OH
  • a process that converts the -OH into an improved leaving group such as a -OSO2CH3 group
  • CIS02Me methanesulfonyl chloride
  • Compounds of Formula (II), wherein X is halogen, preferably CI or Br, can be prepared from compounds of Formula (IV) by treatment with a halogen source (e.g., N-bromosuccinimide (NBS) or N- chlorosuccinimide (NCS)) and a radical initiator (e.g., (PhC02)2 or azobisisobutyronitrile (AIBN)) in a suitable solvent, such as tetrachloromethane, at temperatures between 55° and 100°C in the presence of ultraviolet light.
  • a halogen source e.g., N-bromosuccinimide (NBS) or N- chlorosuccinimide (NCS)
  • a radical initiator e.g., (PhC02)2 or azobisisobutyronitrile (AIBN)
  • suitable solvent such as tetrachloromethane
  • compounds of Formula (II), wherein X is hydrogen, OH, CI, Br, or I can be prepared from compounds of Formula (V) by treatment with trifluoroacetic anhydride or trifluoroacetyl halide (including trifluoroacetyl fluoride, trifluoroacetyl chloride and trifluoroacetyl bromide) in the presence of a base (e.g., pyridine or 4-dimethylaminopyridine) in a suitable solvent, (e.g., ethyl acetate, tetrahydrofuran, 2-methyl tetrahydrofuran, or ethanol), at a temperature between 0°C and 75°C.
  • a base e.g., pyridine or 4-dimethylaminopyridine
  • suitable solvent e.g., ethyl acetate, tetrahydrofuran, 2-methyl tetrahydrofuran, or ethanol
  • Compounds of Formula (V), wherein X is hydrogen, OH, or halogen can be prepared from compounds of Formula (VI) by treatment with a hydroxylamine hydrochloride salt or a hydroxylamine solution in water, in the presence of a base, such as triethylamine or potassium carbonate, in a suitable solvent, such as methanol or ethanol, at a temperature between 0°C and 80°C.
  • a base such as triethylamine or potassium carbonate
  • a suitable solvent such as methanol or ethanol
  • Compounds of Formula (VI), can be prepared from compounds of Formula (VII), wherein Y is CI, Br or I, via metal-promoted reaction with a suitable cyanide reagent, such as Pd(0)/Zn(CN)2 or CuCN, in a suitable solvent (e.g., dimethylformamide or N-methylpyrrolidone) at elevated temperature between 100°C and 120°C.
  • a suitable cyanide reagent such as Pd(0)/Zn(CN)2 or CuCN
  • a suitable solvent e.g., dimethylformamide or N-methylpyrrolidone
  • Compounds of Formula (VII), wherein X is CI, Br, I or OS02Me and Y is CI, Br, I or CN, are either commercially available or can be prepared from compounds of Formula (VIII), via treatment with an acid source (e.g., hydrochloric acid, hydrobromic acid, or hydroiodic acid), or with a halogen source (e.g., CC Br, CCU or ) in the presence of triphenylphosphine, or with methanesulfonyl chloride (CIS02Me), in a suitable solvent, (e.g., dichloromethane) at a temperature between 0°C and 100°C.
  • an acid source e.g., hydrochloric acid, hydrobromic acid, or hydroiodic acid
  • a halogen source e.g., CC Br, CCU or
  • CIS02Me methanesulfonyl chloride
  • suitable solvent e.g., dichloromethan
  • compounds of Formula (I) can be prepared from compounds of Formula (IX) by treatment with trifluoroacetic anhydride or trifluoroacetyl halide (including trifluoroacetyl fluoride, trifluoroacetyl chloride and trifluoroacetyl bromide) in the presence of a base (e.g., pyridine or 4- dimethylaminopyridine) in a suitable solvent, (e.g., ethyl acetate, tetrahydrofuran, 2-methyl tetrahydrofuran, or ethanol), at a temperature between 0°C and 75°C.
  • a base e.g., pyridine or 4- dimethylaminopyridine
  • suitable solvent e.g., ethyl acetate, tetrahydrofuran, 2-methyl tetrahydrofuran, or ethanol
  • compounds of formula (XI) can optionally be obtained via a coupling transformation with compounds of formula (III) and compounds of formula (VII), wherein X is OH, via a process that converts the -OH into an improved leaving group, such as a -OSO2CH3 group, for example by using methanesulfonyl chloride (CIS02Me), prior to treatment with the compounds of formula (III).
  • a catalyst e.g., BU4NHSO4, Bu4NBr, BU4NI , Nal, or 4-dimethylaminopyridine
  • compounds of formula (XI) can optionally be obtained via a coupling transformation with compounds of formula (III) and compounds of formula (VII), wherein X is OH, via a process that converts the -OH into an improved leaving group, such as a -OSO2CH3 group, for example by using methanesulfonyl chloride (CIS02Me), prior to treatment with the compounds of formula (III).
  • the compounds of Formula (I) of the present invention have, for practical purposes, a very advantageous level of biological activity for protecting plants against diseases that are caused by fungi.
  • the compounds of Formula (I) can be used in the agricultural sector and related fields of use, e.g., as active ingredients for controlling plant pests or on non-living materials for the control of spoilage microorganisms or organisms potentially harmful to man.
  • the novel compounds are distinguished by excellent activity at low rates of application, by being well tolerated by plants and by being environmentally safe. They have very useful curative, preventive and systemic properties and can be used for protecting numerous cultivated plants.
  • the compounds of Formula (I) can be used to inhibit or destroy the pests that occur on plants or parts of plants (fruit, blossoms, leaves, stems, tubers, roots) of different crops of useful plants, while at the same time protecting also those parts of the plants that grow later, e.g., from phytopathogenic microorganisms.
  • the present invention further relates to a method for controlling or preventing infestation of plants or plant propagation material and/or harvested food crops susceptible to microbial attack by treating plants or plant propagation material and/or harvested food crops wherein an effective amount a compound of Formula (I) is applied to the plants, to parts thereof or the locus thereof. It is also possible to use compounds of Formula (I) as a fungicide.
  • fungicide as used herein means a compound that controls, modifies, or prevents the growth of fungi.
  • fungicidally effective amount where used means the quantity of such a compound or combination of such compounds that is capable of producing an effect on the growth of fungi. Controlling or modifying effects include all deviation from natural development, such as killing, retardation and the like, and prevention includes barrier or other defensive formation in or on a plant to prevent fungal infection.
  • the compounds of Formula (I) can be used for controlling fungi in related areas, for example in the protection of technical materials, including wood and wood related technical products, in food storage, in hygiene management.
  • the compounds of Formula (I) are for example, effective against fungi and fungal vectors of disease as well as phytopathogenic bacteria and viruses.
  • These fungi and fungal vectors of disease as well as phytopathogenic bacteria and viruses are for example:
  • capsulatum Laetisaria fuciformis, Leptographium lindbergi, Leveillula taurica, Lophodermium seditiosum, Microdochium nivale, Microsporum spp, Monilinia spp, Mucor spp, Mycosphaerella spp. including M. graminicola, M. pomi, Oncobasidium theobromaeon, Ophiostoma piceae, Paracoccidioides spp, Penicillium spp. including P. digitatum, P. italicum, Petriellidium spp, Peronosclerospora spp. Including P. maydis, P.
  • leucotricha Polymyxa graminis, Polymyxa betae, Pseudocercosporella herpotrichoides, Pseudomonas spp, Pseudoperonospora spp. including P. cubensis, P. humuli, Pseudopeziza tracheiphila, Puccinia Spp. including P. hordei, P. recondita, P. striiformis, P. triticina, Pyrenopeziza spp, Pyrenophora spp, Pyricularia spp. including P. oryzae, Pythium spp. including P.
  • the compounds of Formula (I) may be used for example on turf, ornamentals, such as flowers, shrubs, broad-leaved trees or evergreens, for example conifers, as well as for tree injection, pest management and the like.
  • target crops and/or useful plants to be protected typically comprise perennial and annual crops, such as berry plants for example blackberries, blueberries, cranberries, raspberries and strawberries; cereals for example barley, maize (corn), millet, oats, rice, rye, sorghum triticale and wheat; fibre plants for example cotton, flax, hemp, jute and sisal; field crops for example sugar and fodder beet, coffee, hops, mustard, oilseed rape (canola), poppy, sugar cane, sunflower, tea and tobacco; fruit trees for example apple, apricot, avocado, banana, cherry, citrus, nectarine, peach, pear and plum; grasses for example Bermuda grass, bluegrass, bentgrass, centipede grass, fescue, ryegrass, St.
  • perennial and annual crops such as berry plants for example blackberries, blueberries, cranberries, raspberries and strawberries
  • cereals for example barley, maize (corn), millet, oats
  • Augustine grass and Zoysia grass herbs such as basil, borage, chives, coriander, lavender, lovage, mint, oregano, parsley, rosemary, sage and thyme; legumes for example beans, lentils, peas and soya beans; nuts for example almond, cashew, ground nut, hazelnut, peanut, pecan, pistachio and walnut; palms for example oil palm; ornamentals for example flowers, shrubs and trees; other trees, for example cacao, coconut, olive and rubber; vegetables for example asparagus, aubergine, broccoli, cabbage, carrot, cucumber, garlic, lettuce, marrow, melon, okra, onion, pepper, potato, pumpkin, rhubarb, spinach and tomato; and vines for example grapes.
  • herbs such as basil, borage, chives, coriander, lavender, lovage, mint, oregano, parsley, rosemary, sage and thyme
  • legumes for example beans, lentils, peas and soya beans
  • useful plants is to be understood as also including useful plants that have been rendered tolerant to herbicides like bromoxynil or classes of herbicides (such as, for example, HPPD inhibitors, ALS inhibitors, for example primisulfuron, prosulfuron and trifloxysulfuron, EPSPS (5-enol- pyrovyl-shikimate-3-phosphate-synthase) inhibitors, GS (glutamine synthetase) inhibitors or PPO (protoporphyrinogen-oxidase) inhibitors) as a result of conventional methods of breeding or genetic engineering.
  • herbicides like bromoxynil or classes of herbicides
  • EPSPS (5-enol- pyrovyl-shikimate-3-phosphate-synthase) inhibitors
  • GS glutamine synthetase
  • PPO protoporphyrinogen-oxidase
  • imazamox by conventional methods of breeding (mutagenesis) is Clearfield® summer rape (Canola).
  • crops that have been rendered tolerant to herbicides or classes of herbicides by genetic engineering methods include glyphosate- and glufosinate-resistant maize varieties commercially available under the trade names RoundupReady®, Herculex I® and LibertyLink®.
  • YieldGard® (maize variety that expresses a CrylA(b) toxin); YieldGard Rootworm® (maize variety that expresses a CrylllB(bl ) toxin); YieldGard Plus® (maize variety that expresses a CrylA(b) and a CrylllB(bl ) toxin); Starlink® (maize variety that expresses a Cry9(c) toxin); Herculex I® (maize variety that expresses a CrylF(a2) toxin and the enzyme phosphinothricine N-acetyltransferase (PAT) to achieve tolerance to the herbicide glufosinate ammonium); NuCOTN 33B® (cotton variety that expresses a CrylA(c) toxin); Bollgard I® (cotton variety that expresses a CrylA(c) toxin); Bollgard II® (cotton variety that
  • crops is to be understood as including also crop plants which have been so transformed by the use of recombinant DNA techniques that they are capable of synthesising one or more selectively acting toxins, such as are known, for example, from toxin-producing bacteria, especially those of the genus Bacillus.
  • Toxins that can be expressed by such transgenic plants include, for example, insecticidal proteins from Bacillus cereus or Bacillus popilliae; or insecticidal proteins from Bacillus thuringiensis, such as ⁇ -endotoxins, e.g. CrylAb, CrylAc, Cryl F, Cry1 Fa2, Cry2Ab, Cry3A, Cry3Bb1 or Cry9C, or vegetative insecticidal proteins (Vip), e.g. Vip1 , Vip2, Vip3 or Vip3A; or insecticidal proteins of bacteria colonising nematodes, for example Photorhabdus spp.
  • insecticidal proteins from Bacillus cereus or Bacillus popilliae such as ⁇ -endotoxins, e.g. CrylAb, CrylAc, Cryl F, Cry1 Fa2, Cry2Ab, Cry3A, Cry3Bb1 or Cry9C, or vegetative insecticidal proteins
  • Xenorhabdus spp. such as Photorhabdus luminescens, Xenorhabdus nematophilus
  • toxins produced by animals such as scorpion toxins, arachnid toxins, wasp toxins and other insect-specific neurotoxins
  • toxins produced by fungi such as Streptomycetes toxins, plant lectins, such as pea lectins, barley lectins or snowdrop lectins
  • agglutinins proteinase inhibitors, such as trypsin inhibitors, serine protease inhibitors, patatin, cystatin, papain inhibitors
  • ribosome-inactivating proteins (RIP) such as ricin, maize-RIP, abrin, luffin, saporin or bryodin
  • steroid metabolism enzymes such as 3-hydroxysteroidoxidase, ecdysteroid-UDP-glycosyl- transferase, cholesterol oxidases, ecdy
  • modified toxins one or more amino acids of the naturally occurring toxin are replaced.
  • amino acid replacements preferably non-naturally present protease recognition sequences are inserted into the toxin, such as, for example, in the case of Cry3A055, a cathepsin-G-recognition sequence is inserted into a Cry3A toxin (see WO 03/018810).
  • Cryl-type deoxyribonucleic acids and their preparation are known, for example, from WO 95/34656, EP-A-0 367 474, EP-A-0 401 979 and WO 90/13651.
  • Transgenic plants containing one or more genes that code for an insecticidal resistance and express one or more toxins are known and some of them are commercially available. Examples of such plants are: YieldGard® (maize variety that expresses a CrylAb toxin); YieldGard Rootworm® (maize variety that expresses a Cry3Bb1 toxin); YieldGard Plus® (maize variety that expresses a CrylAb and a Cry3Bb1 toxin); Starlink® (maize variety that expresses a Cry9C toxin); Herculex I® (maize variety that expresses a Cry1 Fa2 toxin and the enzyme phosphinothricine N-acetyltransferase (PAT) to achieve tolerance to the herbicide glufosinate ammonium); NuCOTN 33B® (cotton variety that expresses a CrylAc toxin); Bollgard I® (cotton variety that expresses a
  • Bt11 Maize from Syngenta Seeds SAS, Chemin de I'Hobit 27, F-31 790 St. Sauveur, France, registration number C/FR/96/05/10. Genetically modified Zea mays which has been rendered resistant to attack by the European corn borer (Ostrinia nubilalis and Sesamia nonagrioides) by transgenic expression of a truncated Cry1 Ab toxin. Bt1 1 maize also transgenically expresses the enzyme PAT to achieve tolerance to the herbicide glufosinate ammonium. 2. Bt176 Maize from Syngenta Seeds SAS, Chemin de I'Hobit 27, F-31 790 St. Sauveur, France, registration number C/FR/96/05/10.
  • MIR604 Maize from Syngenta Seeds SAS, Chemin de I'Hobit 27, F-31 790 St. Sauveur, France, registration number C/FR/96/05/10. Maize which has been rendered insect-resistant by transgenic expression of a modified Cry3A toxin. This toxin is Cry3A055 modified by insertion of a cathepsin-G- protease recognition sequence. The preparation of such transgenic maize plants is described in WO 03/018810.
  • MON 863 Maize from Monsanto Europe S.A. 270-272 Avenue de Tervuren, B-1 150 Brussels, Belgium, registration number C/DE/02/9. MON 863 expresses a Cry3Bb1 toxin and has resistance to certain Coleoptera insects.
  • NK603 * MON 810 Maize from Monsanto Europe S.A. 270-272 Avenue de Tervuren, B-1 150 Brussels, Belgium, registration number C/GB/02/M3/03. Consists of conventionally bred hybrid maize varieties by crossing the genetically modified varieties NK603 and MON 810.
  • NK603 * MON 810 Maize transgenically expresses the protein CP4 EPSPS, obtained from Agrobacterium sp. strain CP4, which imparts tolerance to the herbicide Roundup® (contains glyphosate), and also a CrylAb toxin obtained from Bacillus thuringiensis subsp. kurstaki which brings about tolerance to certain Lepidoptera, include the European corn borer.
  • the compounds of Formula (I) may be used in controlling or preventing phytopathogenic diseases, especially phytopathogenic fungi (such as Phakopsora pachyrhizi) on soy bean plants.
  • phytopathogenic diseases especially phytopathogenic fungi (such as Phakopsora pachyrhizi)
  • transgenic soybean plants expressing toxins for example insecticidal proteins such as delta-endotoxins, e.g. Cry1 Ac (Cry1 Ac Bt protein). Accordingly, this may include transgenic soybean plants comprising event MON87701 (see U.S. Patent No.
  • transgenic soybean plants may comprise event SYHT0H2 - HPPD tolerance (U.S. Patent Application Publication No. 2014/0201860 and related applications and patents), event MON89788 - glyphosate tolerance (U.S. Pat. No. 7,632,985 and related applications and patents), event MON87708 - dicamba tolerance (U.S. Patent Application Publication No. US 201 1/0067134 and related applications and patents), event DP-356043-5 - glyphosate and ALS tolerance (U.S. Patent Application Publication No. US 2010/0184079 and related applications and patents), event A2704-12 - glufosinate tolerance (U.S. Patent Application Publication No.
  • event DAS-40278-9 - tolerance to 2,4- dichlorophenoxyacetic acid and aryloxyphenoxypropionate see WO 201 1/022469, WO 201 1/022470, WO 201 1/022471 , and related applications and patents
  • event 127 - ALS tolerance WO 2010/080829 and related applications and patents
  • event GTS 40-3-2 - glyphosate tolerance event DAS-68416-4- 2,4-dichlorophenoxyacetic acid and glufosinate tolerance
  • event FG72 - glyphosate and isoxaflutole tolerance event BPS-CV127-9 - ALS tolerance and GU262 - glufosinate tolerance or event SYHT04R - HPPD tolerance.
  • compounds of Formula (I) according to the present invention when used in controlling or preventing phytopathogenic diseases, especially phytopathogenic fungi (such as Phakopsora pachyrhizi) on soy bean plants (in particular any of the transgenic soybean plants as described above), may display a synergistic interaction between the active ingredients.
  • phytopathogenic diseases especially phytopathogenic fungi (such as Phakopsora pachyrhizi) on soy bean plants (in particular any of the transgenic soybean plants as described above
  • locus means fields in or on which plants are growing, or where seeds of cultivated plants are sown, or where seed will be placed into the soil. It includes soil, seeds, and seedlings, as well as established vegetation.
  • plant propagation material is understood to denote generative parts of the plant, such as seeds, which can be used for the multiplication of the latter, and vegetative material, such as cuttings or tubers, for example potatoes.
  • vegetative material such as cuttings or tubers, for example potatoes.
  • seeds in the strict sense
  • roots fruits, tubers, bulbs, rhizomes and parts of plants.
  • Germinated plants and young plants which are to be transplanted after germination or after emergence from the soil, may also be mentioned. These young plants can be protected before transplantation by a total or partial treatment by immersion.
  • plant propagation material is understood to denote seeds.
  • the compounds of Formula (I) may be used in unmodified form or, preferably, together with the adjuvants conventionally employed in the art of formulation.
  • Suitable carriers and adjuvants can be solid or liquid and are substances useful in formulation technology, e.g. natural or regenerated mineral substances, solvents, dispersants, wetting agents, tackifiers, thickeners, binders or fertilizers.
  • Such carriers are for example described in WO 97/33890.
  • Wettable powders are in the form of finely divided particles which disperse readily in water or other liquid carriers.
  • the particles contain the active ingredient retained in a solid matrix.
  • Typical solid matrices include fuller's earth, kaolin clays, silicas and other readily wet organic or inorganic solids. Wettable powders normally contain from 5% to 95% of the active ingredient plus a small amount of wetting, dispersing or emulsifying agent.
  • Emulsifiable concentrates are homogeneous liquid compositions dispersible in water or other liquid and may consist entirely of the active compound with a liquid or solid emulsifying agent, or may also contain a liquid carrier, such as xylene, heavy aromatic naphthas, isophorone and other nonvolatile organic solvents. In use, these concentrates are dispersed in water or other liquid and normally applied as a spray to the area to be treated. The amount of active ingredient may range from 0.5% to 95% of the concentrate.
  • Granular formulations include both extrudates and relatively coarse particles and are usually applied without dilution to the area in which treatment is required.
  • Typical carriers for granular Formulations include sand, fuller's earth, attapulgite clay, bentonite clays, montmorillonite clay, vermiculite, perlite, calcium carbonate, brick, pumice, pyrophyllite, kaolin, dolomite, plaster, wood flour, ground corn cobs, ground peanut hulls, sugars, sodium chloride, sodium sulphate, sodium silicate, sodium borate, magnesia, mica, iron oxide, zinc oxide, titanium oxide, antimony oxide, cryolite, gypsum, diatomaceous earth, calcium sulphate and other organic or inorganic materials which absorb or which can be coated with the active compound.
  • Granular Formulations normally contain 5% to 25% of active ingredients which may include surface-active agents such as heavy aromatic naphthas, kerosene and other petroleum fractions, or vegetable oils; and/or stickers such as dextrins, glue or synthetic resins. Dusts are free-flowing admixtures of the active ingredient with finely divided solids such as talc, clays, flours and other organic and inorganic solids which act as dispersants and carriers.
  • active ingredients may include surface-active agents such as heavy aromatic naphthas, kerosene and other petroleum fractions, or vegetable oils; and/or stickers such as dextrins, glue or synthetic resins.
  • Dusts are free-flowing admixtures of the active ingredient with finely divided solids such as talc, clays, flours and other organic and inorganic solids which act as dispersants and carriers.
  • Microcapsules are typically droplets or granules of the active ingredient enclosed in an inert porous shell which allows escape of the enclosed material to the surroundings at controlled rates.
  • Encapsulated droplets are typically 1 to 50 microns in diameter.
  • the enclosed liquid typically constitutes 50 to 95% of the weight of the capsule and may include solvent in addition to the active compound.
  • Encapsulated granules are generally porous granules with porous membranes sealing the granule pore openings, retaining the active species in liquid form inside the granule pores.
  • Granules typically range from 1 millimetre to 1 centimetre and preferably 1 to 2 millimetres in diameter. Granules are formed by extrusion, agglomeration or prilling, or are naturally occurring.
  • Shell or membrane materials include natural and synthetic rubbers, cellulosic materials, styrene-butadiene copolymers, polyacrylonitriles, polyacrylates, polyesters, polyamides, polyureas, polyurethanes and starch xanthates.
  • compositions for agrochemical applications include simple solutions of the active ingredient in a solvent in which it is completely soluble at the desired concentration, such as acetone, alkylated naphthalenes, xylene and other organic solvents.
  • Pressurised sprayers wherein the active ingredient is dispersed in finely-divided form as a result of vaporisation of a low boiling dispersant solvent carrier, may also be used.
  • Suitable agricultural adjuvants and carriers that are useful in formulating the compositions of the invention in the formulation types described above are well known to those skilled in the art.
  • Liquid carriers that can be employed include, for example, water, toluene, xylene, petroleum naphtha, crop oil, acetone, methyl ethyl ketone, cyclohexanone, acetic anhydride, acetonitrile, acetophenone, amyl acetate, 2-butanone, chlorobenzene, cyclohexane, cyclohexanol, alkyl acetates, diacetonalcohol, 1 ,2-dichloropropane, diethanolamine, p-diethylbenzene, diethylene glycol, diethylene glycol abietate, diethylene glycol butyl ether, diethylene glycol ethyl ether, diethylene glycol methyl ether, ⁇ , ⁇ -dimethyl formamide, dimethyl sulfoxide, 1 ,4-dioxane, dipropylene glycol, dipropylene glycol methyl ether, dipropylene glyco
  • Suitable solid carriers include, for example, talc, titanium dioxide, pyrophyllite clay, silica, attapulgite clay, kieselguhr, chalk, diatomaxeous earth, lime, calcium carbonate, bentonite clay, fuller's earth, cotton seed hulls, wheat flour, soybean flour, pumice, wood flour, walnut shell flour and lignin.
  • a broad range of surface-active agents are advantageously employed in both said liquid and solid compositions, especially those designed to be diluted with carrier before application.
  • These agents when used, normally comprise from 0.1 % to 15% by weight of the formulation. They can be anionic, cationic, non-ionic or polymeric in character and can be employed as emulsifying agents, wetting agents, suspending agents or for other purposes.
  • Typical surface active agents include salts of alkyl sulfates, such as diethanolammonium lauryl sulphate; alkylarylsulfonate salts, such as calcium dodecylbenzenesulfonate; alkylphenol-alkylene oxide addition products, such as nonylphenol-C.sub.
  • alcohol-alkylene oxide addition products such as tridecyl alcohol-C.sub. 16 ethoxylate
  • soaps such as sodium stearate
  • alkylnaphthalenesulfonate salts such as sodium dibutylnaphthalenesulfonate
  • dialkyl esters of sulfosuccinate salts such as sodium di(2-ethylhexyl) sulfosuccinate
  • sorbitol esters such as sorbitol oleate
  • quaternary amines such as lauryl trimethylammonium chloride
  • polyethylene glycol esters of fatty acids such as polyethylene glycol stearate
  • salts of mono and dialkyl phosphate esters such as mono and dialkyl phosphate esters.
  • adjuvants commonly utilized in agricultural compositions include crystallisation inhibitors, viscosity modifiers, suspending agents, spray droplet modifiers, pigments, antioxidants, foaming agents, anti-foaming agents, light-blocking agents, compatibilizing agents, antifoam agents, sequestering agents, neutralising agents and buffers, corrosion inhibitors, dyes, odorants, spreading agents, penetration aids, micronutrients, emollients, lubricants and sticking agents.
  • biocidally active ingredients or compositions may be combined with the compositions of the invention and used in the methods of the invention and applied simultaneously or sequentially with the compositions of the invention. When applied simultaneously, these further active ingredients may be formulated together with the compositions of the invention or mixed in, for example, the spray tank. These further biocidally active ingredients may be fungicides, herbicides, insecticides, bactericides, acaricides, nematicides and/or plant growth regulators.
  • Pesticidal agents are referred to herein using their common name are known, for example, from “The Pesticide Manual”, 15th Ed., British Crop Protection Council 2009.
  • compositions of the invention may also be applied with one or more systemically acquired resistance inducers ("SAR" inducer).
  • SAR inducers are known and described in, for example, United States Patent No. US 6,919,298 and include, for example, salicylates and the commercial SAR inducer acibenzolar-S-methyl.
  • the compounds of Formula (I) may be used in the form of (fungicidal) compositions for controlling or protecting against phytopathogenic microorganisms, comprising as active ingredient at least one compound of Formula (I) or of at least one preferred individual compound as defined herein, in free form or in agrochemically usable salt form, and at least one of the above-mentioned adjuvants.
  • the invention therefore provides a composition, preferably a fungicidal composition, comprising at least one compound Formula (I) an agriculturally acceptable carrier and optionally an adjuvant.
  • An agricultural acceptable carrier is for example a carrier that is suitable for agricultural use.
  • Agricultural carriers are well known in the art.
  • said composition may comprise at least one or more pesticidally-active compounds, for example an additional fungicidal active ingredient in addition to the compound of Formula (I).
  • the compound of Formula (I) may be the sole active ingredient of a composition or it may be admixed with one or more additional active ingredients such as a pesticide, fungicide, synergist, herbicide or plant growth regulator where appropriate.
  • An additional active ingredient may, in some cases, result in unexpected synergistic activities.
  • Suitable additional active ingredients include the following: acycloamino acid fungicides, aliphatic nitrogen fungicides, amide fungicides, anilide fungicides, antibiotic fungicides, aromatic fungicides, arsenical fungicides, aryl phenyl ketone fungicides, benzamide fungicides, benzanilide fungicides, benzimidazole fungicides, benzothiazole fungicides, botanical fungicides, bridged diphenyl fungicides, carbamate fungicides, carbanilate fungicides, conazole fungicides, copper fungicides, dicarboximide fungicides, dinitrophenol fungicides, dithiocarbamate fungicides, dithiolane fungicides, furamide fungicides, furanilide fungicides, hydrazide fungicides, imidazole fungicides, mercury fungicides, morpholine fung
  • suitable additional active ingredients also include the following: 3-difluoromethyl- 1-methyl-1 H-pyrazole-4-carboxylic acid (9-dichloromethylene-1 ,2,3,4-tetrahydro-1 ,4-methano- naphthalen-5-yl)-amide , 3-difluoromethyl-1-methyl-1 H-pyrazole-4-carboxylic acid methoxy-[1-methyl- 2-(2,4,6-trichlorophenyl)-ethyl]-amide , 1-methyl-3-difluoromethyl-1 H-pyrazole-4-carboxylic acid (2- dichloromethylene-3-ethyl-1-methyl-indan-4-yl)-amide (1072957-71-1 ), 1-methyl-3-difluoromethyl-1 H- pyrazole-4-carboxylic acid (4'-methylsulfanyl-biphenyl-2-yl)-amide, 1-methyl-3-difluoromethyl-4H- pyrazole
  • the compounds of the invention may also be used in combination with anthelmintic agents.
  • anthelmintic agents include, compounds selected from the macrocyclic lactone class of compounds such as ivermectin, avermectin, abamectin, emamectin, eprinomectin, doramectin, selamectin, moxidectin, nemadectin and milbemycin derivatives as described in EP- 357460, EP- 444964 and EP-594291.
  • Additional anthelmintic agents include semisynthetic and biosynthetic avermectin/milbemycin derivatives such as those described in US-5015630, WO-9415944 and WO- 9522552. Additional anthelmintic agents include the benzimidazoles such as albendazole, cambendazole, fenbendazole, flubendazole, mebendazole, oxfendazole, oxibendazole, parbendazole, and other members of the class. Additional anthelmintic agents include imidazothiazoles and tetrahydropyrimidines such as tetramisole, levamisole, pyrantel pamoate, oxantel or morantel.
  • Additional anthelmintic agents include flukicides, such as triclabendazole and clorsulon and the cestocides, such as praziquantel and epsiprantel.
  • flukicides such as triclabendazole and clorsulon
  • cestocides such as praziquantel and epsiprantel.
  • the compounds of the invention may be used in combination with derivatives and analogues of the paraherquamide/marcfortine class of anthelmintic agents, as well as the antiparasitic oxazolines such as those disclosed in US-5478855, US- 4639771 and DE-19520936.
  • the compounds of the invention may be used in combination with derivatives and analogues of the general class of dioxomorpholine antiparasitic agents as described in WO 96/15121 and also with anthelmintic active cyclic depsipeptides such as those described in WO 96/1 1945, WO 93/19053, WO 93/25543, EP 0 626 375, EP 0 382 173, WO 94/19334, EP 0 382 173, and EP 0 503 538.
  • the compounds of the invention may be used in combination with other ectoparasiticides; for example, fipronil; pyrethroids; organophosphates; insect growth regulators such as lufenuron; ecdysone agonists such as tebufenozide and the like; neonicotinoids such as imidacloprid and the like.
  • ectoparasiticides for example, fipronil; pyrethroids; organophosphates; insect growth regulators such as lufenuron; ecdysone agonists such as tebufenozide and the like; neonicotinoids such as imidacloprid and the like.
  • the compounds of the invention may be used in combination with terpene alkaloids, for example those described in International Patent Application Publication Numbers WO 95/19363 or WO 04/72086, particularly the compounds disclosed therein.
  • Organophosphates acephate, azamethiphos, azinphos-ethyl, azinphos- methyl, bromophos, bromophos-ethyl, cadusafos, chlorethoxyphos, chlorpyrifos, chlorfenvinphos, chlormephos, demeton, demeton-S-methyl, demeton-S-methyl sulphone, dialifos, diazinon, dichlorvos, dicrotophos, dimethoate, disulfoton, ethion, ethoprophos, etrimfos, famphur, fenamiphos, fenitrothion, fensulfothion, fenthion, flupyrazofos, fonofos, formothion, fosthiazate, heptenophos, isazophos, isothioate, isoxathion, malathion, me
  • Carbamates alanycarb, aldicarb, 2-sec-butylphenyl methylcarbamate, benfuracarb, carbaryl, carbofuran, carbosulfan, cloethocarb, ethiofencarb, fenoxycarb, fenthiocarb, furathiocarb, HCN-801 , isoprocarb, indoxacarb, methiocarb, methomyl, 5-methyl-m-cumenylbutyryl(methyl)carbamate, oxamyl, pirimicarb, propoxur, thiodicarb, thiofanox, triazamate, UC-51717.
  • Pyrethroids acrinathin, allethrin, alphametrin, 5-benzyl-3-furylmethyl (E)-(1 R)-cis-2,2- dimethyl-3-(2-oxothiolan-3-ylidenemethyl)cyclopropanecarboxylate, bifenthrin, beta-cyfluthrin, cyfluthrin, a-cypermethrin, beta-cypermethrin, bioallethrin, bioallethrin((S)-cyclopentylisomer), bioresmethrin, bifenthrin, NCI-85193, cycloprothrin, cyhalothrin, cythithrin, cyphenothrin, deltamethrin, empenthrin, esfenvalerate, ethofenprox, fenfluthrin, fenpropathrin, fenvalerate,
  • Arthropod growth regulators a) chitin synthesis inhibitors: benzoylureas: chlorfluazuron, diflubenzuron, fluazuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, teflubenzuron, triflumuron, buprofezin, diofenolan, hexythiazox, etoxazole, chlorfentazine; b) ecdysone antagonists: halofenozide, methoxyfenozide, tebufenozide; c) juvenoids: pyriproxyfen, methoprene (including S-methoprene), fenoxycarb; d) lipid biosynthesis inhibitors: spirodiclofen.
  • antiparasitics acequinocyl, amitraz, AKD-1022, ANS-1 18, azadirachtin, Bacillus thuringiensis, bensultap, bifenazate, binapacryl, bromopropylate, BTG-504, BTG-505, camphechlor, cartap, chlorobenzilate, chlordimeform, chlorfenapyr, chromafenozide, clothianidine, cyromazine, diacloden, diafenthiuron, DBI-3204, dinactin, dihydroxymethyldihydroxypyrrolidine, dinobuton, dinocap, endosulfan, ethiprole, ethofenprox, fenazaquin, flumite, MTI- 800, fenpyroximate, fluacrypyrim, flubenzimine, flubrocythrinate, flufenzine, flufenprox, fluproxyfen, halofenprox, hydra
  • Biological agents Bacillus thuringiensis ssp aizawai, kurstaki, Bacillus thuringiensis delta endotoxin, baculovirus, entomopathogenic bacteria, virus and fungi.
  • Bactericides chlortetracycline, oxytetracycline, streptomycin.
  • TX means one compound selected from the group consisting of the compounds as represented in Tables 1.1 to 1.3 and Tables 2.1 and 2.2 (below), or the compounds 1.1 to 1.190 described in Table T1 , (below):
  • an acaricide selected from the group of substances consisting of 1 , 1-bis(4-chlorophenyl)-2- ethoxyethanol (lUPAC name) (910) + TX, 2,4-dichlorophenyl benzenesulfonate (lUPAC/Chemical Abstracts name) (1059) + TX, 2-fluoro-A/-methyl-A/-1-naphthylacetamide (lUPAC name) (1295) + TX, 4-chlorophenyl phenyl sulfone (lUPAC name) (981 ) + TX, abamectin (1 ) + TX, acequinocyl (3) + TX, acetoprole [CCN] + TX, acrinathrin (9) + TX, aldicarb (16) + TX, aldoxycarb (863) + TX, alpha- cypermethrin (202) + TX, amidithion (870) + TX, amid
  • an algicide selected from the group of substances consisting of bethoxazin [CCN] + TX, copper dioctanoate (lUPAC name) (170) + TX, copper sulfate (172) + TX, cybutryne [CCN] + TX, dichlone (1052) + TX, dichlorophen (232) + TX, endothal (295) + TX, fentin (347) + TX, hydrated lime [CCN] + TX, nabam (566) + TX, quinoclamine (714) + TX, quinonamid (1379) + TX, simazine (730) + TX, triphenyltin acetate (lUPAC name) (347) and triphenyltin hydroxide (lUPAC name) (347) + TX,
  • an anthelmintic selected from the group of substances consisting of abamectin (1 ) + TX, crufomate (101 1 ) + TX, doramectin (alternative name) [CCN] + TX, emamectin (291 ) + TX, emamectin benzoate (291 ) + TX, eprinomectin (alternative name) [CCN] + TX, ivermectin (alternative name) [CCN] + TX, milbemycin oxime (alternative name) [CCN] + TX, moxidectin (alternative name) [CCN] + TX, piperazine [CCN] + TX, selamectin (alternative name) [CCN] + TX, spinosad (737) and thiophanate (1435) + TX,
  • a soil sterilant selected from the group of substances consisting of iodomethane (lUPAC name) (542) and methyl bromide (537) + TX,
  • a chemosterilant selected from the group of substances consisting of apholate [CCN] + TX, bisazir (alternative name) [CCN] + TX, busulfan (alternative name) [CCN] + TX, diflubenzuron (250) + TX, dimatif (alternative name) [CCN] + TX, hemel [CCN] + TX, hempa [CCN] + TX, metepa [CCN] + TX, methiotepa [CCN] + TX, methyl apholate [CCN] + TX, morzid [CCN] + TX, penfluron (alternative name) [CCN] + TX, tepa [CCN] + TX, thiohempa (alternative name) [CCN] + TX, thiotepa (alternative name) [CCN] + TX, tretamine (alternative name) [CCN] and
  • a molluscicide selected from the group of substances consisting of bis(tributyltin) oxide (lUPAC name) (913) + TX, bromoacetamide [CCN] + TX, calcium arsenate [CCN] + TX, cloethocarb (999) + TX, copper acetoarsenite [CCN] + TX, copper sulfate (172) + TX, fentin (347) + TX, ferric phosphate (lUPAC name) (352) + TX, metaldehyde (518) + TX, methiocarb (530) + TX, niclosamide (576) + TX, niclosamide-olamine (576) + TX, pentachlorophenol (623) + TX, sodium pentachlorophenoxide (623) + TX, tazimcarb (1412) + TX, thiodicarb (799) + TX, tributyltin oxide (913)
  • a nematicide selected from the group of substances consisting of AKD-3088 (compound code) + TX, 1 ,2-dibromo-3-chloropropane (lUPAC/Chemical Abstracts name) (1045) + TX, 1 ,2- dichloropropane (lUPAC/ Chemical Abstracts name) (1062) + TX, 1 ,2-dichloropropane with 1 ,3- dichloropropene (lUPAC name) (1063) + TX, 1 ,3-dichloropropene (233) + TX, 3,4- dichlorotetrahydrothiophene 1 , 1-dioxide (lUPAC/Chemical Abstracts name) (1065) + TX, 3-(4- chlorophenyl)-5-methylrhodanine (lUPAC name) (980) + TX, 5-methyl-6-thioxo-1 ,3,5-thiadiazinan-3- ylacetic acid (lUPAC name) (1286)
  • a nitrification inhibitor selected from the group of substances consisting of potassium ethylxanthate [CCN] and nitrapyrin (580) + TX,
  • a plant activator selected from the group of substances consisting of acibenzolar (6) + TX, acibenzolar-S-methyl (6) + TX, probenazole (658) and Reynoutria sachalinensis extract (alternative name) (720) + TX,
  • a rodenticide selected from the group of substances consisting of 2-isovalerylindan-1 ,3-dione
  • a virucide selected from the group of substances consisting of imanin (alternative name) [CCN] and ribavirin (alternative name) [CCN] + TX,
  • a wound protectant selected from the group of substances consisting of mercuric oxide (512) + TX, octhilinone (590) and thiophanate-methyl (802) + TX,
  • the mixtures as described above can be used in a method for controlling pests, which comprises applying a composition comprising a mixture as described above to the pests or their environment, with the exception of a method for treatment of the human or animal body by surgery or therapy and diagnostic methods practised on the human or animal body.
  • compositions according to the invention can also comprise further solid or liquid auxiliaries, such as stabilizers, for example unepoxidized or epoxidized vegetable oils (for example epoxidized coconut oil, rapeseed oil or soya oil), antifoams, for example silicone oil, preservatives, viscosity regulators, binders and/or tackifiers, fertilizers or other active ingredients for achieving specific effects, for example bactericides, fungicides, nematocides, plant activators, molluscicides or herbicides.
  • auxiliaries such as stabilizers, for example unepoxidized or epoxidized vegetable oils (for example epoxidized coconut oil, rapeseed oil or soya oil), antifoams, for example silicone oil, preservatives, viscosity regulators, binders and/or tackifiers, fertilizers or other active ingredients for achieving specific effects, for example bactericides, fungicides, nematocides
  • compositions according to the invention are prepared in a manner known per se, in the absence of auxiliaries for example by grinding, screening and/or compressing a solid active ingredient and in the presence of at least one auxiliary for example by intimately mixing and/or grinding the active ingredient with the auxiliary (auxiliaries).
  • auxiliaries for example by grinding, screening and/or compressing a solid active ingredient and in the presence of at least one auxiliary for example by intimately mixing and/or grinding the active ingredient with the auxiliary (auxiliaries).
  • Another aspect of the invention is related to the use of a compound of Formula (I) or of a preferred individual compound as defined herein, of a composition comprising at least one compound of Formula (I) or at least one preferred individual compound as above-defined, or of a fungicidal or insecticidal mixture comprising at least one compound of Formula (I) or at least one preferred individual compound as above-defined, in admixture with other fungicides or insecticides as described above, for controlling or preventing infestation of plants, e.g. useful plants such as crop plants, propagation material thereof, e.g. seeds, harvested crops, e.g. harvested food crops, or non-living materials by insects or by phytopathogenic microorganisms, preferably fungal organisms.
  • useful plants such as crop plants, propagation material thereof, e.g. seeds, harvested crops, e.g. harvested food crops, or non-living materials by insects or by phytopathogenic microorganisms, preferably fungal organisms.
  • a further aspect of the invention is related to a method of controlling or preventing an infestation of plants, e.g., useful plants such as crop plants, propagation material thereof, e.g. seeds, harvested crops, e.g., harvested food crops, or of non-living materials by insects or by phytopathogenic or spoilage microorganisms or organisms potentially harmful to man, especially fungal organisms, which comprises the application of a compound of Formula (I) or of a preferred individual compound as above-defined as active ingredient to the plants, to parts of the plants or to the locus thereof, to the propagation material thereof, or to any part of the non-living materials.
  • useful plants such as crop plants, propagation material thereof, e.g. seeds, harvested crops, e.g., harvested food crops, or of non-living materials by insects or by phytopathogenic or spoilage microorganisms or organisms potentially harmful to man, especially fungal organisms
  • a compound of Formula (I) or of a preferred individual compound as above-defined as active ingredient to the plants, to parts
  • a preferred method of controlling or preventing an infestation of crop plants by phytopathogenic microorganisms, especially fungal organisms, or insects which comprises the application of a compound of Formula (I), or an agrochemical composition which contains at least one of said compounds, is foliar application.
  • the frequency of application and the rate of application will depend on the risk of infestation by the corresponding pathogen or insect.
  • the compounds of Formula (I) can also penetrate the plant through the roots via the soil (systemic action) by drenching the locus of the plant with a liquid Formulation, or by applying the compounds in solid form to the soil, e.g. in granular form (soil application). In crops of water rice such granulates can be applied to the flooded rice field.
  • the compounds of Formula (I) may also be applied to seeds (coating) by impregnating the seeds or tubers either with a liquid formulation of the fungicide or coating them with a solid formulation.
  • rates of 0.001 to 50 g of a compound of Formula (I) per kg of seed preferably from 0.01 to 10g per kg of seed are generally sufficient.
  • composition comprising a compound of Formula (I) according to the present invention is applied either preventative, meaning prior to disease development or curative, meaning after disease development.
  • a seed dressing formulation is applied in a manner known per se to the seeds employing the combination of the invention and a diluent in suitable seed dressing formulation form, e.g. as an aqueous suspension or in a dry powder form having good adherence to the seeds.
  • suitable seed dressing formulation form e.g. as an aqueous suspension or in a dry powder form having good adherence to the seeds.
  • seed dressing formulations are known in the art.
  • Seed dressing formulations may contain the single active ingredients or the combination of active ingredients in encapsulated form, e.g. as slow release capsules or microcapsules.
  • the formulations include from 0.01 to 90% by weight of active agent, from 0 to 20% agriculturally acceptable surfactant and 10 to 99.99% solid or liquid formulation inerts and adjuvant(s), the active agent consisting of at least the compound of Formula (I) optionally together with other active agents, particularly microbiocides or conservatives or the like.
  • Concentrated forms of compositions generally contain in between about 2 and 80%, preferably between about 5 and 70% by weight of active agent.
  • Application forms of formulation may for example contain from 0.01 to 20% by weight, preferably from 0.01 to 5% by weight of active agent. Whereas commercial products will preferably be formulated as concentrates, the end user will normally employ diluted formulations.
  • Table 1.1 This table discloses 65 specific compounds of the formula (T-1 ):
  • A is 2,5-thienyl and R and R 2 , are hydrogen, and Z is as defined below in the Table 1.
  • Tables 1.2 to 1.3 make available 65 individual compounds of the formula (T-1 ) in which A, R , and R 2 are as specifically defined in Tables 1.2 to 1 .3, which refer to Table 1 wherein Z is specifically defined.
  • Table 1.2 This table discloses 65 specific compounds of formula (T-1 ) wherein A is 3,5-thienyl and R and R 2 are hydrogen, Z is as defined above in Table 1.
  • Table 1.3 This table discloses 65 specific compounds of formula (T-1 ) wherein A is 2,5-thienyl and R is hydrogen, R 2 is methyl, and Z is as defined above in Table 1.
  • R is hydrogen and Z is as defined below in Table 2.
  • Table 2.2 (which follows Table 2.1 ) makes available 372 individual compounds of the formula (T- 2) in which R is as specifically defined in Table 2.2, which refers to Table 2 wherein Z is specifically defined.
  • 3H-imidazole-4-carboxylic acid 2.31 1 1 H-tetrazole-5-carboxylic acid methyl 3H-imidazole-4-carboxylate 2.312 methyl 1 H-tetrazole-5-carboxylate ethyl 3H-imidazole-4-carboxylate 2.313 ethyl 1 H-tetrazole-5-carboxylate propyl 3H-imidazole-4-carboxylate 2.314 propyl 1 H-tetrazole-5-carboxylate prop-2-enyl 3H-imidazole-4- prop-2-enyl 1 H-tetrazole-5-
  • Table 2.2 This table discloses 372 specific compounds of formula (T-2) wherein R is methyl and Z is as defined above in Table 2.
  • Z as defined in Tables 1 and 2 above (with the exceptions of compound no.s 1.034, 1.036 to 1.039, 1.041 to 1.043, 1.046 to 1 .048, 1.050, 1.051 , 1.053 to 1.065 identified as radicals), Z groups are disclosed as a compound where the available ring nitrogen (as designated by an N-H group) is the binding point to the rest of the molecule in accordance with a Z radical for the compounds of Formula (I) of the present invention.
  • the compounds of the invention can be distinguished from known compounds by virtue of greater efficacy at low application rates, which can be verified by the person skilled in the art using the experimental procedures outlined in the Examples, using lower application rates if necessary, for example 50 ppm, 12.5 ppm, 6 ppm, 3 ppm, 1.5 ppm, 0.8 ppm or 0.2 ppm.
  • Compounds of Formula (I) may possess any number of benefits including, inter alia, advantageous levels of biological activity for protecting plants against diseases that are caused by fungi or superior properties for use as agrochemical active ingredients (for example, greater biological activity, an advantageous spectrum of activity, an increased safety profile (including improved crop tolerance), improved physico-chemical properties, or increased biodegradability).
  • Type of column Waters ACQUITY UPLC HSS T3; Column length: 30 mm; Internal diameter of column: 2.1 mm; Particle Size: 1.8 micron; Temperature: 60°C.
  • Type of column Waters ACQUITY UPLC HSS T3; Column length: 30 mm; Internal diameter of column: 2.1 mm; Particle Size: 1 .8 micron; Temperature: 60°C.
  • enantiomerically pure final compounds may be obtained from racemic materials as appropriate via standard physical separation techniques, such as reverse phase chiral chromatography, or through stereoselective synthetic techniques, e.g., by using chiral starting materials.
  • Active ingredient [compound of Formula (I)] 25 % 50 % 75 %
  • the active ingredient is thoroughly mixed with the adjuvants and the mixture is thoroughly ground in a suitable mill, affording wettable powders that can be diluted with water to give suspensions of the desired concentration.
  • Active ingredient [compound of Formula (I)] 25 % 50 % 75 %
  • the active ingredient is thoroughly mixed with the adjuvants and the mixture is thoroughly ground in a suitable mill, affording powders that can be used directly for seed treatment.
  • Emulsions of any required dilution which can be used in plant protection, can be obtained from this concentrate by dilution with water.
  • Active ingredient [compound of Formula (I)] 5 % 6 % 4 %
  • Ready-for-use dusts are obtained by mixing the active ingredient with the carrier and grinding the mixture in a suitable mill. Such powders can also be used for dry dressings for seed.
  • the active ingredient is mixed and ground with the adjuvants, and the mixture is moistened with water.
  • the mixture is extruded and then dried in a stream of air.
  • polyethylene glycol (mol. wt. 200) 3 %
  • the finely ground active ingredient is uniformly applied, in a mixer, to the kaolin moistened with polyethylene glycol. Non-dusty coated granules are obtained in this manner.
  • Active ingredient [compound of Formula (I)] 40 %
  • Silicone oil (in the form of a 75 % emulsion in water) 1 %
  • the finely ground active ingredient is intimately mixed with the adjuvants, giving a suspension concentrate from which suspensions of any desired dilution can be obtained by dilution with water. Using such dilutions, living plants as well as plant propagation material can be treated and protected against infestation by microorganisms, by spraying, pouring or immersion.
  • Silicone oil (in the form of a 75 % emulsion in water) 0.2 %
  • the finely ground active ingredient is intimately mixed with the adjuvants, giving a suspension concentrate from which suspensions of any desired dilution can be obtained by dilution with water.
  • a suspension concentrate from which suspensions of any desired dilution can be obtained by dilution with water.
  • living plants as well as plant propagation material can be treated and protected against infestation by microorganisms, by spraying, pouring or immersion.
  • 28 parts of a combination of the compound of Formula I are mixed with 2 parts of an aromatic solvent and 7 parts of toluene diisocyanate/polymethylene-polyphenylisocyanate-mixture (8: 1 ).
  • This mixture is emulsified in a mixture of 1.2 parts of polyvinylalcohol, 0.05 parts of a defoamer and 51.6 parts of water until the desired particle size is achieved.
  • a mixture of 2.8 parts 1 ,6- diaminohexane in 5.3 parts of water is added. The mixture is agitated until the polymerization reaction is completed.
  • the obtained capsule suspension is stabilized by adding 0.25 parts of a thickener and 3 parts of a dispersing agent.
  • the capsule suspension Formulation contains 28% of the active ingredients.
  • the medium capsule diameter is 8-15 microns.
  • the resulting formulation is applied to seeds as an aqueous suspension in an apparatus suitable for that purpose.
  • AIBN azobisisobutyronitrile
  • DIPEA N,N-di-isopropylethylamine
  • EtOAc ethyl acetate

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Plant Pathology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Agronomy & Crop Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Compounds of the formula (I) wherein the substituents are as defined in claim 1, useful as pesticides, especially as fungicides.

Description

Microbiocidal Oxadiazole Derivatives
The present invention relates to microbiocidal oxadiazole derivatives, e.g., as active ingredients, which have microbiocidal activity, in particular, fungicidal activity. The invention also relates to agrochemical compositions which comprise at least one of the oxadiazole derivatives, to processes of preparation of these compounds and to uses of the oxadiazole derivatives or compositions in agriculture or horticulture for controlling or preventing infestation of plants, harvested food crops, seeds or non-living materials by phytopathogenic microorganisms, preferably fungi.
WO 2015/185485 describes the use of substituted oxadiazoles for combating phytopathogenic fungi.
According to the present invention, there is provided a compound of Formula (I):
Figure imgf000002_0001
wherein
A is selected from A-1 , A-2 or A-3;
Figure imgf000002_0002
(A-1 ) (A-2) (A-3) R and R2 independently represent hydrogen, methyl, ethyl, fluoro, cyano, difluoromethyl or trifluoromethyl; and
Z is selected from Z Z2 or Z3; wherein Z represents a 4- to 6-membered non-aromatic heterocyclyl ring containing 1 ring nitrogen, wherein the heterocyclyl optionally comprises 1 or 2 additional ring members independently selected from N, O, S, C(O) and S(0)2 with the proviso that the heterocyclyl ring cannot contain 2 contiguous atoms selected from O and S, or the heterocyclyl optionally comprises 1 additional ring member NR3, wherein the heterocyclyl is optionally substituted by 1 or 2 substituents, which may be the same or different, selected from R4, and wherein further the heterocyclyl is bound to the rest of the molecule through a ring nitrogen;
R3 represents hydrogen, hydroxy, amino, formyl, d salkyl, d salkoxy, d salkylcarbonyl, Ci- 3alkoxycarbonyl, N-Ci salkylaminocarbonyl, N,N-diCi-3alkylaminocarbonyl, N-Ci-3alkoxyaminocarbonyl, N-Ci-3alkyl-N-Ci-3alkoxy-aminocarbonyl, Ci-2alkylsulfonyl, N-Ci-2alkylaminosulfonyl, N,N-diCi- 2alkylaminosulfonyl, Ci-2alkyldicarbonyl, Ci-2alkoxydicarbonyl, N-Ci-2alkylaminodicarbonyl or N,N-diCi- 2alkylaminodicarbonyl; R4 represents cyano, halogen, hydroxy, amino, methyl, ethyl, difluoromethyl, trifluoromethyl, methoxy, N-methylamino or N,N-dimethylamino;
Z2 represents a 5- or 6-membered heteroaryl ring containing 1 ring nitrogen, wherein the heteroaryl optionally comprises 1 , 2 or 3 additional ring members independently selected from O, S, or N, and wherein the heteroaryl is optionally substituted by: 1 or 2 substituents selected from R5, 1 substituent selected from R6, or 1 substituent selected from R5 and 1 substituent selected from R6, and wherein further the heteroaryl is bound to the rest of the molecule through a ring nitrogen;
R5 represents hydroxyl, amino, cyano, halogen, formyl, nitro, Ci-4alkyl, Ci-4alkoxy, C3-4alkenyl, C3-4alkynyl, C3-4alkenyloxy, C3-4alkynyloxy, cyanoCi-2alkyl, Ci-2haloalkyl, hydroxyCi-2alkyl, Ci-2alkoxyCi- 2alkyl, Ci-2alkoxyCi-2alkoxyCi-2alkyl, Ν,Ν-dimethylamino, Ci-3alkoxycarbonylCi-2alkyl, Ci- 3alkylcarbonyloxyCi-2alkyl, N-Ci-3alkylaminocarbonylCi-2alkyl, N,N-diCi-3alkylaminocarbonylCi-2alkyl, Ci-2alkylsulfonyl, d salkylcarbonyl, Ci salkyldicarbonyl, Ci salkoxydicarbonyl, N-Ci- 3alkylaminodicarbonyl, or N,N-diCi-3alkylaminodicarbonyl; or
R5 represents -C(0)N(Ra)(Rb) wherein:
Ra represents hydrogen, Ci-ealkyl, C3-4alkenyl, C3-4alkynyl, Ci shaloalkyl, C3-4haloalkenyl, Ci- 4alkoxy, Ci-2alkoxyCi-3alkyl, C2-3haloalkoxy, C3-4alkenyloxy, C3-4alkynyloxy, N-Ci salkylamino, or N,N- diCi-2alkylamino; or
Ra represents C3-scycloalkyl, C3-5cycloalkylCi-2alkyl, phenyl, phenylCi-2alkyl, heterocyclyl, wherein the heterocyclyl moiety is a 4- to 6-membered non-aromatic ring which comprises 1 or 2 heteroatoms independently selected from N, O or S, with the proviso that the heterocyclyl cannot contain 2 contiguous atoms selected from O and S, heteroaryl or heteroarylCi-2alkyl, wherein the heteroaryl moiety is a 5- or 6-membered aromatic ring which comprises 1 , 2, 3, or 4 heteroatoms individually selected from N, O and S; wherein the cycloalkyi, phenyl, heterocyclyl or heteroaryl is optionally substituted by 1 or 2 substituents, which may be the same or different, selected from hydroxyl, amino, formyl, acyl, cyano, halogen, methyl, trifluoromethyl, methoxy, or Ν,Ν-dimethylamino, and wherein when Ra represents cycloalkyi or heterocyclyl, these cycles optionally contain 1 group selected from C(O) or S(0)2; and
Rb represents hydrogen, methyl, ethyl, propyl, prop-2-enyl, prop-2-ynyl, cyclopropyl, or cyclopropylmethyl; or Ra and Rb, together with the nitrogen atom they share, form an azetidinyl, pyrrolidinyl, isooxazolidinyl, morpholino, piperazin-4-yl, or piperidinyl ring optionally substituted by 1 or 2 groups selected from halogen, methyl, ethyl or methoxy; or R5 represents -C(0)0-Rc, wherein:
Rc represents hydrogen, Ci-ealkyl, C3-salkenyl, C3-salkynyl, Ci shaloalkyl, C3-4haloalkenyl, N,N- diCi-3alkylaminoCi-3alkyl, C3-6cycloalkyl, C3-4cycloalkylCi-2alkyl, phenyl, heterocyclyl, wherein the heterocyclyl moiety is a 4- to 6-membered non-aromatic ring which comprises 1 or 2 heteroatoms independently selected from O, S and N, with the proviso that the heterocyclyl cannot contain 2 contiguous atoms selected from O and S, heteroaryl, wherein the heteroaryl moiety is a 5- or 6- membered aromatic ring which comprises 1 , 2 or 3 heteroatoms individually selected from N, O and S; and wherein the cycloalkyi, phenyl, heterocyclyl or heteroaryl is optionally substituted by 1 or 2 substituents, which may be the same or different, selected from hydroxyl, amino, formyl, methylcarbonyl, cyano, halogen, methyl, trifluoromethyl, methoxy, or Ν,Ν-dimethylamino, and wherein when Rc represents cycloalkyi or heterocyclyl, these cycles optionally contain 1 group selected from C(O) or S(0)2; or
R5 represents -N(Rd)(Re) or -Ci-2alkyl-N(Rd)(Re), wherein
Rd represents d salkyl, C3-4alkenyl, C3-4alkynyl, methylcarbonyl, methoxycarbonyl, N- methylaminocarbonyl, Ν,Ν-dimethylaminocarbonyl, N-methoxyaminocarbonyl, N-methyl-N-methoxy- aminocarbonyl, methylsulfonyl, N-methylaminosulfonyl, Ν,Ν-dimethylaminosulfonyl, methyldicarbonyl, N-methylaminodicarbonyl, or Ν,Ν-dimethylaminodicarbonyl; and
Re represents hydrogen, methyl, ethyl, or propyl; or
Rd and Re, together with the nitrogen atom they share, form an azetidinyl, pyrrolidinyl, isooxazolidinyl, morpholino, piperazin-4-yl, or piperidinyl ring optionally substituted by 1 or 2 groups selected from halogen, methyl, ethyl or methoxy; or
R5 represents -CH=N(Rf), wherein Rf represents Ci-4alkyl, Ci-4alkoxy, C2-4alkenoxy, or C2- 4alkynoxy; R6 represents C3-6cycloalkyl, phenyl, heteroaryl, wherein the heteroaryl moiety is a 5- or 6- membered aromatic ring which comprises 1 , 2, 3 or 4 heteroatoms individually selected from N, O and S, heterocyclyl, wherein the heterocyclyl moiety is a 4- to 6-membered non-aromatic ring which comprises 1 or 2 heteroatoms individually selected from N, O and S, and wherein the cycloalkyi, phenyl, heteroaryl and heterocyclyl is optionally substituted by 1 or 2 substituents, which may be the same or different, selected from hydroxyl, amino, formyl, acyl, cyano, halogen, methyl, trifluoromethyl, methoxy, Ν,Ν-dimethylamino, and wherein when R6 represents cycloalkyl or heterocyclyl, these cycles optionally contain 1 group selected from C(O) or S(0)2; and
Z3 represents a heterobicyclyl which is a 7- to 9-membered saturated, partially saturated, or aromatic fused ring or saturated spirocyclic ring system containing 1 nitrogen, wherein the heterobicyclyl optionally comprises 1 or 2 additional ring members independently selected from N, O, S, C(O) and S(0)2 with the proviso that the heterobicyclyl cannot contain 2 contiguous atoms selected from O and S, wherein the heterobicyclyl is optionally substituted by 1 substituent selected from R7, and wherein further the heterobicyclyl is bound to the rest of the molecule through a ring nitrogen; and
R7 is cyano, fluoro, chloro, amino, hydroxy, methyl, difluoromethyl, trifluoromethyl, methoxy, N,N- dimethylamino, formyl, methylcarbonyl, methoxycarbonyl, N-methylaminocarbonyl, or N,N- dimethylaminocarbonyl; or a salt or N-oxide thereof.
Surprisingly, it has been found that the novel compounds of Formula (I) have, for practical purposes, a very advantageous level of biological activity for protecting plants against diseases that are caused by fungi.
According to a second aspect of the invention, there is provided an agrochemical composition comprising a fungicidally effective amount of a compound of Formula (I). Such an agricultural composition may further comprise at least one additional active ingredient and/or an agrochemically- acceptable diluent or carrier.
According to a third aspect of the invention, there is provided a method of controlling or preventing infestation of useful plants by phytopathogenic microorganisms, wherein a fungicidally effective amount of a compound of Formula (I), or a composition comprising this compound as active ingredient, is applied to the plants, to parts thereof or the locus thereof.
According to a fourth aspect of the invention, there is provided the use of a compound of Formula (I) as a fungicide. According to this particular aspect of the invention, the use may exclude methods for the treatment of the human or animal body by surgery or therapy.
As used herein, the term "halogen" or "halo" refers to fluorine (fluoro), chlorine (chloro), bromine (bromo) or iodine (iodo), preferably fluorine, chlorine or bromine.
As used herein, cyano means a -CN group.
As used herein, the term "hydroxyl" or "hydroxy" means an -OH group. As used herein, amino means an -NH2 group.
As used herein, acyl means a -C(0)CH3 group.
As used herein, formyl means a -C(0)H group.
As used herein, the term "Ci ealkyl" refers to a straight or branched hydrocarbon chain radical consisting solely of carbon and hydrogen atoms, containing no unsaturation, having from one to six carbon atoms, and which is attached to the rest of the molecule by a single bond. Ci-4alkyl, d salkyl and Ci-2alkyl are to be construed accordingly. Examples of d ealkyl include, but are not limited to, methyl, ethyl, n-propyl, 1-methylethyl (isopropyl), n-butyl, and 1-dimethylethyl (i-butyl). A "Ci- C2alkylene" group refers to the corresponding definition of Ci-2alkyl, except that such radical is attached to the rest of the molecule by two single bonds. Examples of Ci-2alkylene, are -CH2- and -CH2CH2-.
As used herein, the term "Ci-4alkoxy" refers to a radical of the formula -ORx where Rx is a Ci- 4alkyl radical as generally defined above. The terms d salkoxy and Ci-2alkoxy are to be construed accordingly. Examples of Ci-4alkoxy include, but are not limited to, methoxy, ethoxy, propoxy, isopropoxy, and i-butoxy.
As used herein, the term "Ci shaloalkyl" refers to a d salkyl radical as generally defined above substituted by one or more of the same or different halogen atoms. Examples of d shaloalkyl include, but are not limited to fluoromethyl, fluoroethyl, difluoromethyl, trifluoromethyl, 2,2,2-trifluoroethyl, and 3,3,3-trifluoropropyl.
As used herein, the term "d-6alkenyl" refers to a straight or branched hydrocarbon chain radical group consisting solely of carbon and hydrogen atoms, containing at least one double bond that can be of either the (E)- or (Z)-configu ration, having from two to six carbon atoms, which is attached to the rest of the molecule by a single bond. d ealkenyl, d-salkenyl, d-4alkenyl and d salkenyl are to be construed accordingly. Examples of d ealkenyl include, but are not limited to, prop-1-enyl, allyl (prop- 2-enyl), and but-1-enyl.
As used herein, the term "d ehaloalkenyl" refers to a d ealkenyl radical as generally defined above substituted by one or more of the same or different halogen atoms. d-4haloalkenyl is to be construed accordingly.
As used herein, the term "d-4alkenoxy" refers to a radical of the formula -ORx where Rx is a C2-
4alkenyl radical as generally defined above.
As used herein, the term "d-6alkynyl" refers to a straight or branched hydrocarbon chain radical group consisting solely of carbon and hydrogen atoms, containing at least one triple bond, having from two to six carbon atoms, and which is attached to the rest of the molecule by a single bond. d-salkynyl and C2-4alkynyl are to be construed accordingly. Examples of d ealkynyl include, but are not limited to, prop-1-ynyl, propargyl (prop-2-ynyl).
As used herein, the term "d-4alkynoxy" refers to a radical of the formula -ORx where Rx is a C2-
4alkynyl radical as generally defined above.
As used herein, the term "d-4alkoxyd-4alkyl" refers to radical of the formula Ry-0-Rx- where Ry is a Ci-4alkyl radical as generally defined above, and Rx is a d-4alkylene radical as generally defined above. As used herein, the term "hydroxyCi-4alkyl" refers to a Cisalkyl radical as generally defined above substituted by one or more hydroxy groups. The term "hydroxyCi-2alkyl" should be construed accordingly.
As used herein, the term "cyanoCi-2alkyl" refers to refers to a Cisalkyl radical as generally defined above substituted by one or more cyano groups.
As used herein, the term "Ci-4alkylcarbonyl" refers to a radical of the formula -C(0)Rx where Rx is a Ci-4alkyl radical as generally defined above.
As used herein, the term "Ci-3alkyldicarbonyl" refers to a radical of the formula -[C(0)]2Rx where Rx is a Ci salkyl radical as generally defined above.
As used herein, the term "Ci-3alkylcarbonyloxyCi-2alkyl" refers to a radical of the formula
RyC(0)ORx- where Ry is a Ci salkyl radical as generally defined above, and Rx is a Ci-2alkylene radical as generally defined above.
As used herein, the term "Ci-2alkoxyCi-2alkoxyCi-2alkyl" refers to a radical of the formula RxORyORz-, where Ry and Rz are Ci-2alkylene radicals as generally defined above, and Rx is a Cisalkyl radical as generally defined above.
As used herein, the term "Ci-3alkoxyaminocarbonyl" refers to a radical of the formula RxONHC(O)-, where Rx is a Ci salkyl radical as generally defined above.
As used herein, the term "N-Ci-3alkyl-N-Ci-3alkoxy-aminocarbonyl" refers to a radical of the formula (Rx)(RxO)NHC(0)- where each Rx is a Ci salkyl radical as generally defined above.
As used herein, the term "Ci salkoxycarbonyl" refers to a radical of the formula RxOC(O)-, where
Rx is a Ci salkyl radical as generally defined above.
As used herein, the term "Ci-3alkoxycarbonylCi-2alkyl" refers to a radical of the formula RxOC(0)Ry-, where Rx is a Ci salkyl radical as generally defined above, and Ry is a Ci-2alkylene radical as generally defined above.
As used herein, the term "Ci-3alkoxydicarbonyl" refers to a radical of the formula RxO[C(0)]2-, where Rx is a Ci salkyl radical as generally defined above. The term Ci-2alkoxydicarbonyl should be construed accordingly.
As used herein, the term "Ci-2alkylsulfonyl" refers to a radical of the formula RXS(0)2-, where Rx is a Cisalkyl radical as generally defined above.
As used herein, the term "N-Ci salkylamino" refers to a radical of the formula RXNH- where Rx is a Ci salkyl radical as generally defined above.
As used herein, the term "N,N-diCi-2alkylamino" refers to a radical of the formula RX(RX)N- where Rx is a Cisalkyl radical as generally defined above.
As used herein, the term "N-Ci-2alkylaminosulfonyl" refers to a radical of the formula RXNH S(0)2- where Rx is a Cisalkyl radical as generally defined above.
As used herein, the term "N,N-diCi-2alkylaminosulfonyl" refers to a radical of the formula Rx(Rx)NS(0)2- where each Rx is independently a Cisalkyl radical as generally defined above.
As used herein, the term "Ci-3alkylaminocarbonyl" refers to a radical of the formula RxNHC(O)- where Rx is a Ci salkyl radical as generally defined above. As used herein, the term "N,N-diCi-3alkylaminocarbonyl" refers to a radical of the formula (Rx)RxNHC(O)- where each Rx is independently a d salkyl radical as generally defined above.
As used herein, the term "N-Ci-3alkylaminodicarbonyl" refers to a radical of the formula RxNH[C(0)]2- where Rx is a d salkyl radical as generally defined above.
As used herein, the term "N,N-diCi-3alkylaminodicarbonyl" refers to a radical of the formula
(Rx)RxNH[C(0)]2- where each Rx is independently a d salkyl radical as generally defined above. The term N,N-diCi-2alkylaminodicarbonyl should be construed accordingly.
As used herein, the term "N,N-diCi-3alkylaminocarbonylCi-2alkyl" refers to a radical of the formula (Rx)RxNHC(0)Ry- where each Rx is independently a d salkyl radical as generally defined above, and Ry is a d-2alkylene radical as generally defined above.
As used herein, the term "d-6cycloalkyl" refers to a stable, monocyclic ring radical which is saturated or partially unsaturated and contains 3 to 6 carbon atoms. d-scycloalkyl and Cscycloalkyl are to be construed accordingly. Examples of d ecycloalkyl include, but are not limited to cyclopropyl, cyclobutyl, cyclopentyl, cyclopenten-1-yl, cyclopenten-3-yl, and cyclohexen-3-yl.
As used herein, the term "d-6cycloalkyld-2alkyl" refers to a d ecycloalkyl ring as defined above attached to the rest of the molecule by a d-2alkylene radical as defined above. Examples of d- 6cycloalkylCi-3alkyl include, but are not limited to cyclopropyl-methyl and cyclobutyl-ethyl.
As used herein, the term "phenyld-2alkyl" refers to a phenyl ring attached to the rest of the molecule by a d-2alkylene radical as defined above. Examples of phenyld-2alkyl include, but are not limited to, benzyl.
As used herein, the term "heteroaryl" generally refers to a 5- or 6-membered monocyclic aromatic ring radical which comprises 1 , 2, 3 or 4 heteroatoms individually selected from nitrogen, oxygen and sulfur. The heteroaryl radical is bonded to the rest of the molecule via a carbon atom or heteroatom. Examples of heteroaryl include but are not limited to, furyl, pyrrolyl, thienyl, pyrazolyl, imidazolyl, thiazolyl, oxazolyl, isoxazolyl, triazolyl, tetrazolyl, pyrazinyl, pyridazinyl, pyrimidyl, pyridyl, and indolyl.
As used herein, the term "heteroaryld-2alkyl" refers to a heteroaryl as generally defined above, attached to the rest of the molecule by a d-2alkylene radical as defined above.
As used herein, the term "heterocyclyl" or "heterocyclic" generally refers to a stable, saturated or partially saturated, 4- to 6-membered, non-aromatic monocyclic ring, which comprises 1 , 2 or 3 heteroatoms individually selected from nitrogen, oxygen and sulfur. The heterocyclyl radical may be bonded to the rest of the molecule via a carbon atom or heteroatom. Examples of heterocyclyl include, but are not limited to, azetidinyl, oxetanyl, pyrrolidyl, tetrahydrofuryl, tetrahydrothienyl, tetrahydrothiopyranyl, piperidinyl, piperazinyl, tetrahydropyranyl, dioxolanyl, and morpholinyl.
As used herein, the term "heterobicyclyl" or "heterobicyclic" refers to a stable, 7- to 9-membered saturated, partially saturated or aromatic fused ring or saturated spirocyclic ring radical containing 1 nitrogen, which comprises 1 or 2 additional ring members individually selected from nitrogen, oxygen and sulfur. The heterobicyclyl radical is bonded to the rest of the molecule via a nitrogen atom. Examples of heterobicyclyl include, but are not limited to, pyrrolopyridine, benzimidazole. The presence of one or more possible asymmetric carbon atoms in a compound of Formula (I) means that the compounds may occur in chiral isomeric forms, i.e., enantiomeric or diastereomeric forms. Also, atropisomers may occur as a result of restricted rotation about a single bond. Formula (I) is intended to include all those possible isomeric forms and mixtures thereof. The present invention includes all those possible isomeric forms and mixtures thereof for a compound of Formula (I). Likewise, Formula (I) is intended to include all possible tautomers (including lactam-lactim tautomerism and keto- enol tautomerism) where present. The present invention includes all possible tautomeric forms for a compound of Formula (I).
In each case, the compounds of Formula (I) according to the invention are in free form, in oxidized form as an N-oxide, in covalently hydrated form, or in salt form, e.g., an agronomically usable or agrochemically acceptable salt form.
N-oxides are oxidized forms of tertiary amines or oxidized forms of nitrogen containing heteroaromatic compounds. They are described for instance in the book "Heterocyclic N-oxides" by A. Albini and S. Pietra, CRC Press, Boca Raton 1991.
The following list provides definitions, including preferred definitions, for substituents A (A-1 , A- 2, A-3), R\ R2, Z (including Z\ Z2, Z3), R3, R4, R5 (including Ra, Rb, Rc, Rd, Re, Rf), R6 and R7, with reference to the compounds of Formula (I) according to the invention. For any one of these substituents, any of the definitions given below may be combined with any definition of any other substituent given below or elsewhere in this document.
A is selected from A-1 , A-2, and A-3. A-1 represents a 2,5-thienyl group, A-2 represents a 2,4- thienyl group, and A-3 represents a 3,5-thienyl group. Preferably, A is A-1. R and R2 independently represent hydrogen, methyl, ethyl, fluoro, cyano, difluoromethyl or trifluoromethyl. Preferably, R and R2 independently represent hydrogen or methyl, more preferably R and R2 both represent hydrogen.
Z is selected from Z , Z2, and Z3.
Z represents a 4-, 5- or 6-membered non-aromatic heterocyclyl ring containing 1 ring nitrogen, wherein the heterocyclyl optionally comprises 1 or 2 additional ring members independently selected from N, O, S, C(O) and S(0)2 with the proviso that the heterocyclyl cannot contain 2 contiguous atoms selected from O and S, or the heterocyclyl optionally comprises 1 additional ring member NR3, wherein the heterocyclyl is optionally substituted by 1 or 2 substituents, which may be the same or different, selected from R4, and wherein further the heterocyclyl is bound to the rest of the molecule through a ring nitrogen.
Preferably, Z represents a 4-, 5- or 6-membered non-aromatic heterocyclyl containing 1 ring nitrogen, wherein the heterocyclyl optionally comprises 1 additional ring member independently selected from N, O, S, C(O) or S(0)2 (in particular, O or C(O)), wherein the heterocyclyl is optionally substituted by 1 or 2 substituents, which may be the same or different, selected from R4, and wherein further the heterocyclyl is bound to the rest of the molecule through a ring nitrogen.
More referably, Z is selected from:
Figure imgf000010_0001
wherein Z is optionally substituted by 1 or 2 substituents, which may be the same or different, selected from R4. In certain embodiments of the invention, Z is optionally substituted by 1 substituent selected from R4.
R3 represents hydrogen, hydroxy, amino, formyl, d salkyl, d salkoxy, d salkylcarbonyl, Ci- 3alkoxycarbonyl, N-Ci salkylaminocarbonyl, N,N-diCi-3alkylaminocarbonyl, N-Ci-3alkoxyaminocarbonyl, N-Ci-3alkyl-N-Ci-3alkoxy-aminocarbonyl, Ci-2alkylsulfonyl, N-Ci-2alkylaminosulfonyl, N,N-diCi- 2alkylaminosulfonyl, Ci-2alkyldicarbonyl, Ci-2alkoxydicarbonyl, N-Ci-2alkylaminodicarbonyl or N,N-diCi- 2alkylaminodicarbonyl.
R4 represents cyano, halogen, hydroxy, amino, methyl, ethyl, difluoromethyl, trifluoromethyl, methoxy, N-methylamino or Ν,Ν-dimethylamino. Preferably, R4 is selected from methyl or ethyl.
Z2 represents a 5- or 6-membered heteroaryl ring containing 1 ring nitrogen, wherein the heteroaryl optionally comprises 1 , 2 or 3 additional ring members independently selected from O, S, or N, and wherein the heteroaryl is optionally substituted by: 1 or 2 substituents selected from R5, 1 substituent selected from R6, or 1 substituent selected from R5 and 1 substituent selected from R6, and wherein further the heteroaryl is bound to the rest of the molecule through a ring nitrogen;
In certain preferred embodiments of the invention, Z2 is optionally substituted by 1 or 2 substituents selected from R5, and most preferably is optionally substituted by a single substituent selected from R5.
Preferably, Z2 is selected from:
Figure imgf000011_0001
wherein Z2 is optionally substituted by: 1 or 2 substituents selected from R5, 1 substituent selected from R6, or 1 substituent selected from R5 and 1 substituent selected from R6.
More referably, Z2 is selected from:
Figure imgf000011_0002
wherein Z2 is optionally substituted by: 1 or 2 substituents selected from R5, 1 substituent selected from R6, or 1 substituent selected from R5 and 1 substituent selected from R6. R5 represents hydroxyl, amino, cyano, halogen, formyl, nitro, Ci-4alkyl, Ci-4alkoxy, C3-4alkenyl,
C3-4alkynyl, C3-4alkenyloxy, C3-4alkynyloxy, cyanoCi-2alkyl, Ci-2haloalkyl, hydroxyCi-2alkyl, Ci-2alkoxyCi- 2alkyl, Ci-2alkoxyCi-2alkoxyCi-2alkyl, Ν,Ν-dimethylamino, Ci-3alkoxycarbonylCi-2alkyl, Ci- 3alkylcarbonyloxyCi-2alkyl, N-Ci-3alkylaminocarbonylCi-2alkyl, N,N-diCi-3alkylaminocarbonylCi-2alkyl, Ci-2alkylsulfonyl, d salkylcarbonyl, C-i salkyldicarbonyl, C-i salkoxydicarbonyl, N-Ci- 3alkylaminodicarbonyl, or N,N-diCi-3alkylaminodicarbonyl; or
R5 represents -C(0)N(Ra)(Rb), wherein:
Ra represents hydrogen, Ci-ealkyl, C3-4alkenyl, C3-4alkynyl, C-i shaloalkyl, C3-4haloalkenyl, Ci- 4alkoxy, Ci-2alkoxyCi-3alkyl, C2-3haloalkoxy, C3-4alkenyloxy, C3-4alkynyloxy, N-Ci salkylamino, or N,N- diCi-2alkylamino; or
Ra represents C3-scycloalkyl, C3-5cycloalkylCi-2alkyl, phenyl, phenylCi-2alkyl, heterocyclyl, heterocyclylCi-2alkyl, wherein the heterocyclyl moiety is a 4- to 6-membered non-aromatic ring which comprises 1 or 2 heteroatoms independently selected from N, O or S, with the proviso that the heterocyclyl cannot contain 2 contiguous atoms selected from O and S, heteroaryl or heteroaryld- 2alkyl, wherein the heteroaryl moiety is a 5- or 6-membered aromatic ring which comprises 1 , 2, 3, or 4 heteroatoms individually selected from N, O and S; wherein the cycloalkyi, phenyl, heterocyclyl or heteroaryl is optionally substituted by 1 or 2 substituents, which may be the same or different, selected from hydroxyl, amino, formyl, acyl, cyano, halogen, methyl, trifluoromethyl, methoxy, or N,N- dimethylamino, and wherein when Ra represents cycloalkyi or heterocyclyl, these cycles optionally contain 1 group selected from C(O) or S(0)2; and
Rb represents hydrogen, methyl, ethyl, propyl, prop-2-enyl, prop-2-ynyl, cyclopropyl, or cyclopropylmethyl; or
Ra and Rb, together with the nitrogen atom they share, form an azetidinyl, pyrrolidinyl or piperidinyl ring optionally substituted by 1 or 2 groups selected from halogen, methyl, ethyl or methoxy; or
R5 represents -C(0)0-Rc, wherein:
Rc represents hydrogen, Ci-ealkyl, C3-salkenyl, C3-salkynyl, Ci shaloalkyl, C3-4haloalkenyl, N,N- diCi-3alkylaminoCi-3alkyl, C3-6cycloalkyl, C3-4cycloalkylCi-2alkyl, phenyl, heterocyclyl, wherein the heterocyclyl moiety is a 4- to 6-membered non-aromatic ring which comprises 1 or 2 heteroatoms independently selected from O, S and N, with the proviso that the heterocyclyl cannot contain 2 contiguous atoms selected from O and S, heteroaryl, wherein the heteroaryl moiety is a 5- or 6- membered aromatic ring which comprises 1 , 2 or 3 heteroatoms individually selected from N, O and S; and wherein the cycloalkyi, phenyl, heterocyclyl or heteroaryl is optionally substituted by 1 or 2 substituents, which may be the same or different, selected from hydroxyl, amino, formyl, methylcarbonyl, cyano, halogen, methyl, trifluoromethyl, methoxy, or Ν,Ν-dimethylamino, and wherein when Rc represents cycloalkyi or heterocyclyl, these cycles optionally contain 1 group selected from C(O) or S(0)2; or R5 represents -N(Rd)(Re) or -Ci-2alkyl-N(Rd)(Re), wherein
Rd represents d salkyl, C3-4alkenyl, C3-4alkynyl, methylcarbonyl, methoxycarbonyl, N- methylaminocarbonyl, Ν,Ν-dimethylaminocarbonyl, N-methoxyaminocarbonyl, N-methyl-N-methoxy- aminocarbonyl, methylsulfonyl, N-methylaminosulfonyl, Ν,Ν-dimethylaminosulfonyl, methyldicarbonyl, N-methylaminodicarbonyl, or Ν,Ν-dimethylaminodicarbonyl; and
Re represents hydrogen, methyl, ethyl, or propyl; or
R5 represents -CH=N(Rf), wherein Rf represents Ci-4alkyl, Ci-4alkoxy, C2-4alkenoxy, or C2- 4alkynoxy;
R6 represents C3-6cycloalkyl, phenyl, heteroaryl, wherein the heteroaryl moiety is a 5- or 6- membered aromatic ring which comprises 1 , 2, 3 or 4 heteroatoms individually selected from N, O and S, heterocyclyl, wherein the heterocyclyl moiety is a 4- to 6-membered non-aromatic ring which comprises 1 or 2 heteroatoms individually selected from N, O and S, and wherein the cycloalkyi, phenyl, heteroaryl and heterocyclyl is optionally substituted by 1 or 2 substituents, which may be the same or different, selected from hydroxyl, amino, formyl, acyl, cyano, halogen, methyl, trifluoromethyl, methoxy, Ν,Ν-dimethylamino, and wherein when R6 represents cycloalkyl or heterocyclyl, these cycles optionally contain 1 group selected from C(O) or S(0)2.
Preferably, R5 is independently selected from hydroxy, amino, cyano, halogen, formyl, nitro, Ci- 4alkyl, Ci-4alkoxy, Ci-2haloalkyl, Ci-2alkoxyCi-2alkyl, Ν,Ν-dimethylamino, -C(0)0-Rc wherein Rc is Ci- 4alkyl, and -C(0)N(Ra)(Rb), wherein Ra is selected from hydrogen, Ci-4alkyl or Ci-4alkoxy, and Rb is selected from hydrogen or methyl, and R6 is phenyl optionally substituted by 1 or 2 substituents, which may be the same or different, selected from hydroxyl, methyl, methoxy, cyano, fluoro, chloro or bromo.
More preferably, R5 is selected from amino, cyano, chloro, fluoro, formyl, nitro, methyl, ethyl, difluoromethyl, methoxymethyl, Ν,Ν-dimethylamino, methoxycarbonyl, ethoxycarbonyl or n- propoxycarbonyl; or -C(0)N(Ra)(Rb) wherein Ra is selected from hydrogen, methyl or methoxy and Rb is selected from hydrogen or methyl, and R6 is phenyl optionally substituted by 1 or 2 substituents, which may be the same or different, selected from fluoro, chloro or bromo.
Z3 represents a heterobicyclyl which is a 7- to 9-membered saturated , partially saturated, or aromatic fused ring or saturated spirocyclic ring system containing 1 nitrogen, wherein the heterobicyclyl optionally comprises 1 or 2 additional ring members independently selected from N, O, S, C(O) and S(0)2 with the proviso that the heterobicyclyl cannot contain 2 contiguous atoms selected from O and S, wherein the heterobicyclyl is optionally substituted by 1 substituent selected from R7, and wherein further the heterobicyclyl is bound to the rest of the molecule through a ring nitrogen; and Preferably, Z3 represents a heterobicyclyl which is a 9-membered saturated, partially saturated, or aromatic fused ring system containing 1 nitrogen, wherein the heterobicyclyl optionally comprises 1 additional ring member independently selected from N, O and S, wherein the heterobicyclyl is optionally substituted by 1 substituent selected from R7, and wherein further the heterobicyclyl is bound to the rest of the molecule through a ring nitrogen.
More preferably, Z3 is selected from:
Figure imgf000013_0001
wherein Z3 is optionally substituted by 1 substituent selected from R7.
R7 is cyano, fluoro, chloro, amino, hydroxy, methyl, difluoromethyl, trifluoromethyl, methoxy, N,N dimethylamino, formyl, methylcarbonyl, methoxycarbonyl, N-methylaminocarbonyl, or N,N dimethylanninocarbonyl. Preferably, R7 is selected from hydroxyl, methoxy, methyl cyano, fluoro or chloro.
Preferably, the compound according to Formula (I) is selected from a compound 1.1 to 1.190 listed in Table T1 (below).
Preferably, in a compound according to Formula (I) of the invention:
A is A-1 ;
R is hydrogen and R2 is hydrogen or methyl;
Z is Z , wherein Z represents a 4-, 5- or 6-membered non-aromatic heterocyclyl containing 1 ring nitrogen, wherein the heterocyclyl optionally comprises 1 additional ring member independently selected from N, O, S, C(O) or S(0)2 (in particular, O or C(O)), wherein the heterocyclyl is optionally substituted by 1 or 2 substituents, which may be the same or different, selected from R4, and wherein further the heterocyclyl is bound to the rest of the molecule through a ring nitrogen; and
R4 represents cyano, halogen, hydroxy, amino, methyl, ethyl, difluoromethyl, trifluoromethyl, methoxy, N-methylamino or N,N-dimethylamino.
More preferably,
A is A-1 ;
R and R2 are hydrogen;
Z is Z , wherein Z represents a 4-, 5- or 6-membered non-aromatic heterocyclyl containing 1 ring nitrogen, wherein the heterocyclyl optionally comprises 1 additional ring member independently selected from N, O, S, C(O) or S(0)2 (in particular, O or C(O)), wherein the heterocyclyl is optionally substituted by 1 or 2 substituents, which may be the same or different, selected from R4, and wherein further the heterocyclyl is bound to the rest of the molecule through a ring nitrogen; and
R4 represents methyl or ethyl. Preferably, in a compound according to Formula (I) of the invention:
A is A-1 ;
R is hydrogen and R2 is hydrogen or methyl; and
Z is Z2, wherein Z2 is selected from:
Figure imgf000014_0001
wherein Z2 is optionally substituted by: 1 or 2 substituents selected from R5, 1 substituent selected from R6, or 1 substituent selected from R5 and 1 substituent selected from R6.
More preferably,
A is A-1 ;
R and R2 are hydrogen; and
Z is Z2, wherein Z2 is selected from:
Figure imgf000015_0001
wherein Z2 is optionally substituted by: 1 or 2 substituents selected from R5 or 1 substituent selected from R6.
Preferably, in a compound according to Formula (I) of the invention:
A is A-1 ;
R is hydrogen and R2 is hydrogen or methyl; and
Z is Z3, wherein Z3 represents a heterobicyclyl which is a 9-membered saturated, partially saturated, or aromatic fused ring system containing 1 nitrogen, wherein the heterobicyclyl optionally comprises 1 additional ring member independently selected from N, O and S, wherein the heterobicyclyl is optionally substituted by 1 substituent selected from R7, and wherein further the heterobicyclyl is bound to the rest of the molecule through a ring nitrogen;
More preferably,
A is A-1 ;
R and R2 are hydrogen;
Z is Z3, wherein Z3 represents a heterobicyclyl which is a 9-membered saturated, partially saturated, or aromatic fused ring system containing 1 nitrogen, wherein the heterobicyclyl optionally comprises 1 additional ring member independently selected from N, O and S, wherein the heterobicyclyl is optionally substituted by 1 substituent selected from R7, and wherein further the heterobicyclyl is bound to the rest of the molecule through a ring nitrogen; and
R7 is selected from hydroxyl, methoxy, methyl cyano, fluoro or chloro.
The compounds of the present invention may be enantiomers of the compound of Formula (I) as represented by a Formula (la) or a Formula (lb), wherein R and R2 are different substituents.
Figure imgf000016_0001
(la) (lb)
It is understood that when in aqueous media, the compounds of Formula (I) according to the invention may be present in a reversible equilibrium with the corresponding covalently hydrated forms (i.e., the compounds of Formula (l-la) and Formula (l-lla) as shown below, which may exist in tautomeric form as the compounds of formula (l-lb) and formula (l-llb)) at the CF3-oxadiazole motif. This dynamic equilibrium may be important for the biological activity of the compounds of Formula (I). The designations of A (A-1 , A-2, A-3), R\ R2, Z (including Z\ Z2, Z3), R3, R4, R5 (including Ra, Rb, Rc, Rd, Re, Rf), R6 and R7, with reference to the compounds of Formula (I) of the present invention apply generally to the compounds of Formula (l-la), Formula (l-lb), Formula (l-lla), and Formula (l-llb), as well do the specific disclosures of combinations of A (A-1 , A-2, A-3), R\ R2, Z (including Z\ Z2, Z3), R3, R4, R5 (including Ra, Rb, Rc, Rd, Re, Rf), R6 and R7, as represented in Tables 1 .1 to 1.3, Tables 2.1 and 2.2, or the compounds 1.1 to 1.190 according to the invention listed in Table T1 (below).
Figure imgf000017_0001
Figure imgf000017_0002
Compounds of the present invention can be made as shown in the following schemes 1 to 10, in which, unless otherwise stated, the definition of each variable is as defined above for a compound of Formula (I).
Compounds of Formula (I) can be prepared from compounds of Formula (II), wherein X is OSO2CH3, CI, Br, or I, via treatment with compounds of Formula (III), in the presence of a base (e.g. triethylamine, A/,A/-di-isopropylethylamine, K2CO3, NaHCCh, Na2C03, CS2CO3, or NaH) in a suitable solvent (e.g. dimethylacetamide, tetrahydrofuran, 2-methyltetrahydrofuran, acetone, toluene, or acetonitrile) at a temperature between 25°C and 1 10°C. In some cases, a better reaction performance may be gained from the use of a catalyst (e.g., BU4NHSO4, Bu4NBr, BU4NI , Nal, or 4- dimethylaminopyridine) and microwave irradiation. Furthermore, compounds of formula (I), can optionally be obtained via a coupling transformation with compounds of formula (III) and compounds of formula (II), wherein X is OH, via a process that converts the -OH into an improved leaving group, such as a -OSO2CH3 group, for example by using methanesulfonyl chloride (CIS02Me), prior to treatment with the compounds of formula (III). For related examples, see: WO 2013/132253, WO 2017/1 18689, and Garcia, M. et al Org. Biomol. Chem. (2004), 11, 1633. This reaction is shown in Scheme 1.
Figure imgf000018_0001
Compounds of Formula (II), wherein X is halogen, preferably CI or Br, can be prepared from compounds of Formula (IV) by treatment with a halogen source (e.g., N-bromosuccinimide (NBS) or N- chlorosuccinimide (NCS)) and a radical initiator (e.g., (PhC02)2 or azobisisobutyronitrile (AIBN)) in a suitable solvent, such as tetrachloromethane, at temperatures between 55° and 100°C in the presence of ultraviolet light. For related examples, see Liu, S. ef al Synthesis (2001 ), 14, 2078, WO 2017/1 18689, and Kompella, A. et al Org. Proc. Res. Dev. (2012), 16, 1794. This reaction is shown in Scheme 2.
Figure imgf000018_0002
Scheme
Alternatively, compounds of Formula (II), wherein X is hydrogen, OH, CI, Br, or I, can be prepared from compounds of Formula (V) by treatment with trifluoroacetic anhydride or trifluoroacetyl halide (including trifluoroacetyl fluoride, trifluoroacetyl chloride and trifluoroacetyl bromide) in the presence of a base (e.g., pyridine or 4-dimethylaminopyridine) in a suitable solvent, (e.g., ethyl acetate, tetrahydrofuran, 2-methyl tetrahydrofuran, or ethanol), at a temperature between 0°C and 75°C. For related examples, see WO 2003/028729, WO 2017/055473, and WO 2010/045251. This reaction is shown in Scheme 3.
Figure imgf000018_0003
Compounds of Formula (V), wherein X is hydrogen, OH, or halogen, can be prepared from compounds of Formula (VI) by treatment with a hydroxylamine hydrochloride salt or a hydroxylamine solution in water, in the presence of a base, such as triethylamine or potassium carbonate, in a suitable solvent, such as methanol or ethanol, at a temperature between 0°C and 80°C. In some cases, a better reaction performance may be gained from the use of a catalyst (e.g., 8-hydroxyquinoline). For related examples, see Kitamura, S. ei al Chem. Pharm. Bull. (2001 ), 49, 268, WO 2017/055473 and WO 2013/066838. This reaction is shown in Scheme 4.
Figure imgf000019_0001
Scheme 4
Compounds of Formula (VI), can be prepared from compounds of Formula (VII), wherein Y is CI, Br or I, via metal-promoted reaction with a suitable cyanide reagent, such as Pd(0)/Zn(CN)2 or CuCN, in a suitable solvent (e.g., dimethylformamide or N-methylpyrrolidone) at elevated temperature between 100°C and 120°C. For related examples, see US 2007/0155739 and WO 2009/022746. This reaction is shown in Scheme 5.
Figure imgf000019_0002
(VII) (VI)
Scheme 5
Compounds of Formula (VII), wherein X is CI, Br, I or OS02Me and Y is CI, Br, I or CN, are either commercially available or can be prepared from compounds of Formula (VIII), via treatment with an acid source (e.g., hydrochloric acid, hydrobromic acid, or hydroiodic acid), or with a halogen source (e.g., CC Br, CCU or ) in the presence of triphenylphosphine, or with methanesulfonyl chloride (CIS02Me), in a suitable solvent, (e.g., dichloromethane) at a temperature between 0°C and 100°C. For related examples, see Liu, H. ei al Bioorg. Med. Chem. (2008), 16, 10013, WO 2014/020350 and Kompella, A. ei al Bioorg. Med. Chem. Lett. (2001 ), 1, 3161 . Compounds of formula (VIII) are commercially available or prepared using known methods. This reaction is shown in Scheme 6.
Figure imgf000019_0003
(VIII) (VII)
Scheme 6 Alternatively, compounds of Formula (I) can be prepared from compounds of Formula (IX) by treatment with trifluoroacetic anhydride or trifluoroacetyl halide (including trifluoroacetyl fluoride, trifluoroacetyl chloride and trifluoroacetyl bromide) in the presence of a base (e.g., pyridine or 4- dimethylaminopyridine) in a suitable solvent, (e.g., ethyl acetate, tetrahydrofuran, 2-methyl tetrahydrofuran, or ethanol), at a temperature between 0°C and 75°C. For related examples, see WO 2003/028729, WO 2017/1 18689, and WO 2010/045251. This reaction is shown in Scheme 7.
Figure imgf000020_0001
Scheme 7 Compounds of Formula (IX), can be prepared from compounds of Formula (X) by treatment with a hydroxylamine hydrochloride salt or a hydroxylamine solution in water, in the presence of a base, such as triethylamine or K2CO3, in a suitable solvent, such as methanol or ethanol, at a temperature between 0°C and 100°C. In some cases, a better reaction performance may be gained from the use of a catalyst (e.g., 8-hydroxyquinoline). For related examples, see Kitamura, S. ef al Chem. Pharm. Bull. (2001 ), 49, 268 and WO 2013/066838. This reaction is shown in Scheme 8.
Figure imgf000020_0002
(X) (IX)
Scheme 8
Compounds of Formula (X), can be prepared from compounds of Formula (XI), wherein Y is CI, Br or I, via metal-promoted reaction with a suitable cyanide reagent, such as Pd(0)/Zn(CN)2 or CuCN, in a suitable solvent (e.g., dimethylformamide or N-methylpyrrolidone) at elevated temperature between 80°C and 120°C. For related examples, see US 2007/0155739, WO 2017/1 18689, and WO 2009/022746. This reaction is shown in Scheme 9.
Figure imgf000020_0003
(XI) (X)
Scheme 9 Compounds of Formula (XI), wherein Y is CN, CI, Br, or I, can be prepared from compounds of Formula (VII), wherein X is OSO2CH3, CI, Br, or I, via treatment with compounds of Formula (III), in the presence of a base (e.g., triethylamine, A/,A/-di-isopropylethylamine, K2CO3, NaHCCh, Na2C03, CS2CO3, or NaH) in a suitable solvent (e.g., dimethylacetamide, tetrahydrofuran, 2-methyltetrahydrofuran, acetone, toluene, or acetonitrile) at a temperature between 25°C and 1 10°C. In some cases, a better reaction performance may be gained from the use of a catalyst (e.g., BU4NHSO4, Bu4NBr, BU4NI , Nal, or 4-dimethylaminopyridine) and microwave irradiation. Furthermore, compounds of formula (XI), can optionally be obtained via a coupling transformation with compounds of formula (III) and compounds of formula (VII), wherein X is OH, via a process that converts the -OH into an improved leaving group, such as a -OSO2CH3 group, for example by using methanesulfonyl chloride (CIS02Me), prior to treatment with the compounds of formula (III). Compounds of formula (III) are commercially available or prepared using known methods. For related examples, see: WO 2013/132253, WO 2017/1 18689, and Garcia, M. et al Org. Biomol. Chem. (2004), 11, 1633. This reaction is shown in Scheme 10.
Figure imgf000021_0001
(III) (VII) (XI)
Scheme 10
As already indicated, surprisingly, it has now been found that the compounds of Formula (I) of the present invention have, for practical purposes, a very advantageous level of biological activity for protecting plants against diseases that are caused by fungi.
The compounds of Formula (I) can be used in the agricultural sector and related fields of use, e.g., as active ingredients for controlling plant pests or on non-living materials for the control of spoilage microorganisms or organisms potentially harmful to man. The novel compounds are distinguished by excellent activity at low rates of application, by being well tolerated by plants and by being environmentally safe. They have very useful curative, preventive and systemic properties and can be used for protecting numerous cultivated plants. The compounds of Formula (I) can be used to inhibit or destroy the pests that occur on plants or parts of plants (fruit, blossoms, leaves, stems, tubers, roots) of different crops of useful plants, while at the same time protecting also those parts of the plants that grow later, e.g., from phytopathogenic microorganisms.
The present invention further relates to a method for controlling or preventing infestation of plants or plant propagation material and/or harvested food crops susceptible to microbial attack by treating plants or plant propagation material and/or harvested food crops wherein an effective amount a compound of Formula (I) is applied to the plants, to parts thereof or the locus thereof. It is also possible to use compounds of Formula (I) as a fungicide. The term "fungicide" as used herein means a compound that controls, modifies, or prevents the growth of fungi. The term "fungicidally effective amount" where used means the quantity of such a compound or combination of such compounds that is capable of producing an effect on the growth of fungi. Controlling or modifying effects include all deviation from natural development, such as killing, retardation and the like, and prevention includes barrier or other defensive formation in or on a plant to prevent fungal infection.
It may also be possible to use compounds of Formula (I) as dressing agents for the treatment of plant propagation material, e.g., seed, such as fruits, tubers or grains, or plant cuttings, for the protection against fungal infections as well as against phytopathogenic fungi occurring in the soil. The propagation material can be treated with a composition comprising a compound of Formula (I) before planting: seed, for example, can be dressed before being sown. The active compounds of Formula (I) can also be applied to grains (coating), either by impregnating the seeds in a liquid formulation or by coating them with a solid formulation. The composition can also be applied to the planting site when the propagation material is being planted, for example, to the seed furrow during sowing. The invention relates also to such methods of treating plant propagation material and to the plant propagation material so treated.
Furthermore, the compounds of Formula (I) can be used for controlling fungi in related areas, for example in the protection of technical materials, including wood and wood related technical products, in food storage, in hygiene management.
In addition, the invention could be used to protect non-living materials from fungal attack, e.g. lumber, wall boards and paint.
The compounds of Formula (I) are for example, effective against fungi and fungal vectors of disease as well as phytopathogenic bacteria and viruses. These fungi and fungal vectors of disease as well as phytopathogenic bacteria and viruses are for example:
Absidia corymbifera, Alternaria spp, Aphanomyces spp, Ascochyta spp, Aspergillus spp. including A. flavus, A. fumigatus, A. nidulans, A. niger, A. terms, Aureobasidium spp. including A. pullulans, Blastomyces dermatitidis, Blumeria graminis, Bremia lactucae, Botryosphaeria spp. including B. dothidea, B. obtusa, Botrytis spp. inclusing B. cinerea, Candida spp. including C. albicans, C. glabrata, C. krusei, C. lusitaniae, C. parapsilosis, C. tropicalis, Cephaloascus fragrans, Ceratocystis spp, Cercospora spp. including C. arachidicola, Cercosporidium personatum, Cladosporium spp, Claviceps purpurea, Coccidioides immitis, Cochliobolus spp, Colletotrichum spp. including C. musae, Cryptococcus neoformans, Diaporthe spp, Didymella spp, Drechslera spp, Elsinoe spp,Epidermophyton spp, Erwinia amylovora, Erysiphe spp. including E. cichoracearum, Eutypa lata, Fusarium spp. including F. culmorum, F. graminearum, F. langsethiae, F. moniliforme, F. oxysporum, F. proliferatum, F. subglutinans, F. solani, Gaeumannomyces graminis, Gibberella fujikuroi, Gloeodes pomigena, Gloeosporium musarum, Glomerella cingulate, Guignardia bidwellii, Gymnosporangium juniperi-virginianae, Helminthosporium spp, Hemileia spp, Histoplasma spp. including H. capsulatum, Laetisaria fuciformis, Leptographium lindbergi, Leveillula taurica, Lophodermium seditiosum, Microdochium nivale, Microsporum spp, Monilinia spp, Mucor spp, Mycosphaerella spp. including M. graminicola, M. pomi, Oncobasidium theobromaeon, Ophiostoma piceae, Paracoccidioides spp, Penicillium spp. including P. digitatum, P. italicum, Petriellidium spp, Peronosclerospora spp. Including P. maydis, P. philippinensis and P. sorghi, Peronospora spp, Phaeosphaeria nodorum, Phakopsora pachyrhizi, Phellinus igniarus, Phialophora spp, Phoma spp, Phomopsis viticola, Phytophthora spp. including P. infestans, Plasmopara spp. including P. halstedii, P. viticola, Pleospora spp., Podosphaera spp. including P. leucotricha, Polymyxa graminis, Polymyxa betae, Pseudocercosporella herpotrichoides, Pseudomonas spp, Pseudoperonospora spp. including P. cubensis, P. humuli, Pseudopeziza tracheiphila, Puccinia Spp. including P. hordei, P. recondita, P. striiformis, P. triticina, Pyrenopeziza spp, Pyrenophora spp, Pyricularia spp. including P. oryzae, Pythium spp. including P. ultimum, Ramularia spp, Rhizoctonia spp, Rhizomucor pusillus, Rhizopus arrhizus, Rhynchosporium spp, Scedosporium spp. including S. apiospermum and S. prolificans, Schizothyrium pomi, Sclerotinia spp, Sclerotium spp, Septoria spp, including S. nodorum, S. tritici, Sphaerotheca macularis, Sphaerotheca fusca (Sphaerotheca fuliginea), Sporothorix spp, Stagonospora nodorum, Stemphylium spp,. Stereum hirsutum, Thanatephorus cucumeris, Thielaviopsis basicola, Tilletia spp, Trichoderma spp. including T. harzianum, T. pseudokoningii, T. viride, Trichophyton spp, Typhula spp, Uncinula necator, Urocystis spp, Ustilago spp, Venturia spp. including V. inaequalis, Verticillium spp, and Xanthomonas spp.
The compounds of Formula (I) may be used for example on turf, ornamentals, such as flowers, shrubs, broad-leaved trees or evergreens, for example conifers, as well as for tree injection, pest management and the like.
Within the scope of present invention, target crops and/or useful plants to be protected typically comprise perennial and annual crops, such as berry plants for example blackberries, blueberries, cranberries, raspberries and strawberries; cereals for example barley, maize (corn), millet, oats, rice, rye, sorghum triticale and wheat; fibre plants for example cotton, flax, hemp, jute and sisal; field crops for example sugar and fodder beet, coffee, hops, mustard, oilseed rape (canola), poppy, sugar cane, sunflower, tea and tobacco; fruit trees for example apple, apricot, avocado, banana, cherry, citrus, nectarine, peach, pear and plum; grasses for example Bermuda grass, bluegrass, bentgrass, centipede grass, fescue, ryegrass, St. Augustine grass and Zoysia grass; herbs such as basil, borage, chives, coriander, lavender, lovage, mint, oregano, parsley, rosemary, sage and thyme; legumes for example beans, lentils, peas and soya beans; nuts for example almond, cashew, ground nut, hazelnut, peanut, pecan, pistachio and walnut; palms for example oil palm; ornamentals for example flowers, shrubs and trees; other trees, for example cacao, coconut, olive and rubber; vegetables for example asparagus, aubergine, broccoli, cabbage, carrot, cucumber, garlic, lettuce, marrow, melon, okra, onion, pepper, potato, pumpkin, rhubarb, spinach and tomato; and vines for example grapes.
The term "useful plants" is to be understood as also including useful plants that have been rendered tolerant to herbicides like bromoxynil or classes of herbicides (such as, for example, HPPD inhibitors, ALS inhibitors, for example primisulfuron, prosulfuron and trifloxysulfuron, EPSPS (5-enol- pyrovyl-shikimate-3-phosphate-synthase) inhibitors, GS (glutamine synthetase) inhibitors or PPO (protoporphyrinogen-oxidase) inhibitors) as a result of conventional methods of breeding or genetic engineering. An example of a crop that has been rendered tolerant to imidazolinones, e.g. imazamox, by conventional methods of breeding (mutagenesis) is Clearfield® summer rape (Canola). Examples of crops that have been rendered tolerant to herbicides or classes of herbicides by genetic engineering methods include glyphosate- and glufosinate-resistant maize varieties commercially available under the trade names RoundupReady®, Herculex I® and LibertyLink®.
The term "useful plants" is to be understood as also including useful plants which have been so transformed by the use of recombinant DNA techniques that they are capable of synthesising one or more selectively acting toxins, such as are known, for example, from toxin-producing bacteria, especially those of the genus Bacillus.
Examples of such plants are: YieldGard® (maize variety that expresses a CrylA(b) toxin); YieldGard Rootworm® (maize variety that expresses a CrylllB(bl ) toxin); YieldGard Plus® (maize variety that expresses a CrylA(b) and a CrylllB(bl ) toxin); Starlink® (maize variety that expresses a Cry9(c) toxin); Herculex I® (maize variety that expresses a CrylF(a2) toxin and the enzyme phosphinothricine N-acetyltransferase (PAT) to achieve tolerance to the herbicide glufosinate ammonium); NuCOTN 33B® (cotton variety that expresses a CrylA(c) toxin); Bollgard I® (cotton variety that expresses a CrylA(c) toxin); Bollgard II® (cotton variety that expresses a CrylA(c) and a CryllA(b) toxin); VIPCOT® (cotton variety that expresses a VIP toxin); NewLeaf® (potato variety that expresses a CrylllA toxin); NatureGard® Agrisure® GT Advantage (GA21 glyphosate-tolerant trait), Agrisure® CB Advantage (Bt1 1 corn borer (CB) trait), Agrisure® RW (corn rootworm trait) and Protecta®.
The term "crops" is to be understood as including also crop plants which have been so transformed by the use of recombinant DNA techniques that they are capable of synthesising one or more selectively acting toxins, such as are known, for example, from toxin-producing bacteria, especially those of the genus Bacillus.
Toxins that can be expressed by such transgenic plants include, for example, insecticidal proteins from Bacillus cereus or Bacillus popilliae; or insecticidal proteins from Bacillus thuringiensis, such as δ-endotoxins, e.g. CrylAb, CrylAc, Cryl F, Cry1 Fa2, Cry2Ab, Cry3A, Cry3Bb1 or Cry9C, or vegetative insecticidal proteins (Vip), e.g. Vip1 , Vip2, Vip3 or Vip3A; or insecticidal proteins of bacteria colonising nematodes, for example Photorhabdus spp. or Xenorhabdus spp., such as Photorhabdus luminescens, Xenorhabdus nematophilus; toxins produced by animals, such as scorpion toxins, arachnid toxins, wasp toxins and other insect-specific neurotoxins; toxins produced by fungi, such as Streptomycetes toxins, plant lectins, such as pea lectins, barley lectins or snowdrop lectins; agglutinins; proteinase inhibitors, such as trypsin inhibitors, serine protease inhibitors, patatin, cystatin, papain inhibitors; ribosome-inactivating proteins (RIP), such as ricin, maize-RIP, abrin, luffin, saporin or bryodin; steroid metabolism enzymes, such as 3-hydroxysteroidoxidase, ecdysteroid-UDP-glycosyl- transferase, cholesterol oxidases, ecdysone inhibitors, HMG-COA-reductase, ion channel blockers, such as blockers of sodium or calcium channels, juvenile hormone esterase, diuretic hormone receptors, stilbene synthase, bibenzyl synthase, chitinases and glucanases.
Further, in the context of the present invention there are to be understood by δ-endotoxins, for example CrylAb, CrylAc, Cryl F, Cry1 Fa2, Cry2Ab, Cry3A, Cry3Bb1 or Cry9C, or vegetative insecticidal proteins (Vip), for example Vip1 , Vip2, Vip3 or Vip3A, expressly also hybrid toxins, truncated toxins and modified toxins. Hybrid toxins are produced recombinantly by a new combination of different domains of those proteins (see, for example, WO 02/15701 ). Truncated toxins, for example a truncated CrylAb, are known. In the case of modified toxins, one or more amino acids of the naturally occurring toxin are replaced. In such amino acid replacements, preferably non-naturally present protease recognition sequences are inserted into the toxin, such as, for example, in the case of Cry3A055, a cathepsin-G-recognition sequence is inserted into a Cry3A toxin (see WO 03/018810).
Examples of such toxins or transgenic plants capable of synthesising such toxins are disclosed, for example, in EP-A-0 374 753, WO93/07278, W095/34656, EP-A-0 427 529, EP-A-451 878 and WO 03/052073.
The processes for the preparation of such transgenic plants are generally known to the person skilled in the art and are described, for example, in the publications mentioned above. Cryl-type deoxyribonucleic acids and their preparation are known, for example, from WO 95/34656, EP-A-0 367 474, EP-A-0 401 979 and WO 90/13651.
The toxin contained in the transgenic plants imparts to the plants tolerance to harmful insects. Such insects can occur in any taxonomic group of insects, but are especially commonly found in the beetles (Coleoptera), two-winged insects (Diptera) and butterflies (Lepidoptera).
Transgenic plants containing one or more genes that code for an insecticidal resistance and express one or more toxins are known and some of them are commercially available. Examples of such plants are: YieldGard® (maize variety that expresses a CrylAb toxin); YieldGard Rootworm® (maize variety that expresses a Cry3Bb1 toxin); YieldGard Plus® (maize variety that expresses a CrylAb and a Cry3Bb1 toxin); Starlink® (maize variety that expresses a Cry9C toxin); Herculex I® (maize variety that expresses a Cry1 Fa2 toxin and the enzyme phosphinothricine N-acetyltransferase (PAT) to achieve tolerance to the herbicide glufosinate ammonium); NuCOTN 33B® (cotton variety that expresses a CrylAc toxin); Bollgard I® (cotton variety that expresses a CrylAc toxin); Bollgard II® (cotton variety that expresses a CrylAc and a Cry2Ab toxin); VipCot® (cotton variety that expresses a Vip3A and a CrylAb toxin); NewLeaf® (potato variety that expresses a Cry3A toxin); NatureGard®, Agrisure® GT Advantage (GA21 glyphosate-tolerant trait), Agrisure® CB Advantage (Bt1 1 corn borer (CB) trait) and Protecta®.
Further examples of such transgenic crops are:
1. Bt11 Maize from Syngenta Seeds SAS, Chemin de I'Hobit 27, F-31 790 St. Sauveur, France, registration number C/FR/96/05/10. Genetically modified Zea mays which has been rendered resistant to attack by the European corn borer (Ostrinia nubilalis and Sesamia nonagrioides) by transgenic expression of a truncated Cry1 Ab toxin. Bt1 1 maize also transgenically expresses the enzyme PAT to achieve tolerance to the herbicide glufosinate ammonium. 2. Bt176 Maize from Syngenta Seeds SAS, Chemin de I'Hobit 27, F-31 790 St. Sauveur, France, registration number C/FR/96/05/10. Genetically modified Zea mays which has been rendered resistant to attack by the European corn borer (Ostrinia nubilalis and Sesamia nonagrioides) by transgenic expression of a CrylAb toxin. Bt176 maize also transgenically expresses the enzyme PAT to achieve tolerance to the herbicide glufosinate ammonium.
3. MIR604 Maize from Syngenta Seeds SAS, Chemin de I'Hobit 27, F-31 790 St. Sauveur, France, registration number C/FR/96/05/10. Maize which has been rendered insect-resistant by transgenic expression of a modified Cry3A toxin. This toxin is Cry3A055 modified by insertion of a cathepsin-G- protease recognition sequence. The preparation of such transgenic maize plants is described in WO 03/018810.
4. MON 863 Maize from Monsanto Europe S.A. 270-272 Avenue de Tervuren, B-1 150 Brussels, Belgium, registration number C/DE/02/9. MON 863 expresses a Cry3Bb1 toxin and has resistance to certain Coleoptera insects.
5. IPC 531 Cotton from Monsanto Europe S.A. 270-272 Avenue de Tervuren, B-1 150 Brussels, Belgium, registration number C/ES/96/02.
6. 1507 Maize from Pioneer Overseas Corporation, Avenue Tedesco, 7 B-1 160 Brussels, Belgium, registration number C/NL/00/10. Genetically modified maize for the expression of the protein Cryl F for achieving resistance to certain Lepidoptera insects and of the PAT protein for achieving tolerance to the herbicide glufosinate ammonium.
7. NK603 * MON 810 Maize from Monsanto Europe S.A. 270-272 Avenue de Tervuren, B-1 150 Brussels, Belgium, registration number C/GB/02/M3/03. Consists of conventionally bred hybrid maize varieties by crossing the genetically modified varieties NK603 and MON 810. NK603 * MON 810 Maize transgenically expresses the protein CP4 EPSPS, obtained from Agrobacterium sp. strain CP4, which imparts tolerance to the herbicide Roundup® (contains glyphosate), and also a CrylAb toxin obtained from Bacillus thuringiensis subsp. kurstaki which brings about tolerance to certain Lepidoptera, include the European corn borer.
The compounds of Formula (I) (including any one of compounds 1.1 to 1.190) according to the present invention comprising a compound of Formula (I) may be used in controlling or preventing phytopathogenic diseases, especially phytopathogenic fungi (such as Phakopsora pachyrhizi) on soy bean plants. In particular, transgenic soybean plants expressing toxins, for example insecticidal proteins such as delta-endotoxins, e.g. Cry1 Ac (Cry1 Ac Bt protein). Accordingly, this may include transgenic soybean plants comprising event MON87701 (see U.S. Patent No. 8,049,071 and related applications and patents, as well as WO 2014/170327 A1 (eg, see paragraph [008] reference to Intacta RR2 PRO™ soybean)), event MON87751 (US. Patent Application Publication No. 2014/0373191 ) or event DAS- 81419 (U.S. Patent No. 8632978 and related applications and patents).
Other transgenic soybean plants may comprise event SYHT0H2 - HPPD tolerance (U.S. Patent Application Publication No. 2014/0201860 and related applications and patents), event MON89788 - glyphosate tolerance (U.S. Pat. No. 7,632,985 and related applications and patents), event MON87708 - dicamba tolerance (U.S. Patent Application Publication No. US 201 1/0067134 and related applications and patents), event DP-356043-5 - glyphosate and ALS tolerance (U.S. Patent Application Publication No. US 2010/0184079 and related applications and patents), event A2704-12 - glufosinate tolerance (U.S. Patent Application Publication No. US 2008/0320616 and related applications and patents), event DP-305423-1 - ALS tolerance (U.S. Patent Application Publication No. US 2008/0312082 and related applications and patents), event A5547-127 - glufosinate tolerance (U.S. Patent Application Publication No. US 2008/0196127 and related applications and patents), event DAS-40278-9 - tolerance to 2,4- dichlorophenoxyacetic acid and aryloxyphenoxypropionate (see WO 201 1/022469, WO 201 1/022470, WO 201 1/022471 , and related applications and patents), event 127 - ALS tolerance (WO 2010/080829 and related applications and patents), event GTS 40-3-2 - glyphosate tolerance, event DAS-68416-4- 2,4-dichlorophenoxyacetic acid and glufosinate tolerance, event FG72 - glyphosate and isoxaflutole tolerance, event BPS-CV127-9 - ALS tolerance and GU262 - glufosinate tolerance or event SYHT04R - HPPD tolerance.
Under certain circumstances, compounds of Formula (I) according to the present invention when used in controlling or preventing phytopathogenic diseases, especially phytopathogenic fungi (such as Phakopsora pachyrhizi) on soy bean plants (in particular any of the transgenic soybean plants as described above), may display a synergistic interaction between the active ingredients.
The term "locus" as used herein means fields in or on which plants are growing, or where seeds of cultivated plants are sown, or where seed will be placed into the soil. It includes soil, seeds, and seedlings, as well as established vegetation.
The term "plants" refers to all physical parts of a plant, including seeds, seedlings, saplings, roots, tubers, stems, stalks, foliage, and fruits.
The term "plant propagation material" is understood to denote generative parts of the plant, such as seeds, which can be used for the multiplication of the latter, and vegetative material, such as cuttings or tubers, for example potatoes. There can be mentioned for example seeds (in the strict sense), roots, fruits, tubers, bulbs, rhizomes and parts of plants. Germinated plants and young plants which are to be transplanted after germination or after emergence from the soil, may also be mentioned. These young plants can be protected before transplantation by a total or partial treatment by immersion. Preferably "plant propagation material" is understood to denote seeds. The compounds of Formula (I) may be used in unmodified form or, preferably, together with the adjuvants conventionally employed in the art of formulation. To this end they may be conveniently Formulated in known manner to emulsifiable concentrates, coatable pastes, directly sprayable or dilutable solutions or suspensions, dilute emulsions, wettable powders, soluble powders, dusts, granulates, and also encapsulations e.g. in polymeric substances. As with the type of the compositions, the methods of application, such as spraying, atomising, dusting, scattering, coating or pouring, are chosen in accordance with the intended objectives and the prevailing circumstances. The compositions may also contain further adjuvants such as stabilizers, antifoams, viscosity regulators, binders or tackifiers as well as fertilizers, micronutrient donors or other formulations for obtaining special effects.
Suitable carriers and adjuvants, e.g. for agricultural use, can be solid or liquid and are substances useful in formulation technology, e.g. natural or regenerated mineral substances, solvents, dispersants, wetting agents, tackifiers, thickeners, binders or fertilizers. Such carriers are for example described in WO 97/33890.
Suspension concentrates are aqueous formulations in which finely divided solid particles of the active compound are suspended. Such formulations include anti-settling agents and dispersing agents and may further include a wetting agent to enhance activity as well an anti-foam and a crystal growth inhibitor. In use, these concentrates are diluted in water and normally applied as a spray to the area to be treated. The amount of active ingredient may range from 0.5% to 95% of the concentrate.
Wettable powders are in the form of finely divided particles which disperse readily in water or other liquid carriers. The particles contain the active ingredient retained in a solid matrix. Typical solid matrices include fuller's earth, kaolin clays, silicas and other readily wet organic or inorganic solids. Wettable powders normally contain from 5% to 95% of the active ingredient plus a small amount of wetting, dispersing or emulsifying agent.
Emulsifiable concentrates are homogeneous liquid compositions dispersible in water or other liquid and may consist entirely of the active compound with a liquid or solid emulsifying agent, or may also contain a liquid carrier, such as xylene, heavy aromatic naphthas, isophorone and other nonvolatile organic solvents. In use, these concentrates are dispersed in water or other liquid and normally applied as a spray to the area to be treated. The amount of active ingredient may range from 0.5% to 95% of the concentrate.
Granular formulations include both extrudates and relatively coarse particles and are usually applied without dilution to the area in which treatment is required. Typical carriers for granular Formulations include sand, fuller's earth, attapulgite clay, bentonite clays, montmorillonite clay, vermiculite, perlite, calcium carbonate, brick, pumice, pyrophyllite, kaolin, dolomite, plaster, wood flour, ground corn cobs, ground peanut hulls, sugars, sodium chloride, sodium sulphate, sodium silicate, sodium borate, magnesia, mica, iron oxide, zinc oxide, titanium oxide, antimony oxide, cryolite, gypsum, diatomaceous earth, calcium sulphate and other organic or inorganic materials which absorb or which can be coated with the active compound. Granular Formulations normally contain 5% to 25% of active ingredients which may include surface-active agents such as heavy aromatic naphthas, kerosene and other petroleum fractions, or vegetable oils; and/or stickers such as dextrins, glue or synthetic resins. Dusts are free-flowing admixtures of the active ingredient with finely divided solids such as talc, clays, flours and other organic and inorganic solids which act as dispersants and carriers.
Microcapsules are typically droplets or granules of the active ingredient enclosed in an inert porous shell which allows escape of the enclosed material to the surroundings at controlled rates. Encapsulated droplets are typically 1 to 50 microns in diameter. The enclosed liquid typically constitutes 50 to 95% of the weight of the capsule and may include solvent in addition to the active compound. Encapsulated granules are generally porous granules with porous membranes sealing the granule pore openings, retaining the active species in liquid form inside the granule pores. Granules typically range from 1 millimetre to 1 centimetre and preferably 1 to 2 millimetres in diameter. Granules are formed by extrusion, agglomeration or prilling, or are naturally occurring. Examples of such materials are vermiculite, sintered clay, kaolin, attapulgite clay, sawdust and granular carbon. Shell or membrane materials include natural and synthetic rubbers, cellulosic materials, styrene-butadiene copolymers, polyacrylonitriles, polyacrylates, polyesters, polyamides, polyureas, polyurethanes and starch xanthates.
Other useful formulations for agrochemical applications include simple solutions of the active ingredient in a solvent in which it is completely soluble at the desired concentration, such as acetone, alkylated naphthalenes, xylene and other organic solvents. Pressurised sprayers, wherein the active ingredient is dispersed in finely-divided form as a result of vaporisation of a low boiling dispersant solvent carrier, may also be used.
Suitable agricultural adjuvants and carriers that are useful in formulating the compositions of the invention in the formulation types described above are well known to those skilled in the art.
Liquid carriers that can be employed include, for example, water, toluene, xylene, petroleum naphtha, crop oil, acetone, methyl ethyl ketone, cyclohexanone, acetic anhydride, acetonitrile, acetophenone, amyl acetate, 2-butanone, chlorobenzene, cyclohexane, cyclohexanol, alkyl acetates, diacetonalcohol, 1 ,2-dichloropropane, diethanolamine, p-diethylbenzene, diethylene glycol, diethylene glycol abietate, diethylene glycol butyl ether, diethylene glycol ethyl ether, diethylene glycol methyl ether, Ν,Ν-dimethyl formamide, dimethyl sulfoxide, 1 ,4-dioxane, dipropylene glycol, dipropylene glycol methyl ether, dipropylene glycol dibenzoate, diproxitol, alkyl pyrrolidinone, ethyl acetate, 2-ethyl hexanol, ethylene carbonate, 1 , 1 , 1-trichloroethane, 2-heptanone, alpha pinene, d-limonene, ethylene glycol, ethylene glycol butyl ether, ethylene glycol methyl ether, gamma-butyrolactone, glycerol, glycerol diacetate, glycerol monoacetate, glycerol triacetate, hexadecane, hexylene glycol, isoamyl acetate, isobornyl acetate, isooctane, isophorone, isopropyl benzene, isopropyl myristate, lactic acid, laurylamine, mesityl oxide, methoxy-propanol, methyl isoamyl ketone, methyl isobutyl ketone, methyl laurate, methyl octanoate, methyl oleate, methylene chloride, m-xylene, n-hexane, n-octylamine, octadecanoic acid, octyl amine acetate, oleic acid, oleylamine, o-xylene, phenol, polyethylene glycol (PEG400), propionic acid, propylene glycol, propylene glycol monomethyl ether, p-xylene, toluene, triethyl phosphate, triethylene glycol, xylene sulfonic acid, paraffin, mineral oil, trichloroethylene, perchloroethylene, ethyl acetate, amyl acetate, butyl acetate, methanol, ethanol, isopropanol, and higher molecular weight alcohols such as amyl alcohol, tetrahydrofurfuryl alcohol, hexanol, octanol, etc., ethylene glycol, propylene glycol, glycerine and N-methyl-2-pyrrolidinone. Water is generally the carrier of choice for the dilution of concentrates.
Suitable solid carriers include, for example, talc, titanium dioxide, pyrophyllite clay, silica, attapulgite clay, kieselguhr, chalk, diatomaxeous earth, lime, calcium carbonate, bentonite clay, fuller's earth, cotton seed hulls, wheat flour, soybean flour, pumice, wood flour, walnut shell flour and lignin.
A broad range of surface-active agents are advantageously employed in both said liquid and solid compositions, especially those designed to be diluted with carrier before application. These agents, when used, normally comprise from 0.1 % to 15% by weight of the formulation. They can be anionic, cationic, non-ionic or polymeric in character and can be employed as emulsifying agents, wetting agents, suspending agents or for other purposes. Typical surface active agents include salts of alkyl sulfates, such as diethanolammonium lauryl sulphate; alkylarylsulfonate salts, such as calcium dodecylbenzenesulfonate; alkylphenol-alkylene oxide addition products, such as nonylphenol-C.sub. 18 ethoxylate; alcohol-alkylene oxide addition products, such as tridecyl alcohol-C.sub. 16 ethoxylate; soaps, such as sodium stearate; alkylnaphthalenesulfonate salts, such as sodium dibutylnaphthalenesulfonate; dialkyl esters of sulfosuccinate salts, such as sodium di(2-ethylhexyl) sulfosuccinate; sorbitol esters, such as sorbitol oleate; quaternary amines, such as lauryl trimethylammonium chloride; polyethylene glycol esters of fatty acids, such as polyethylene glycol stearate; block copolymers of ethylene oxide and propylene oxide; and salts of mono and dialkyl phosphate esters.
Other adjuvants commonly utilized in agricultural compositions include crystallisation inhibitors, viscosity modifiers, suspending agents, spray droplet modifiers, pigments, antioxidants, foaming agents, anti-foaming agents, light-blocking agents, compatibilizing agents, antifoam agents, sequestering agents, neutralising agents and buffers, corrosion inhibitors, dyes, odorants, spreading agents, penetration aids, micronutrients, emollients, lubricants and sticking agents.
In addition, further, other biocidally active ingredients or compositions may be combined with the compositions of the invention and used in the methods of the invention and applied simultaneously or sequentially with the compositions of the invention. When applied simultaneously, these further active ingredients may be formulated together with the compositions of the invention or mixed in, for example, the spray tank. These further biocidally active ingredients may be fungicides, herbicides, insecticides, bactericides, acaricides, nematicides and/or plant growth regulators.
Pesticidal agents are referred to herein using their common name are known, for example, from "The Pesticide Manual", 15th Ed., British Crop Protection Council 2009.
In addition, the compositions of the invention may also be applied with one or more systemically acquired resistance inducers ("SAR" inducer). SAR inducers are known and described in, for example, United States Patent No. US 6,919,298 and include, for example, salicylates and the commercial SAR inducer acibenzolar-S-methyl.
The compounds of Formula (I) are normally used in the form of agrochemical compositions and can be applied to the crop area or plant to be treated, simultaneously or in succession with further compounds. These further compounds can be e.g. fertilizers or micronutrient donors or other preparations, which influence the growth of plants. They can also be selective herbicides or nonselective herbicides as well as insecticides, fungicides, bactericides, nematicides, molluscicides or mixtures of several of these preparations, if desired together with further carriers, surfactants or application promoting adjuvants customarily employed in the art of formulation.
The compounds of Formula (I) may be used in the form of (fungicidal) compositions for controlling or protecting against phytopathogenic microorganisms, comprising as active ingredient at least one compound of Formula (I) or of at least one preferred individual compound as defined herein, in free form or in agrochemically usable salt form, and at least one of the above-mentioned adjuvants.
The invention therefore provides a composition, preferably a fungicidal composition, comprising at least one compound Formula (I) an agriculturally acceptable carrier and optionally an adjuvant. An agricultural acceptable carrier is for example a carrier that is suitable for agricultural use. Agricultural carriers are well known in the art. Preferably said composition may comprise at least one or more pesticidally-active compounds, for example an additional fungicidal active ingredient in addition to the compound of Formula (I).
The compound of Formula (I) may be the sole active ingredient of a composition or it may be admixed with one or more additional active ingredients such as a pesticide, fungicide, synergist, herbicide or plant growth regulator where appropriate. An additional active ingredient may, in some cases, result in unexpected synergistic activities.
Examples of suitable additional active ingredients include the following: acycloamino acid fungicides, aliphatic nitrogen fungicides, amide fungicides, anilide fungicides, antibiotic fungicides, aromatic fungicides, arsenical fungicides, aryl phenyl ketone fungicides, benzamide fungicides, benzanilide fungicides, benzimidazole fungicides, benzothiazole fungicides, botanical fungicides, bridged diphenyl fungicides, carbamate fungicides, carbanilate fungicides, conazole fungicides, copper fungicides, dicarboximide fungicides, dinitrophenol fungicides, dithiocarbamate fungicides, dithiolane fungicides, furamide fungicides, furanilide fungicides, hydrazide fungicides, imidazole fungicides, mercury fungicides, morpholine fungicides, organophosphorous fungicides, organotin fungicides, oxathiin fungicides, oxazole fungicides, phenylsulfamide fungicides, polysulfide fungicides, pyrazole fungicides, pyridine fungicides, pyrimidine fungicides, pyrrole fungicides, quaternary ammonium fungicides, quinoline fungicides, quinone fungicides, quinoxaline fungicides, strobilurin fungicides, sulfonamide fungicides, thiadiazole fungicides, thiazole fungicides, thiazolidine fungicides, thiocarbamate fungicides, thiophene fungicides, triazine fungicides, triazole fungicides, triazolopyrimidine fungicides, urea fungicides, valinamide fungicides, and zinc fungicides.
Examples of suitable additional active ingredients also include the following: 3-difluoromethyl- 1-methyl-1 H-pyrazole-4-carboxylic acid (9-dichloromethylene-1 ,2,3,4-tetrahydro-1 ,4-methano- naphthalen-5-yl)-amide , 3-difluoromethyl-1-methyl-1 H-pyrazole-4-carboxylic acid methoxy-[1-methyl- 2-(2,4,6-trichlorophenyl)-ethyl]-amide , 1-methyl-3-difluoromethyl-1 H-pyrazole-4-carboxylic acid (2- dichloromethylene-3-ethyl-1-methyl-indan-4-yl)-amide (1072957-71-1 ), 1-methyl-3-difluoromethyl-1 H- pyrazole-4-carboxylic acid (4'-methylsulfanyl-biphenyl-2-yl)-amide, 1-methyl-3-difluoromethyl-4H- pyrazole-4-carboxylic acid [2-(2,4-dichloro-phenyl)-2-methoxy-1-methyl-ethyl]-amide, (5-Chloro-2,4- dimethyl-pyridin-3-yl)-(2,3,44rimethoxy-6-methyl-phenyl)-methanone, (5-Bromo-4-chloro-2-methoxy- pyridin-3-yl)-(2,3,4-trimethoxy-6-methyl-phenyl)-methanone, 2-{2-[(E)-3-(2,6-Dichloro-phenyl)-1- methyl-prop-2-en-(E)-ylideneaminooxymethyl]-phenyl}-2-[(Z)-methoxyimino]-N-methyl-acetam 3- [5-(4-Chloro-phenyl)-2,3-dimethyl-isoxazolidin-3-yl]-pyridine, (E)-N-methyl-2- [2- (2, 5- dimethylphenoxymethyl) phenyl]-2-methoxy-iminoacetanriide, 4-bromo-2-cyano-N, N-dimethyl-6- trifluoromethylbenzinriidazole-1-sulphonanriide, a- [N-(3-chloro-2, 6-xylyl)-2-methoxyacetamido]-y- butyrolactone, 4-chloro-2-cyano-N,N - dimethyl-5-p-tolylimidazole-1-sulfonanriide, N-allyl-4, 5,-dimethyl- 2-trimethylsilylthiophene-3-carboxanriide, N- (l-cyano-1 , 2-d i m ethyl p ropy I )-2- (2, 4-dichlorophenoxy) propionamide, N- (2-methoxy-5-pyridyl)-cyclopropane carboxamide, (.+-.)-cis-1-(4-chlorophenyl)-2- (1 H-1 ,2,4-triazol-1-yl)-cycloheptanol, 2-(1-iert-butyl)-1-(2-chlorophenyl)-3-(1 ,2,4-triazol-1-yl)-propan-2- ol, 2 6'-dibromo-2-methyl-4-trifluoromethoxy-4'-trifluoromethyl-1 ,3-thiazole- 5-carboxanilide, 1- imidazolyl-1-(4'-chlorophenoxy)-3,3-dimethylbutan-2-one, methyl (E)-2-[2-[6-(2- cyanophenoxy)pyrimidin-4-yloxy]phenyl]3-methoxyacrylate, methyl (E)-2-[2-[6-(2- thioamidophenoxy)pyrimidin-4-yloxy]phenyl]-3-methoxyacrylate, methyl (E)-2-[2-[6-(2- fluorophenoxy)pyrimidin-4-yloxy]phenyl]-3-methoxyacrylate, methyl (E)-2-[2-[6-(2,6- difluorophenoxy)pyrimidin-4-yloxy]phenyl]-3-methoxyacryla te, methyl (E)-2-[2-[3-(pyrimidin-2- yloxy)phenoxy]phenyl]-3-methoxyacrylate, methyl (E)-2-[2-[3-(5-methylpyrimidin-2-yloxy)- phenoxy]phenyl]-3-methoxyacrylate, methyl (E)-2-[2-[3-(phenyl-sulphonyloxy)phenoxy]phenyl-3- methoxyacrylate, methyl (E)-2-[2-[3-(4-nitrophenoxy)phenoxy]phenyl]-3-methoxyacrylate, methyl (E)-2- [2-phenoxyphenyl]-3-methoxyacrylate, methyl (E)-2-[2-(3,5-dimethyl-benzoyl)pyrrol-1-yl]-3- methoxyacrylate, methyl (E)-2-[2-(3-methoxyphenoxy)phenyl]-3-methoxyacrylate, methyl (E)-2[2-(2- phenylethen-1-yl)-phenyl]-3-methoxyacrylate, methyl (E)-2-[2-(3,5-dichlorophenoxy)pyridin-3-yl]-3- methoxyacrylate, methyl (E)-2-(2-(3-(1 , 1 ,2,2-tetrafluoroethoxy)phenoxy)phenyl)-3-methoxyacrylate, methyl (E)-2-(2-[3-(alpha-hydroxybenzyl)phenoxy]phenyl)-3-methoxyacrylate, methyl (E)-2-(2-(4- phenoxypyridin-2-yloxy)phenyl)-3-methoxyacrylate, methyl (E)-2-[2-(3-n-propyloxy-phenoxy)phenyl]3- methoxyacrylate, methyl (E)-2-[2-(3-isopropyloxyphenoxy)phenyl]-3-methoxyacrylate, methyl (E)-2-[2- [3-(2-fluorophenoxy)phenoxy]phenyl]-3-methoxyacrylate, methyl (E)-2-[2-(3-ethoxyphenoxy)phenyl]-3- methoxyacrylate, methyl (E)-2-[2-(4-ieri-butyl-pyridin-2-yloxy)phenyl]-3-methoxyacrylate, methyl (E)-2- [2-[3-(3-cyanophenoxy)phenoxy]phenyl]-3-methoxyacrylate, methyl (E)-2-[2-[(3-methyl-pyridin-2- yloxymethyl)phenyl]-3-methoxyacrylate, methyl (E)-2-[2-[6-(2-methyl-phenoxy)pyrimidin-4- yloxy]phenyl]-3-methoxyacrylate, methyl (E)-2-[2-(5-bromo-pyridin-2-yloxymethyl)phenyl]-3- methoxyacrylate, methyl (E)-2-[2-(3-(3-iodopyridin-2-yloxy)phenoxy)phenyl]-3-methoxyacrylate, methyl (E)-2-[2-[6-(2-chloropyridin-3-yloxy)pyrimidin-4-yloxy]phenyl]-3-methoxyac rylate, methyl (E),(E)-2-[2- (5,6-dimethylpyrazin-2-ylmethyloximinomethyl)phenyl]-3-methox yacrylate, methyl (E)-2-{2-[6-(6- methylpyridin-2-yloxy)pyrimidin-4-yloxy]phenyl}-3-methoxy-a crylate, methyl (E),(E)-2-{ 2-(3- methoxyphenyl)methyloximinomethyl]-phenyl}-3-methoxyacrylate, methyl (E)-2-{2-(6-(2- azidophenoxy)-pyrimidin-4-yloxy]phenyl}-3-methoxyacrylate, methyl (E),(E)-2-{2-[6-phenylpyrimidin-4- yl)-methyloximinomethyl]phenyl}-3-methox yacrylate, methyl (E),(E)-2-{2-[(4-chlorophenyl)- methyloximinomethyl]-phenyl}-3-methoxyacryl ate, methyl (E)-2-{2-[6-(2-n-propylphenoxy)-1 ,3,5- triazin-4-yloxy]phenyl}-3-methoxyacr ylate, methyl (E),(E)-2-{2-[(3- nitrophenyl)methyloximinomethyl]phenyl}-3-methoxyacrylate, 3-chloro-7-(2-aza-2,7,7-trimethyl-oct-3- en-5-ine), 2,6-dichloro-N-(4-trifluoromethylbenzyl)-benzamide, 3-iodo-2-propinyl alcohol, 4- chlorophenyl-3-iodopropargyl formal, 3-bromo-2,3-diiodo-2-propenyl ethylcarbamate, 2,3,3-triiodoallyl alcohol, 3-bromo-2,3-diiodo-2-propenyl alcohol, 3-iodo-2-propinyl n-butylcarbamate, 3-iodo-2-propinyl n-hexylcarbamate, 3-iodo-2-propinyl cyclohexyl-carbamate, 3-iodo-2-propinyl phenylcarbamate; phenol derivatives, such as tribromophenol, tetrachlorophenol, 3-methyl-4-chlorophenol, 3,5-dimethyl- 4-chlorophenol, phenoxyethanol, dichlorophene, o-phenylphenol, m-phenylphenol, p-phenylphenol, 2- benzyl-4-chlorophenol, 5-hydroxy-2(5H)-furanone; 4,5-dichlorodithiazolinone, 4,5-benzodithiazolinone, 4,5-trimethylenedithiazolinone, 4,5-dichloro-(3H)-1 ,2-dithiol-3-one, 3,5-dimethyl-tetrahydro-1 ,3,5- thiadiazine-2-thione, N-(2-p-chlorobenzoylethyl)-hexaminium chloride, acibenzolar, acypetacs, alanycarb, albendazole, aldimorph, allicin, allyl alcohol, ametoctradin, amisulbrom, amobam, ampropylfos, anilazine, asomate, aureofungin, azaconazole, azafendin, azithiram, azoxystrobin, barium polysulfide, benalaxyl, benalaxyl-M, benodanil, benomyl, benquinox, bentaluron, benthiavalicarb, benthiazole, benzalkonium chloride, benzamacril, benzamorf, benzohydroxamic acid, benzovindiflupyr, berberine, bethoxazin, biloxazol, binapacryl, biphenyl, bitertanol, bithionol, bixafen, blasticidin-S, boscalid, bromothalonil, bromuconazole, bupirimate, buthiobate, butylamine calcium polysulfide, captafol, captan, carbamorph, carbendazim, carbendazim chlorhydrate, carboxin, carpropamid, carvone, CGA41396, CGA41397, chinomethionate, chitosan, chlobenthiazone, chloraniformethan, chloranil, chlorfenazole, chloroneb, chloropicrin, chlorothalonil, chlorozolinate, chlozolinate, climbazole, clotrimazole, clozylacon, copper containing compounds such as copper acetate, copper carbonate, copper hydroxide, copper naphthenate, copper oleate, copper oxychloride, copper oxyquinolate, copper silicate, copper sulphate, copper tallate, copper zinc chromate and Bordeaux mixture, cresol, cufraneb, cuprobam, cuprous oxide, cyazofamid, cyclafuramid, cycloheximide, cyflufenamid, cymoxanil, cypendazole, cyproconazole, cyprodinil, dazomet, debacarb, decafentin, dehydroacetic acid, di-2- pyridyl disulphide 1 , 1 '-dioxide, dichlofluanid, diclomezine, dichlone, dicloran, dichlorophen, dichlozoline, diclobutrazol, diclocymet, diethofencarb, difenoconazole, difenzoquat, diflumetorim, O, O- di-iso-propyl-S-benzyl thiophosphate, dimefluazole, dimetachlone, dimetconazole, dimethomorph, dimethirimol, diniconazole, diniconazole-M, dinobuton, dinocap, dinocton, dinopenton, dinosulfon, dinoterbon, diphenylamine, dipyrithione, disulfiram, ditalimfos, dithianon, dithioether, dodecyl dimethyl ammonium chloride, dodemorph, dodicin, dodine, doguadine, drazoxolon, edifenphos, enestroburin, epoxiconazole, etaconazole, etem, ethaboxam, ethirimol, ethoxyquin, ethilicin, ethyl (Z)-N-benzyl-N ([methyl (methyl-thioethylideneamino- oxycarbonyl) amino] thio)^-alaninate, etridiazole, famoxadone, fenamidone, fenaminosulf, fenapanil, fenarimol, fenbuconazole, fenfuram, fenhexamid, fenitropan, fenoxanil, fenpiclonil, fenpicoxamid, fenpropidin, fenpropimorph, fenpyrazamine, fentin acetate, fentin hydroxide, ferbam, ferimzone, fluazinam, fludioxonil, flumetover, flumorph, flupicolide, fluopyram, fluoroimide, fluotrimazole, fluoxastrobin, fluquinconazole, flusilazole, flusulfamide, flutanil, flutolanil, flutriafol, fluxapyroxad, folpet, formaldehyde, fosetyl, fuberidazole, furalaxyl, furametpyr, furcarbanil, furconazole, furfural, furmecyclox, furophanate, glyodin, griseofulvin, guazatine, halacrinate, hexa chlorobenzene, hexachlorobutadiene, hexachlorophene, hexaconazole, hexylthiofos, hydrargaphen, hydroxyisoxazole, hymexazole, imazalil, imazalil sulphate, imibenconazole, iminoctadine, iminoctadine triacetate, inezin, iodocarb, ipconazole, ipfentrifluconazole, iprobenfos, iprodione, iprovalicarb, isopropanyl butyl carbamate, isoprothiolane, isopyrazam, isotianil, isovaledione, izopamfos, kasugamycin, kresoxim-methyl, LY186054, LY21 1795, LY248908, mancozeb, mandipropamid, maneb, mebenil, mecarbinzid, mefenoxam, mefentrifluconazole, mepanipyrim, mepronil, mercuric chloride, mercurous chloride, meptyldinocap, metalaxyl, metalaxyl-M, metam, metazoxolon, metconazole, methasulfocarb, methfuroxam, methyl bromide, methyl iodide, methyl isothiocyanate, metiram, metiram-zinc, metominostrobin, metrafenone, metsulfovax, milneb, moroxydine, myclobutanil, myclozolin, nabam, natamycin, neoasozin, nickel dimethyldithiocarbamate, nitrostyrene, nitrothal-iso- propyl, nuarimol, octhilinone, ofurace, organomercury compounds, orysastrobin, osthol, oxadixyl, oxasulfuron, oxine-copper, oxolinic acid, oxpoconazole, oxycarboxin, parinol, pefurazoate, penconazole, pencycuron, penflufen, pentachlorophenol, penthiopyrad, phenamacril, phenazin oxide, phosdiphen, phosetyl-AI, phosphorus acids, phthalide, picoxystrobin, piperalin, polycarbamate, polyoxin D, polyoxrim, polyram, probenazole, prochloraz, procymidone, propamidine, propamocarb, propiconazole, propineb, propionic acid, proquinazid, prothiocarb, prothioconazole, pydiflumetofen, pyracarbolid, pyraclostrobin, pyrametrostrobin, pyraoxystrobin, pyrazophos, pyribencarb, pyridinitril, pyrifenox, pyrimethanil, pyriofenone, pyroquilon, pyroxychlor, pyroxyfur, pyrrolnitrin, quaternary ammonium compounds, quinacetol, quinazamid, quinconazole, quinomethionate, quinoxyfen, quintozene, rabenzazole, santonin, sedaxane, silthiofam, simeconazole, sipconazole, sodium pentachlorophenate, spiroxamine, streptomycin, sulphur, sultropen, tebuconazole, tebfloquin, tecloftalam, tecnazene, tecoram, tetraconazole, thiabendazole, thiadifluor, thicyofen, thifluzamide, 2- (thiocyanomethylthio) benzothiazole, thiophanate-methyl, thioquinox, thiram, tiadinil, timibenconazole, tioxymid, tolclofos-m ethyl, tolylfluanid, triadimefon, triadimenol, triamiphos, triarimol, triazbutil, triazoxide, tricyclazole, tridemorph, trifloxystrobin, triflumazole, triforine, triflumizole, triticonazole, uniconazole, urbacide, validamycin, valifenalate, vapam, vinclozolin, zarilamid, zineb, ziram, and zoxamide.
The compounds of the invention may also be used in combination with anthelmintic agents. Such anthelmintic agents include, compounds selected from the macrocyclic lactone class of compounds such as ivermectin, avermectin, abamectin, emamectin, eprinomectin, doramectin, selamectin, moxidectin, nemadectin and milbemycin derivatives as described in EP- 357460, EP- 444964 and EP-594291. Additional anthelmintic agents include semisynthetic and biosynthetic avermectin/milbemycin derivatives such as those described in US-5015630, WO-9415944 and WO- 9522552. Additional anthelmintic agents include the benzimidazoles such as albendazole, cambendazole, fenbendazole, flubendazole, mebendazole, oxfendazole, oxibendazole, parbendazole, and other members of the class. Additional anthelmintic agents include imidazothiazoles and tetrahydropyrimidines such as tetramisole, levamisole, pyrantel pamoate, oxantel or morantel. Additional anthelmintic agents include flukicides, such as triclabendazole and clorsulon and the cestocides, such as praziquantel and epsiprantel. The compounds of the invention may be used in combination with derivatives and analogues of the paraherquamide/marcfortine class of anthelmintic agents, as well as the antiparasitic oxazolines such as those disclosed in US-5478855, US- 4639771 and DE-19520936.
The compounds of the invention may be used in combination with derivatives and analogues of the general class of dioxomorpholine antiparasitic agents as described in WO 96/15121 and also with anthelmintic active cyclic depsipeptides such as those described in WO 96/1 1945, WO 93/19053, WO 93/25543, EP 0 626 375, EP 0 382 173, WO 94/19334, EP 0 382 173, and EP 0 503 538.
The compounds of the invention may be used in combination with other ectoparasiticides; for example, fipronil; pyrethroids; organophosphates; insect growth regulators such as lufenuron; ecdysone agonists such as tebufenozide and the like; neonicotinoids such as imidacloprid and the like.
The compounds of the invention may be used in combination with terpene alkaloids, for example those described in International Patent Application Publication Numbers WO 95/19363 or WO 04/72086, particularly the compounds disclosed therein.
Other examples of such biologically active compounds that the compounds of the invention may be used in combination with include but are not restricted to the following:
Organophosphates: acephate, azamethiphos, azinphos-ethyl, azinphos- methyl, bromophos, bromophos-ethyl, cadusafos, chlorethoxyphos, chlorpyrifos, chlorfenvinphos, chlormephos, demeton, demeton-S-methyl, demeton-S-methyl sulphone, dialifos, diazinon, dichlorvos, dicrotophos, dimethoate, disulfoton, ethion, ethoprophos, etrimfos, famphur, fenamiphos, fenitrothion, fensulfothion, fenthion, flupyrazofos, fonofos, formothion, fosthiazate, heptenophos, isazophos, isothioate, isoxathion, malathion, methacriphos, methamidophos, methidathion, methyl- parathion, mevinphos, monocrotophos, naled, omethoate, oxydemeton-methyl, paraoxon, parathion, parathion-methyl, phenthoate, phosalone, phosfolan, phosphocarb, phosmet, phosphamidon, phorate, phoxim, pirimiphos, pirimiphos- methyl, profenofos, propaphos, proetamphos, prothiofos, pyraclofos, pyridapenthion, quinalphos, sulprophos, temephos, terbufos, tebupirimfos, tetrachlorvinphos, thimeton, triazophos, trichlorfon, vamidothion.
Carbamates: alanycarb, aldicarb, 2-sec-butylphenyl methylcarbamate, benfuracarb, carbaryl, carbofuran, carbosulfan, cloethocarb, ethiofencarb, fenoxycarb, fenthiocarb, furathiocarb, HCN-801 , isoprocarb, indoxacarb, methiocarb, methomyl, 5-methyl-m-cumenylbutyryl(methyl)carbamate, oxamyl, pirimicarb, propoxur, thiodicarb, thiofanox, triazamate, UC-51717.
Pyrethroids: acrinathin, allethrin, alphametrin, 5-benzyl-3-furylmethyl (E)-(1 R)-cis-2,2- dimethyl-3-(2-oxothiolan-3-ylidenemethyl)cyclopropanecarboxylate, bifenthrin, beta-cyfluthrin, cyfluthrin, a-cypermethrin, beta-cypermethrin, bioallethrin, bioallethrin((S)-cyclopentylisomer), bioresmethrin, bifenthrin, NCI-85193, cycloprothrin, cyhalothrin, cythithrin, cyphenothrin, deltamethrin, empenthrin, esfenvalerate, ethofenprox, fenfluthrin, fenpropathrin, fenvalerate, flucythrinate, flumethrin, fluvalinate (D isomer), imiprothrin, cyhalothrin, lambda-cyhalothrin, permethrin, phenothrin, prallethrin, pyrethrins (natural products), resmethrin, tetramethrin, transfluthrin, theta-cypermethrin, silafluofen, t- fluvalinate, tefluthrin, tralomethrin, Zeta-cypermethrin.
Arthropod growth regulators: a) chitin synthesis inhibitors: benzoylureas: chlorfluazuron, diflubenzuron, fluazuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, teflubenzuron, triflumuron, buprofezin, diofenolan, hexythiazox, etoxazole, chlorfentazine; b) ecdysone antagonists: halofenozide, methoxyfenozide, tebufenozide; c) juvenoids: pyriproxyfen, methoprene (including S-methoprene), fenoxycarb; d) lipid biosynthesis inhibitors: spirodiclofen.
Other antiparasitics: acequinocyl, amitraz, AKD-1022, ANS-1 18, azadirachtin, Bacillus thuringiensis, bensultap, bifenazate, binapacryl, bromopropylate, BTG-504, BTG-505, camphechlor, cartap, chlorobenzilate, chlordimeform, chlorfenapyr, chromafenozide, clothianidine, cyromazine, diacloden, diafenthiuron, DBI-3204, dinactin, dihydroxymethyldihydroxypyrrolidine, dinobuton, dinocap, endosulfan, ethiprole, ethofenprox, fenazaquin, flumite, MTI- 800, fenpyroximate, fluacrypyrim, flubenzimine, flubrocythrinate, flufenzine, flufenprox, fluproxyfen, halofenprox, hydramethylnon, IKI- 220, kanemite, NC-196, neem guard, nidinorterfuran, nitenpyram, SD-35651 , WL-108477, pirydaryl, propargite, protrifenbute, pymethrozine, pyridaben, pyrimidifen, NC-1 1 1 1 , R-195,RH-0345, RH-2485, RYI-210, S-1283, S-1833, SI-8601 , silafluofen, silomadine, spinosad, tebufenpyrad, tetradifon, tetranactin, thiacloprid, thiocyclam, thiamethoxam, tolfenpyrad, triazamate, triethoxyspinosyn, trinactin, verbutin, vertalec, YI-5301.
Biological agents: Bacillus thuringiensis ssp aizawai, kurstaki, Bacillus thuringiensis delta endotoxin, baculovirus, entomopathogenic bacteria, virus and fungi.
Bactericides: chlortetracycline, oxytetracycline, streptomycin.
Other biological agents: enrofloxacin, febantel, penethamate, moloxicam, cefalexin, kanamycin, pimobendan, clenbuterol, omeprazole, tiamulin, benazepril, pyriprole, cefquinome, florfenicol, buserelin, cefovecin, tulathromycin, ceftiour, carprofen, metaflumizone, praziquarantel, thiabendazole.
The following mixtures of the compounds of Formula (I) with active ingredients are preferred. The abbreviation "TX" means one compound selected from the group consisting of the compounds as represented in Tables 1.1 to 1.3 and Tables 2.1 and 2.2 (below), or the compounds 1.1 to 1.190 described in Table T1 , (below):
an adjuvant selected from the group of substances consisting of petroleum oils (alternative name) (628) + TX,
an acaricide selected from the group of substances consisting of 1 , 1-bis(4-chlorophenyl)-2- ethoxyethanol (lUPAC name) (910) + TX, 2,4-dichlorophenyl benzenesulfonate (lUPAC/Chemical Abstracts name) (1059) + TX, 2-fluoro-A/-methyl-A/-1-naphthylacetamide (lUPAC name) (1295) + TX, 4-chlorophenyl phenyl sulfone (lUPAC name) (981 ) + TX, abamectin (1 ) + TX, acequinocyl (3) + TX, acetoprole [CCN] + TX, acrinathrin (9) + TX, aldicarb (16) + TX, aldoxycarb (863) + TX, alpha- cypermethrin (202) + TX, amidithion (870) + TX, amidoflumet [CCN] + TX, amidothioate (872) + TX, amiton (875) + TX, amiton hydrogen oxalate (875) + TX, amitraz (24) + TX, aramite (881 ) + TX, arsenous oxide (882) + TX, AVI 382 (compound code) + TX, AZ 60541 (compound code) + TX, azinphos-ethyl (44) + TX, azinphos-methyl (45) + TX, azobenzene (lUPAC name) (888) + TX, azocyclotin (46) + TX, azothoate (889) + TX, benomyl (62) + TX, benoxafos (alternative name) [CCN] + TX, benzoximate (71 ) + TX, benzyl benzoate (lUPAC name) [CCN] + TX, bifenazate (74) + TX, bifenthrin (76) + TX, binapacryl (907) + TX, brofenvalerate (alternative name) + TX, bromocyclen (918) + TX, bromophos (920) + TX, bromophos-ethyl (921 ) + TX, bromopropylate (94) + TX, buprofezin (99) + TX, butocarboxim (103) + TX, butoxycarboxim (104) + TX, butylpyridaben (alternative name) + TX, calcium polysulfide (lUPAC name) (1 11 ) + TX, camphechlor (941 ) + TX, carbanolate (943) + TX, carbaryl (1 15) + TX, carbofuran (1 18) + TX, carbophenothion (947) + TX, CGA 50'439 (development code) (125) + TX, chinomethionat (126) + TX, chlorbenside (959) + TX, chlordimeform (964) + TX, chlordimeform hydrochloride (964) + TX, chlorfenapyr (130) + TX, chlorfenethol (968) + TX, chlorfenson (970) + TX, chlorfensulfide (971 ) + TX, chlorfenvinphos (131 ) + TX, chlorobenzilate (975) + TX, chloromebuform (977) + TX, chloromethiuron (978) + TX, chloropropylate (983) + TX, chlorpyrifos (145) + TX, chlorpyrifos-methyl (146) + TX, chlorthiophos (994) + TX, cinerin I (696) + TX, cinerin II (696) + TX, cinerins (696) + TX, clofentezine (158) + TX, closantel (alternative name) [CCN] + TX, coumaphos (174) + TX, crotamiton (alternative name) [CCN] + TX, crotoxyphos (1010) + TX, cufraneb (1013) + TX, cyanthoate (1020) + TX, cyflumetofen (CAS Reg. No.: 400882-07-7) + TX, cyhalothrin (196) + TX, cyhexatin (199) + TX, cypermethrin (201 ) + TX, DCPM (1032) + TX, DDT (219) + TX, demephion (1037) + TX, demephion-0 (1037) + TX, demephion-S (1037) + TX, demeton (1038) + TX, demeton-methyl (224) + TX, demeton-0 (1038) + TX, demeton-O-methyl (224) + TX, demeton-S (1038) + TX, demeton- S-methyl (224) + TX, demeton-S-methylsulfon (1039) + TX, diafenthiuron (226) + TX, dialifos (1042) + TX, diazinon (227) + TX, dichlofluanid (230) + TX, dichlorvos (236) + TX, dicliphos (alternative name) + TX, dicofol (242) + TX, dicrotophos (243) + TX, dienochlor (1071 ) + TX, dimefox (1081 ) + TX, dimethoate (262) + TX, dinactin (alternative name) (653) + TX, dinex (1089) + TX, dinex-diclexine (1089) + TX, dinobuton (269) + TX, dinocap (270) + TX, dinocap-4 [CCN] + TX, dinocap-6 [CCN] + TX, dinocton (1090) + TX, dinopenton (1092) + TX, dinosulfon (1097) + TX, dinoterbon (1098) + TX, dioxathion (1 102) + TX, diphenyl sulfone (lUPAC name) (1 103) + TX, disulfiram (alternative name) [CCN] + TX, disulfoton (278) + TX, DNOC (282) + TX, dofenapyn (1 1 13) + TX, doramectin (alternative name) [CCN] + TX, endosulfan (294) + TX, endothion (1 121 ) + TX, EPN (297) + TX, eprinomectin (alternative name) [CCN] + TX, ethion (309) + TX, ethoate-methyl (1 134) + TX, etoxazole (320) + TX, etrimfos (1 142) + TX, fenazaflor (1 147) + TX, fenazaquin (328) + TX, fenbutatin oxide (330) + TX, fenothiocarb (337) + TX, fenpropathrin (342) + TX, fenpyrad (alternative name) + TX, fenpyroximate (345) + TX, fenson (1 157) + TX, fentrifanil (1 161 ) + TX, fenvalerate (349) + TX, fipronil (354) + TX, fluacrypyrim (360) + TX, fluazuron (1 166) + TX, flubenzimine (1 167) + TX, flucycloxuron (366) + TX, flucythrinate (367) + TX, fluenetil (1 169) + TX, flufenoxuron (370) + TX, flumethrin (372) + TX, fluorbenside (1 174) + TX, fluvalinate (1 184) + TX, FMC 1 137 (development code) (1 185) + TX, formetanate (405) + TX, formetanate hydrochloride (405) + TX, formothion (1 192) + TX, formparanate (1 193) + TX, gamma-HCH (430) + TX, glyodin (1205) + TX, halfenprox (424) + TX, heptenophos (432) + TX, hexadecyl cyclopropanecarboxylate (lUPAC/Chemical Abstracts name) (1216) + TX, hexythiazox (441 ) + TX, iodomethane (lUPAC name) (542) + TX, isocarbophos (alternative name) (473) + TX, isopropyl 0-(methoxyaminothiophosphoryl)salicylate (lUPAC name) (473) + TX, ivermectin (alternative name) [CCN] + TX, jasmolin I (696) + TX, jasmolin II (696) + TX, jodfenphos (1248) + TX, lindane (430) + TX, lufenuron (490) + TX, malathion (492) + TX, malonoben (1254) + TX, mecarbam (502) + TX, mephosfolan (1261 ) + TX, mesulfen (alternative name) [CCN] + TX, methacrifos (1266) + TX, methamidophos (527) + TX, methidathion (529) + TX, methiocarb (530) + TX, methomyl (531 ) + TX, methyl bromide (537) + TX, metolcarb (550) + TX, mevinphos (556) + TX, mexacarbate (1290) + TX, milbemectin (557) + TX, milbemycin oxime (alternative name) [CCN] + TX, mipafox (1293) + TX, monocrotophos (561 ) + TX, morphothion (1300) + TX, moxidectin (alternative name) [CCN] + TX, naled (567) + TX, NC-184 (compound code) + TX, NC-512 (compound code) + TX, nifluridide (1309) + TX, nikkomycins (alternative name) [CCN] + TX, nitrilacarb (1313) + TX, nitrilacarb 1 : 1 zinc chloride complex (1313) + TX, NNI-0101 (compound code) + TX, NNI-0250 (compound code) + TX, omethoate (594) + TX, oxamyl (602) + TX, oxydeprofos (1324) + TX, oxydisulfoton (1325) + TX, pp'-DDT (219) + TX, parathion (615) + TX, permethrin (626) + TX, petroleum oils (alternative name) (628) + TX, phenkapton (1330) + TX, phenthoate (631 ) + TX, phorate (636) + TX, phosalone (637) + TX, phosfolan (1338) + TX, phosmet (638) + TX, phosphamidon (639) + TX, phoxim (642) + TX, pirimiphos-methyl (652) + TX, polychloroterpenes (traditional name) (1347) + TX, polynactins (alternative name) (653) + TX, proclonol (1350) + TX, profenofos (662) + TX, promacyl (1354) + TX, propargite (671 ) + TX, propetamphos (673) + TX, propoxur (678) + TX, prothidathion (1360) + TX, prothoate (1362) + TX, pyrethrin I (696) + TX, pyrethrin II (696) + TX, pyrethrins (696) + TX, pyridaben (699) + TX, pyridaphenthion (701 ) + TX, pyrimidifen (706) + TX, pyrimitate (1370) + TX, quinalphos (71 1 ) + TX, quintiofos (1381 ) + TX, R-1492 (development code) (1382) + TX, RA-17 (development code) (1383) + TX, rotenone (722) + TX, schradan (1389) + TX, sebufos (alternative name) + TX, selamectin (alternative name) [CCN] + TX, Sl- 0009 (compound code) + TX, sophamide (1402) + TX, spirodiclofen (738) + TX, spiromesifen (739) + TX, SSI-121 (development code) (1404) + TX, sulfiram (alternative name) [CCN] + TX, sulfluramid (750) + TX, sulfotep (753) + TX, sulfur (754) + TX, SZI-121 (development code) (757) + TX, tau-fluvalinate (398) + TX, tebufenpyrad (763) + TX, TEPP (1417) + TX, terbam (alternative name) + TX, tetrachlorvinphos (777) + TX, tetradifon (786) + TX, tetranactin (alternative name) (653) + TX, tetrasul (1425) + TX, thiafenox (alternative name) + TX, thiocarboxime (1431 ) + TX, thiofanox (800) + TX, thiometon (801 ) + TX, thioquinox (1436) + TX, thuringiensin (alternative name) [CCN] + TX, triamiphos (1441 ) + TX, triarathene (1443) + TX, triazophos (820) + TX, triazuron (alternative name) + TX, trichlorfon (824) + TX, trifenofos (1455) + TX, trinactin (alternative name) (653) + TX, vamidothion (847) + TX, vaniliprole [CCN] and YI-5302 (compound code) + TX,
an algicide selected from the group of substances consisting of bethoxazin [CCN] + TX, copper dioctanoate (lUPAC name) (170) + TX, copper sulfate (172) + TX, cybutryne [CCN] + TX, dichlone (1052) + TX, dichlorophen (232) + TX, endothal (295) + TX, fentin (347) + TX, hydrated lime [CCN] + TX, nabam (566) + TX, quinoclamine (714) + TX, quinonamid (1379) + TX, simazine (730) + TX, triphenyltin acetate (lUPAC name) (347) and triphenyltin hydroxide (lUPAC name) (347) + TX,
an anthelmintic selected from the group of substances consisting of abamectin (1 ) + TX, crufomate (101 1 ) + TX, doramectin (alternative name) [CCN] + TX, emamectin (291 ) + TX, emamectin benzoate (291 ) + TX, eprinomectin (alternative name) [CCN] + TX, ivermectin (alternative name) [CCN] + TX, milbemycin oxime (alternative name) [CCN] + TX, moxidectin (alternative name) [CCN] + TX, piperazine [CCN] + TX, selamectin (alternative name) [CCN] + TX, spinosad (737) and thiophanate (1435) + TX,
an avicide selected from the group of substances consisting of chloralose (127) + TX, endrin (1 122) + TX, fenthion (346) + TX, pyridin-4-amine (lUPAC name) (23) and strychnine (745) + TX, a bactericide selected from the group of substances consisting of 1-hydroxy-1 /-/-pyridine-2- thione (lUPAC name) (1222) + TX, 4-(quinoxalin-2-ylamino)benzenesulfonamide (lUPAC name) (748) + TX, 8-hydroxyquinoline sulfate (446) + TX, bronopol (97) + TX, copper dioctanoate (lUPAC name) (170) + TX, copper hydroxide (lUPAC name) (169) + TX, cresol [CCN] + TX, dichlorophen (232) + TX, dipyrithione (1 105) + TX, dodicin (1 1 12) + TX, fenaminosulf (1 144) + TX, formaldehyde (404) + TX, hydrargaphen (alternative name) [CCN] + TX, kasugamycin (483) + TX, kasugamycin hydrochloride hydrate (483) + TX, nickel bis(dimethyldithiocarbamate) (lUPAC name) (1308) + TX, nitrapyrin (580) + TX, octhilinone (590) + TX, oxolinic acid (606) + TX, oxytetracycline (61 1 ) + TX, potassium hydroxyquinoline sulfate (446) + TX, probenazole (658) + TX, streptomycin (744) + TX, streptomycin sesquisulfate (744) + TX, tecloftalam (766) + TX, and thiomersal (alternative name) [CCN] + TX, a biological agent selected from the group of substances consisting of Adoxophyes orana GV (alternative name) (12) + TX, Agrobacterium radiobacter (alternative name) (13) + TX, Amblyseius spp. (alternative name) (19) + TX, Anagrapha falcifera NPV (alternative name) (28) + TX, Anagrus atomus (alternative name) (29) + TX, Aphelinus abdominalis (alternative name) (33) + TX, Aphidius colemani (alternative name) (34) + TX, Aphidoletes aphidimyza (alternative name) (35) + TX, Autographa californica NPV (alternative name) (38) + TX, Bacillus firmus (alternative name) (48) + TX, Bacillus sphaericus Neide (scientific name) (49) + TX, Bacillus thuringiensis Berliner (scientific name) (51 ) + TX, Bacillus thuringiensis subsp. aizawai (scientific name) (51 ) + TX, Bacillus thuringiensis subsp. israelensis (scientific name) (51 ) + TX, Bacillus thuringiensis subsp. japonensis (scientific name) (51 ) + TX, Bacillus thuringiensis subsp. kurstaki (scientific name) (51 ) + TX, Bacillus thuringiensis subsp. tenebrionis (scientific name) (51 ) + TX, Beauveria bassiana (alternative name) (53) + TX, Beauveria brongniartii (alternative name) (54) + TX, Chrysoperla carnea (alternative name) (151 ) + TX, Cryptolaemus montrouzieri (alternative name) (178) + TX, Cydia pomonella GV (alternative name) (191 ) + TX, Dacnusa sibirica (alternative name) (212) + TX, Diglyphus isaea (alternative name) (254) + TX, Encarsia formosa (scientific name) (293) + TX, Eretmocerus eremicus (alternative name) (300) + TX, Helicoverpa zea NPV (alternative name) (431 ) + TX, Heterorhabditis bacteriophora and H. megidis (alternative name) (433) + TX, Hippodamia convergens (alternative name) (442) + TX, Leptomastix dactylopii (alternative name) (488) + TX, Macrolophus caliginosus (alternative name) (491 ) + TX, Mamestra brassicae NPV (alternative name) (494) + TX, Metaphycus helvolus (alternative name) (522) + TX, Metarhizium anisopliae var. acridum (scientific name) (523) + TX, Metarhizium anisopliae var. anisopliae (scientific name) (523) + TX, Neodiprion sertifer NPV and N. lecontei NPV (alternative name) (575) + TX, Orius spp. (alternative name) (596) + TX, Paecilomyces fumosoroseus (alternative name) (613) + TX, Phytoseiulus persimilis (alternative name) (644) + TX, Spodoptera exigua multicapsid nuclear polyhedrosis virus (scientific name) (741 ) + TX, Steinemema bibionis (alternative name) (742) + TX, Steinemema carpocapsae (alternative name) (742) + TX, Steinemema feltiae (alternative name) (742) + TX, Steinemema glaseri (alternative name) (742) + TX, Steinemema riobrave (alternative name) (742) + TX, Steinemema riobravis (alternative name) (742) + TX, Steinemema scapterisci (alternative name) (742) + TX, Steinemema spp. (alternative name) (742) + TX, Trichogramma spp. (alternative name) (826) + TX, Typhlodromus occidentalis (alternative name) (844) and Verticillium lecanii (alternative name) (848) + TX, bacillus subtilis var. amyloliquefaciens Strain FZB24 (available from Novozymes Biologicals Inc., 5400 Corporate Circle, Salem, VA 24153, U.S.A. and known under the trade name Taegro®) + TX,
a soil sterilant selected from the group of substances consisting of iodomethane (lUPAC name) (542) and methyl bromide (537) + TX,
a chemosterilant selected from the group of substances consisting of apholate [CCN] + TX, bisazir (alternative name) [CCN] + TX, busulfan (alternative name) [CCN] + TX, diflubenzuron (250) + TX, dimatif (alternative name) [CCN] + TX, hemel [CCN] + TX, hempa [CCN] + TX, metepa [CCN] + TX, methiotepa [CCN] + TX, methyl apholate [CCN] + TX, morzid [CCN] + TX, penfluron (alternative name) [CCN] + TX, tepa [CCN] + TX, thiohempa (alternative name) [CCN] + TX, thiotepa (alternative name) [CCN] + TX, tretamine (alternative name) [CCN] and uredepa (alternative name) [CCN] + TX, an insect pheromone selected from the group of substances consisting of (E)-dec-5-en-1-yl acetate with (E)-dec-5-en-1-ol (lUPAC name) (222) + TX, (E)-tridec-4-en-1-yl acetate (lUPAC name) (829) + TX, (E)-6-methylhept-2-en-4-ol (lUPAC name) (541 ) + TX, (E,Z)-tetradeca-4, 10-dien-1-yl acetate (lUPAC name) (779) + TX, (Z)-dodec-7-en-1-yl acetate (lUPAC name) (285) + TX, (Z)-hexadec- 1 1-enal (lUPAC name) (436) + TX, (Z)-hexadec-l 1-en-1-yl acetate (lUPAC name) (437) + TX, (Z)- hexadec-13-en-1 1-yn-1-yl acetate (lUPAC name) (438) + TX, (Z)-icos-13-en-10-one (lUPAC name) (448) + TX, (Z)-tetradec-7-en-1-al (lUPAC name) (782) + TX, (Z)-tetradec-9-en-1-ol (lUPAC name) (783) + TX, (Z)-tetradec-9-en-1-yl acetate (lUPAC name) (784) + TX, (7E,9Z)-dodeca-7,9-dien-1-yl acetate (lUPAC name) (283) + TX, (9Z, 1 1 E)-tetradeca-9, 1 1-dien-1-yl acetate (lUPAC name) (780) + TX, (9Z, 12E)-tetradeca-9, 12-dien-1-yl acetate (lUPAC name) (781 ) + TX, 14-methyloctadec-1-ene (lUPAC name) (545) + TX, 4-methylnonan-5-ol with 4-methylnonan-5-one (lUPAC name) (544) + TX, alpha-multistriatin (alternative name) [CCN] + TX, brevicomin (alternative name) [CCN] + TX, codlelure (alternative name) [CCN] + TX, codlemone (alternative name) (167) + TX, cuelure (alternative name) (179) + TX, disparlure (277) + TX, dodec-8-en-1-yl acetate (lUPAC name) (286) + TX, dodec-9-en-1-yl acetate (lUPAC name) (287) + TX, dodeca-8 + TX, 10-dien-1-yl acetate (lUPAC name) (284) + TX, dominicalure (alternative name) [CCN] + TX, ethyl 4-methyloctanoate (lUPAC name) (317) + TX, eugenol (alternative name) [CCN] + TX, frontalin (alternative name) [CCN] + TX, gossyplure (alternative name) (420) + TX, grandlure (421 ) + TX, grandlure I (alternative name) (421 ) + TX, grandlure II (alternative name) (421 ) + TX, grandlure III (alternative name) (421 ) + TX, grandlure IV (alternative name) (421 ) + TX, hexalure [CCN] + TX, ipsdienol (alternative name) [CCN] + TX, ipsenol (alternative name) [CCN] + TX, japonilure (alternative name) (481 ) + TX, lineatin (alternative name) [CCN] + TX, litlure (alternative name) [CCN] + TX, looplure (alternative name) [CCN] + TX, medlure [CCN] + TX, megatomoic acid (alternative name) [CCN] + TX, methyl eugenol (alternative name) (540) + TX, muscalure (563) + TX, octadeca-2, 13-dien-1-yl acetate (lUPAC name) (588) + TX, octadeca-3, 13-dien- 1-yl acetate (lUPAC name) (589) + TX, orfralure (alternative name) [CCN] + TX, oryctalure (alternative name) (317) + TX, ostramone (alternative name) [CCN] + TX, siglure [CCN] + TX, sordidin (alternative name) (736) + TX, sulcatol (alternative name) [CCN] + TX, tetrad ec- 1 1 -en- 1-yl acetate (lUPAC name) (785) + TX, trimedlure (839) + TX, trimedlure A (alternative name) (839) + TX, trimedlure Bi (alternative name) (839) + TX, trimedlure B2 (alternative name) (839) + TX, trimedlure C (alternative name) (839) and trunc-call (alternative name) [CCN] + TX, an insect repellent selected from the group of substances consisting of 2-(octylthio)ethanol (lUPAC name) (591 ) + TX, butopyronoxyl (933) + TX, butoxy(polypropylene glycol) (936) + TX, dibutyl adipate (lUPAC name) (1046) + TX, dibutyl phthalate (1047) + TX, dibutyl succinate (lUPAC name) (1048) + TX, diethylamide [CCN] + TX, dimethyl carbate [CCN] + TX, dimethyl phthalate [CCN] + TX, ethyl hexanediol (1 137) + TX, hexamide [CCN] + TX, methoquin-butyl (1276) + TX, methylneodecanamide [CCN] + TX, oxamate [CCN] and picaridin [CCN] + TX,
an insecticide selected from the group of substances consisting of 1-dichloro-1-nitroethane (lUPAC/Chemical Abstracts name) (1058) + TX, 1 ,1-dichloro-2,2-bis(4-ethylphenyl)ethane (lUPAC name) (1056), + TX, 1 ,2-dichloropropane (lUPAC/Chemical Abstracts name) (1062) + TX, 1 ,2- dichloropropane with 1 ,3-dichloropropene (lUPAC name) (1063) + TX, 1-bromo-2-chloroethane (lUPAC/Chemical Abstracts name) (916) + TX, 2,2,2-trichloro-1-(3,4-dichlorophenyl)ethyl acetate (lUPAC name) (1451 ) + TX, 2,2-dichlorovinyl 2-ethylsulfinylethyl methyl phosphate (lUPAC name) (1066) + TX, 2-(1 ,3-dithiolan-2-yl)phenyl dimethylcarbamate (lUPAC/ Chemical Abstracts name) (1 109) + TX, 2-(2-butoxyethoxy)ethyl thiocyanate (lUPAC/Chemical Abstracts name) (935) + TX, 2-(4,5- dimethyl-1 ,3-dioxolan-2-yl)phenyl methylcarbamate (lUPAC/ Chemical Abstracts name) (1084) + TX, 2-(4-chloro-3,5-xylyloxy)ethanol (lUPAC name) (986) + TX, 2-chlorovinyl diethyl phosphate (lUPAC name) (984) + TX, 2-imidazolidone (lUPAC name) (1225) + TX, 2-isovalerylindan-1 ,3-dione (lUPAC name) (1246) + TX, 2-methyl(prop-2-ynyl)aminophenyl methylcarbamate (lUPAC name) (1284) + TX, 2-thiocyanatoethyl laurate (lUPAC name) (1433) + TX, 3-bromo-1-chloroprop-1-ene (lUPAC name) (917) + TX, 3-methyl-1-phenylpyrazol-5-yl dimethylcarbamate (lUPAC name) (1283) + TX, 4- methyl(prop-2-ynyl)amino-3,5-xylyl methylcarbamate (lUPAC name) (1285) + TX, 5,5-dimethyl-3- oxocyclohex-1-enyl dimethylcarbamate (lUPAC name) (1085) + TX, abamectin (1 ) + TX, acephate (2) + TX, acetamiprid (4) + TX, acethion (alternative name) [CCN] + TX, acetoprole [CCN] + TX, acrinathrin (9) + TX, acrylonitrile (lUPAC name) (861 ) + TX, alanycarb (15) + TX, aldicarb (16) + TX, aldoxycarb (863) + TX, aldrin (864) + TX, allethrin (17) + TX, allosamidin (alternative name) [CCN] + TX, allyxycarb (866) + TX, alpha-cypermethrin (202) + TX, alpha-ecdysone (alternative name) [CCN] + TX, aluminium phosphide (640) + TX, amidithion (870) + TX, amidothioate (872) + TX, aminocarb (873) + TX, amiton (875) + TX, amiton hydrogen oxalate (875) + TX, amitraz (24) + TX, anabasine (877) + TX, athidathion (883) + TX, AVI 382 (compound code) + TX, AZ 60541 (compound code) + TX, azadirachtin (alternative name) (41 ) + TX, azamethiphos (42) + TX, azinphos-ethyl (44) + TX, azinphos-methyl (45) + TX, azothoate (889) + TX, Bacillus thuringiensis delta endotoxins (alternative name) (52) + TX, barium hexafluorosilicate (alternative name) [CCN] + TX, barium polysulfide (lUPAC/Chemical Abstracts name) (892) + TX, barthrin [CCN] + TX, Bayer 22/190 (development code) (893) + TX, Bayer 22408 (development code) (894) + TX, bendiocarb (58) + TX, benfuracarb (60) + TX, bensultap (66) + TX, beta-cyfluthrin (194) + TX, beta-cypermethrin (203) + TX, bifenthrin (76) + TX, bioallethrin (78) + TX, bioallethrin S-cyclopentenyl isomer (alternative name) (79) + TX, bioethanomethrin [CCN] + TX, biopermethrin (908) + TX, bioresmethrin (80) + TX, bis(2-chloroethyl) ether (lUPAC name) (909) + TX, bistrifluron (83) + TX, borax (86) + TX, brofenvalerate (alternative name) + TX, bromfenvinfos (914) + TX, bromocyclen (918) + TX, bromo-DDT (alternative name) [CCN] + TX, bromophos (920) + TX, bromophos-ethyl (921 ) + TX, bufencarb (924) + TX, buprofezin (99) + TX, butacarb (926) + TX, butathiofos (927) + TX, butocarboxim (103) + TX, butonate (932) + TX, butoxycarboxim (104) + TX, butylpyridaben (alternative name) + TX, cadusafos (109) + TX, calcium arsenate [CCN] + TX, calcium cyanide (444) + TX, calcium polysulfide (lUPAC name) (1 1 1 ) + TX, camphechlor (941 ) + TX, carbanolate (943) + TX, carbaryl (1 15) + TX, carbofuran (1 18) + TX, carbon disulfide (lUPAC/Chemical Abstracts name) (945) + TX, carbon tetrachloride (lUPAC name) (946) + TX, carbophenothion (947) + TX, carbosulfan (1 19) + TX, cartap (123) + TX, cartap hydrochloride (123) + TX, cevadine (alternative name) (725) + TX, chlorbicyclen (960) + TX, chlordane (128) + TX, chlordecone (963) + TX, chlordimeform (964) + TX, chlordimeform hydrochloride (964) + TX, chlorethoxyfos (129) + TX, chlorfenapyr (130) + TX, chlorfenvinphos (131 ) + TX, chlorfluazuron (132) + TX, chlormephos (136) + TX, chloroform [CCN] + TX, chloropicrin (141 ) + TX, chlorphoxim (989) + TX, chlorprazophos (990) + TX, chlorpyrifos (145) + TX, chlorpyrifos-methyl (146) + TX, chlorthiophos (994) + TX, chromafenozide (150) + TX, cinerin I (696) + TX, cinerin II (696) + TX, cinerins (696) + TX, cis-resmethrin (alternative name) + TX, cismethrin (80) + TX, clocythrin (alternative name) + TX, cloethocarb (999) + TX, closantel (alternative name) [CCN] + TX, clothianidin (165) + TX, copper acetoarsenite [CCN] + TX, copper arsenate [CCN] + TX, copper oleate [CCN] + TX, coumaphos (174) + TX, coumithoate (1006) + TX, crotamiton (alternative name) [CCN] + TX, crotoxyphos (1010) + TX, crufomate (101 1 ) + TX, cryolite (alternative name) (177) + TX, CS 708 (development code) (1012) + TX, cyanofenphos (1019) + TX, cyanophos (184) + TX, cyanthoate (1020) + TX, cyclethrin [CCN] + TX, cycloprothrin (188) + TX, cyfluthrin (193) + TX, cyhalothrin (196) + TX, cypermethrin (201 ) + TX, cyphenothrin (206) + TX, cyromazine (209) + TX, cythioate (alternative name) [CCN] + TX, cf-limonene (alternative name) [CCN] + TX, cf-tetramethrin (alternative name) (788) + TX, DAEP (1031 ) + TX, dazomet (216) + TX, DDT (219) + TX, decarbofuran (1034) + TX, deltamethrin (223) + TX, demephion (1037) + TX, demephion-0 (1037) + TX, demephion-S (1037) + TX, demeton (1038) + TX, demeton-methyl (224) + TX, demeton-0 (1038) + TX, demeton-O-methyl (224) + TX, demeton-S (1038) + TX, demeton-S-methyl (224) + TX, demeton- S-methylsulphon (1039) + TX, diafenthiuron (226) + TX, dialifos (1042) + TX, diamidafos (1044) + TX, diazinon (227) + TX, dicapthon (1050) + TX, dichlofenthion (1051 ) + TX, dichlorvos (236) + TX, dicliphos (alternative name) + TX, dicresyl (alternative name) [CCN] + TX, dicrotophos (243) + TX, dicyclanil (244) + TX, dieldrin (1070) + TX, diethyl 5-methylpyrazol-3-yl phosphate (lUPAC name) (1076) + TX, diflubenzuron (250) + TX, dilor (alternative name) [CCN] + TX, dimefluthrin [CCN] + TX, dimefox (1081 ) + TX, dimetan (1085) + TX, dimethoate (262) + TX, dimethrin (1083) + TX, dimethylvinphos (265) + TX, dimetilan (1086) + TX, dinex (1089) + TX, dinex-diclexine (1089) + TX, dinoprop (1093) + TX, dinosam (1094) + TX, dinoseb (1095) + TX, dinotefuran (271 ) + TX, diofenolan (1099) + TX, dioxabenzofos (1 100) + TX, dioxacarb (1 101 ) + TX, dioxathion (1 102) + TX, disulfoton (278) + TX, dithicrofos (1 108) + TX, DNOC (282) + TX, doramectin (alternative name) [CCN] + TX, DSP (1 1 15) + TX, ecdysterone (alternative name) [CCN] + TX, El 1642 (development code) (1 1 18) + TX, emamectin (291 ) + TX, emamectin benzoate (291 ) + TX, EMPC (1 120) + TX, empenthrin (292) + TX, endosulfan (294) + TX, endothion (1 121 ) + TX, endrin (1 122) + TX, EPBP (1 123) + TX, EPN (297) + TX, epofenonane (1 124) + TX, eprinomectin (alternative name) [CCN] + TX, esfenvalerate (302) + TX, etaphos (alternative name) [CCN] + TX, ethiofencarb (308) + TX, ethion (309) + TX, ethiprole (310) + TX, ethoate-methyl (1 134) + TX, ethoprophos (312) + TX, ethyl formate (lUPAC name) [CCN] + TX, ethyl-DDD (alternative name) (1056) + TX, ethylene dibromide (316) + TX, ethylene dichloride (chemical name) (1 136) + TX, ethylene oxide [CCN] + TX, etofenprox (319) + TX, etrimfos (1 142) + TX, EXD (1 143) + TX, famphur (323) + TX, fenamiphos (326) + TX, fenazaflor (1 147) + TX, fenchlorphos (1 148) + TX, fenethacarb (1 149) + TX, fenfluthrin (1 150) + TX, fenitrothion (335) + TX, fenobucarb (336) + TX, fenoxacrim (1 153) + TX, fenoxycarb (340) + TX, fenpirithrin (1 155) + TX, fenpropathrin (342) + TX, fenpyrad (alternative name) + TX, fensulfothion (1 158) + TX, fenthion (346) + TX, fenthion-ethyl [CCN] + TX, fenvalerate (349) + TX, fipronil (354) + TX, flonicamid (358) + TX, flubendiamide (CAS. Reg. No.: 272451-65-7) + TX, flucofuron (1 168) + TX, flucycloxuron (366) + TX, flucythrinate (367) + TX, fluenetil (1 169) + TX, flufenerim [CCN] + TX, flufenoxuron (370) + TX, flufenprox (1 171 ) + TX, flumethrin (372) + TX, fluvalinate (1 184) + TX, FMC 1 137 (development code) (1 185) + TX, fonofos (1 191 ) + TX, formetanate (405) + TX, formetanate hydrochloride (405) + TX, formothion (1 192) + TX, formparanate (1 193) + TX, fosmethilan (1 194) + TX, fospirate (1 195) + TX, fosthiazate (408) + TX, fosthietan (1 196) + TX, furathiocarb (412) + TX, furethrin (1200) + TX, gamma-cyhalothrin (197) + TX, gamma-HCH (430) + TX, guazatine (422) + TX, guazatine acetates (422) + TX, GY-81 (development code) (423) + TX, halfenprox (424) + TX, halofenozide (425) + TX, HCH (430) + TX, HEOD (1070) + TX, heptachlor (121 1 ) + TX, heptenophos (432) + TX, heterophos [CCN] + TX, hexaflumuron (439) + TX, HHDN (864) + TX, hydramethylnon (443) + TX, hydrogen cyanide (444) + TX, hydroprene (445) + TX, hyquincarb (1223) + TX, imidacloprid (458) + TX, imiprothrin (460) + TX, indoxacarb (465) + TX, iodomethane (lUPAC name) (542) + TX, IPSP (1229) + TX, isazofos (1231 ) + TX, isobenzan (1232) + TX, isocarbophos (alternative name) (473) + TX, isodrin (1235) + TX, isofenphos (1236) + TX, isolane (1237) + TX, isoprocarb (472) + TX, isopropyl 0-(methoxyaminothiophosphoryl)salicylate (lUPAC name) (473) + TX, isoprothiolane (474) + TX, isothioate (1244) + TX, isoxathion (480) + TX, ivermectin (alternative name) [CCN] + TX, jasmolin I (696) + TX, jasmolin II (696) + TX, jodfenphos (1248) + TX, juvenile hormone I (alternative name) [CCN] + TX, juvenile hormone II (alternative name) [CCN] + TX, juvenile hormone III (alternative name) [CCN] + TX, kelevan (1249) + TX, kinoprene (484) + TX, lambda-cyhalothrin (198) + TX, lead arsenate [CCN] + TX, lepimectin (CCN) + TX, leptophos (1250) + TX, lindane (430) + TX, lirimfos (1251 ) + TX, lufenuron (490) + TX, lythidathion (1253) + TX, m-cumenyl methylcarbamate (lUPAC name) (1014) + TX, magnesium phosphide (lUPAC name) (640) + TX, malathion (492) + TX, malonoben (1254) + TX, mazidox (1255) + TX, mecarbam (502) + TX, mecarphon (1258) + TX, menazon (1260) + TX, mephosfolan (1261 ) + TX, mercurous chloride (513) + TX, mesulfenfos (1263) + TX, metaflumizone (CCN) + TX, metam (519) + TX, metam-potassium (alternative name) (519) + TX, metam-sodium (519) + TX, methacrifos (1266) + TX, methamidophos (527) + TX, methanesulfonyl fluoride (lUPAC/Chemical Abstracts name) (1268) + TX, methidathion (529) + TX, methiocarb (530) + TX, methocrotophos (1273) + TX, methomyl (531 ) + TX, methoprene (532) + TX, methoquin-butyl (1276) + TX, methothrin (alternative name) (533) + TX, methoxychlor (534) + TX, methoxyfenozide (535) + TX, methyl bromide (537) + TX, methyl isothiocyanate (543) + TX, methylchloroform (alternative name) [CCN] + TX, methylene chloride [CCN] + TX, metofluthrin [CCN] + TX, metolcarb (550) + TX, metoxadiazone (1288) + TX, mevinphos (556) + TX, mexacarbate (1290) + TX, milbemectin (557) + TX, milbemycin oxime (alternative name) [CCN] + TX, mipafox (1293) + TX, mirex (1294) + TX, monocrotophos (561 ) + TX, morphothion (1300) + TX, moxidectin (alternative name) [CCN] + TX, naftalofos (alternative name) [CCN] + TX, naled (567) + TX, naphthalene (lUPAC/Chemical Abstracts name) (1303) + TX, NC-170 (development code) (1306) + TX, NC-184 (compound code) + TX, nicotine (578) + TX, nicotine sulfate (578) + TX, nifluridide (1309) + TX, nitenpyram (579) + TX, nithiazine (131 1 ) + TX, nitrilacarb (1313) + TX, nitrilacarb 1 : 1 zinc chloride complex (1313) + TX, NNI-0101 (compound code) + TX, NNI-0250 (compound code) + TX, nornicotine (traditional name) (1319) + TX, novaluron (585) + TX, noviflumuron (586) + TX, 0-5-dichloro-4-iodophenyl O-ethyl ethylphosphonothioate (lUPAC name) (1057) + TX, 0,0-diethyl 0-4-methyl-2-oxo-2A -chromen-7-yl phosphorothioate (lUPAC name) (1074) + TX, Ο,Ο-diethyl 0-6-methyl-2-propylpyrimidin-4-yl phosphorothioate (lUPAC name) (1075) + TX, 0, 0, 0',Ο'-tetrapropyl dithiopyrophosphate (lUPAC name) (1424) + TX, oleic acid (lUPAC name) (593) + TX, omethoate (594) + TX, oxamyl (602) + TX, oxydemeton-methyl (609) + TX, oxydeprofos (1324) + TX, oxydisulfoton (1325) + TX, pp'-DDT (219) + TX, para-dichlorobenzene [CCN] + TX, parathion (615) + TX, parathion-methyl (616) + TX, penfluron (alternative name) [CCN] + TX, pentachlorophenol (623) + TX, pentachlorophenyl laurate (lUPAC name) (623) + TX, permethrin (626) + TX, petroleum oils (alternative name) (628) + TX, PH 60-38 (development code) (1328) + TX, phenkapton (1330) + TX, phenothrin (630) + TX, phenthoate (631 ) + TX, phorate (636) + TX, phosalone (637) + TX, phosfolan (1338) + TX, phosmet (638) + TX, phosnichlor (1339) + TX, phosphamidon (639) + TX, phosphine (lUPAC name) (640) + TX, phoxim (642) + TX, phoxim-methyl (1340) + TX, pirimetaphos (1344) + TX, pirimicarb (651 ) + TX, pirimiphos-ethyl (1345) + TX, pirimiphos-methyl (652) + TX, polychlorodicyclopentadiene isomers (lUPAC name) (1346) + TX, polychloroterpenes (traditional name) (1347) + TX, potassium arsenite [CCN] + TX, potassium thiocyanate [CCN] + TX, prallethrin (655) + TX, precocene I (alternative name) [CCN] + TX, precocene II (alternative name) [CCN] + TX, precocene III (alternative name) [CCN] + TX, primidophos (1349) + TX, profenofos (662) + TX, profluthrin [CCN] + TX, promacyl (1354) + TX, promecarb (1355) + TX, propaphos (1356) + TX, propetamphos (673) + TX, propoxur (678) + TX, prothidathion (1360) + TX, prothiofos (686) + TX, prothoate (1362) + TX, protrifenbute [CCN] + TX, pymetrozine (688) + TX, pyraclofos (689) + TX, pyrazophos (693) + TX, pyresmethrin (1367) + TX, pyrethrin I (696) + TX, pyrethrin II (696) + TX, pyrethrins (696) + TX, pyridaben (699) + TX, pyridalyl (700) + TX, pyridaphenthion (701 ) + TX, pyrimidifen (706) + TX, pyrimitate (1370) + TX, pyriproxyfen (708) + TX, quassia (alternative name) [CCN] + TX, quinalphos (71 1 ) + TX, quinalphos-methyl (1376) + TX, quinothion (1380) + TX, quintiofos (1381 ) + TX, R-1492 (development code) (1382) + TX, rafoxanide (alternative name) [CCN] + TX, resmethrin (719) + TX, rotenone (722) + TX, RU 15525 (development code) (723) + TX, RU 25475 (development code) (1386) + TX, ryania (alternative name) (1387) + TX, ryanodine (traditional name) (1387) + TX, sabadilla (alternative name) (725) + TX, schradan (1389) + TX, sebufos (alternative name) + TX, selamectin (alternative name) [CCN] + TX, SI-0009 (compound code) + TX, SI-0205 (compound code) + TX, SI-0404 (compound code) + TX, SI-0405 (compound code) + TX, silafluofen (728) + TX, SN 72129 (development code) (1397) + TX, sodium arsenite [CCN] + TX, sodium cyanide (444) + TX, sodium fluoride (lUPAC/Chemical Abstracts name) (1399) + TX, sodium hexafluorosilicate (1400) + TX, sodium pentachlorophenoxide (623) + TX, sodium selenate (lUPAC name) (1401 ) + TX, sodium thiocyanate [CCN] + TX, sophamide (1402) + TX, spinosad (737) + TX, spiromesifen (739) + TX, spirotetrmat (CCN) + TX, sulcofuron (746) + TX, sulcofuron-sodium (746) + TX, sulfluramid (750) + TX, sulfotep (753) + TX, sulfuryl fluoride (756) + TX, sulprofos (1408) + TX, tar oils (alternative name) (758) + TX, tau-fluvalinate (398) + TX, tazimcarb (1412) + TX, TDE (1414) + TX, tebufenozide (762) + TX, tebufenpyrad (763) + TX, tebupirimfos (764) + TX, teflubenzuron (768) + TX, tefluthrin (769) + TX, temephos (770) + TX, TEPP (1417) + TX, terallethrin (1418) + TX, terbam (alternative name) + TX, terbufos (773) + TX, tetrachloroethane [CCN] + TX, tetrachlorvinphos (777) + TX, tetramethrin (787) + TX, theta-cypermethrin (204) + TX, thiacloprid (791 ) + TX, thiafenox (alternative name) + TX, thiamethoxam (792) + TX, thicrofos (1428) + TX, thiocarboxime (1431 ) + TX, thiocyclam (798) + TX, thiocyclam hydrogen oxalate (798) + TX, thiodicarb (799) + TX, thiofanox (800) + TX, thiometon (801 ) + TX, thionazin (1434) + TX, thiosultap (803) + TX, thiosultap-sodium (803) + TX, thuringiensin (alternative name) [CCN] + TX, tolfenpyrad (809) + TX, tralomethrin (812) + TX, transfluthrin (813) + TX, transpermethrin (1440) + TX, triamiphos (1441 ) + TX, triazamate (818) + TX, triazophos (820) + TX, triazuron (alternative name) + TX, trichlorfon (824) + TX, trichlormetaphos-3 (alternative name) [CCN] + TX, trichloronat (1452) + TX, trifenofos (1455) + TX, triflumuron (835) + TX, trimethacarb (840) + TX, triprene (1459) + TX, vamidothion (847) + TX, vaniliprole [CCN] + TX, veratridine (alternative name) (725) + TX, veratrine (alternative name) (725) + TX, XMC (853) + TX, xylylcarb (854) + TX, Yl- 5302 (compound code) + TX, zeta-cypermethrin (205) + TX, zetamethrin (alternative name) + TX, zinc phosphide (640) + TX, zolaprofos (1469) and ZXI 8901 (development code) (858) + TX, cyantraniliprole [736994-63-19 + TX, chlorantraniliprole [500008-45-7] + TX, cyenopyrafen [560121-52-0] + TX, cyflumetofen [400882-07-7] + TX, pyrifluquinazon [337458-27-2] + TX, spinetoram [187166-40-1 + 187166-15-0] + TX, spirotetramat [203313-25-1] + TX, sulfoxaflor [946578-00-3] + TX, flufiprole [704886-18-0] + TX, meperfluthrin [915288-13-0] + TX, tetramethylfluthrin [84937-88-2] + TX, triflumezopyrim (disclosed in WO 2012/0921 15) + TX,
a molluscicide selected from the group of substances consisting of bis(tributyltin) oxide (lUPAC name) (913) + TX, bromoacetamide [CCN] + TX, calcium arsenate [CCN] + TX, cloethocarb (999) + TX, copper acetoarsenite [CCN] + TX, copper sulfate (172) + TX, fentin (347) + TX, ferric phosphate (lUPAC name) (352) + TX, metaldehyde (518) + TX, methiocarb (530) + TX, niclosamide (576) + TX, niclosamide-olamine (576) + TX, pentachlorophenol (623) + TX, sodium pentachlorophenoxide (623) + TX, tazimcarb (1412) + TX, thiodicarb (799) + TX, tributyltin oxide (913) + TX, trifenmorph (1454) + TX, trimethacarb (840) + TX, triphenyltin acetate (lUPAC name) (347) and triphenyltin hydroxide (lUPAC name) (347) + TX, pyriprole [394730-71-3] + TX,
a nematicide selected from the group of substances consisting of AKD-3088 (compound code) + TX, 1 ,2-dibromo-3-chloropropane (lUPAC/Chemical Abstracts name) (1045) + TX, 1 ,2- dichloropropane (lUPAC/ Chemical Abstracts name) (1062) + TX, 1 ,2-dichloropropane with 1 ,3- dichloropropene (lUPAC name) (1063) + TX, 1 ,3-dichloropropene (233) + TX, 3,4- dichlorotetrahydrothiophene 1 , 1-dioxide (lUPAC/Chemical Abstracts name) (1065) + TX, 3-(4- chlorophenyl)-5-methylrhodanine (lUPAC name) (980) + TX, 5-methyl-6-thioxo-1 ,3,5-thiadiazinan-3- ylacetic acid (lUPAC name) (1286) + TX, 6-isopentenylaminopurine (alternative name) (210) + TX, abamectin (1 ) + TX, acetoprole [CCN] + TX, alanycarb (15) + TX, aldicarb (16) + TX, aldoxycarb (863) + TX, AZ 60541 (compound code) + TX, benclothiaz [CCN] + TX, benomyl (62) + TX, butylpyridaben (alternative name) + TX, cadusafos (109) + TX, carbofuran (1 18) + TX, carbon disulfide (945) + TX, carbosulfan (1 19) + TX, chloropicrin (141 ) + TX, chlorpyrifos (145) + TX, cloethocarb (999) + TX, cytokinins (alternative name) (210) + TX, dazomet (216) + TX, DBCP (1045) + TX, DCIP (218) + TX, diamidafos (1044) + TX, dichlofenthion (1051 ) + TX, dicliphos (alternative name) + TX, dimethoate (262) + TX, doramectin (alternative name) [CCN] + TX, emamectin (291 ) + TX, emamectin benzoate (291 ) + TX, eprinomectin (alternative name) [CCN] + TX, ethoprophos (312) + TX, ethylene dibromide (316) + TX, fenamiphos (326) + TX, fenpyrad (alternative name) + TX, fensulfothion (1 158) + TX, fosthiazate (408) + TX, fosthietan (1 196) + TX, furfural (alternative name) [CCN] + TX, GY-81 (development code) (423) + TX, heterophos [CCN] + TX, iodomethane (lUPAC name) (542) + TX, isamidofos (1230) + TX, isazofos (1231 ) + TX, ivermectin (alternative name) [CCN] + TX, kinetin (alternative name) (210) + TX, mecarphon (1258) + TX, metam (519) + TX, metam-potassium (alternative name) (519) + TX, metam-sodium (519) + TX, methyl bromide (537) + TX, methyl isothiocyanate (543) + TX, milbemycin oxime (alternative name) [CCN] + TX, moxidectin (alternative name) [CCN] + TX, Myrothecium verrucaria composition (alternative name) (565) + TX, NC-184 (compound code) + TX, oxamyl (602) + TX, phorate (636) + TX, phosphamidon (639) + TX, phosphocarb [CCN] + TX, sebufos (alternative name) + TX, selamectin (alternative name) [CCN] + TX, spinosad (737) + TX, terbam (alternative name) + TX, terbufos (773) + TX, tetrachlorothiophene (lUPAC/ Chemical Abstracts name) (1422) + TX, thiafenox (alternative name) + TX, thionazin (1434) + TX, triazophos (820) + TX, triazuron (alternative name) + TX, xylenols [CCN] + TX, YI-5302 (compound code) and zeatin (alternative name) (210) + TX, fluensulfone [318290-98-1] + TX,
a nitrification inhibitor selected from the group of substances consisting of potassium ethylxanthate [CCN] and nitrapyrin (580) + TX,
a plant activator selected from the group of substances consisting of acibenzolar (6) + TX, acibenzolar-S-methyl (6) + TX, probenazole (658) and Reynoutria sachalinensis extract (alternative name) (720) + TX,
a rodenticide selected from the group of substances consisting of 2-isovalerylindan-1 ,3-dione
(lUPAC name) (1246) + TX, 4-(quinoxalin-2-ylamino)benzenesulfonamide (lUPAC name) (748) + TX, alpha-chlorohydrin [CCN] + TX, aluminium phosphide (640) + TX, antu (880) + TX, arsenous oxide (882) + TX, barium carbonate (891 ) + TX, bisthiosemi (912) + TX, brodifacoum (89) + TX, bromadiolone (91 ) + TX, bromethalin (92) + TX, calcium cyanide (444) + TX, chloralose (127) + TX, chlorophacinone (140) + TX, cholecalciferol (alternative name) (850) + TX, coumachlor (1004) + TX, coumafuryl (1005) + TX, coumatetralyl (175) + TX, crimidine (1009) + TX, difenacoum (246) + TX, difethialone (249) + TX, diphacinone (273) + TX, ergocalciferol (301 ) + TX, flocoumafen (357) + TX, fluoroacetamide (379) + TX, flupropadine (1 183) + TX, flupropadine hydrochloride (1 183) + TX, gamma-HCH (430) + TX, HCH (430) + TX, hydrogen cyanide (444) + TX, iodomethane (lUPAC name) (542) + TX, lindane (430) + TX, magnesium phosphide (lUPAC name) (640) + TX, methyl bromide (537) + TX, norbormide (1318) + TX, phosacetim (1336) + TX, phosphine (lUPAC name) (640) + TX, phosphorus [CCN] + TX, pindone (1341 ) + TX, potassium arsenite [CCN] + TX, pyrinuron (1371 ) + TX, scilliroside (1390) + TX, sodium arsenite [CCN] + TX, sodium cyanide (444) + TX, sodium fluoroacetate (735) + TX, strychnine (745) + TX, thallium sulfate [CCN] + TX, warfarin (851 ) and zinc phosphide (640) + TX, a synergist selected from the group of substances consisting of 2-(2-butoxyethoxy)ethyl piperonylate (lUPAC name) (934) + TX, 5-(1 ,3-benzodioxol-5-yl)-3-hexylcyclohex-2-enone (lUPAC name) (903) + TX, farnesol with nerolidol (alternative name) (324) + TX, MB-599 (development code) (498) + TX, MGK 264 (development code) (296) + TX, piperonyl butoxide (649) + TX, piprotal (1343) + TX, propyl isomer (1358) + TX, S421 (development code) (724) + TX, sesamex (1393) + TX, sesasmolin (1394) and sulfoxide (1406) + TX,
an animal repellent selected from the group of substances consisting of anthraquinone (32) + TX, chloralose (127) + TX, copper naphthenate [CCN] + TX, copper oxychloride (171 ) + TX, diazinon (227) + TX, dicyclopentadiene (chemical name) (1069) + TX, guazatine (422) + TX, guazatine acetates (422) + TX, methiocarb (530) + TX, pyridin-4-amine (lUPAC name) (23) + TX, thiram (804) + TX, trimethacarb (840) + TX, zinc naphthenate [CCN] and ziram (856) + TX,
a virucide selected from the group of substances consisting of imanin (alternative name) [CCN] and ribavirin (alternative name) [CCN] + TX,
a wound protectant selected from the group of substances consisting of mercuric oxide (512) + TX, octhilinone (590) and thiophanate-methyl (802) + TX,
and biologically active compounds selected from the group consisting of ametoctradin [865318- 97-4] + TX, amisulbrom [348635-87-0] + TX, azaconazole [60207-31-0] + TX, benzovindiflupyr [1072957-71-1] + TX, bitertanol [70585-36-3] + TX, bixafen [581809-46-3] + TX, bromuconazole [1 16255-48-2] + TX, coumoxystrobin [850881-70-8] + TX, cyproconazole [94361-06-5] + TX, difenoconazole [1 19446-68-3] + TX, diniconazole [83657-24-3] + TX, enoxastrobin [238410-1 1-2] + TX, epoxiconazole [106325-08-0] + TX, fenbuconazole [1 14369-43-6] + TX, fenpyrazamine [473798-59-3] + TX, fluquinconazole [136426-54-5] + TX, flusilazole [85509-19-9] + TX, flutriafol [76674-21-0] + TX, fluxapyroxad [907204-31-3] + TX, fluopyram [658066-35-4] + TX, fenaminstrobin [366815-39-6] + TX, isofetamid [875915-78-9] + TX, hexaconazole [79983-71-4] + TX, imazalil [35554-44-0] + TX, imiben- conazole [86598-92-7] + TX, ipconazole [125225-28-7] + TX, ipfentrifluconazole [1417782-08-1] + TX, isotianil [224049-04-1] + TX, mandestrobin [173662-97-0] (can be prepared according to the procedures described in WO 2010/093059) + TX, mefentrifluconazole [1417782-03-6] + TX, metconazole [1251 16- 23-6] + TX, myclobutanil [88671-89-0] + TX, paclobutrazol [76738-62-0] + TX, pefurazoate [101903-30- 4] + TX, penflufen [494793-67-8] + TX, penconazole [66246-88-6] + TX, prothioconazole [178928-70- 6] + TX, pyrifenox [88283-41-4] + TX, prochloraz [67747-09-5] + TX, propiconazole [60207-90-1] + TX, simeconazole [149508-90-7] + TX, tebuconazole [107534-96-3] + TX, tetraconazole [1 12281-77-3] + TX, triadimefon [43121-43-3] + TX, triadimenol [55219-65-3] + TX, triflumizole [99387-89-0] + TX, triticonazole [131983-72-7] + TX, ancymidol [12771-68-5] + TX, fenarimol [60168-88-9] + TX, nuarimol [63284-71-9] + TX, bupirimate [41483-43-6] + TX, dimethirimol [5221-53-4] + TX, ethirimol [23947-60- 6] + TX, dodemorph [1593-77-7] + TX, fenpropidin [67306-00-7] + TX, fenpropimorph [67564-91-4] + TX, spiroxamine [1 18134-30-8] + TX, tridemorph [81412-43-3] + TX, cyprodinil [121552-61-2] + TX, mepanipyrim [1 10235-47-7] + TX, pyrimethanil [531 12-28-0] + TX, fenpiclonil [74738-17-3] + TX, fludioxonil [131341-86-1] + TX, fluindapyr [1383809-87-7] + TX, benalaxyl [71626-1 1-4] + TX, furalaxyl [57646-30-7] + TX, metalaxyl [57837-19-1] + TX, R-metalaxyl [70630-17-0] + TX, ofurace [58810-48-3] + TX, oxadixyl [77732-09-3] + TX, benomyl [17804-35-2] + TX, carbendazim [10605-21-7] + TX, debacarb [62732-91-6] + TX, fuberidazole [3878-19-1] + TX, thiabendazole [148-79-8] + TX, chlozolinate [84332-86-5] + TX, dichlozoline [24201-58-9] + TX, iprodione [36734-19-7] + TX, myclozoline [54864-61-8] + TX, procymidone [32809-16-8] + TX, vinclozoline [50471-44-8] + TX, boscalid [188425-85-6] + TX, carboxin [5234-68-4] + TX, fenfuram [24691-80-3] + TX, flutolanil [66332- 96-5] + TX, flutianil [958647-10-4] + TX, mepronil [55814-41-0] + TX, oxycarboxin [5259-88-1] + TX, penthiopyrad [183675-82-3] + TX, thifluzamide [130000-40-7] + TX, guazatine [108173-90-6] + TX, dodine [2439-10-3] [1 12-65-2] (free base) + TX, iminoctadine [13516-27-3] + TX, azoxystrobin [131860- 33-8] + TX, dimoxystrobin [149961-52-4] + TX, enestroburin {Proc. BCPC, Int. Congr., Glasgow, 2003, 1 , 93} + TX, fluoxastrobin [361377-29-9] + TX, kresoxim-methyl [143390-89-0] + TX, metominostrobin [133408-50-1] + TX, trifloxystrobin [141517-21-7] + TX, orysastrobin [248593-16-0] + TX, picoxystrobin [1 17428-22-5] + TX, pyraclostrobin [175013-18-0] + TX, pyraoxystrobin [862588-1 1-2] + TX, ferbam [14484-64-1] + TX, mancozeb [8018-01-7] + TX, maneb [12427-38-2] + TX, metiram [9006-42-2] + TX, propineb [12071-83-9] + TX, thiram [137-26-8] + TX, zineb [12122-67-7] + TX, ziram [137-30-4] + TX, captafol [2425-06-1] + TX, captan [133-06-2] + TX, dichlofluanid [1085-98-9] + TX, fluoroimide [41205- 21-4] + TX, folpet [133-07-3 ] + TX, tolylfluanid [731-27-1] + TX, bordeaux mixture [801 1-63-0] + TX, copperhydroxid [20427-59-2] + TX, copperoxychlorid [1332-40-7] + TX, coppersulfat [7758-98-7] + TX, copperoxid [1317-39-1] + TX, mancopper [53988-93-5] + TX, oxine-copper [10380-28-6] + TX, dinocap [131-72-6] + TX, nitrothal-isopropyl [10552-74-6] + TX, edifenphos [17109-49-8] + TX, iprobenphos [26087-47-8] + TX, isoprothiolane [50512-35-1] + TX, phosdiphen [36519-00-3] + TX, pyrazophos [13457-18-6] + TX, tolclofos-methyl [57018-04-9] + TX, acibenzolar-S-methyl [135158-54-2] + TX, anilazine [101-05-3] + TX, benthiavalicarb [413615-35-7] + TX, blasticidin-S [2079-00-7] + TX, chinomethionat [2439-01-2] + TX, chloroneb [2675-77-6] + TX, chlorothalonil [1897-45-6] + TX, cyflufenamid [180409-60-3] + TX, cymoxanil [57966-95-7] + TX, dichlone [1 17-80-6] + TX, diclocymet [139920-32-4] + TX, diclomezine [62865-36-5] + TX, dicloran [99-30-9] + TX, diethofencarb [87130-20- 9] + TX, dimethomorph [1 10488-70-5] + TX, SYP-LI90 (Flumorph) [21 1867-47-9] + TX, dithianon [3347- 22-6] + TX, ethaboxam [162650-77-3] + TX, etridiazole [2593-15-9] + TX, famoxadone [131807-57-3] + TX, fenamidone [161326-34-7] + TX, fenoxanil [1 15852-48-7] + TX, fentin [668-34-8] + TX, ferimzone [89269-64-7] + TX, fluazinam [79622-59-6] + TX, fluopicolide [2391 10-15-7] + TX, flusulfamide [106917- 52-6] + TX, fenhexamid [126833-17-8] + TX, fosetyl-aluminium [39148-24-8] + TX, hymexazol [10004- 44-1] + TX, iprovalicarb [140923-17-7] + TX, IKF-916 (Cyazofamid) [1201 16-88-3] + TX, kasugamycin [6980-18-3] + TX, methasulfocarb [66952-49-6] + TX, metrafenone [220899-03-6] + TX, pencycuron [66063-05-6] + TX, phthalide [27355-22-2] + TX, picarbutrazox [500207-04-5] + TX, polyoxins [1 1 1 13- 80-7] + TX, probenazole [27605-76-1] + TX, propamocarb [25606-41-1] + TX, proquinazid [189278-12- 4] + TX, pydiflumetofen [1228284-64-7] + TX, pyrametostrobin [915410-70-7] + TX, pyroquilon [57369- 32-1] + TX, pyriofenone [688046-61-9] + TX, pyribencarb [799247-52-2] + TX, pyrisoxazole [847749- 37-5] + TX, quinoxyfen [124495-18-7] + TX, quintozene [82-68-8] + TX, sulfur [7704-34-9] + TX, Timorex Gold™ (plant extract containing tea tree oil from the Stockton Group) + TX, tebufloquin [376645-78-2] + TX, tiadinil [223580-51-6] + TX, triazoxide [72459-58-6] + TX, tolprocarb [91 1499-62-2] + TX, triclopyricarb [902760-40-1] + TX, tricyclazole [41814-78-2] + TX, triforine [26644-46-2] + TX, validamycin [37248-47-8] + TX, valifenalate [283159-90-0] + TX, zoxamide (RH7281 ) [156052-68-5] + TX, mandipropamid [374726-62-2] + TX, isopyrazam [881685-58-1] + TX, phenamacril + TX, sedaxane [874967-67-6] + TX, trinexapac-ethyl [95266-40-3] + TX, 3-difluoromethyl-1-methyl-1 H-pyrazole-4- carboxylic acid (9-dichloromethylene-1 ,2,3,4-tetrahydro-1 ,4-methano-naphthalen-5-yl)-amide (dislosed in WO 2007/048556) + TX, 3-difluoromethyl-1-methyl-1 H-pyrazole-4-carboxylic acid (3',4',5'-trifluoro- biphenyl-2-yl)-amide (disclosed in WO 2006/087343) + TX, [(3S,4R,4aR,6S,6aS, 12R, 12aS, 12bS)-3- [(cyclopropylcarbonyl)oxy]- 1 ,3,4,4a,5,6,6a, 12,12a, 12b-decahydro-6, 12-dihydroxy-4,6a, 12b-trimethyl- 1 1-oxo-9-(3-pyridinyl)-2/-/, 1 1 /-/naphtho[2, 1 ]pyrano[3,4-e]pyran-4-yl]methyl-cyclopropanecarboxylate [915972-17-7] + TX and 1 ,3,5-trimethyl-N-(2-methyl-1-oxopropyl)-N-[3-(2-methylpropyl)-4-[2,2,2- trifluoro-1-methoxy-1-(trifluoromethyl)ethyl]phenyl]-1 H-pyrazole-4-carboxamide [926914-55-8] + TX, or a biologically active compound selected from the group consisting of N-[(5-chloro-2- isopropyl-phenyl)methyl]-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-pyrazole-4-carboxamide (can be prepared according to the procedures described in WO 2010/130767) + TX, 2,6-Dimethyl- 1 H,5H-[1 ,4]dithiino[2,3-c:5,6-c']dipyrrole-1 ,3,5,7(2H,6H)-tetrone (can be prepared according to the procedures described in WO 201 1/138281 ) + TX, 6-ethyl-5,7-dioxo-pyrrolo[4,5][1 ,4]dithiino[1 ,2- c]isothiazole-3-carbonitrile + TX, 4-(2-bromo-4-fluoro-phenyl)-N-(2-chloro-6-fluoro-phenyl)-2,5- dimethyl-pyrazol-3-amine (can be prepared according to the procedures described in WO 2012/031061 ) + TX, 3-(difluoromethyl)-N-(7-fluoro-1 , 1 ,3-trimethyl-indan-4-yl)-1-methyl-pyrazole-4- carboxamide (can be prepared according to the procedures described in WO 2012/084812) + TX, CAS 850881-30-0 + TX, 3-(3,4-dichloro-1 ,2-thiazol-5-ylmethoxy)-1 ,2-benzothiazole 1 , 1-dioxide (can be prepared according to the procedures described in WO 2007/129454) + TX, 2-[2-[(2,5- dimethylphenoxy)methyl]phenyl]-2-methoxy-N-methyl-acetamide + TX, 3-(4,4-difluoro-3,4-dihydro-3,3- dimethylisoquinolin-1-yl)quinolone (can be prepared according to the procedures described in WO 2005/070917) + TX, 2-[2-fluoro-6-[(8-fluoro-2-methyl-3-quinolyl)oxy]phenyl]propan-2-ol (can be prepared according to the procedures described in WO 201 1/081 174) + TX, 2-[2-[(7,8-difluoro-2- methyl-3-quinolyl)oxy]-6-fluoro-phenyl]propan-2-ol (can be prepared according to the procedures described in WO 201 1/081 174) + TX, oxathiapiprolin + TX [1003318-67-9], tert-butyl N-[6-[[[(1- methyltetrazol-5-yl)-phenyl-methylene]amino]oxymethyl]-2-pyridyl]carbamate + TX, N-[2-(3,4- difluorophenyl)phenyl]-3-(trifluoromethyl)pyrazine-2-carboxamide (can be prepared according to the procedures described in WO 2007/ 072999) + TX, 3-(difluoromethyl)-1-methyl-N-[(3R)-1 , 1 ,3- trimethylindan-4-yl]pyrazole-4-carboxamide (can be prepared according to the procedures described in WO 2014/013842) + TX, 2,2,2-trifluoroethyl N-[2-methyl-1-[[(4- methylbenzoyl)amino]methyl]propyl]carbamate + TX, (2RS)-2-[4-(4-chlorophenoxy)-a,a,a-trifluoro-o- tolyl]-1-(1 H-1 ,2,4-triazol-1-yl)propan-2-ol + TX, (2RS)-2-[4-(4-chlorophenoxy)-a,a,a-trifluoro-o-tolyl]-3- methyl-1-(1 H-1 ,2,4-triazol-1-yl)butan-2-ol + TX, 2-(difluoromethyl)-N-[(3R)-3-ethyl-1 , 1-dimethyl-indan- 4-yl]pyridine-3-carboxamide + TX, 2-(difluoromethyl)-N-[3-ethyl-1 , 1-dimethyl-indan-4-yl]pyridine-3- carboxamide + TX, N'-(2,5-dimethyl-4-phenoxy-phenyl)-N-ethyl-N-methyl-formamidine + TX, N'-[4-(4,5- dichlorothiazol-2-yl)oxy-2,5-dimethyl-phenyl]-N-ethyl-N-methyl-formamidine (can be prepared according to the procedures described in WO 2007/031513) + TX, [2-[3-[2-[1-[2-[3,5- bis(difluoromethyl)pyrazol-1-yl]acetyl]-4-piperidyl]thiazol-4-yl]-4,5-dihydroisoxazol-5-yl]-3-chloro- phenyl] methanesulfonate (can be prepared according to the procedures described in WO 2012/025557) + TX, but-3-ynyl N-[6-[[(Z)-[(1-methyltetrazol-5-yl)-phenyl-methylene]amino]oxymethyl]- 2-pyridyl]carbamate (can be prepared according to the procedures described in WO 2010/000841 ) + TX, 2-[[3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl]-4H-1 ,2,4-triazole-3-thione (can be prepared according to the procedures described in WO 2010/146031 ) + TX, methyl N-[[5-[4-(2,4- dimethylphenyl)triazol-2-yl]-2-methyl-phenyl]nriethyl]carbanriate + TX, 3-chloro-6-methyl-5-phenyl-4- (2,4,6-trifluorophenyl)pyridazine (can be prepared according to the procedures described in WO 2005/121 104) + TX, 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1-(1 ,2,4-triazol-1-yl)propan-2-ol (can be prepared according to the procedures described in WO 2013/024082) + TX, 3-chloro-4-(2,6- difluorophenyl)-6-methyl-5-phenyl-pyridazine (can be prepared according to the procedures described in WO 2012/020774) + TX, 4-(2,6-difluorophenyl)-6-methyl-5-phenyl-pyridazine-3-carbonitrile (can be prepared according to the procedures described in WO 2012/020774) + TX, (R)-3-(difluoromethyl)-1- methyl-N-[1 , 1 ,3-trimethylindan-4-yl]pyrazole-4-carboxanriide (can be prepared according to the procedures described in WO 201 1/162397 ) + TX, 3-(difluoromethyl)-N-(7-fluoro-1 , 1 ,3-trimethyl-indan- 4-yl)-1-methyl-pyrazole-4-carboxamide (can be prepared according to the procedures described in WO 2012/084812) + TX, 1-[2-[[1-(4-chlorophenyl)pyrazol-3-yl]oxymethyl]-3-methyl-phenyl]-4-methyl- tetrazol-5-one (can be prepared according to the procedures described in WO 2013/162072) + TX, 1 - methyl-4-[3-methyl-2-[[2-methyl-4-(3,4,5-trimethylpyrazol-1-yl)phenoxy]methyl]phenyl]tetrazol-5-one (can be prepared according to the procedures described in WO 2014/051 165) + TX, (Z,2E)-5-[1-(4- chlorophenyl)pyrazol-3-yl]oxy-2-methoxyimino-N,3-dimethyl-pent-3-enamide + TX, (4- phenoxyphenyl)methyl 2-amino-6-methyl-pyridine-3-carboxylate + TX, N-(5-chloro-2-isopropylbenzyl)- N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methylpyrazole-4-carboxanriide [1255734-28-1] (can be prepared according to the procedures described in WO 2010/130767) + TX, 3-(difluoromethyl)-N-[(R)- 2,3-dihydro-1 , 1 ,3-trimethyl-1 H-inden-4-yl]-1-methylpyrazole-4-carboxamide [1352994-67-2] + TX, N'- (2,5-dimethyl-4-phenoxy-phenyl)-N-ethyl-N-methyl-fornrianriidine + TX, N'-[4-(4,5-dichloro-thiazol-2- yloxy)-2,5-dimethyl-phenyl]-N-ethyl-N-methyl-fornrianriidine + TX, N'-(2,5-dimethyl-4-phenoxy-phenyl)- N-ethyl-N-methyl-formamidine + TX, N'-[4-(4,5-dichloro-thiazol-2-yloxy)-2,5-dimethyl-phenyl]-N-ethyl- N-meth l-formamidine + TX,
Figure imgf000050_0001
O (fenpicoxamid [517875-34-2] (as described in WO
2003/035617)) + TX, (1 S)-2,2-bis(4-fluorophenyl)-1-methylethyl N-{[3-(acetyloxy)-4-methoxy-2- pyridyl]carbonyl}-L-alaninate [1961312-55-9] (as described in WO 2016/122802) + TX, 2- (difluoromethyl)-N-(l ,1 ,3-trimethylindan-4-yl)pyridine-3-carboxamide + TX, 2-(difluoromethyl)-N-(3- ethyl-1 , 1-dimethyl-indan-4-yl)pyridine-3-carboxamide + TX, 2-(difluoromethyl)-N-(1 , 1-dimethyl-3- propyl-indan-4-yl)pyridine-3-carboxamide + TX, 2-(difluoromethyl)-N-(3-isobutyl-1 , 1-dimethyl-indan-4- yl)pyridine-3-carboxamide + TX, 2-(difluoromethyl)-N-[(3R)-1 , 1 ,3-trimethylindan-4-yl]pyridine-3- carboxamide + TX, 2-(difluoromethyl)-N-[(3R)-3-ethyl-1 , 1-dimethyl-indan-4-yl]pyridine-3-carboxamide + TX, and 2-(difluoromethyl)-N-[(3R)-1 , 1-dimethyl-3-propyl-indan-4-yl]pyridine-3-carboxamide + TX, wherein each of these carboxamide compounds can be prepared according to the procedures described in WO 2014/095675 and/or WO 2016/139189.
The references in brackets behind the active ingredients, e.g. [3878-19-1] refer to the Chemical Abstracts Registry number. The above described mixing partners are known. Where the active ingredients are included in "The Pesticide Manual" [The Pesticide Manual - A World Compendium; Thirteenth Edition; Editor: C. D. S. TomLin; The British Crop Protection Council], they are described therein under the entry number given in round brackets hereinabove for the particular compound; for example, the compound "abamectin" is described under entry number (1 ). Where "[CCN]" is added hereinabove to the particular compound, the compound in question is included in the "Compendium of Pesticide Common Names", which is accessible on the internet [A. Wood; Compendium of Pesticide Common Names, Copyright © 1995-2004]; for example, the compound "acetoprole" is described under the internet address http://www.alanwood.net/pesticides/acetoprole.html.
Most of the active ingredients described above are referred to hereinabove by a so-called "common name", the relevant "ISO common name" or another "common name" being used in individual cases. If the designation is not a "common name", the nature of the designation used instead is given in round brackets for the particular compound; in that case, the lUPAC name, the lUPAC/Chemical Abstracts name, a "chemical name", a "traditional name", a "compound name" or a "develoment code" is used or, if neither one of those designations nor a "common name" is used, an "alternative name" is employed. "CAS Reg. No" means the Chemical Abstracts Registry Number.
The active ingredient mixture of the compounds of formula (I) selected from one compound as represented in Tables 1.1 to 1.3 and Tables 2.1 and 2.2 (below), or the compounds 1.1 to 1.190 described in Table T1 (below), is preferably in a mixing ratio of from 100: 1 to 1 :6000, especially from 50: 1 to 1 :50, more especially in a ratio of from 20: 1 to 1 :20, even more especially from 10:1 to 1 :10, very especially from 5:1 and 1 :5, special preference being given to a ratio of from 2:1 to 1 :2, and a ratio of from 4:1 to 2:1 being likewise preferred, above all in a ratio of 1 : 1 , or 5: 1 , or 5:2, or 5:3, or 5:4, or 4: 1 , or 4:2, or 4:3, or 3: 1 , or 3:2, or 2: 1 , or 1 :5, or 2:5, or 3:5, or 4:5, or 1 :4, or 2:4, or 3:4, or 1 :3, or 2:3, or 1 :2, or 1 :600, or 1 :300, or 1 :150, or 1 :35, or 2:35, or 4:35, or 1 :75, or 2:75, or 4:75, or 1 :6000, or 1 :3000, or 1 :1500, or 1 :350, or 2:350, or 4:350, or 1 :750, or 2:750, or 4:750. Those mixing ratios are by weight.
The mixtures as described above can be used in a method for controlling pests, which comprises applying a composition comprising a mixture as described above to the pests or their environment, with the exception of a method for treatment of the human or animal body by surgery or therapy and diagnostic methods practised on the human or animal body.
The mixtures comprising a compound as represented in Tables 1.1 to 1 .3 and Tables 2.1 and 2.2 (below), or the compounds 1.1 to 1.190 described in Table T1 (below), and one or more active ingredients as described above can be applied, for example, in a single "ready-mix" form, in a combined spray mixture composed from separate formulations of the single active ingredient components, such as a "tank-mix", and in a combined use of the single active ingredients when applied in a sequential manner, i.e. one after the other with a reasonably short period, such as a few hours or days. The order of applying a compound as represented in in Tables 1.1 to 1.3 and Tales 2.1 and 2.2 (below), or the compounds 1.1 to 1.190 described in Table T1 (below), and the active ingredient(s) as described above, is not essential for working the present invention.
The compositions according to the invention can also comprise further solid or liquid auxiliaries, such as stabilizers, for example unepoxidized or epoxidized vegetable oils (for example epoxidized coconut oil, rapeseed oil or soya oil), antifoams, for example silicone oil, preservatives, viscosity regulators, binders and/or tackifiers, fertilizers or other active ingredients for achieving specific effects, for example bactericides, fungicides, nematocides, plant activators, molluscicides or herbicides.
The compositions according to the invention are prepared in a manner known per se, in the absence of auxiliaries for example by grinding, screening and/or compressing a solid active ingredient and in the presence of at least one auxiliary for example by intimately mixing and/or grinding the active ingredient with the auxiliary (auxiliaries). These processes for the preparation of the compositions and the use of the compounds (I) for the preparation of these compositions are also a subject of the invention.
Another aspect of the invention is related to the use of a compound of Formula (I) or of a preferred individual compound as defined herein, of a composition comprising at least one compound of Formula (I) or at least one preferred individual compound as above-defined, or of a fungicidal or insecticidal mixture comprising at least one compound of Formula (I) or at least one preferred individual compound as above-defined, in admixture with other fungicides or insecticides as described above, for controlling or preventing infestation of plants, e.g. useful plants such as crop plants, propagation material thereof, e.g. seeds, harvested crops, e.g. harvested food crops, or non-living materials by insects or by phytopathogenic microorganisms, preferably fungal organisms.
A further aspect of the invention is related to a method of controlling or preventing an infestation of plants, e.g., useful plants such as crop plants, propagation material thereof, e.g. seeds, harvested crops, e.g., harvested food crops, or of non-living materials by insects or by phytopathogenic or spoilage microorganisms or organisms potentially harmful to man, especially fungal organisms, which comprises the application of a compound of Formula (I) or of a preferred individual compound as above-defined as active ingredient to the plants, to parts of the plants or to the locus thereof, to the propagation material thereof, or to any part of the non-living materials.
Controlling or preventing means reducing infestation by phytopathogenic or spoilage microorganisms or organisms potentially harmful to man, especially fungal organisms, to such a level that an improvement is demonstrated.
A preferred method of controlling or preventing an infestation of crop plants by phytopathogenic microorganisms, especially fungal organisms, or insects which comprises the application of a compound of Formula (I), or an agrochemical composition which contains at least one of said compounds, is foliar application. The frequency of application and the rate of application will depend on the risk of infestation by the corresponding pathogen or insect. However, the compounds of Formula (I) can also penetrate the plant through the roots via the soil (systemic action) by drenching the locus of the plant with a liquid Formulation, or by applying the compounds in solid form to the soil, e.g. in granular form (soil application). In crops of water rice such granulates can be applied to the flooded rice field. The compounds of Formula (I) may also be applied to seeds (coating) by impregnating the seeds or tubers either with a liquid formulation of the fungicide or coating them with a solid formulation.
A formulation, e.g. a composition containing the compound of Formula (I), and, if desired, a solid or liquid adjuvant or monomers for encapsulating the compound of Formula (I), may be prepared in a known manner, typically by intimately mixing and/or grinding the compound with extenders, for example solvents, solid carriers and, optionally, surface active compounds (surfactants).
Advantageous rates of application are normally from 5g to 2kg of active ingredient (a.i.) per hectare (ha), preferably from 10g to 1 kg a.i./ha, most preferably from 20g to 600g a.i./ha. When used as seed drenching agent, convenient dosages are from 10mg to 1g of active substance per kg of seeds.
When the combinations of the present invention are used for treating seed, rates of 0.001 to 50 g of a compound of Formula (I) per kg of seed, preferably from 0.01 to 10g per kg of seed are generally sufficient.
Suitably, a composition comprising a compound of Formula (I) according to the present invention is applied either preventative, meaning prior to disease development or curative, meaning after disease development.
The compositions of the invention may be employed in any conventional form, for example in the form of a twin pack, a powder for dry seed treatment (DS), an emulsion for seed treatment (ES), a flowable concentrate for seed treatment (FS), a solution for seed treatment (LS), a water dispersible powder for seed treatment (WS), a capsule suspension for seed treatment (CF), a gel for seed treatment (GF), an emulsion concentrate (EC), a suspension concentrate (SC), a suspo-emulsion (SE), a capsule suspension (CS), a water dispersible granule (WG), an emulsifiable granule (EG), an emulsion, water in oil (EO), an emulsion, oil in water (EW), a micro-emulsion (ME), an oil dispersion (OD), an oil miscible flowable (OF), an oil miscible liquid (OL), a soluble concentrate (SL), an ultra-low volume suspension (SU), an ultra-low volume liquid (UL), a technical concentrate (TK), a dispersible concentrate (DC), a wettable powder (WP) or any technically feasible formulation in combination with agriculturally acceptable adjuvants.
Such compositions may be produced in conventional manner, e.g. by mixing the active ingre- dients with appropriate formulation inerts (diluents, solvents, fillers and optionally other formulating ingredients such as surfactants, biocides, anti-freeze, stickers, thickeners and compounds that provide adjuvancy effects). Also conventional slow release formulations may be employed where long lasting efficacy is intended. Particularly, formulations to be applied in spraying forms, such as water dispersible concentrates (e.g. EC, SC, DC, OD, SE, EW, EO and the like), wettable powders and granules, may contain surfactants such as wetting and dispersing agents and other compounds that provide adjuvancy effects, e.g. the condensation product of formaldehyde with naphthalene sulphonate, an alkylarylsulphonate, a lignin sulphonate, a fatty alkyl sulphate, and ethoxylated alkylphenol and an ethoxylated fatty alcohol.
A seed dressing formulation is applied in a manner known per se to the seeds employing the combination of the invention and a diluent in suitable seed dressing formulation form, e.g. as an aqueous suspension or in a dry powder form having good adherence to the seeds. Such seed dressing formulations are known in the art. Seed dressing formulations may contain the single active ingredients or the combination of active ingredients in encapsulated form, e.g. as slow release capsules or microcapsules.
In general, the formulations include from 0.01 to 90% by weight of active agent, from 0 to 20% agriculturally acceptable surfactant and 10 to 99.99% solid or liquid formulation inerts and adjuvant(s), the active agent consisting of at least the compound of Formula (I) optionally together with other active agents, particularly microbiocides or conservatives or the like. Concentrated forms of compositions generally contain in between about 2 and 80%, preferably between about 5 and 70% by weight of active agent. Application forms of formulation may for example contain from 0.01 to 20% by weight, preferably from 0.01 to 5% by weight of active agent. Whereas commercial products will preferably be formulated as concentrates, the end user will normally employ diluted formulations.
Whereas it is preferred to formulate commercial products as concentrates, the end user will normally use dilute formulations.
Table 1.1 : This table discloses 65 specific compounds of the formula (T-1 ):
Figure imgf000054_0001
wherein A is 2,5-thienyl and R and R2, are hydrogen, and Z is as defined below in the Table 1.
Each of Tables 1.2 to 1.3 (which follow Table 1.1 ) make available 65 individual compounds of the formula (T-1 ) in which A, R , and R2 are as specifically defined in Tables 1.2 to 1 .3, which refer to Table 1 wherein Z is specifically defined.
Table 1
Compound Compound
z Z
no. no.
1.001 1 H-pyrazole-4-carboxylic acid 1.034 4-fluoropyrazol-1-yl
methyl 1 H-pyrazole-4-
1.002 1.035 1 H-pyrazole-4-carbonitrile
carboxylate
1.003 ethyl 1 H-pyrazole-4-carboxylate 1.036 5-(2-bromophenyl)tetrazol-1-yl
propyl 1 H-pyrazole-4-
1.004 1.037 4-nitropyrazol-1-yl
carboxylate
prop-2-enyl 1 H-pyrazole-4-
1.005 1.038 py rro lo[2 , 3-b] py rid i n- 1 -yl
carboxylate
prop-2-ynyl 1 H-pyrazole-4-
1.006 1.039 pyrazol-1-yl
carboxylate tert-butyl 1 H-pyrazole-4-
1.040 methyl 1 H-1 ,2,4-triazole-3-carboxylate carboxylate
isopropyl 1 H-pyrazole-4-
1.041 4-m ethylpyrazol- 1 -yl
carboxylate
2-(dimethylamino)ethyl 1 H-
1.042 1 ,2,3-triazol-1-yl
pyrazole-4-carboxylate
2-methoxyethyl 1 H-pyrazole-4-
1.043 1 ,2,4-triazol-1-yl
carboxylate
cyclopropyl 1 H-pyrazole-4-
1.044 5,5-dimethyl-isoxazolidin-3-one carboxylate
cyclopropylmethyl 1 H-pyrazole-
1.045 N,N-dimethyl-1 H-1 ,2,4-triazol-3-amine 4-carboxylate
1 H-pyrazole-4-carboxamide 1.046 benzimidazol-1-yl
N-m ethyl- 1 H-pyrazole-4-
1.047 5-methoxybenzimidazol-1-yl carboxamide
N-ethyl-1 H-pyrazole-4-
1.048 6-methoxybenzimidazol-1-yl carboxamide
N-propyl-1 H-pyrazole-4-
1.049 1 H-pyrazole-4-carbaldehyde carboxamide
N-isopropyl-1 H-pyrazole-4-
1.050 3,5-dimethylpyrazol-1-yl
carboxamide
N-prop-2-enyl-1 H-pyrazole-4-
1.051 azetidin-1-yl
carboxamide
N-prop-2-ynyl-1 H-pyrazole-4- methyl 3-(methoxymethyl)-1 H-
1.052
carboxamide pyrazole-4-carboxylate
N-cyclopropyl-1 H-pyrazole-4- 5-(difluoromethyl)-3-amino-1 ,2,4-
1.053
carboxamide triazol-2-yl
N-(cyclopropylmethyl)-1 H-
1.054 1-piperidyl
py razo le-4-carboxa m id e
N-(2-methoxyethyl)-1 H-pyrazole-
1.055 morpholin-4-yl
4-carboxamide
N-methoxy-1 H-pyrazole-4-
1.056 3-oxo-morpholin-4-yl
carboxamide
N-ethoxy-1 H-pyrazole-4-
1.057 3-oxo-isoxazolid in-2-yl
carboxamide
N-prop-2-enyloxy-1 H-pyrazole-4-
1.058 5,5-dimethyl-3-oxo-isoxazolidin-2-yl carboxamide
N-methoxy-N-methyl-1 H-
1.059 2-oxo-1-piperidyl
py razo le-4-carboxa m id e
N-ethoxy-N-methyl-1 H-pyrazole-
1.060 3 , 3-d imethyl-2-oxo- 1 -pi peridyl 4-carboxamide
N,N-dimethyl-1 H-pyrazole-4-
1.061 4,4-dimethyl-3-oxo-isoxazolidin-2-yl carboxamide
N,N-diethyl-1 H-pyrazole-4-
1.062 4-m ethyl-2-oxo- 1 -pyridyl
carboxamide
N-ethyl-N-m ethyl- 1 H-pyrazole-4-
1.063 2-oxo-1-pyridyl
carboxamide N-prop-2-enyl-N-methyl-1 H-
1.031 1.064 1 , 1-dioxo-1 ,2-thiazolidin-2-yl
py razo le-4-carboxa m id e
1.032 imidazol-1-yl 1.065 2-oxo pyrrol id i n- 1 -yl
1.033 5-m ethyl-3-am inopyrazol-2-yl
Table 1.2: This table discloses 65 specific compounds of formula (T-1 ) wherein A is 3,5-thienyl and R and R2 are hydrogen, Z is as defined above in Table 1. Table 1.3: This table discloses 65 specific compounds of formula (T-1 ) wherein A is 2,5-thienyl and R is hydrogen, R2 is methyl, and Z is as defined above in Table 1.
Table 2.1 : This table discloses 372 specific compounds of the formula (T-2):
Figure imgf000056_0001
wherein R is hydrogen and Z is as defined below in Table 2.
Table 2.2 (which follows Table 2.1 ) makes available 372 individual compounds of the formula (T- 2) in which R is as specifically defined in Table 2.2, which refers to Table 2 wherein Z is specifically defined.
Table 2
Compound Compound
Z Z
no. no.
2.001 2H-pyrazole-3-carboxylic acid 2.187 1 H-1 ,2,4-triazole-3-carboxylic acid methyl 1 H-1 ,2,4-triazole-3-
2.002 methyl 2H-pyrazole-3-carboxylate 2.188
carboxylate
ethyl 1 H-1 ,2,4-triazole-3-
2.003 ethyl 2H-pyrazole-3-carboxylate 2.189
carboxylate
propyl 1 H-1 ,2,4-triazole-3-
2.004 propyl 2H-pyrazole-3-carboxylate 2.190
carboxylate
prop-2-enyl 2H-pyrazole-3- prop-2-enyl 1 H-1 ,2,4-triazole-3-
2.005 2.191
carboxylate carboxylate
prop-2-ynyl 2H-pyrazole-3- prop-2-ynyl 1 H-1 ,2,4-triazole-3-
2.006 2.192
carboxylate carboxylate
tert-butyl 2H-pyrazole-3- tert-butyl 1 H-1 ,2,4-triazole-3-
2.007 2.193
carboxylate carboxylate
isopropyl 2H-pyrazole-3- isopropyl 1 H-1 ,2,4-triazole-3-
2.008 2.194
carboxylate carboxylate 2-(dimethylamino)ethyl 2H- 2-(dimethylamino)ethyl 1 H-1 , 2,4-
2.195
pyrazole-3-carboxylate triazole-3-carboxylate
2-methoxyethyl 2H-pyrazole-3- 2- methoxyethyl 1 H-1 ,2,4-triazole-
2.196
carboxylate 3- carboxylate
cyclopropyl 2H-pyrazole-3- cyclopropyl 1 H-1 ,2,4-triazole-3-
2.197
carboxylate carboxylate
cyclopropylmethyl 2H-pyrazole-3- cyclopropylmethyl 1 H-1 , 2,4-
2.198
carboxylate triazole-3-carboxylate
2H-pyrazole-3-carboxamide 2.199 1 H-1 ,2,4-triazole-3-carboxamide
N-methyl-2H-pyrazole-3- N-methyl-1 H-1 ,2,4-triazole-3-
2.200
carboxamide carboxamide
N-ethyl-2H-pyrazole-3- N-ethyl-1 H-1 ,2,4-triazole-3-
2.201
carboxamide carboxamide
N-propyl-2H-pyrazole-3- N-propyl-1 H-1 ,2,4-triazole-3-
2.202
carboxamide carboxamide
N-isopropyl-2H-pyrazole-3- N-isopropyl-1 H-1 ,2,4-triazole-3-
2.203
carboxamide carboxamide
N-prop-2-enyl-2H-pyrazole-3- N-prop-2-enyl-1 H-1 ,2,4-triazole-3-
2.204
carboxamide carboxamide
N-prop-2-ynyl-2H-pyrazole-3- N-prop-2-ynyl-1 H-1 ,2,4-triazole-3-
2.205
carboxamide carboxamide
N-cyclopropyl-2H-pyrazole-3- N-cyclopropyl-1 H-1 ,2,4-triazole-3-
2.206
carboxamide carboxamide
N-(cyclopropylmethyl)-2H- N-(cyclopropylmethyl)-1 H-1 ,2,4-
2.207
py razo le-3-carboxa m id e triazole-3-carboxam id e
N-(2-methoxyethyl)-2H-pyrazole- N-(2-methoxyethyl)-1 H-1 ,2,4-
2.208
3-carboxamide triazole-3-carboxamide
N-methoxy-2H-pyrazole-3- N-methoxy-1 H-1 ,2,4-triazole-3-
2.209
carboxamide carboxamide
N-ethoxy-2H-pyrazole-3- N-ethoxy-1 H-1 ,2,4-triazole-3-
2.210
carboxamide carboxamide
N-prop-2-enyloxy-2H-pyrazole-3- N-prop-2-enyloxy-1 H-1 ,2,4-
2.21 1
carboxamide triazole-3-carboxamide
N-methoxy-N-methyl-2H-pyrazole- N-methoxy-N-methyl-1 H-1 ,2,4-
2.212
3-carboxamide triazole-3-carboxamide
N-ethoxy-N-methyl-2H-pyrazole-3- N-ethoxy-N-methyl-1 H-1 ,2,4-
2.213
carboxamide triazole-3-carboxamide
N,N-dimethyl-2H-pyrazole-3- N,N-dimethyl-1 H-1 ,2,4-triazole-3-
2.214
carboxamide carboxamide
N , N-d iethyl-2H-pyrazole-3- N,N-diethyl-1 H-1 ,2,4-triazole-3-
2.215
carboxamide carboxamide
N-ethyl-N-methyl-2H-pyrazole-3- N-ethyl-N-methyl-1 H-1 ,2,4-
2.216
carboxamide triazole-3-carboxamide
N-prop-2-enyl-N-methyl-2H- N-prop-2-enyl-N-methyl-1 H-1 ,2,4-
2.217
py razo le-3-carboxa m id e triazole-3-carboxamide 1 H-pyrazole-3-carboxylic acid 2.218 3H-triazole-4-carboxylic acid methyl 1 H-pyrazole-3-carboxylate 2.219 methyl 3H-triazole-4-carboxylate ethyl 1 H-pyrazole-3-carboxylate 2.220 ethyl 3H-triazole-4-carboxylate propyl 1 H-pyrazole-3-carboxylate 2.221 propyl 3H-triazole-4-carboxylate prop-2-enyl 1 H-pyrazole-3- prop-2-enyl 3H-triazole-4-
2.222
carboxylate carboxylate
prop-2-ynyl 1 H-pyrazole-3- prop-2-ynyl 3H-triazole-4-
2.223
carboxylate carboxylate
tert-butyl 1 H-pyrazole-3-
2.224 tert-butyl 3H-triazole-4-carboxylate carboxylate
isopropyl 1 H-pyrazole-3-
2.225 isopropyl 3H-triazole-4-carboxylate carboxylate
2-(dimethylamino)ethyl 1 H- 2-(dimethylamino)ethyl 3H-
2.226
pyrazole-3-carboxylate triazole-4-carboxylate
2-methoxyethyl 1 H-pyrazole-3- 2-methoxyethyl 3H-triazole-4-
2.227
carboxylate carboxylate
cyclopropyl 1 H-pyrazole-3- cyclopropyl 3H-triazole-4-
2.228
carboxylate carboxylate
cyclopropylmethyl 1 H-pyrazole-3- cyclopropylmethyl 3H-triazole-4-
2.229
carboxylate carboxylate
1 H-pyrazole-3-carboxamide 2.230 3H-triazole-4-carboxamide
N-m ethyl- 1 H-pyrazole-3- N-methyl-3H-triazole-4-
2.231
carboxamide carboxamide
N-ethyl-1 H-pyrazole-3-
2.232 N-ethyl-3H-triazole-4-carboxamide carboxamide
N-propyl-1 H-pyrazole-3- N-propyl-3H-triazole-4-
2.233
carboxamide carboxamide
N-isopropyl-1 H-pyrazole-3- N-isopropyl-3H-triazole-4-
2.234
carboxamide carboxamide
N-prop-2-enyl-1 H-pyrazole-3- N-prop-2-enyl-3H-triazole-4-
2.235
carboxamide carboxamide
N-prop-2-ynyl-1 H-pyrazole-3- N-prop-2-ynyl-3H-triazole-4-
2.236
carboxamide carboxamide
N-cyclopropyl-1 H-pyrazole-3- N-cyclopropyl-3H-triazole-4-
2.237
carboxamide carboxamide
N-(cyclopropylmethyl)-1 H- N-(cyclopropylmethyl)-3H-triazole-
2.238
py razo le-3-carboxa m id e 4-carboxamide
N-(2-methoxyethyl)-1 H-pyrazole- N-(2-methoxyethyl)-3H-triazole-4-
2.239
3-carboxamide carboxamide
N-methoxy-1 H-pyrazole-3- N-methoxy-3H-triazole-4-
2.240
carboxamide carboxamide
N-ethoxy-1 H-pyrazole-3- N-ethoxy-3H-triazole-4-
2.241
carboxamide carboxamide N-prop-2-enyloxy-1 H-pyrazole-3- N-prop-2-enyloxy-3H-triazole-4-
2.242
carboxamide carboxamide
N-methoxy-N-methyl-1 H-pyrazole- N-methoxy-N-methyl-3H-triazole-
2.243
3-carboxamide 4-carboxamide
N-ethoxy-N-methyl-1 H-pyrazole-3- N-ethoxy-N-methyl-3H-triazole-4-
2.244
carboxamide carboxamide
N,N-dimethyl-1 H-pyrazole-3- N,N-dimethyl-3H-triazole-4-
2.245
carboxamide carboxamide
N,N-diethyl-1 H-pyrazole-3- N , N-d iethyl-3H-triazole-4-
2.246
carboxamide carboxamide
N-ethyl-N-m ethyl- 1 H-pyrazole-3- N-ethyl-N-methyl-3H-triazole-4-
2.247
carboxamide carboxamide
N-prop-2-enyl-N-methyl-1 H- N-prop-2-enyl-N-methyl-3H-
2.248
py razo le-3-carboxa m id e triazole-4-carboxamide
1 H-imidazole-2-carboxylic acid 2.249 2H-triazole-4-carboxylic acid methyl 1 H-imidazole-2-carboxylate 2.250 methyl 2H-triazole-4-carboxylate ethyl 1 H-imidazole-2-carboxylate 2.251 ethyl 2H-triazole-4-carboxylate propyl 1 H-imidazole-2-carboxylate 2.252 propyl 2H-triazole-4-carboxylate prop-2-enyl 1 H-imidazole-2- prop-2-enyl 2H-triazole-4-
2.253
carboxylate carboxylate
prop-2-ynyl 1 H-imidazole-2- prop-2-ynyl 2H-triazole-4-
2.254
carboxylate carboxylate
tert-butyl 1 H-imidazole-2-
2.255 tert-butyl 2H-triazole-4-carboxylate carboxylate
isopropyl 1 H-imidazole-2-
2.256 isopropyl 2H-triazole-4-carboxylate carboxylate
2-(dimethylamino)ethyl 1 H- 2-(dimethylamino)ethyl 2H-
2.257
imidazole-2-carboxylate triazole-4-carboxylate
2-methoxyethyl 1 H-imidazole-2- 2-methoxyethyl 2H-triazole-4-
2.258
carboxylate carboxylate
cyclopropyl 1 H-imidazole-2- cyclopropyl 2H-triazole-4-
2.259
carboxylate carboxylate
cyclopropylmethyl 1 H-imidazole-2- cyclopropylmethyl 2H-triazole-4-
2.260
carboxylate carboxylate
1 H-imidazole-2-carboxamide 2.261 2H-triazole-4-carboxamide
N-methyl-1 H-imidazole-2- N-methyl-2H-triazole-4-
2.262
carboxamide carboxamide
N-ethyl-1 H-imidazole-2-
2.263 N-ethyl-2H-triazole-4-carboxamide carboxamide
N-propyl-1 H-imidazole-2- N-propyl-2H-triazole-4-
2.264
carboxamide carboxamide
N-isopropyl-1 H-imidazole-2- N-isopropyl-2H-triazole-4-
2.265
carboxamide carboxamide N-prop-2-enyl-1 H-imidazole-2- N-prop-2-enyl-2H-triazole-4-
2.266
carboxamide carboxamide
N-prop-2-ynyl-1 H-imidazole-2- N-prop-2-ynyl-2H-triazole-4-
2.267
carboxamide carboxamide
N-cyclopropyl-1 H-imidazole-2- N-cyclopropyl-2H-triazole-4-
2.268
carboxamide carboxamide
N-(cyclopropylmethyl)-1 H- N-(cyclopropylmethyl)-2H-triazole-
2.269
imidazole-2-carboxamide 4-carboxamide
N-(2-methoxyethyl)-1 H-imidazole- N-(2-methoxyethyl)-2H-triazole-4-
2.270
2-carboxamide carboxamide
N-methoxy-1 H-imidazole-2- N-methoxy-2H-triazole-4-
2.271
carboxamide carboxamide
N-ethoxy-1 H-imidazole-2- N-ethoxy-2H-triazole-4-
2.272
carboxamide carboxamide
N-prop-2-enyloxy-1 H-imidazole-2- N-prop-2-enyloxy-2H-triazole-4-
2.273
carboxamide carboxamide
N-methoxy-N-methyl-1 H- N-methoxy-N-methyl-2H-triazole-
2.274
imidazole-2-carboxamide 4-carboxamide
N-ethoxy-N-methyl-1 H-imidazole- N-ethoxy-N-methyl-2H-triazole-4-
2.275
2-carboxamide carboxamide
N,N-dimethyl-1 H-imidazole-2- N,N-dimethyl-2H-triazole-4-
2.276
carboxamide carboxamide
N,N-diethyl-1 H-imidazole-2- N , N-d iethyl-2H-triazole-4-
2.277
carboxamide carboxamide
N-ethyl-N-methyl-1 H-imidazole-2- N-ethyl-N-methyl-2H-triazole-4-
2.278
carboxamide carboxamide
N-prop-2-enyl-N-methyl-1 H- N-prop-2-enyl-N-methyl-2H-
2.279
imidazole-2-carboxamide triazole-4-carboxamide
1 H-imidazole-4-carboxylic acid 2.280 1 H-triazole-4-carboxylic acid methyl 1 H-imidazole-4-carboxylate 2.281 methyl 1 H-triazole-4-carboxylate ethyl 1 H-imidazole-4-carboxylate 2.282 ethyl 1 H-triazole-4-carboxylate propyl 1 H-imidazole-4-carboxylate 2.283 propyl 1 H-triazole-4-carboxylate prop-2-enyl 1 H-imidazole-4- prop-2-enyl 1 H-triazole-4-
2.284
carboxylate carboxylate
prop-2-ynyl 1 H-imidazole-4- prop-2-ynyl 1 H-triazole-4-
2.285
carboxylate carboxylate
tert-butyl 1 H-imidazole-4-
2.286 tert-butyl 1 H-triazole-4-carboxylate carboxylate
isopropyl 1 H-imidazole-4-
2.287 isopropyl 1 H-triazole-4-carboxylate carboxylate
2-(dimethylamino)ethyl 1 H- 2-(dimethylamino)ethyl 1 H-
2.288
imidazole-4-carboxylate triazole-4-carboxylate
2-methoxyethyl 1 H-imidazole-4- 2-methoxyethyl 1 H-triazole-4-
2.289
carboxylate carboxylate cyclopropyl 1 H-imidazole-4- cyclopropyl 1 H-triazole-4-
2.290
carboxylate carboxylate
cyclopropylmethyl 1 H-imidazole-4- cyclopropylmethyl 1 H-triazole-4-
2.291
carboxylate carboxylate
1 H-imidazole-4-carboxamide 2.292 1 H-triazole-4-carboxamide
N-methyl-1 H-imidazole-4- N-methyl-1 H-triazole-4-
2.293
carboxamide carboxamide
N-ethyl-1 H-imidazole-4-
2.294 N-ethyl-1 H-triazole-4-carboxam ide carboxamide
N-propyl-1 H-imidazole-4- N-propyl-1 H-triazole-4-
2.295
carboxamide carboxamide
N-isopropyl-1 H-imidazole-4- N-isopropyl-1 H-triazole-4-
2.296
carboxamide carboxamide
N-prop-2-enyl-1 H-imidazole-4- N-prop-2-enyl-1 H-triazole-4-
2.297
carboxamide carboxamide
N-prop-2-ynyl-1 H-imidazole-4- N-prop-2-ynyl-1 H-triazole-4-
2.298
carboxamide carboxamide
N-cyclopropyl-1 H-imidazole-4- N-cyclopropyl-1 H-triazole-4-
2.299
carboxamide carboxamide
N-(cyclopropylmethyl)-1 H- N-(cyclopropylmethyl)-1 H-triazole-
2.300
imidazole-4-carboxamide 4-carboxamide
N-(2-methoxyethyl)-1 H-imidazole- N-(2-m ethoxyethyl)- 1 H-triazole-4-
2.301
4-carboxamide carboxamide
N-methoxy-1 H-imidazole-4- N-methoxy-1 H-triazole-4-
2.302
carboxamide carboxamide
N-ethoxy-1 H-imidazole-4- N-ethoxy-1 H-triazole-4-
2.303
carboxamide carboxamide
N-prop-2-enyloxy-1 H-imidazole-4- N-prop-2-enyloxy-1 H-triazole-4-
2.304
carboxamide carboxamide
N-methoxy-N-methyl-1 H- N-methoxy-N-methyl-1 H-triazole-
2.305
imidazole-4-carboxamide 4-carboxamide
N-ethoxy-N-methyl-1 H-imidazole- N-ethoxy-N-methyl-1 H-triazole-4-
2.306
4-carboxamide carboxamide
N,N-dimethyl-1 H-imidazole-4- N,N-dimethyl-1 H-triazole-4-
2.307
carboxamide carboxamide
N,N-diethyl-1 H-imidazole-4- N,N-diethyl-1 H-triazole-4-
2.308
carboxamide carboxamide
N-ethyl-N-methyl-1 H-imidazole-4- N-ethyl-N-methyl-1 H-triazole-4-
2.309
carboxamide carboxamide
N-prop-2-enyl-N-methyl-1 H- N-prop-2-enyl-N-methyl-1 H-
2.310
imidazole-4-carboxamide triazole-4-carboxamide
3H-imidazole-4-carboxylic acid 2.31 1 1 H-tetrazole-5-carboxylic acid methyl 3H-imidazole-4-carboxylate 2.312 methyl 1 H-tetrazole-5-carboxylate ethyl 3H-imidazole-4-carboxylate 2.313 ethyl 1 H-tetrazole-5-carboxylate propyl 3H-imidazole-4-carboxylate 2.314 propyl 1 H-tetrazole-5-carboxylate prop-2-enyl 3H-imidazole-4- prop-2-enyl 1 H-tetrazole-5-
2.315
carboxylate carboxylate
prop-2-ynyl 3H-imidazole-4- prop-2-ynyl 1 H-tetrazole-5-
2.316
carboxylate carboxylate
tert-butyl 3H-imidazole-4- tert-butyl 1 H-tetrazole-5-
2.317
carboxylate carboxylate
isopropyl 3H-imidazole-4- isopropyl 1 H-tetrazole-5-
2.318
carboxylate carboxylate
2-(dimethylamino)ethyl 3H- 2-(dimethylamino)ethyl 1 H-
2.319
imidazole-4-carboxylate tetrazole-5-carboxylate
2-methoxyethyl 3H-imidazole-4- 2-methoxyethyl 1 H-tetrazole-5-
2.320
carboxylate carboxylate
cyclopropyl 3H-imidazole-4- cyclopropyl 1 H-tetrazole-5-
2.321
carboxylate carboxylate
cyclopropylmethyl 3H-imidazole-4- cyclopropylmethyl 1 H-tetrazole-5-
2.322
carboxylate carboxylate
3H-imidazole-4-carboxamide 2.323 1 H-tetrazole-5-carboxamide
N-methyl-3H-imidazole-4- N-methyl-1 H-tetrazole-5-
2.324
carboxamide carboxamide
N-ethyl-3H-imidazole-4- N-ethyl-1 H-tetrazole-5-
2.325
carboxamide carboxamide
N-propyl-3H-imidazole-4- N-propyl-1 H-tetrazole-5-
2.326
carboxamide carboxamide
N-isopropyl-3H-imidazole-4- N-isopropyl-1 H-tetrazole-5-
2.327
carboxamide carboxamide
N-prop-2-enyl-3H-imidazole-4- N-prop-2-enyl-1 H-tetrazole-5-
2.328
carboxamide carboxamide
N-prop-2-ynyl-3H-imidazole-4- N-prop-2-ynyl-1 H-tetrazole-5-
2.329
carboxamide carboxamide
N-cyclopropyl-3H-imidazole-4- N-cyclopropyl-1 H-tetrazole-5-
2.330
carboxamide carboxamide
N-(cyclopropylmethyl)-3H- N-(cyclopropylmethyl)-1 H-
2.331
imidazole-4-carboxamide tetrazole-5-carboxamide
N-(2-methoxyethyl)-3H-imidazole- N-(2-methoxyethyl)-1 H-tetrazole-5-
2.332
4-carboxamide carboxamide
N-methoxy-3H-imidazole-4- N-methoxy-1 H-tetrazole-5-
2.333
carboxamide carboxamide
N-ethoxy-3H-imidazole-4- N-ethoxy-1 H-tetrazole-5-
2.334
carboxamide carboxamide
N-prop-2-enyloxy-3H-imidazole-4- N-prop-2-enyloxy-1 H-tetrazole-5-
2.335
carboxamide carboxamide
N-methoxy-N-methyl-3H- N-methoxy-N-methyl-1 H-tetrazole-
2.336
imidazole-4-carboxamide 5-carboxamide N-ethoxy-N-methyl-3H-imidazole- N-ethoxy-N-methyl-1 H-tetrazole-5-
2.337
4-carboxamide carboxamide
N,N-dimethyl-3H-imidazole-4- N,N-dimethyl-1 H-tetrazole-5-
2.338
carboxamide carboxamide
N,N-diethyl-3H-imidazole-4- N,N-diethyl-1 H-tetrazole-5-
2.339
carboxamide carboxamide
N-ethyl-N-methyl-3H-imidazole-4- N-ethyl-N-m ethyl- 1 H-tetrazole-5-
2.340
carboxamide carboxamide
N-prop-2-enyl-N-methyl-3H- N-prop-2-enyl-N-methyl-1 H-
2.341
imidazole-4-carboxamide tetrazole-5-carboxamide
2H-1 ,2,4-triazole-3-carboxylic acid 2.342 2H-tetrazole-5-carboxylic acid methyl 2H-1 ,2,4-triazole-3-
2.343 methyl 2H-tetrazole-5-carboxylate carboxylate
ethyl 2H-1 ,2,4-triazole-3-
2.344 ethyl 2H-tetrazole-5-carboxylate carboxylate
propyl 2H-1 ,2,4-triazole-3-
2.345 propyl 2H-tetrazole-5-carboxylate carboxylate
prop-2-enyl 2H-1 ,2,4-triazole-3- prop-2-enyl 2H-tetrazole-5-
2.346
carboxylate carboxylate
prop-2-ynyl 2H-1 ,2,4-triazole-3- prop-2-ynyl 2H-tetrazole-5-
2.347
carboxylate carboxylate
tert-butyl 2H-1 ,2,4-triazole-3- tert-butyl 2H-tetrazole-5-
2.348
carboxylate carboxylate
isopropyl 2H-1 ,2,4-triazole-3- isopropyl 2H-tetrazole-5-
2.349
carboxylate carboxylate
2-(dimethylamino)ethyl 21-1-1 ,2,4- 2-(dimethylamino)ethyl 2H-
2.350
triazole-3-carboxylate tetrazole-5-carboxylate
2- methoxyethyl 2H-1 ,2,4-triazole- 2-methoxyethyl 2H-tetrazole-5-
2.351
3- carboxylate carboxylate
cyclopropyl 2H-1 ,2,4-triazole-3- cyclopropyl 2H-tetrazole-5-
2.352
carboxylate carboxylate
cyclopropylmethyl 21-1-1 ,2,4- cyclopropylmethyl 2H-tetrazole-5-
2.353
triazole-3-carboxylate carboxylate
2H-1 ,2,4-triazole-3-carboxamide 2.354 2H-tetrazole-5-carboxamide
N-methyl-2H-1 ,2,4-triazole-3- N-methyl-2H-tetrazole-5-
2.355
carboxamide carboxamide
N-ethyl-2H-1 ,2,4-triazole-3- N-ethyl-2H-tetrazole-5-
2.356
carboxamide carboxamide
N-propyl-2H-1 ,2,4-triazole-3- N-propyl-2H-tetrazole-5-
2.357
carboxamide carboxamide
N-isopropyl-2H-1 ,2,4-triazole-3- N-isopropyl-2H-tetrazole-5-
2.358
carboxamide carboxamide
N-prop-2-enyl-2H-1 ,2,4-triazole-3- N-prop-2-enyl-2H-tetrazole-5-
2.359
carboxamide carboxamide N-prop-2-ynyl-2H-1 ,2,4-triazole-3- N-prop-2-ynyl-2H-tetrazole-5-
2.174 2.360
carboxamide carboxamide
N-cyclopropyl-2H-1 ,2,4-triazole-3- N-cyclopropyl-2H-tetrazole-5-
2.175 2.361
carboxamide carboxamide
N-(cyclopropylmethyl)-2H-1 ,2,4- N-(cyclopropylmethyl)-2H-
2.176 2.362
triazole-3-carboxamide tetrazole-5-carboxamide
N-(2-methoxyethyl)-2H-1 ,2,4- N-(2-methoxyethyl)-2H-tetrazole-5-
2.177 2.363
triazole-3-carboxamide carboxamide
N-methoxy-2H-1 ,2,4-triazole-3- N-methoxy-2H-tetrazole-5-
2.178 2.364
carboxamide carboxamide
N-ethoxy-2H-1 ,2,4-triazole-3- N-ethoxy-2H-tetrazole-5-
2.179 2.365
carboxamide carboxamide
N-prop-2-enyloxy-2H-1 ,2,4- N-prop-2-enyloxy-2H-tetrazole-5-
2.180 2.366
triazole-3-carboxamide carboxamide
N-methoxy-N-methyl-2H-1 ,2,4- N-methoxy-N-methyl-2H-tetrazole-
2.181 2.367
triazole-3-carboxamide 5-carboxamide
N-ethoxy-N-methyl-2H-1 ,2,4- N-ethoxy-N-methyl-2H-tetrazole-5-
2.182 2.368
triazole-3-carboxamide carboxamide
N,N-dimethyl-2H-1 ,2,4-triazole-3- N,N-dimethyl-2H-tetrazole-5-
2.183 2.369
carboxamide carboxamide
N,N-diethyl-2H-1 ,2,4-triazole-3- N,N-diethyl-2H-tetrazole-5-
2.184 2.370
carboxamide carboxamide
N-ethyl-N-methyl-2H-1 ,2,4- N-ethyl-N-methyl-2H-tetrazole-5-
2.185 2.371
triazole-3-carboxamide carboxamide
N-prop-2-enyl-N-methyl-2H-1 ,2,4- N-prop-2-enyl-N-methyl-2H-
2.186 2.372
triazole-3-carboxamide tetrazole-5-carboxamide
Table 2.2: This table discloses 372 specific compounds of formula (T-2) wherein R is methyl and Z is as defined above in Table 2. For Z as defined in Tables 1 and 2 above (with the exceptions of compound no.s 1.034, 1.036 to 1.039, 1.041 to 1.043, 1.046 to 1 .048, 1.050, 1.051 , 1.053 to 1.065 identified as radicals), Z groups are disclosed as a compound where the available ring nitrogen (as designated by an N-H group) is the binding point to the rest of the molecule in accordance with a Z radical for the compounds of Formula (I) of the present invention.
By way of example, the Z radical of compound 1 .001 (1 H-pyrazole-4-carboxylic acid) in Table 1 is:
Figure imgf000065_0001
3
the Z radical of compound 1.021 (N-(cyclopropylmethyl)-1 H-pyrazole-4-carboxamide) in Table 1 is:
Figure imgf000065_0002
the Z radical of compound 1.035 (1 H-pyrazole-4-carbonitrile) in Table 1 is:
Figure imgf000065_0003
the Z radical of compound 1.049 (1 H-pyrazole-4-carbaldehyde) in Table 1 is:
Figure imgf000065_0004
the Z radical of compound 2.194 (isopropyl 1 H-1 ,2,4-triazole-3-carboxylate) in Table 2 is:
Figure imgf000065_0005
The following general procedure was used in a combinatorial fashion using appropriate building blocks (compounds of Formulas (II) and (III)) to provide the compounds of Formula (I). The compounds prepared via the following combinatorial protocol were analyzed using LC/MS Method B. EXAMPLES
The Examples which follow serve to illustrate the invention. The compounds of the invention can be distinguished from known compounds by virtue of greater efficacy at low application rates, which can be verified by the person skilled in the art using the experimental procedures outlined in the Examples, using lower application rates if necessary, for example 50 ppm, 12.5 ppm, 6 ppm, 3 ppm, 1.5 ppm, 0.8 ppm or 0.2 ppm.
Compounds of Formula (I) may possess any number of benefits including, inter alia, advantageous levels of biological activity for protecting plants against diseases that are caused by fungi or superior properties for use as agrochemical active ingredients (for example, greater biological activity, an advantageous spectrum of activity, an increased safety profile (including improved crop tolerance), improved physico-chemical properties, or increased biodegradability).
Throughout this description, temperatures are given in degrees Celsius (°C) and "mp." means melting point. LC/MS means Liquid Chromatography Mass Spectrometry and the description of the apparatus and the method (Methods A, B and C) is as follows:
The description of the LC/MS apparatus and the method A is:
SQ Detector 2 from Waters
lonisation method: Electrospray
Polarity: positive and negative ions
Capillary (kV) 3.0, Cone (V) 30.00, Extractor (V) 2.00, Source Temperature (°C) 150, Desolvation
Temperature (°C) 350, Cone Gas Flow (L/Hr) 0, Desolvation Gas Flow (L/Hr) 650
Mass range: 100 to 900 Da
DAD Wavelength range (nm): 210 to 500
Method Waters ACQUITY UPLC with the following HPLC gradient conditions:
(Solvent A: Water/Methanol 20:1 + 0.05% formic acid and Solvent B: Acetonitrile+ 0.05% formic acid)
Time (minutes) A (%) B (%) Flow rate (ml/min)
0 100 0 0.85
1.2 0 100 0.85
1.5 0 100 0.85 Type of column: Waters ACQUITY UPLC HSS T3; Column length: 30 mm; Internal diameter of column: 2.1 mm; Particle Size: 1.8 micron; Temperature: 60°C.
The description of the LC/MS apparatus and the method B is:
SQ Detector 2 from Waters lonisation method: Electrospray
Polarity: positive ions
Capillary (kV) 3.5, Cone (V) 30.00, Extractor (V) 3.00, Source Temperature (°C) 150, Desolvation Temperature (°C) 400, Cone Gas Flow (L/Hr) 60, Desolvation Gas Flow (L/Hr) 700
Mass range: 140 to 800 Da
DAD Wavelength range (nm): 210 to 400
Method Waters ACQUITY UPLC with the following HPLC gradient conditions:
(Solvent A: Water/Methanol 9: 1 + 0.1 % formic acid and Solvent B: Acetonitrile + 0.1 % formic acid)
Time (minutes) A (%) B (%) Flow rate (ml/min)
0 100 0 0.75
2.5 0 100 0.75
2.8 0 100 0.75
3.0 100 0 0.75
Type of column: Waters ACQUITY UPLC HSS T3; Column length: 30 mm; Internal diameter of column: 2.1 mm; Particle Size: 1 .8 micron; Temperature: 60°C.
The description of the LC/MS apparatus and the method C is:
SQ Detector 2 from Waters
lonisation method: Electrospray
ACQUITY H Class UPLC, Mass Spectrometer from Waters
Polarity: positive and Negative Polarity Switch
Scan Type MS1 Scan
Capillary (kV) 3.00, Cone (V) 40.00, Desolvation Temperature (°C) 500, Cone Gas Flow (L/Hr) 50, Desolvation Gas Flow (L/Hr) 1000
Mass range: 0 to 2000 Da
DAD Wavelength range (nm): 200 to 350
Method Waters ACQUITY UPLC with the following HPLC gradient conditions:
(Solvent A: Water +,0.1 % formic acid and Solvent B: Acetonitrile)
Time (minutes) A (%) B (%) Flow rate (ml/min)
0 70 30 0.5
0.05 70 30 0.5
0.8 5 95 0.5
1.8 5 95 0.5
2.45 70 30 0.5
2.50 70 30 0.5 Type of column: Waters ACQUITY UPLC BEH C18; Column length: 50 mm; Internal diameter of column: 2.1 mm; Particle Size: 1 .7 micron; Temperature: 35°C.
Where necessary, enantiomerically pure final compounds may be obtained from racemic materials as appropriate via standard physical separation techniques, such as reverse phase chiral chromatography, or through stereoselective synthetic techniques, e.g., by using chiral starting materials.
Formulation Examples
Wettable powders a) b) c)
Active ingredient [compound of Formula (I)] 25 % 50 % 75 %
sodium lignosulfonate 5 % 5 %
sodium lauryl sulfate 3 % - 5 %
sodium diisobutylnaphthalenesulfonate 6 % 10 %
phenol polyethylene glycol ether 2 %
(7-8 mol of ethylene oxide)
highly dispersed silicic acid 5 % 10 % 10 %
Kaolin 62 % 27 %
The active ingredient is thoroughly mixed with the adjuvants and the mixture is thoroughly ground in a suitable mill, affording wettable powders that can be diluted with water to give suspensions of the desired concentration.
Powders for dry seed treatment a) b) c)
Active ingredient [compound of Formula (I)] 25 % 50 % 75 %
light mineral oil 5 % 5 % 5 %
highly dispersed silicic acid 5 % 5 %
Kaolin 65 % 40 %
Talcum 20 %
The active ingredient is thoroughly mixed with the adjuvants and the mixture is thoroughly ground in a suitable mill, affording powders that can be used directly for seed treatment.
Emulsifiable concentrate
active ingredient [compound of Formula (I)] 10 %
octylphenol polyethylene glycol ether 3 %
(4-5 mol of ethylene oxide)
calcium dodecylbenzenesulfonate 3 %
castor oil polyglycol ether (35 mol of ethylene oxide) 4 % Cyclohexanone 30 %
xylene mixture 50 %
Emulsions of any required dilution, which can be used in plant protection, can be obtained from this concentrate by dilution with water.
Dusts a) b) c)
Active ingredient [compound of Formula (I)] 5 % 6 % 4 %
Talcum 95 %
Kaolin 94 %
mineral filler 96 %
Ready-for-use dusts are obtained by mixing the active ingredient with the carrier and grinding the mixture in a suitable mill. Such powders can also be used for dry dressings for seed.
Extruder granules
Active ingredient [compound of Formula (I)] 15 %
sodium lignosulfonate 2 %
Carboxymethylcellulose 1 %
Kaolin 82 %
The active ingredient is mixed and ground with the adjuvants, and the mixture is moistened with water. The mixture is extruded and then dried in a stream of air.
Coated granules
Active ingredient [compound of Formula (I)] 8 %
polyethylene glycol (mol. wt. 200) 3 %
Kaolin 89 %
The finely ground active ingredient is uniformly applied, in a mixer, to the kaolin moistened with polyethylene glycol. Non-dusty coated granules are obtained in this manner.
Suspension concentrate
Active ingredient [compound of Formula (I)] 40 %
propylene glycol 10 %
nonylphenol polyethylene glycol ether (15 mol of ethylene oxide) 6 %
Sodium lignosulfonate 10 %
Carboxymethylcellulose 1 %
Silicone oil (in the form of a 75 % emulsion in water) 1 %
Water 32 % The finely ground active ingredient is intimately mixed with the adjuvants, giving a suspension concentrate from which suspensions of any desired dilution can be obtained by dilution with water. Using such dilutions, living plants as well as plant propagation material can be treated and protected against infestation by microorganisms, by spraying, pouring or immersion.
Flowable concentrate for seed treatment
Active ingredient [compound of Formula (I)] 40 %
propylene glycol 5 %
copolymer butanol PO/EO 2 %
tristyrenephenole with 10-20 moles EO 2 %
1 ,2-benzisothiazolin-3-one (in the form of a 20% solution in water) 0.5 %
monoazo-pigment calcium salt 5 %
Silicone oil (in the form of a 75 % emulsion in water) 0.2 %
Water 45.3 %
The finely ground active ingredient is intimately mixed with the adjuvants, giving a suspension concentrate from which suspensions of any desired dilution can be obtained by dilution with water. Using such dilutions, living plants as well as plant propagation material can be treated and protected against infestation by microorganisms, by spraying, pouring or immersion.
Slow-Release Capsule Suspension
28 parts of a combination of the compound of Formula I are mixed with 2 parts of an aromatic solvent and 7 parts of toluene diisocyanate/polymethylene-polyphenylisocyanate-mixture (8: 1 ). This mixture is emulsified in a mixture of 1.2 parts of polyvinylalcohol, 0.05 parts of a defoamer and 51.6 parts of water until the desired particle size is achieved. To this emulsion a mixture of 2.8 parts 1 ,6- diaminohexane in 5.3 parts of water is added. The mixture is agitated until the polymerization reaction is completed.
The obtained capsule suspension is stabilized by adding 0.25 parts of a thickener and 3 parts of a dispersing agent. The capsule suspension Formulation contains 28% of the active ingredients. The medium capsule diameter is 8-15 microns.
The resulting formulation is applied to seeds as an aqueous suspension in an apparatus suitable for that purpose.
AIBN = azobisisobutyronitrile
DMF = dimethylformamide
DMA = dimethylacetamide
DIPEA = N,N-di-isopropylethylamine EtOAc = ethyl acetate
HCI = hydrochloric acid
mp = melting point
°C = degrees Celsius
MeOH = methyl alcohol
NaOH = sodium hydroxide
NBS = N-bromosuccinimide
min = minutes
rt = room temperature
h = hour(s)
TFAA = trifluoroacetic acid anhydride
THF = tetrahydrofuran
Rt = retention time (in minutes)
LC/MS = Liquid Chromatography Mass Spectrometry (description of the apparatus and the methods used for LC/MS analysis are given above)
Preparation Examples
Using the synthetic techniques described both above and below, compounds of formula (I) may be prepared accordingly.
Example 1 : This example illustrates the preparation of N,N-dimethyl-1-[[5-[5-(trifluoromethyl)-1 ,2,4- oxadiazol-3-yl]-2-thienyl]methyl]-1 ,2,4-triazol-3-amine (Compound 1.4 of Table T1 )
Figure imgf000071_0001
Step 1 : Preparation of N'-hvdroxy-5-methyl-thiophene-2-carboxamidine
Figure imgf000071_0002
To a suspension of 5-methylthiophene-2-carbonitrile (9.0 g, 73 mmol) in ethanol (365 mL) stirring at room temperature was added triethylamine (20.6 mL, 146 mmol) followed by the portionwise introduction of hydroxylamine hydrochloride (10.3 g, 146 mmol). The reaction contents were heated at reflux for 3.5 hours, cooled to 25°C, and concentrated under reduced pressure to provide N'-hydroxy- 5-methyl-thiophene-2-carboxamidine as a crude residue which was used in the next transformations without further purification. LC/MS (Method A) retention time = 0.24 minutes, 156 (M+H).
Step 2: Preparation of 3-(5-methyl-2-thienyl)-5-(trifluoromethyl)-1 ,2,4-oxadiazole
Figure imgf000072_0001
To a suspension of crude N'-hydroxy-5-methyl-thiophene-2-carboxamidine (32.0 g) in tetrahydrofuran (1.0 L) was introduced pyridine (24 mL, 292 mmol) and the contents were cooled to 10°C. To this suspension, TFAA (30.9 mL, 219 mL) was introduced dropwise. The reaction mixture was allowed to warm to 25°C overnight, and then concentrated at reduced pressure. The resultant residue was dissolved in ethyl acetate, washed with an aqueous 1 M HCI solution, water, and a saturated aqueous Na2C03 solution. The organic layer was dried over sodium sulfate, filtered, and the volatiles were removed at reduced pressure. The crude residue was purified by flash chromatography over silica gel using a cyclohexane/EtOAc eluent gradient to afford 3-(5-methyl-2-thienyl)-5-(trifluoromethyl)-1 ,2,4- oxadiazole as a clear oil (13.1 g, 76% yield). LC/MS (Method A) retention time = 1.13 minutes, mass not detected.
Ή NMR (400 MHz, CDCIs) δ ppm: 7.68 (d, 1 H), 6.84 (d, 1 H), 2.57 (s, 3H).
9F NMR (400 MHz, CDCI3) δ ppm: -65.44 (s). Step 3a: Preparation of 3-[5-(bromomethyl)-2-thienyll-5-(trifluoromethyl)-1 ,2,4-oxadiazole
Figure imgf000072_0002
To a solution of 3-(5-methyl-2-thienyl)-5-(trifluoromethyl)-1 ,2,4-oxadiazole (13.1 g, 55.7 mmol) and tetrachloromethane (1 1 1 mL) under argon atmosphere was added AIBN (0.93 g, 5.6 mmol) then NBS (1 1.02 g, 61.3 mmol). The contents were heated at 70°C for 18 hours. The mixture was cooled to 25°C then diluted with dichloromethane and water. The layers were separated, the organic phase was dried over sodium sulfate, and the volatiles were removed under reduced pressure. The crude residue was purified by flash chromatography over silica gel using a cyclohexane/EtOAc eluent gradient to afford 3-[5-(bromomethyl)-2-thienyl]-5-(trifluoromethyl)-1 ,2,4-oxadiazole as a yellow oil (3.86 g, 22% yield). LC/MS (Method A) retention time = 1 .14 minutes, mass not detected.
Ή NMR (400 MHz, CDCI3) δ ppm: 8.1 1 (d, 1 H), 7.55 (d, 1 H), 4.53 (s, 2H).
9F NMR (400 MHz, CDCI3) δ ppm: -65.31 (s). 3-[5-(dibromomethyl)-2-thienyl]-5-(trifluoromethyl)-1 ,2,4-oxadiazole was isolated as by-product as a yellow amorphous solid (13.0 g)
Figure imgf000073_0001
Ή NMR (400 MHz, CDCIs) δ ppm: 7.73 (d, 1 H), 7.32 (d, 1 H), 6.91 (s, 1 H).
Step 4: Preparation of N,N-dimethyl-1-[[5-[5-(trifluoromethvn-1 ,2,4-oxadiazol-3-yll-2-thienyllmethyll- 1 ,2,4-triazol-3-amine A solution of 3-[5-(bromomethyl)-2-thienyl]-5-(trifluoromethyl)-1 ,2,4-oxadiazole (150 mg, 0.48 mmol), N,N-dimethyl-4H-1 ,2,4-triazol-3-amine (64 mg, 0.57 mmol), and potassium carbonate (133 mg, 0.96 mmol) in acetonitrile (6.0 mL) was stirred at rt overnight. The solids were removed by filtration, washed with ethyl acetate, and the volatiles were removed under reduced pressure. The resultant residue purified by flash chromatography over silica gel using a cyclohexane/EtOAc eluent gradient to afford N,N-dimethyl-1-[[5-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl]-2-thienyl]methyl]-1 ,2,4-triazol-3- amine as a yellow solid (49 mg, 30% yield). LC/MS (Method A) retention time = 0.96 minutes, 345 (M+H). mp: 1 13-1 16°C
Ή NMR (400 MHz, CDCI3) δ ppm: 7.78 (s, 1 H), 7.75 (d, 1 H), 7.1 1 (d, 1 H), 5.37 (s, 2H), 2.99 (s, 6H).
Example 2: This example illustrates the preparation of methyl 1-[[5-[5-(trifluoromethyl)-1 ,2,4-oxadiazol- 3-yl]-2-thienyl]methyl]-1 ,2,4-triazole-3-carbox late (Compound 1.6 of Table T1 )
Figure imgf000073_0002
A mixture of 3-[5-(bromomethyl)-2-thienyl]-5-(trifluoromethyl)-1 ,2,4-oxadiazole (1.0 g, 3.2 mmol), methyl 1 H-1 ,2,4-triazole-3-carboxylate (610 mg, 4.8 mmol) and potassium carbonate (880 mg, 6.4 mmol) in acetonitrile (32 mL) was heated at 1 10°C for 2 hours. The resultant orange suspension was filtered to remove the solids and the filtrate solution was then concentrated under reduced pressure. The resultant crude residue was purified by chromatography on silica gel using a cyclohexane/ethyl acetate gradient to afford 750 mg of the title compound as a white solid. LC/MS (Method A) retention time = 0.91 minutes, 360 (M+H). Ή NMR (400 MHz, CDCIs) δ ppm: 8.25 (s, 1 H), 7.81 (d, 1 H), 7.22 (d, 1 H), 5.65 (s, 2H), 4.05 (s, 3H). methyl 2-[[5-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl]-2-thienyl]methyl]-1 ,2,4-triazole-3- carboxylate (Compound 1.55 of Table T1 ) was isolated as a byproduct in form of a colorless gum (306 mg), LC/MS (Method A) retention time = 0.91 minutes, 360 M+H).
Figure imgf000074_0001
Ή NMR (400 MHz, CDCI3) δ ppm: 8.05 (s, 1 H), 7.75 (d, 1 H), 7.22 (d, 1 H), 6.50 (s, 2H), 4.05 (s, 3H).
Example 3: This example illustrates the preparation of propyl 2-[[5-[5-(trifluoromethyl)-1 ,2,4-oxadiazol- 3- l]-2-thienyl]methyl]-1 ,2,4-triazole-3-carboxylate (Compound 1.44 of Table T1 )
Figure imgf000074_0002
triazole-3-carboxylate (100 mg, 0.27 mmol) and propanol (0.83 mL) was introduced concentrated sulfuric acid (0.01 mL). The white suspension was stirred 12 hours under reflux during which time it turned into a clear solution. The reaction mixture was concentrated under reduced pressure and the residue was purified by flash chromatography on silica gel using a cyclohexane/ethyl acetate gradient to afford 47mg of the title compound as a colorless gum. LC/MS (Method A) retention time = 1.10 minutes, 388 (M+H).
Ή NMR (400 MHz, CDCI3) δ ppm: 8.05 (s, 1 H), 7.75 (d, 1 H), 7.25 (d, 1 H), 6.05 (s, 2H), 4.45 (t, 2H), 1.85 (m, 2H), 1.05 (t, 3H).
Example 4: This example illustrates the preparation of N-methyl-N-methoxy-2-[[5-[5-(trifluoromethyl)- 1 ,2,4-oxadiazol-3-yl]-2-thienyl]methyl]-1 ,2,4-triazole-3-carboxamide (Compound 1.61 of Table T1 )
Figure imgf000075_0001
To a clear solution of O-methylhydroxylamine hydrochloride (136 mg, 1.67 mmol) in toluene (2 mL) was introduced dropwise diethylaluminum chloride (1 M in toluene, 1.67 mL, 1 .67 mmol). After 10 minutes, methyl 2-[[5-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl]-2-thienyl]methyl]-1 ,2,4-triazole-3- carboxylate (150 mg, 0.41 mmol) was added and the mixture was heated for 12 hours at 70°C. The reaction was quenched with water (ca. 0.030 mL) and the suspension was concentrated under reduced pressure. The resultant residue was purified by flash chromatography on silica gel using a cyclohexane/ethyl acetate gradient to afford 64 mg of the title compound as a white solid, m.p: 135- 140°C; LC/MS (Method A) retention time = 0.93 minutes, 375 (M+H).
Ή NMR (400 MHz, CDCIs) δ ppm: 7.95 (s, 1 H), 7.75 (d, 1 H), 7.35 (d, 1 H), 6.12 (s, 2H), 3.97 (s, 3H).
Example 5: This example illustrates the preparation of methyl 1-[[5-[5-(trifluoromethyl)-1 ,2,4-oxadiazol- 3-yl]-2-thienyl]methyl]pyrazole-3-carbox late (Compound 1.53 of Table T1 )
Figure imgf000075_0002
A mixture of 3-[5-(bromomethyl)-2-thienyl]-5-(trifluoromethyl)-1 ,2,4-oxadiazole (1.0 g, 3.2 mmol), methyl 1 H-pyrazole-3-carboxylate (600 mg, 4.8 mmol) and potassium carbonate (880 mg, 6.4mmol) in acetonitrile (32 mL) was heated at 1 10°C for 2 hours. The orange suspension was filtered to remove the solids and the filtrate solution was then concentrated under reduced pressure. The resultant crude residue was purified by flash chromatography on silica gel using a cyclohexane/ethyl acetate gradient to afford 610 mg of the title compound as a white solid. LC/MS (Method A) retention time = 1.00 minutes, 359 (M+H).
Ή NMR (400 MHz, CDCI3) δ ppm: 7.78 (d, 1 H), 7.51 (d, 1 H), 7.12 (d, 1 H), 6.89 (d, 1 H), 5.61 (s, 2H), 3.98 (s, 3H). methyl 2-[[5-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl]-2-thienyl]methyl]pyrazole-3-carboxylate (Compound 1.54 of Table T1 ) was isolated as a byproduct in form of a white solid (274 mg). LC/MS (Method A) retention time = 1.10 minutes, 359 M+H).
Figure imgf000076_0001
Ή NMR (400 MHz, CDCIs) δ ppm: 7.72 (d, 1 H), 7.58 (d, 1 H), 7.18 (d, 1 H), 6.89 (d, 1 H), 6.05 (s, 2H), 3.98 (s, 3H).
Example 6: This example illustrates the preparation of ethyl 1-[[5-[5-(trifluoromethyl)-1 ,2,4-oxadiazol- 3-yl]-2-thienyl]methyl]pyrazole-3-carbox late (Compound 1.42 of Table T1 )
Figure imgf000076_0002
To a solution of methyl 1-[[5-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl]-2-thienyl]methyl]pyrazole- 3-carboxylate (100 mg, 0.27 mmol) and ethanol (0.83 mL) was introduced concentrated sulfuric acid (0.01 mL). The white suspension was stirred for 2 hours at reflux during which time it became a clear solution. The reaction mixture was concentrated under reduced pressure and the resultant crude residue was purified by reverse phase column chromatography using a water/acetonitrile eluent gradient to afford 20 mg of the title compound as a white solid, mp: 120-124°C; LC/MS (Method A) retention time = 1.07 minutes, 373 (M+H).
Ή NMR (400 MHz, CDCI3) δ ppm: 7.71 (d, 1 H), 7.52 (d, 1 H), 7.12 (d, 1 H), 6.85 (d, 1 H), 5.62 (s, 2H), 4.45 (q, 2H), 1.45 (t, 3H).
Example 7: This example illustrates the preparation of N,N-dimethyl-2-[[5-[5-(trifluoromethyl)-1 ,2,4- oxadiazol-3-yl]-2-thienyl]methyl]pyrazole-3-carboxamide (Compound 1.58 of Table T1 )
Figure imgf000077_0001
To a clear solution of N-methylmethanamine hydrochloride (136 mg, 1 .67 mmol) in toluene (2 mL) was introduced dropwise diethylaluminum chloride (1 M in toluene, 1.67 mL, 1.67 mmol). After 10 minutes, methyl 2-[[5-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl]-2-thienyl]methyl]pyrazole-3-carboxylate (150 mg, 0.41 mmol) was added and the mixture was heated for 12 hours at 70°C. The reaction was quenched with water (ca. 0.030 mL) and the suspension was concentrated under reduced pressure. The resultant residue was purified by flash chromatography on silica gel using a cyclohexane/ethyl acetate gradient to afford the title compound (105 mg, 67% yield) as a yellow gum. LC/MS (Method A) retention time = 0.96 minutes, 372 (M+H).
Ή NMR (400 MHz, CDCIs) δ ppm: 7.71 (d, 1 H), 7.55 (d, 1 H), 7.12 (d, 1 H), 6.42 (d, 1 H), 5.78 (s, 2H), 3.05 (s, 3H), 3.15 (s, 3H).
The following general procedure was performed in a combinatorial fashion using appropriate building blocks (compounds of Formula (II) and (III)) to provide the compounds of Formula (I). The compounds prepared via the following combinatorial protocol were analyzed using LC/MS Method B.
Figure imgf000077_0002
By way of exemplification, [[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl]heteroaryl]methylbromide derivatives of formula (II) (0.03 mmol) in acetonitrile (1.0 mL) was transferred to microwave w'als containing amine derivative of Formula (III) (0.03 mmol), potassium carbonate (0.06 mmol), and were stirred under microwaves irradiation at 120°C for 20 minutes in the parallel microwave apparatus. The solvent was removed under a stream of nitrogen. The resultant crude residues were solubilized in a mixture of MeOH (250 μί) and DMA (500 μί) and directly submitted for preparative LC/MS purification which provided the compounds of Formula (I). Structures of isomers were assigned by NMR techniques.
Where necessary, enantiomerically pure final compounds may be obtained from racemic materials as appropriate via standard physical separation techniques, such as reverse phase chiral chromatography, or through stereoselective synthetic techniques, (e.g., by using chiral starting materials).
Table T1 : Melting point (mp) data and/or retention times (Rt) for compounds according to Formula (I):
Figure imgf000078_0001
Figure imgf000079_0001
Figure imgf000080_0001
Figure imgf000081_0001
Figure imgf000082_0001
Figure imgf000083_0001
Figure imgf000084_0001
Figure imgf000085_0001
Figure imgf000086_0001
Figure imgf000087_0001
Figure imgf000088_0001
Figure imgf000089_0001
Figure imgf000090_0001
Figure imgf000091_0001
Figure imgf000092_0001
Figure imgf000093_0001
Figure imgf000094_0001
Figure imgf000095_0001
Figure imgf000096_0001
Figure imgf000097_0001
Figure imgf000098_0001
Figure imgf000099_0001
Figure imgf000100_0001
Figure imgf000101_0001
Figure imgf000102_0001
Figure imgf000103_0001
Figure imgf000104_0001
Figure imgf000105_0001
Figure imgf000106_0001
Figure imgf000107_0001
Figure imgf000108_0001
Figure imgf000109_0001
Figure imgf000110_0001
Figure imgf000111_0001
Figure imgf000112_0001
Figure imgf000113_0001
Figure imgf000114_0001
Figure imgf000115_0001
Figure imgf000116_0001
Figure imgf000117_0001
Figure imgf000118_0001
Figure imgf000119_0001
Figure imgf000120_0001
BIOLOGICAL EXAMPLES Leaf disks or leaf segments of various plant species are cut from plants grown in a greenhouse.
The cut leaf disks or segments are placed in multiwell plates (24-well format) onto water agar. The leaf disks are sprayed with a test solution before (preventative) or after (curative) inoculation. Compounds to be tested are prepared as DMSO solutions (max. 10 mg/mL) which are diluted to the appropriate concentration with 0.025% Tween20 just before spraying. The inoculated leaf disks or segments are incubated under defined conditions (temperature, relative humidity, light, etc.) according to the respective test system. A single evaluation of disease level is carried out 3 to 14 days after inoculation, depending on the pathosystem. Percent disease control relative to the untreated check leaf disks or segments is then calculated. General examples of liquid culture tests in well plates:
Mycelia fragments or conidia suspensions of a fungus prepared either freshly from liquid cultures of the fungus or from cryogenic storage, are directly mixed into nutrient broth. DMSO solutions of the test compound (max. 10 mg/mL) are diluted with 0.025% Tween20 by a factor of 50 and 10 μΙ_ of this solution is pipetted into a microtiter plate (96-well format). The nutrient broth containing the fungal spores/mycelia fragments is then added to give an end concentration of the tested compound. The test plates are incubated in the dark at 24°C and 96% relative humidity. The inhibition of fungal growth is determined photometrically after 2 to 7 days, depending on the pathosystem, and percent antifungal activity relative to the untreated check is calculated.
Example 1 : Fungicidal activity against Puccinia recondita f. sp. tritici I wheat / leaf disc preventative (Brown rust)
Wheat leaf segments cv. Kanzler were placed on agar in multiwell plates (24-well format) and sprayed with the formulated test compound diluted in water. The leaf disks were inoculated with a spore suspension of the fungus 1 day after application. The inoculated leaf segments were incubated at 19°C and 75% relative humidity (rh) under a light regime of 12 hours light / 12 hours darkness in a climate cabinet and the activity of a compound was assessed as percent disease control compared to untreated when an appropriate level of disease damage appears in untreated check leaf segments (7 to 9 days after application).
The following compounds at 200 ppm in the applied formulation give at least 80% disease control in this test when compared to untreated control leaf disks under the same conditions, which show extensive disease development.
Compounds (from Table T1 ) 1.1 , 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, 1.10, 1.1 1 , 1.12, 1.13, 1.14, 1.16, 1 .17, 1 .18, 1 .19, 1 .21 , 1 .22, 1.23, 1.24, 1.25, 1.26, 1.30, 1.32, 1.33, 1 .34, 1 .35, 1 .36, 1 .37, 1.38, 1.39, 1 .40, 1 .41 , 1 .42, 1 .43, 1 .44, 1.45, 1.46, 1.47, 1.48, 1.49, 1.50, 1.51 , 1 .52, 1 .53, 1 .54, 1 .55, 1.56, 1.57, 1.58, 1.59, 1.60, 1 .61 , 1 .62, 1 .63, 1 .64, 1.66, 1.68, 1.70, 1.71 , 1.73, 1.79, 1 .82, 1 .83, 1 .84, 1.85, 1.88, 1 .91 , 1 .94, 1 .95, 1 .96, 1 .98, 1.100, 1.101 , 1 .102, 1.103, 1 .105, 1.106, 1 .109, 1.1 13, 1.1 15, 1.120, 1.122, 1.126, 1 .128, 1.129, 1.130, 1.137, 1.140, 1.144, 1.145, 1.149, 1.151 , 1.153, 1.155, 1.156, 1.157, 1.158, 1.159, 1.160, 1.161 , 1.162, 1.163, 1.164, 1.165, 1.166, 1.167, 1.168, 1.169, 1.176 and 1.177.
Example 2: Fungicidal activity against Puccinia recondita f. sp. tritici I wheat / leaf disc curative
(Brown rust) Wheat leaf segments cv. Kanzler are placed on agar in multiwell plates (24-well format). The leaf segments are then inoculated with a spore suspension of the fungus. Plates were stored in darkness at 19°C and 75% relative humidity. The formulated test compound diluted in water was applied 1 day after inoculation. The leaf segments were incubated at 19°C and 75% relative humidity under a light regime of 12 hours light / 12 hours darkness in a climate cabinet and the activity of a compound was assessed as percent disease control compared to untreated when an appropriate level of disease damage appears in untreated check leaf segments (6 to 8 days after application).
The following compounds at 200 ppm in the applied formulation give at least 80% disease control in this test when compared to untreated control leaf disks under the same conditions, which show extensive disease development.
Compounds (from Table T1 ) 1.1 , 1.2, 1 .4, 1.6, 1.8, 1 .9, 1.1 1 , 1.13, 1.14, 1.16, 1.17, 1 .19, 1.21 , 1.22, 1.23, 1 .24, 1 .25, 1 .30, 1 .32, 1 .33, 1.34, 1.35, 1.36, 1.37, 1.38, 1.39, 1.40, 1 .41 , 1 .42, 1 .43, 1 .44, 1.45, 1.46, 1 .47, 1 .48, 1 .49, 1 .50, 1 .51 , 1.52, 1.53, 1.54, 1.55, 1.56, 1.57, 1.58, 1 .59, 1 .60, 1 .61 , 1 .63, 1.64, 1.66, 1.68, 1.70, 1.73, 1.79, 1.82, 1.83, 1.84, 1.85, 1.88, 1.91 , 1.94, 1.95, 1.96, 1.98, 1.100, 1.101 , 1.102, 1.103, 1.105, 1.106, 1.109, 1.1 13, 1.120, 1.122, 1.126, 1.128, 1.129, 1.130, 1.137, 1.140, 1.144, 1.145, 1.151 , 1.153, 1.158, 1 .160, 1.161 , 1 .164, 1.166, 1.168, 1.169, 1.176 and 1 .177.
Example 3: Fungicidal activity against Phakopsora pachyrhizi I soybean / leaf disc preventative (Asian soybean rust)
Soybean leaf disks are placed on water agar in multiwell plates (24-well format) and sprayed with the formulated test compound diluted in water. One day after application leaf discs are inoculated by spraying a spore suspension on the lower leaf surface. After an incubation period in a climate cabinet of 24-36 hours in darkness at 20°C and 75% rh leaf disc are kept at 20°C with 12 h light/day and 75% rh. The activity of a compound is assessed as percent disease control compared to untreated when an appropriate level of disease damage appears in untreated check leaf disks (12 to 14 days after application).
The following compounds at 200 ppm in the applied formulation give at least 80% disease control in this test when compared to untreated control leaf disks under the same conditions, which show extensive disease development.
Compounds (from Table T1 ) 1.1 , 1.4, 1.6, 1.13, 1.14, 1.17, 1.19, 1.21 , 1.23, 1.24, 1.25, 1.30, 1.32, 1.33, 1 .34, 1 .35, 1 .38, 1.39, 1.40, 1.41 , 1.42, 1.43, 1.44, 1.45, 1.46, 1.47, 1.48, 1.49, 1.50, 1.51 , 1.52, 1.53, 1 .54, 1.55, 1.56, 1.57, 1 .58, 1.59, 1.60 and 1.61. Example 4: Fungicidal activity against Glomerella lagenarium (Colletotrichum lagenarium) liguid culture / cucumber / preventative (Anthracnose)
Conidia of the fungus from cryogenic storage are directly mixed into nutrient broth (PDB - potato dextrose broth). After placing a (DMSO) solution of test compound into a microtiter plate (96-well format), the nutrient broth containing the fungal spores is added. The test plates are incubated at 24 C and the inhibition of growth is measured photometrically 3 to 4 days after application.
The following compounds at 20 ppm in the applied formulation give at least 80% disease control in this test when compared to untreated control under the same conditions, which show extensive disease development.
Compounds (from Table T1) 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, 1.10, 1.11, 1.12, 1.13, 1.14, 1.15, 1.16, 1.17, 1.18, 1.19, 1.20, 1.21, 1.22, 1.23, 1.24, 1.25, 1.26, 1.27, 1.28, 1.29, 1.30, 1.31, 1.32, 1.33, 1.34, 1.35, 1.36, 1.37, 1.38, 1.39, 1.40, 1.41, 1.42, 1.43, 1.44, 1.45, 1.46, 1.47, 1.48, 1.49, 1.50, 1.51, 1.52, 1.53, 1.54, 1.55, 1.56, 1.57, 1.59, 1.60, 1.61, 1.62, 1.64, 1.66, 1.68, 1.70, 1.71 , 1.73, 1.79, 1.82, 1.84, 1.85, 1.88, 1.91, 1.94, 1.95, 1.96, 1.98, 1.100, 1.101, 1.102, 1.103, 1.105, 1.106, 1.109, 1.115, 1.120, 1.122, 1.126, 1.128, 1.129, 1.130, 1.137, 1.140, 1.144, 1.145, 1.149, 1.151, 1.153, 1.155, 1.156, 1.157, 1.158, 1.159, 1.160, 1.161, 1.162, 1.163, 1.164, 1.165, 1.166, 1.167, 1.168 and 1.169.

Claims

CLAIMS:
1. A compound of Formula (I):
Figure imgf000124_0001
wherein
A is selected from A-1 , A-2 or A-3;
Figure imgf000124_0002
(A-1 ) (A-2) (A-3)
R and R2 independently represent hydrogen, methyl, ethyl, fluoro, cyano, difluoromethyl or trifluoromethyl; and
Z is selected from Z , Z2 or Z3; wherein
Z represents a 4- to 6-membered non-aromatic heterocyclyl ring containing 1 ring nitrogen, wherein the heterocyclyl optionally comprises 1 or 2 additional ring members independently selected from N, O, S, C(O) and S(0)2 with the proviso that the heterocyclyl ring cannot contain 2 contiguous atoms selected from O and S, or the heterocyclyl optionally comprises 1 additional ring member NR3, wherein the heterocyclyl is optionally substituted by 1 or 2 substituents, which may be the same or different, selected from R4, and wherein further the heterocyclyl is bound to the rest of the molecule through a ring nitrogen;
R3 represents hydrogen, hydroxy, amino, formyl, d salkyl, d salkoxy, d salkylcarbonyl, Ci- 3alkoxycarbonyl, N-Ci salkylaminocarbonyl, N,N-diCi-3alkylaminocarbonyl, N-Ci-3alkoxyaminocarbonyl, N-Ci-3alkyl-N-Ci-3alkoxy-aminocarbonyl, Ci-2alkylsulfonyl, N-Ci-2alkylaminosulfonyl, N,N-diCi- 2alkylaminosulfonyl, Ci-2alkyldicarbonyl, Ci-2alkoxydicarbonyl, N-Ci-2alkylaminodicarbonyl or N,N-diCi- 2alkylaminodicarbonyl;
R4 represents cyano, halogen, hydroxy, amino, methyl, ethyl, difluoromethyl, trifluoromethyl, methoxy, N-methylamino or N,N-dimethylamino;
Z2 represents a 5- or 6-membered heteroaryl ring containing 1 ring nitrogen, wherein the heteroaryl optionally comprises 1 , 2 or 3 additional ring members independently selected from O, S, or N, and wherein the heteroaryl is optionally substituted by: 1 or 2 substituents selected from R5, 1 substituent selected from R6, or 1 substituent selected from R5 and 1 substituent selected from R6, and wherein further the heteroaryl is bound to the rest of the molecule through a ring nitrogen; R5 represents hydroxyl, amino, cyano, halogen, formyl, nitro, Ci-4alkyl, Ci-4alkoxy, C3-4alkenyl,
C3-4alkynyl, C3-4alkenyloxy, C3-4alkynyloxy, cyanoCi-2alkyl, Ci-2haloalkyl, hydroxyCi-2alkyl, Ci-2alkoxyCi- 2alkyl, Ci-2alkoxyCi-2alkoxyCi-2alkyl, Ν,Ν-dimethylamino, Ci-3alkoxycarbonylCi-2alkyl, Ci- 3alkylcarbonyloxyCi-2alkyl, N-Ci-3alkylaminocarbonylCi-2alkyl, N,N-diCi-3alkylaminocarbonylCi-2alkyl, Ci-2alkylsulfonyl, d salkylcarbonyl, C-i salkyldicarbonyl, C-i salkoxydicarbonyl, N-Ci- 3alkylaminodicarbonyl, or N,N-diCi-3alkylaminodicarbonyl; or
R5 represents -C(0)N(Ra)(Rb), wherein:
Ra represents hydrogen, Ci-ealkyl, C3-4alkenyl, C3-4alkynyl, Ci shaloalkyl, C3-4haloalkenyl, Ci- 4alkoxy, Ci-2alkoxyCi-3alkyl, C2-3haloalkoxy, C3-4alkenyloxy, C3-4alkynyloxy, N-Ci salkylamino, or N,N- diCi-2alkylamino; or
Ra represents C3-scycloalkyl, C3-5cycloalkylCi-2alkyl, phenyl, phenylCi-2alkyl, heterocyclyl, wherein the heterocyclyl moiety is a 4- to 6-membered non-aromatic ring which comprises 1 or 2 heteroatoms independently selected from N, O or S, with the proviso that the heterocyclyl cannot contain 2 contiguous atoms selected from O and S, heteroaryl or heteroarylCi-2alkyl, wherein the heteroaryl moiety is a 5- or 6-membered aromatic ring which comprises 1 , 2, 3, or 4 heteroatoms individually selected from N, O and S; wherein the cycloalkyi, phenyl, heterocyclyl or heteroaryl is optionally substituted by 1 or 2 substituents, which may be the same or different, selected from hydroxyl, amino, formyl, acyl, cyano, halogen, methyl, trifluoromethyl, methoxy, or Ν,Ν-dimethylamino, and wherein when Ra represents cycloalkyi or heterocyclyl, these cycles optionally contain 1 group selected from C(O) or S(0)2; and
Rb represents hydrogen, methyl, ethyl, propyl, prop-2-enyl, prop-2-ynyl, cyclopropyl, or cyclopropylmethyl; or
Ra and Rb, together with the nitrogen atom they share, form an azetidinyl, pyrrolidinyl, isooxazolidinyl, morpholino, piperazin-4-yl, or piperidinyl ring optionally substituted by 1 or 2 groups selected from halogen, methyl, ethyl or methoxy; or
R5 represents -C(0)0-Rc, wherein:
Rc represents hydrogen, Ci-ealkyl, C3-salkenyl, C3-salkynyl, Ci shaloalkyl, C3-4haloalkenyl, N,N- diCi-3alkylaminoCi-3alkyl, C3-6cycloalkyl, C3-4cycloalkylCi-2alkyl, phenyl, heterocyclyl, wherein the heterocyclyl moiety is a 4- to 6-membered non-aromatic ring which comprises 1 or 2 heteroatoms independently selected from O, S and N, with the proviso that the heterocyclyl cannot contain 2 contiguous atoms selected from O and S, heteroaryl, wherein the heteroaryl moiety is a 5- or 6- membered aromatic ring which comprises 1 , 2 or 3 heteroatoms individually selected from N, O and S; and wherein the cycloalkyi, phenyl, heterocyclyl or heteroaryl is optionally substituted by 1 or 2 substituents, which may be the same or different, selected from hydroxyl, amino, formyl, methylcarbonyl, cyano, halogen, methyl, trifluoromethyl, methoxy, or Ν,Ν-dimethylamino, and wherein when Rc represents cycloalkyi or heterocyclyl, these cycles optionally contain 1 group selected from C(O) or S(0)2; or R5 represents -N(Rd)(Re) or -Ci-2alkyl-N(Rd)(Re), wherein
Rd represents d salkyl, C3-4alkenyl, C3-4alkynyl, methylcarbonyl, methoxycarbonyl, N- methylaminocarbonyl, Ν,Ν-dimethylaminocarbonyl, N-methoxyaminocarbonyl, N-methyl-N-methoxy- aminocarbonyl, methylsulfonyl, N-methylaminosulfonyl, Ν,Ν-dimethylaminosulfonyl, methyldicarbonyl, N-methylaminodicarbonyl, or Ν,Ν-dimethylaminodicarbonyl; and
Re represents hydrogen, methyl, ethyl, or propyl; or
Rd and Re, together with the nitrogen atom they share, form an azetidinyl, pyrrolidinyl, isooxazolidinyl, morpholino, piperazin-4-yl, or piperidinyl ring optionally substituted by 1 or 2 groups selected from halogen, methyl, ethyl or methoxy; or
R5 represents -CH=N(Rf), wherein Rf represents Ci-4alkyl, Ci-4alkoxy, C2-4alkenoxy, or C2- 4alkynoxy;
R6 represents C3-6cycloalkyl, phenyl, heteroaryl, wherein the heteroaryl moiety is a 5- or 6- membered aromatic ring which comprises 1 , 2, 3 or 4 heteroatoms individually selected from N, O and S, heterocyclyl, wherein the heterocyclyl moiety is a 4- to 6-membered non-aromatic ring which comprises 1 or 2 heteroatoms individually selected from N, O and S, and wherein the cycloalkyi, phenyl, heteroaryl and heterocyclyl is optionally substituted by 1 or 2 substituents, which may be the same or different, selected from hydroxyl, amino, formyl, acyl, cyano, halogen, methyl, trifluoromethyl, methoxy, Ν,Ν-dimethylamino, and wherein when R6 represents cycloalkyi or heterocyclyl, these cycles optionally contain 1 group selected from C(O) or S(0)2; and
Z3 represents a heterobicyclyl which is a 7- to 9-membered saturated, partially saturated, or aromatic fused ring or saturated spirocyclic ring system containing 1 nitrogen, wherein the heterobicyclyl optionally comprises 1 or 2 additional ring members independently selected from N, O, S, C(O) and S(0)2 with the proviso that the heterobicyclyl cannot contain 2 contiguous atoms selected from O and S, wherein the heterobicyclyl is optionally substituted by 1 substituent selected from R7, and wherein further the heterobicyclyl is bound to the rest of the molecule through a ring nitrogen; and
R7 is cyano, fluoro, chloro, amino, hydroxy, methyl, difluoromethyl, trifluoromethyl, methoxy, N,N- dimethylamino, formyl, methylcarbonyl, methoxycarbonyl, N-methylaminocarbonyl, or N,N- dimethylaminocarbonyl; or a salt or N-oxide thereof.
2. A compound according to claim 1 , wherein A is A-1.
3. A compound according to claim 1 or claim 2, wherein R and R2 are hydrogen.
4. A com ound according to any one of claims 1 to 3, wherein Z is Z selected from:
Figure imgf000127_0001
wherein Z is optionally substituted by 1 or 2 substituents, which may be the same or different, selected from R4.
5. A compound according to claim 4, wherein R4 is selected from methyl or ethyl.
6. A com ound according to any one of claims 1 to 3, wherein Z is Z2 selected from:
Figure imgf000127_0002
wherein Z2 is optionally substituted by: 1 or 2 substituents selected from R5, 1 substituent selected from R6, or 1 substituent selected from R5 and 1 substituent selected from R6.
7. A compound according to claim 6, wherein R5 is independently selected from hydroxy, amino, cyano, halogen, formyl, nitro, Ci-4alkyl, Ci-4alkoxy, Ci-2haloalkyl, Ci-2alkoxyCi-2alkyl, N,N- dimethylamino, -C(0)0-Rc wherein Rc is Ci-4alkyl and -C(0)N(Ra)(Rb), wherein Ra is selected from hydrogen, Ci-4alkyl or Ci-4alkoxy, and Rb is selected from hydrogen or methyl; and R6 is phenyl optionally substituted by 1 or 2 substituents, which may be the same or different, selected from hydroxyl, methyl, methoxy, cyano, fluoro, chloro or bromo.
8. A compound according to claim 7, wherein R5 is selected from amino, cyano, chloro, fluoro, formyl, nitro, methyl, ethyl, difluoromethyl, methoxymethyl, Ν,Ν-dimethylamino, methoxycarbonyl, ethoxycarbonyl or n-propoxycarbonyl; and
R6 is phenyl optionally substituted by 1 or 2 substituents, which may be the same or different, selected from fluoro, chloro or bromo.
9. A compound according to any one of claims 6 to 8, wherein Z2 is optionally substituted by 1 or 2 substituents selected from R5.
10. A compound according to an one of claims 1 to 3, wherein Z is Z3 selected from:
Figure imgf000128_0001
wherein Z3 is optionally substituted by 1 substituent selected from R7.
1 1. A compound according to claim 10, wherein R7 is selected from hydroxyl, methoxy, methyl, cyano, fluoro or chloro.
12. An agrochemical composition comprising a fungicidally effective amount of a compound of Formula (I) according to any one of claims 1 to 1 1.
13. The composition according to claim 12, further comprising at least one additional active ingredient and/or an agrochemically-acceptable diluent or carrier.
14. A method of controlling or preventing infestation of useful plants by phytopathogenic microorganisms, wherein a fungicidally effective amount of a compound of Formula (I) according to any one of claims 1 to 1 1 , or a composition comprising this compound as active ingredient, is applied to the plants, to parts thereof or the locus thereof.
15. Use of a compound of Formula (I) according to any one of claims 1 to 1 1 as a fungicide.
PCT/EP2018/055042 2017-03-03 2018-03-01 Microbiocidal oxadiazole derivatives WO2018158365A1 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
MX2019010261A MX2019010261A (en) 2017-03-03 2018-03-01 Microbiocidal oxadiazole derivatives.
EP18708404.1A EP3589629A1 (en) 2017-03-03 2018-03-01 Microbiocidal oxadiazole derivatives
US16/489,805 US11358957B2 (en) 2017-03-03 2018-03-01 Microbiocidal oxadiazole derivatives
JP2019547632A JP2020510670A (en) 2017-03-03 2018-03-01 Microbicidal oxadiazole derivatives
CN201880014967.1A CN110382492B (en) 2017-03-03 2018-03-01 Microbiocidal oxadiazole derivatives
BR112019018238-1A BR112019018238B1 (en) 2017-03-03 2018-03-01 COMPOUND, AGROCHEMICAL COMPOSITION, METHOD OF CONTROL OR PREVENTION OF INFESTATION OF USEFUL PLANTS BY PHYTOPATHOGENIC MICROORGANISMS AND USE OF SAID COMPOUND AS A FUNGICIDE
CONC2019/0009262A CO2019009262A2 (en) 2017-03-03 2019-08-27 Oxadiazole derivatives microbicides
IL269023A IL269023B (en) 2017-03-03 2019-08-29 Microbiocidal oxadiazole derivatives

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
EP17159202 2017-03-03
EP17159202.5 2017-03-03
EP17160411 2017-03-10
EP17160411.9 2017-03-10
IN201711043196 2017-12-01
IN201711043196 2017-12-01

Publications (1)

Publication Number Publication Date
WO2018158365A1 true WO2018158365A1 (en) 2018-09-07

Family

ID=61557278

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2018/055042 WO2018158365A1 (en) 2017-03-03 2018-03-01 Microbiocidal oxadiazole derivatives

Country Status (11)

Country Link
US (1) US11358957B2 (en)
EP (1) EP3589629A1 (en)
JP (1) JP2020510670A (en)
CN (1) CN110382492B (en)
BR (1) BR112019018238B1 (en)
CL (1) CL2019002512A1 (en)
CO (1) CO2019009262A2 (en)
IL (1) IL269023B (en)
MX (1) MX2019010261A (en)
UY (1) UY37623A (en)
WO (1) WO2018158365A1 (en)

Cited By (130)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019150219A2 (en) 2018-01-30 2019-08-08 Pi Industries Ltd. Novel oxadiazoles
WO2020007658A1 (en) * 2018-07-02 2020-01-09 Syngenta Crop Protection Ag 3-(2-thienyl)-5-(trifluoromethyl)-1,2,4-oxadiazole derivatives as agrochemical fungicides
JP2020516598A (en) * 2017-04-06 2020-06-11 エフ エム シー コーポレーションＦｍｃ Ｃｏｒｐｏｒａｔｉｏｎ Fungicidal oxadiazole
WO2020165403A1 (en) 2019-02-15 2020-08-20 Syngenta Crop Protection Ag Phenyl substituted thiazole derivatives as microbiocidal compounds
WO2020182649A1 (en) 2019-03-08 2020-09-17 Syngenta Crop Protection Ag Pesticidally active azole-amide compounds
WO2020188014A1 (en) 2019-03-20 2020-09-24 Syngenta Crop Protection Ag Pesticidally active azole amide compounds
WO2020188027A1 (en) 2019-03-20 2020-09-24 Syngenta Crop Protection Ag Pesticidally active azole amide compounds
WO2020193387A1 (en) 2019-03-22 2020-10-01 Syngenta Crop Protection Ag Fungicidal compounds
WO2020193341A1 (en) 2019-03-22 2020-10-01 Syngenta Crop Protection Ag N-[1-(5-bromo-2-pyrimidin-2-yl-1,2,4-triazol-3-yl)ethyl]-2-cyclopropyl-6-(trifluoromethyl)pyridine-4-carboxamide derivatives and related compounds as insecticides
WO2020193618A1 (en) 2019-03-27 2020-10-01 Syngenta Crop Protection Ag Microbiocidal thiazole derivatives
WO2020201398A1 (en) 2019-04-05 2020-10-08 Syngenta Crop Protection Ag Pesticidally active diazine-amide compounds
WO2020201079A1 (en) 2019-03-29 2020-10-08 Syngenta Crop Protection Ag Pesticidally active diazine-amide compounds
WO2020208096A1 (en) 2019-04-10 2020-10-15 Syngenta Crop Protection Ag Fungicidal compositions
WO2020208036A1 (en) 2019-04-11 2020-10-15 Syngenta Crop Protection Ag Pesticidally active diazine-amide compounds
WO2020208095A1 (en) 2019-04-10 2020-10-15 Syngenta Crop Protection Ag Microbiocidal picolinamide derivatives
WO2020239855A1 (en) 2019-05-29 2020-12-03 Syngenta Crop Protection Ag Microbiocidal derivatives
WO2020239854A1 (en) 2019-05-29 2020-12-03 Syngenta Crop Protection Ag Microbiocidal derivatives
WO2020239856A1 (en) 2019-05-29 2020-12-03 Syngenta Crop Protection Ag Microbiocidal derivatives
WO2020239853A1 (en) 2019-05-29 2020-12-03 Syngenta Crop Protection Ag Microbiocidal derivatives
WO2021004968A1 (en) 2019-07-05 2021-01-14 Syngenta Crop Protection Ag Microbiocidal picolinamide derivatives
WO2021009026A1 (en) 2019-07-12 2021-01-21 Syngenta Crop Protection Ag Methyl 2-[(4-methoxyimino-tetralin-6-yl]prop-2-enoate derivatives, chromane, isochromane, 6,7,8,9-tetrahydrobenzo[7]annulene, 1h-isobenzofurane and indane analogues thereof, and similar compounds, as agrochemical fungicides
WO2021033133A1 (en) 2019-08-19 2021-02-25 Pi Industries Ltd. Novel oxadiazole compounds containing 5- membered heteroaromatic ring for controlling or preventing phytopathogenic fungi
WO2021037614A1 (en) 2019-08-23 2021-03-04 Syngenta Crop Protection Ag Pesticidally active pyrazine-amide compounds
WO2021043616A1 (en) 2019-09-02 2021-03-11 Syngenta Crop Protection Ag Strigolactone derivatives as plant growth regulator compounds
WO2021053110A1 (en) 2019-09-20 2021-03-25 Syngenta Crop Protection Ag Pesticidally active heterocyclic derivatives with sulfur and sulfoximine containing substituents
WO2021053161A1 (en) 2019-09-20 2021-03-25 Syngenta Crop Protection Ag Pesticidally active cyclic amine compounds
WO2021083936A1 (en) 2019-11-01 2021-05-06 Syngenta Crop Protection Ag Pesticidally active fused bicyclic heteroaromatic compounds
WO2021090865A1 (en) * 2019-11-07 2021-05-14 日本農薬株式会社 Oxadiazoline compound or salts thereof, agricultural and horticultural bactericide containing said compound, and method for using same
WO2021110891A1 (en) 2019-12-04 2021-06-10 Syngenta Crop Protection Ag Pesticidally active fused bicyclic heteroaromatic amino compounds
WO2021122645A1 (en) 2019-12-20 2021-06-24 Syngenta Crop Protection Ag Pesticidally active azole-amide compounds
WO2021136722A1 (en) 2019-12-31 2021-07-08 Syngenta Crop Protection Ag Pesticidally active heterocyclic derivatives with sulfur containing substituents
WO2021140122A1 (en) 2020-01-06 2021-07-15 Syngenta Crop Protection Ag Pesticidally active heterocyclic derivatives with sulfur containing substituents
WO2021148639A1 (en) 2020-01-24 2021-07-29 Syngenta Crop Protection Ag Pesticidally active fused bicyclic heteroaromatic compounds
WO2021151926A1 (en) 2020-01-30 2021-08-05 Syngenta Crop Protection Ag Pesticidally active fused bicyclic heteroaromatic amino compounds
WO2021160680A1 (en) 2020-02-11 2021-08-19 Syngenta Crop Protection Ag Pesticidally active cyclic amine compounds
WO2021170881A1 (en) 2020-02-27 2021-09-02 Syngenta Crop Protection Ag Pesticidally active diazine-bisamide compounds
WO2021175822A1 (en) 2020-03-02 2021-09-10 Syngenta Crop Protection Ag Pesticidally amidine-substituted benzoic acid amide compounds
WO2021176007A1 (en) 2020-03-05 2021-09-10 Syngenta Crop Protection Ag Fungicidal compositions
WO2021176057A1 (en) 2020-03-05 2021-09-10 Syngenta Crop Protection Ag Fungicidal compositions
WO2021180592A1 (en) 2020-03-13 2021-09-16 Syngenta Crop Protection Ag Methods of controlling or preventing infestation of plants by the phytopathogenic microorganism corynespora cassiicola
WO2021180596A1 (en) 2020-03-13 2021-09-16 Syngenta Crop Protection Ag Methods of controlling or preventing infestation of plants by the phytopathogenic microorganism corynespora cassiicola
WO2021180598A1 (en) 2020-03-13 2021-09-16 Syngenta Crop Protection Ag Methods of controlling or preventing infestation of plants by the phytopathogenic microorganism corynespora cassiicola
WO2021204857A1 (en) 2020-04-08 2021-10-14 Syngenta Crop Protection Ag Microbiocidal quinoline dihydro-(thiazine)oxazine derivatives
WO2021204822A1 (en) 2020-04-08 2021-10-14 Syngenta Crop Protection Ag Microbiocidal quinoline dihydro-(thiazine)oxazine derivatives
WO2021204855A1 (en) 2020-04-08 2021-10-14 Syngenta Crop Protection Ag Microbiocidal quinoline dihydropyrrolopyrazine derivatives
WO2021213929A1 (en) 2020-04-20 2021-10-28 Syngenta Crop Protection Ag Pesticidally active substituted 1,3-dihydro-2h-imidazo[4,5-c]pyridin-2-one derivatives with sulfur containing substituents
WO2021219778A1 (en) 2020-04-30 2021-11-04 Syngenta Crop Protection Ag Microbiocidal compounds
WO2021219775A1 (en) 2020-04-30 2021-11-04 Syngenta Crop Protection Ag Microbiocidal compounds
WO2021219810A1 (en) 2020-04-30 2021-11-04 Syngenta Crop Protection Ag Pesticidally active heterocyclic derivatives with sulfur containing substituents
WO2021219780A1 (en) 2020-05-01 2021-11-04 Syngenta Crop Protection Ag Microbiocidal compounds
WO2021224409A1 (en) 2020-05-06 2021-11-11 Syngenta Crop Protection Ag Pesticidally active heterocyclic derivatives with sulfur containing substituents
WO2021224102A1 (en) 2020-05-05 2021-11-11 Syngenta Crop Protection Ag Microbiocidal compounds
WO2021244951A1 (en) 2020-06-03 2021-12-09 Syngenta Crop Protection Ag Fungicidal compositions
WO2021244952A1 (en) 2020-06-03 2021-12-09 Syngenta Crop Protection Ag Microbiocidal derivatives
WO2021244950A1 (en) 2020-06-03 2021-12-09 Syngenta Crop Protection Ag Fungicidal compositions
WO2022013417A1 (en) 2020-07-17 2022-01-20 Syngenta Crop Protection Ag Pesticidally active heterocyclic derivatives with sulfur containing substituents
WO2022017975A1 (en) 2020-07-18 2022-01-27 Syngenta Crop Protection Ag Pesticidally active heterocyclic derivatives with sulfur containing substituents
WO2022043576A2 (en) 2020-08-31 2022-03-03 Syngenta Crop Protection Ag Pesticidally active heterocyclic derivatives with sulfur containing substituents
WO2022048988A1 (en) 2020-09-02 2022-03-10 Syngenta Participations Ag Plant growth regulator compounds
WO2022049144A1 (en) 2020-09-02 2022-03-10 Syngenta Crop Protection Ag Pesticidally active heterocyclic derivatives with sulfur containing substituents
WO2022049146A1 (en) 2020-09-02 2022-03-10 Syngenta Crop Protection Ag Pesticidally active heterocyclic derivatives with sulfur containing substituents
WO2022049141A1 (en) 2020-09-01 2022-03-10 Syngenta Crop Protection Ag Pesticidally active heterocyclic derivatives with sulfur containing substituents
WO2022053567A1 (en) 2020-09-09 2022-03-17 Syngenta Crop Protection Ag Pesticidally active heterocyclic derivatives with sulfur containing substituents
WO2022058580A1 (en) 2020-09-21 2022-03-24 Syngenta Crop Protection Ag Microbiocidal compounds
WO2022084346A1 (en) 2020-10-22 2022-04-28 Syngenta Crop Protection Ag Zealactone derivatives as plant growth regulators
WO2022101265A1 (en) 2020-11-13 2022-05-19 Syngenta Crop Protection Ag Pesticidally active fused bicyclic heteroaromatic compounds
WO2022117650A1 (en) 2020-12-02 2022-06-09 Syngenta Crop Protection Ag Fungicidal compositions
WO2022117653A1 (en) 2020-12-02 2022-06-09 Syngenta Crop Protection Ag Fungicidal compositions
WO2022157188A2 (en) 2021-01-23 2022-07-28 Syngenta Crop Protection Ag Pesticidally active heteroaromatic compounds
WO2022157122A1 (en) 2021-01-22 2022-07-28 Syngenta Crop Protection Ag Method for the control or suppression of phytopathogenic bacteria
WO2022157334A1 (en) 2021-01-21 2022-07-28 Syngenta Crop Protection Ag Pesticidally active heterocyclic derivatives with sulfur containing substituents
WO2022207665A1 (en) 2021-03-31 2022-10-06 Syngenta Crop Protection Ag Microbiocidal quinoline/quinoxaline benzothiazine derivatives
WO2022207462A1 (en) 2021-03-30 2022-10-06 Syngenta Crop Protection Ag Pesticidally active cyclic amine compounds
WO2022207479A1 (en) 2021-03-27 2022-10-06 Syngenta Crop Protection Ag Microbiocidal isonicotinic amide derivatives
WO2022219146A2 (en) 2021-04-16 2022-10-20 Syngenta Crop Protection Ag Pesticidally active cyclic amine compounds
WO2022223376A1 (en) 2021-04-20 2022-10-27 Syngenta Crop Protection Ag Microbiocidal quinoline/quinoxaline isoquinoline derivatives
WO2022233869A1 (en) 2021-05-04 2022-11-10 Syngenta Crop Protection Ag Use of clethodim for insect control
WO2022253645A1 (en) 2021-06-01 2022-12-08 Syngenta Crop Protection Ag Microbiocidal tetrahydroisoquinoline derivatives
WO2022253841A1 (en) 2021-06-02 2022-12-08 Syngenta Crop Protection Ag Pesticidally active heterocyclic derivatives with sulfoximine containing substituents
WO2022258481A1 (en) 2021-06-09 2022-12-15 Syngenta Crop Protection Ag Pesticidally active diazine-amide compounds
WO2022268648A1 (en) 2021-06-24 2022-12-29 Syngenta Crop Protection Ag 2-[3-[1 [(quinazolin-4-yl)amino]ethyl]pyrazin-2-yl]thiazole-5-carbonitrile derivatives and similar compounds as pesticides
WO2023275116A1 (en) 2021-07-02 2023-01-05 Syngenta Crop Protection Ag Use of fluazifop-p-butyl for insect control
WO2023006789A1 (en) 2021-07-29 2023-02-02 Syngenta Crop Protection Ag Pesticidally active fused bicyclic heteroaromatic compounds
WO2023006634A1 (en) 2021-07-27 2023-02-02 Syngenta Crop Protection Ag Method for controlling diamide resistant pests & compounds therefor
WO2023012044A1 (en) 2021-08-02 2023-02-09 Syngenta Crop Protection Ag Microbiocidal pyrazole derivatives
WO2023012081A1 (en) 2021-08-05 2023-02-09 Syngenta Crop Protection Ag Method for controlling diamide resistant pests & compounds therefor
WO2023017094A1 (en) 2021-08-10 2023-02-16 Syngenta Crop Protection Ag 2,2-difluoro-5h-[1,3]dioxolo[4,5-f]isoindol-7-one derivatives as pesticides
WO2023017016A1 (en) 2021-08-10 2023-02-16 Syngenta Crop Protection Ag Fungicide mixture
WO2023021020A1 (en) 2021-08-19 2023-02-23 Syngenta Crop Protection Ag Method for controlling diamide resistant pests & compounds therefor
WO2023061838A1 (en) 2021-10-14 2023-04-20 Syngenta Crop Protection Ag Imidazo[1,2-a]pyridine derivatives
WO2023072945A1 (en) 2021-10-25 2023-05-04 Syngenta Crop Protection Ag Pesticidally active heterocyclic derivatives with sulfur containing substituents
WO2023072784A1 (en) 2021-10-29 2023-05-04 Syngenta Crop Protection Ag Fungicidal compositions comprising fludioxonil
WO2023072785A1 (en) 2021-10-29 2023-05-04 Syngenta Crop Protection Ag Fungicidal compositions
WO2023072849A1 (en) 2021-10-27 2023-05-04 Syngenta Crop Protection Ag Pesticidally active pyridazinone compounds
WO2023089049A2 (en) 2021-11-19 2023-05-25 Syngenta Crop Protection Ag Microbiocidal isonicotinic amide derivatives
WO2023094303A1 (en) 2021-11-25 2023-06-01 Syngenta Crop Protection Ag Microbiocidal heterobiaryl amide derivatives
WO2023094304A1 (en) 2021-11-25 2023-06-01 Syngenta Crop Protection Ag Microbiocidal heterobiaryl amide derivatives
WO2023099460A1 (en) 2021-12-02 2023-06-08 Syngenta Crop Protection Ag Fungicidal compositions
WO2023104714A1 (en) 2021-12-10 2023-06-15 Syngenta Crop Protection Ag Pesticidally active pyridazinone compounds
EP4197333A1 (en) 2021-12-15 2023-06-21 Syngenta Crop Protection AG Method for controlling diamide resistant pests & compounds therefor
WO2023110869A1 (en) 2021-12-15 2023-06-22 Syngenta Crop Protection Ag Microbiocidal bicycle heterocyclic derivatives
WO2023111215A1 (en) 2021-12-17 2023-06-22 Syngenta Crop Protection Ag Microbiocidal pyridine-substituted benzothiazine derivatives
WO2023110928A1 (en) 2021-12-17 2023-06-22 Syngenta Crop Protection Ag Fungicidal compositions
WO2023110871A1 (en) 2021-12-17 2023-06-22 Syngenta Crop Protection Ag Microbiocidal pyrazole derivatives
WO2023110710A1 (en) 2021-12-13 2023-06-22 Syngenta Crop Protection Ag Method for controlling diamide resistant pests & compounds therefor
WO2023118434A1 (en) 2021-12-22 2023-06-29 Globachem Nv Pesticidally active amide compounds
WO2023118011A1 (en) 2021-12-22 2023-06-29 Syngenta Crop Protection Ag Microbiocidal aza-heterobiaryl derivatives
WO2023117625A1 (en) 2021-12-22 2023-06-29 Syngenta Crop Protection Ag Fungicidal compositions
WO2023139166A1 (en) 2022-01-19 2023-07-27 Syngenta Crop Protection Ag Methods for controlling plant pathogens
WO2023148206A1 (en) 2022-02-02 2023-08-10 Syngenta Crop Protection Ag Microbiocidal n-amide derivatives
WO2023148369A1 (en) 2022-02-07 2023-08-10 Syngenta Crop Protection Ag Pesticidally active heterocyclic derivatives with sulfur containing substituents
WO2023148368A1 (en) 2022-02-07 2023-08-10 Syngenta Crop Protection Ag Pesticidally active heterocyclic derivatives with sulfur containing substituents
WO2023166067A1 (en) 2022-03-02 2023-09-07 Syngenta Crop Protection Ag Microbiocidal pyridazinone amide derivatives
WO2023187191A1 (en) 2022-04-01 2023-10-05 Syngenta Crop Protection Ag Pesticidally active heterocyclic derivatives with sulfur containing substituents
WO2023209238A1 (en) 2022-04-29 2023-11-02 Syngenta Crop Protection Ag Fungicidal compositions
WO2023217989A1 (en) 2022-05-12 2023-11-16 Syngenta Crop Protection Ag Alkoxy heteroaryl- carboxamide or thioamide compounds
WO2023247552A1 (en) 2022-06-21 2023-12-28 Syngenta Crop Protection Ag Microbiocidal bicyclic heterocyclic carboxamide derivatives
WO2023247360A1 (en) 2022-06-21 2023-12-28 Syngenta Crop Protection Ag Pesticidally active fused bicyclic heteroaromatic compounds
WO2024008567A1 (en) 2022-07-07 2024-01-11 Syngenta Crop Protection Ag Precision application devices and compositions
WO2024017788A1 (en) 2022-07-22 2024-01-25 Syngenta Crop Protection Ag Solid form of a heterocyclic amide derivative
WO2024018016A1 (en) 2022-07-21 2024-01-25 Syngenta Crop Protection Ag Crystalline forms of 1,2,4-oxadiazole fungicides
WO2024022910A1 (en) 2022-07-26 2024-02-01 Syngenta Crop Protection Ag 1-[1-[2-(pyrimidin-4-yl)-1,2,4-triazol-3-yl]ethyl]-3-[2,4-dichloro-5-phenyl]urea derivatives and similar compounds as pesticides
WO2024033374A1 (en) 2022-08-11 2024-02-15 Syngenta Crop Protection Ag Novel arylcarboxamide or arylthioamide compounds
WO2024038053A1 (en) 2022-08-16 2024-02-22 Syngenta Crop Protection Ag New use of pydiflumetofen
WO2024056732A1 (en) 2022-09-16 2024-03-21 Syngenta Crop Protection Ag Pesticidally active cyclic amine compounds
WO2024068655A1 (en) 2022-09-28 2024-04-04 Syngenta Crop Protection Ag Fungicidal compositions
WO2024068656A1 (en) 2022-09-28 2024-04-04 Syngenta Crop Protection Ag Fungicidal compositions
WO2024068950A1 (en) 2022-09-30 2024-04-04 Syngenta Crop Protection Ag Microbiocidal pyrazole derivatives
WO2024068838A1 (en) 2022-09-28 2024-04-04 Syngenta Crop Protection Ag Fungicidal compositions
WO2024068947A1 (en) 2022-09-30 2024-04-04 Syngenta Crop Protection Ag Microbiocidal pyrazole derivatives

Citations (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4639771A (en) 1984-10-31 1987-01-27 Kabushiki Kaisha Toshiba Image processing system
EP0276432A2 (en) * 1986-12-12 1988-08-03 Ciba-Geigy Ag Pesticides
EP0357460A2 (en) 1988-09-02 1990-03-07 Sankyo Company Limited 13-Substituted milbemycin derivatives, their preparation and use
EP0367474A1 (en) 1988-11-01 1990-05-09 Mycogen Corporation Novel bacillus thuringiensis isolate denoted b.t. ps81gg, active against lepidopteran pests, and a gene encoding a lepidopteran-active toxin
EP0374753A2 (en) 1988-12-19 1990-06-27 American Cyanamid Company Insecticidal toxines, genes coding therefor, antibodies binding them, transgenic plant cells and plants expressing these toxines
EP0382173A2 (en) 1989-02-07 1990-08-16 Meiji Seika Kaisha Ltd. PF 1022 substance, method of producing same and anthelmintic composition containing same
WO1990013651A1 (en) 1989-05-09 1990-11-15 Imperial Chemical Industries Plc Bacterial genes
US5015630A (en) 1989-01-19 1991-05-14 Merck & Co., Inc. 5-oxime avermectin derivatives
EP0427529A1 (en) 1989-11-07 1991-05-15 Pioneer Hi-Bred International, Inc. Larvicidal lectins and plant insect resistance based thereon
EP0444964A1 (en) 1990-03-01 1991-09-04 Sankyo Company Limited Milbemycin ether derivatives, their preparation and their anthelmintic uses
EP0451878A1 (en) 1985-01-18 1991-10-16 Plant Genetic Systems, N.V. Modifying plants by genetic engineering to combat or control insects
EP0503538A1 (en) 1991-03-08 1992-09-16 Meiji Seika Kaisha Ltd. Medicinal composition containing an anthelmintic cyclic depsipeptide
WO1993007278A1 (en) 1991-10-04 1993-04-15 Ciba-Geigy Ag Synthetic dna sequence having enhanced insecticidal activity in maize
WO1993019053A1 (en) 1992-03-17 1993-09-30 Fujisawa Pharmaceutical Co., Ltd. Depsipeptide derivative, production thereof and use thereof
WO1993025543A2 (en) 1992-06-11 1993-12-23 Bayer Aktiengesellschaft Enniatines and enniatine derivates used to control endoparasites
EP0594291A1 (en) 1992-09-01 1994-04-27 Sankyo Company Limited Novel processes for the production of 13-ether derivatives of milbemycins, and novel intermediates therefor
WO1994015944A1 (en) 1993-01-18 1994-07-21 Pfizer Limited New antiparasitic agents related to the milbemycins and avermectins
WO1994019334A1 (en) 1993-02-19 1994-09-01 Meiji Seika Kaisha, Ltd. Pf1022 derivative, cyclic depsipeptide
EP0626375A1 (en) 1993-05-26 1994-11-30 Bayer Ag Octacyclodepsipeptides having endoparasiticidal activity
WO1995019363A1 (en) 1994-01-14 1995-07-20 Pfizer Inc. Antiparasitic pyrrolobenzoxazine compounds
WO1995022552A1 (en) 1994-02-16 1995-08-24 Pfizer Limited Antiparasitic agents
WO1995034656A1 (en) 1994-06-10 1995-12-21 Ciba-Geigy Ag Novel bacillus thuringiensis genes coding toxins active against lepidopteran pests
US5478855A (en) 1992-04-28 1995-12-26 Yashima Chemical Industry Co., Ltd. 2-(2,6-difluorophenyl)-4-(2-ethoxy-4-tert-butylphenyl)-2-oxazoline
WO1996011945A2 (en) 1994-10-18 1996-04-25 Bayer Aktiengesellschaft Cyclic depsipeptide sulfonylation, sulfenylation and phosphorylation process
WO1996015121A1 (en) 1994-11-10 1996-05-23 Bayer Aktiengesellschaft Use of dioxomorpholines to combat endoparasites, novel dioxomorpholines and process for their production
DE19520936A1 (en) 1995-06-08 1996-12-12 Bayer Ag Ectoparasiticides means
WO1997033890A1 (en) 1996-03-11 1997-09-18 Novartis Ag Pyrimidin-4-one derivatives as pesticide
WO2002015701A2 (en) 2000-08-25 2002-02-28 Syngenta Participations Ag Bacillus thuringiensis crystal protein hybrids
WO2003018810A2 (en) 2001-08-31 2003-03-06 Syngenta Participations Ag Modified cry3a toxins and nucleic acid sequences coding therefor
WO2003028729A2 (en) 2001-10-03 2003-04-10 Pharmacia Corporation Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade
WO2003035617A2 (en) 2001-10-23 2003-05-01 Dow Agrosciences Llc Patent Department Derivatives of uk-2a
WO2003052073A2 (en) 2001-12-17 2003-06-26 Syngenta Participations Ag Novel corn event
WO2004072086A2 (en) 2003-02-14 2004-08-26 Pfizer Limited Antiparasitic terpene alkaloids
US6919298B2 (en) 2002-04-04 2005-07-19 Valent Biosciences Corporation Enhanced herbicide composition
WO2005070917A1 (en) 2004-01-23 2005-08-04 Sankyo Agro Company, Limited 3-(dihydro(tetrahydro)isoquinolin-1-yl)quinolines
WO2005121104A1 (en) 2004-06-09 2005-12-22 Sumitomo Chemical Company, Limited Pyridazine compound and use thereof
WO2006087343A1 (en) 2005-02-16 2006-08-24 Basf Aktiengesellschaft Pyrazole carboxylic acid anilides, method for the production thereof and agents containing them for controlling pathogenic fungi
WO2007031513A1 (en) 2005-09-13 2007-03-22 Bayer Cropscience Ag Pesticide thiazolyloxy substituted phenylamidine derivatives
WO2007048556A1 (en) 2005-10-25 2007-05-03 Syngenta Participations Ag Heterocyclic amide derivatives useful as microbiocides
WO2007072999A1 (en) 2005-12-22 2007-06-28 Nihon Nohyaku Co., Ltd Pyrazinecarboxamide derivatives and plant disease controlling agents containing the same
US20070155739A1 (en) 2005-12-30 2007-07-05 Alantos Pharmaceuticals, Inc. Substituted bis-amide metalloprotease inhibitors
WO2007129454A1 (en) 2006-05-08 2007-11-15 Kumiai Chemical Industry Co., Ltd. 1,2-benzisothiazole derivative, and agricultural or horticultural plant disease-controlling agent
US20080196127A1 (en) 2005-04-11 2008-08-14 Bayer Bioscience N.V. Elite Event A5547-127 and Methods and Kits For Identifying Such Event in Biological Samples
US20080312082A1 (en) 2006-10-31 2008-12-18 Kinney Anthony J Soybean event dp-305423-1 and compositions and methods for the identification and/or detection thereof
US20080320616A1 (en) 2005-04-08 2008-12-25 Bayer Bioscience N.V. Elite Event A2407-12 and Methods and Kits for Identifying Such Event in Biological Samples
WO2009022746A1 (en) 2007-08-10 2009-02-19 Nippon Soda Co., Ltd. Nitrogen-containing heterocyclic compound and pest control agent
WO2009029632A1 (en) * 2007-08-27 2009-03-05 Helicon Therapeutics, Inc. Therapeutic isoxazole compounds
US7632985B2 (en) 2005-05-27 2009-12-15 Monsanto Technology Llc Soybean event MON89788 and methods for detection thereof
WO2010000841A1 (en) 2008-07-04 2010-01-07 Bayer Cropscience Sa Fungicide hydroximoyl-tetrazole derivatives
WO2010045251A2 (en) 2008-10-17 2010-04-22 Xenon Pharmaceuticals, Inc. Spiro-oxindole compounds and their use as therapeutic agents
WO2010080829A1 (en) 2009-01-07 2010-07-15 Basf Agrochemical Products B.V. Soybean event 127 and methods related thereto
US20100184079A1 (en) 2006-06-28 2010-07-22 Pioneer Hi-Bred International, Inc. Soybean event 3560.4.3.5 and compositions and methods for the identification and detection thereof
WO2010093059A1 (en) 2009-02-16 2010-08-19 住友化学株式会社 Method for producing phenylacetamide compound
WO2010130767A2 (en) 2009-05-15 2010-11-18 Bayer Cropscience Ag Fungicide pyrazole carboxamides derivatives
WO2010146031A2 (en) 2009-06-16 2010-12-23 Basf Se Fungicidal mixtures
WO2011022470A1 (en) 2009-08-19 2011-02-24 Dow Agrosciences Llc Control of aad-1 monocot volunteers in fields of dicot crops
WO2011022471A1 (en) 2009-08-19 2011-02-24 Dow Agrosciences Llc Detection of aad-1 event das-40278-9
WO2011022469A2 (en) 2009-08-19 2011-02-24 Dow Agrosciences Llc Aad-1 event das-40278-9, related transgenic corn lines, and event-specific identification thereof
US20110067134A1 (en) 2009-09-17 2011-03-17 Brinker Ronald J Soybean transgenic event mon 87708 and methods of use thereof
WO2011081174A1 (en) 2010-01-04 2011-07-07 日本曹達株式会社 Nitrogen-containing heterocyclic compound and agricultural/horticultural germicide
US8049071B2 (en) 2007-11-15 2011-11-01 Monsanto Technology Llc Soybean plant and seed corresponding to transgenic event MON87701 and methods for detection thereof
WO2011138281A2 (en) 2010-05-06 2011-11-10 Bayer Cropscience Ag Process for the preparation of dithiine tetracarboxydiimides
WO2011162397A1 (en) 2010-06-24 2011-12-29 Sumitomo Chemical Company, Limited Plant disease control composition and method of controlling plant disease
WO2012020774A1 (en) 2010-08-10 2012-02-16 住友化学株式会社 Plant disease control composition and application for same
WO2012025557A1 (en) 2010-08-25 2012-03-01 Bayer Cropscience Ag Heteroarylpiperidine and -piperazine derivatives as fungicides
WO2012031061A2 (en) 2010-09-01 2012-03-08 E. I. Du Pont De Nemours And Company Fungicidal pyrazoles and their mixtures
WO2012084812A1 (en) 2010-12-20 2012-06-28 Isagro Ricerca S.R.L. Aminoindanes amides having a high fungicidal activity and their phytosanitary compositions
WO2012092115A1 (en) 2010-12-29 2012-07-05 E. I. Du Pont De Nemours And Company Mesoionic pyrido [1,2 -a] pyrimidine pesticides
WO2013024082A1 (en) 2011-08-15 2013-02-21 Basf Se Fungicidal substituted 1-{2-cyclyloxy-2-[2-halo-4-(4-halogen-phenoxy)-phenyl]-ethyl}-1h-[1,2,4]triazole compounds
WO2013066838A1 (en) 2011-10-31 2013-05-10 Glaxosmithkline Llc Compounds and methods
WO2013132253A1 (en) 2012-03-07 2013-09-12 Institute Of Cancer Research: Royal Cancer Hospital (The) 3-aryl-5-substituted-isoquinolin-1-one compounds and their therapeutic use
WO2013162072A1 (en) 2012-04-27 2013-10-31 Sumitomo Chemical Company, Limited Tetrazolinone compounds and its use as pesticides
US8632978B2 (en) 2011-07-26 2014-01-21 Dow Agrosciences, Llc. Soybean event pDAB9582.814.19.1 detection method
WO2014013842A1 (en) 2012-07-20 2014-01-23 住友化学株式会社 Composition for controlling plant disease and application therefor
WO2014020350A1 (en) 2012-08-01 2014-02-06 Proximagen Limited Par2 receptor antagonists
WO2014051165A1 (en) 2012-09-28 2014-04-03 Sumitomo Chemical Company, Limited Tetrazolinone compounds and their use as pesticides
WO2014095675A1 (en) 2012-12-19 2014-06-26 Bayer Cropscience Ag Difluoromethyl-nicotinic-indanyl carboxamides as fungicides
US20140201860A1 (en) 2010-12-15 2014-07-17 Syngenta Participations Ag Soybean event syht0h2 and compositions and methods for detection thereof
WO2014170327A1 (en) 2013-04-19 2014-10-23 Bayer Cropscience Ag Method for combating pests
US20140373191A1 (en) 2013-06-14 2014-12-18 Monsanto Technology, Llc Soybean transgenic event mon87751 and methods for detection and use thereof
WO2015185485A1 (en) 2014-06-06 2015-12-10 Basf Se Use of substituted oxadiazoles for combating phytopathogenic fungi
WO2016122802A1 (en) 2014-12-30 2016-08-04 Dow Agrosciences Llc Picolinamide compounds with fungicidal activity
WO2016139189A1 (en) 2015-03-05 2016-09-09 Bayer Cropscience Aktiengesellschaft Fungicidally active compound combinations
WO2017055473A1 (en) 2015-10-02 2017-04-06 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
WO2017118689A1 (en) 2016-01-08 2017-07-13 Syngenta Participations Ag Microbiocidal oxadiazole derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2211008A5 (en) 1972-12-18 1974-07-12 Pepro
ZA879329B (en) * 1986-12-12 1988-06-13 Ciba-Geigy Ag Pesticides
WO2017085100A1 (en) * 2015-11-19 2017-05-26 Basf Se Substituted oxadiazoles for combating phytopathogenic fungi

Patent Citations (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4639771A (en) 1984-10-31 1987-01-27 Kabushiki Kaisha Toshiba Image processing system
EP0451878A1 (en) 1985-01-18 1991-10-16 Plant Genetic Systems, N.V. Modifying plants by genetic engineering to combat or control insects
EP0276432A2 (en) * 1986-12-12 1988-08-03 Ciba-Geigy Ag Pesticides
EP0357460A2 (en) 1988-09-02 1990-03-07 Sankyo Company Limited 13-Substituted milbemycin derivatives, their preparation and use
EP0367474A1 (en) 1988-11-01 1990-05-09 Mycogen Corporation Novel bacillus thuringiensis isolate denoted b.t. ps81gg, active against lepidopteran pests, and a gene encoding a lepidopteran-active toxin
EP0374753A2 (en) 1988-12-19 1990-06-27 American Cyanamid Company Insecticidal toxines, genes coding therefor, antibodies binding them, transgenic plant cells and plants expressing these toxines
US5015630A (en) 1989-01-19 1991-05-14 Merck & Co., Inc. 5-oxime avermectin derivatives
EP0382173A2 (en) 1989-02-07 1990-08-16 Meiji Seika Kaisha Ltd. PF 1022 substance, method of producing same and anthelmintic composition containing same
WO1990013651A1 (en) 1989-05-09 1990-11-15 Imperial Chemical Industries Plc Bacterial genes
EP0427529A1 (en) 1989-11-07 1991-05-15 Pioneer Hi-Bred International, Inc. Larvicidal lectins and plant insect resistance based thereon
EP0444964A1 (en) 1990-03-01 1991-09-04 Sankyo Company Limited Milbemycin ether derivatives, their preparation and their anthelmintic uses
EP0503538A1 (en) 1991-03-08 1992-09-16 Meiji Seika Kaisha Ltd. Medicinal composition containing an anthelmintic cyclic depsipeptide
WO1993007278A1 (en) 1991-10-04 1993-04-15 Ciba-Geigy Ag Synthetic dna sequence having enhanced insecticidal activity in maize
WO1993019053A1 (en) 1992-03-17 1993-09-30 Fujisawa Pharmaceutical Co., Ltd. Depsipeptide derivative, production thereof and use thereof
US5478855A (en) 1992-04-28 1995-12-26 Yashima Chemical Industry Co., Ltd. 2-(2,6-difluorophenyl)-4-(2-ethoxy-4-tert-butylphenyl)-2-oxazoline
WO1993025543A2 (en) 1992-06-11 1993-12-23 Bayer Aktiengesellschaft Enniatines and enniatine derivates used to control endoparasites
EP0594291A1 (en) 1992-09-01 1994-04-27 Sankyo Company Limited Novel processes for the production of 13-ether derivatives of milbemycins, and novel intermediates therefor
WO1994015944A1 (en) 1993-01-18 1994-07-21 Pfizer Limited New antiparasitic agents related to the milbemycins and avermectins
WO1994019334A1 (en) 1993-02-19 1994-09-01 Meiji Seika Kaisha, Ltd. Pf1022 derivative, cyclic depsipeptide
EP0626375A1 (en) 1993-05-26 1994-11-30 Bayer Ag Octacyclodepsipeptides having endoparasiticidal activity
WO1995019363A1 (en) 1994-01-14 1995-07-20 Pfizer Inc. Antiparasitic pyrrolobenzoxazine compounds
WO1995022552A1 (en) 1994-02-16 1995-08-24 Pfizer Limited Antiparasitic agents
WO1995034656A1 (en) 1994-06-10 1995-12-21 Ciba-Geigy Ag Novel bacillus thuringiensis genes coding toxins active against lepidopteran pests
WO1996011945A2 (en) 1994-10-18 1996-04-25 Bayer Aktiengesellschaft Cyclic depsipeptide sulfonylation, sulfenylation and phosphorylation process
WO1996015121A1 (en) 1994-11-10 1996-05-23 Bayer Aktiengesellschaft Use of dioxomorpholines to combat endoparasites, novel dioxomorpholines and process for their production
DE19520936A1 (en) 1995-06-08 1996-12-12 Bayer Ag Ectoparasiticides means
WO1997033890A1 (en) 1996-03-11 1997-09-18 Novartis Ag Pyrimidin-4-one derivatives as pesticide
WO2002015701A2 (en) 2000-08-25 2002-02-28 Syngenta Participations Ag Bacillus thuringiensis crystal protein hybrids
WO2003018810A2 (en) 2001-08-31 2003-03-06 Syngenta Participations Ag Modified cry3a toxins and nucleic acid sequences coding therefor
WO2003028729A2 (en) 2001-10-03 2003-04-10 Pharmacia Corporation Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade
WO2003035617A2 (en) 2001-10-23 2003-05-01 Dow Agrosciences Llc Patent Department Derivatives of uk-2a
WO2003052073A2 (en) 2001-12-17 2003-06-26 Syngenta Participations Ag Novel corn event
US6919298B2 (en) 2002-04-04 2005-07-19 Valent Biosciences Corporation Enhanced herbicide composition
WO2004072086A2 (en) 2003-02-14 2004-08-26 Pfizer Limited Antiparasitic terpene alkaloids
WO2005070917A1 (en) 2004-01-23 2005-08-04 Sankyo Agro Company, Limited 3-(dihydro(tetrahydro)isoquinolin-1-yl)quinolines
WO2005121104A1 (en) 2004-06-09 2005-12-22 Sumitomo Chemical Company, Limited Pyridazine compound and use thereof
WO2006087343A1 (en) 2005-02-16 2006-08-24 Basf Aktiengesellschaft Pyrazole carboxylic acid anilides, method for the production thereof and agents containing them for controlling pathogenic fungi
US20080320616A1 (en) 2005-04-08 2008-12-25 Bayer Bioscience N.V. Elite Event A2407-12 and Methods and Kits for Identifying Such Event in Biological Samples
US20080196127A1 (en) 2005-04-11 2008-08-14 Bayer Bioscience N.V. Elite Event A5547-127 and Methods and Kits For Identifying Such Event in Biological Samples
US7632985B2 (en) 2005-05-27 2009-12-15 Monsanto Technology Llc Soybean event MON89788 and methods for detection thereof
WO2007031513A1 (en) 2005-09-13 2007-03-22 Bayer Cropscience Ag Pesticide thiazolyloxy substituted phenylamidine derivatives
WO2007048556A1 (en) 2005-10-25 2007-05-03 Syngenta Participations Ag Heterocyclic amide derivatives useful as microbiocides
WO2007072999A1 (en) 2005-12-22 2007-06-28 Nihon Nohyaku Co., Ltd Pyrazinecarboxamide derivatives and plant disease controlling agents containing the same
US20070155739A1 (en) 2005-12-30 2007-07-05 Alantos Pharmaceuticals, Inc. Substituted bis-amide metalloprotease inhibitors
WO2007129454A1 (en) 2006-05-08 2007-11-15 Kumiai Chemical Industry Co., Ltd. 1,2-benzisothiazole derivative, and agricultural or horticultural plant disease-controlling agent
US20100184079A1 (en) 2006-06-28 2010-07-22 Pioneer Hi-Bred International, Inc. Soybean event 3560.4.3.5 and compositions and methods for the identification and detection thereof
US20080312082A1 (en) 2006-10-31 2008-12-18 Kinney Anthony J Soybean event dp-305423-1 and compositions and methods for the identification and/or detection thereof
WO2009022746A1 (en) 2007-08-10 2009-02-19 Nippon Soda Co., Ltd. Nitrogen-containing heterocyclic compound and pest control agent
WO2009029632A1 (en) * 2007-08-27 2009-03-05 Helicon Therapeutics, Inc. Therapeutic isoxazole compounds
US8049071B2 (en) 2007-11-15 2011-11-01 Monsanto Technology Llc Soybean plant and seed corresponding to transgenic event MON87701 and methods for detection thereof
WO2010000841A1 (en) 2008-07-04 2010-01-07 Bayer Cropscience Sa Fungicide hydroximoyl-tetrazole derivatives
WO2010045251A2 (en) 2008-10-17 2010-04-22 Xenon Pharmaceuticals, Inc. Spiro-oxindole compounds and their use as therapeutic agents
WO2010080829A1 (en) 2009-01-07 2010-07-15 Basf Agrochemical Products B.V. Soybean event 127 and methods related thereto
WO2010093059A1 (en) 2009-02-16 2010-08-19 住友化学株式会社 Method for producing phenylacetamide compound
WO2010130767A2 (en) 2009-05-15 2010-11-18 Bayer Cropscience Ag Fungicide pyrazole carboxamides derivatives
WO2010146031A2 (en) 2009-06-16 2010-12-23 Basf Se Fungicidal mixtures
WO2011022470A1 (en) 2009-08-19 2011-02-24 Dow Agrosciences Llc Control of aad-1 monocot volunteers in fields of dicot crops
WO2011022471A1 (en) 2009-08-19 2011-02-24 Dow Agrosciences Llc Detection of aad-1 event das-40278-9
WO2011022469A2 (en) 2009-08-19 2011-02-24 Dow Agrosciences Llc Aad-1 event das-40278-9, related transgenic corn lines, and event-specific identification thereof
US20110067134A1 (en) 2009-09-17 2011-03-17 Brinker Ronald J Soybean transgenic event mon 87708 and methods of use thereof
WO2011081174A1 (en) 2010-01-04 2011-07-07 日本曹達株式会社 Nitrogen-containing heterocyclic compound and agricultural/horticultural germicide
WO2011138281A2 (en) 2010-05-06 2011-11-10 Bayer Cropscience Ag Process for the preparation of dithiine tetracarboxydiimides
WO2011162397A1 (en) 2010-06-24 2011-12-29 Sumitomo Chemical Company, Limited Plant disease control composition and method of controlling plant disease
WO2012020774A1 (en) 2010-08-10 2012-02-16 住友化学株式会社 Plant disease control composition and application for same
WO2012025557A1 (en) 2010-08-25 2012-03-01 Bayer Cropscience Ag Heteroarylpiperidine and -piperazine derivatives as fungicides
WO2012031061A2 (en) 2010-09-01 2012-03-08 E. I. Du Pont De Nemours And Company Fungicidal pyrazoles and their mixtures
US20140201860A1 (en) 2010-12-15 2014-07-17 Syngenta Participations Ag Soybean event syht0h2 and compositions and methods for detection thereof
WO2012084812A1 (en) 2010-12-20 2012-06-28 Isagro Ricerca S.R.L. Aminoindanes amides having a high fungicidal activity and their phytosanitary compositions
WO2012092115A1 (en) 2010-12-29 2012-07-05 E. I. Du Pont De Nemours And Company Mesoionic pyrido [1,2 -a] pyrimidine pesticides
US8632978B2 (en) 2011-07-26 2014-01-21 Dow Agrosciences, Llc. Soybean event pDAB9582.814.19.1 detection method
WO2013024082A1 (en) 2011-08-15 2013-02-21 Basf Se Fungicidal substituted 1-{2-cyclyloxy-2-[2-halo-4-(4-halogen-phenoxy)-phenyl]-ethyl}-1h-[1,2,4]triazole compounds
WO2013066838A1 (en) 2011-10-31 2013-05-10 Glaxosmithkline Llc Compounds and methods
WO2013132253A1 (en) 2012-03-07 2013-09-12 Institute Of Cancer Research: Royal Cancer Hospital (The) 3-aryl-5-substituted-isoquinolin-1-one compounds and their therapeutic use
WO2013162072A1 (en) 2012-04-27 2013-10-31 Sumitomo Chemical Company, Limited Tetrazolinone compounds and its use as pesticides
WO2014013842A1 (en) 2012-07-20 2014-01-23 住友化学株式会社 Composition for controlling plant disease and application therefor
WO2014020350A1 (en) 2012-08-01 2014-02-06 Proximagen Limited Par2 receptor antagonists
WO2014051165A1 (en) 2012-09-28 2014-04-03 Sumitomo Chemical Company, Limited Tetrazolinone compounds and their use as pesticides
WO2014095675A1 (en) 2012-12-19 2014-06-26 Bayer Cropscience Ag Difluoromethyl-nicotinic-indanyl carboxamides as fungicides
WO2014170327A1 (en) 2013-04-19 2014-10-23 Bayer Cropscience Ag Method for combating pests
US20140373191A1 (en) 2013-06-14 2014-12-18 Monsanto Technology, Llc Soybean transgenic event mon87751 and methods for detection and use thereof
WO2015185485A1 (en) 2014-06-06 2015-12-10 Basf Se Use of substituted oxadiazoles for combating phytopathogenic fungi
WO2016122802A1 (en) 2014-12-30 2016-08-04 Dow Agrosciences Llc Picolinamide compounds with fungicidal activity
WO2016139189A1 (en) 2015-03-05 2016-09-09 Bayer Cropscience Aktiengesellschaft Fungicidally active compound combinations
WO2017055473A1 (en) 2015-10-02 2017-04-06 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
WO2017118689A1 (en) 2016-01-08 2017-07-13 Syngenta Participations Ag Microbiocidal oxadiazole derivatives

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
"The Pesticide Manual - A World Compendium", THE BRITISH CROP PROTECTION COUNCIL
"The Pesticide Manual", 2009, BRITISH CROP PROTECTION COUNCIL
A. WOOD: "Compendium of Pesticide Common Names", 1995, COPYRIGHT
GARCIA, M. ET AL., ORG. BIOMOL. CHEM., vol. 11, 2004, pages 1633
KITAMURA, S. ET AL., CHEM. PHARM. BULL., vol. 49, 2001, pages 268
KOMPELLA, A. ET AL., BIOORG. MED. CHEM. LETT., vol. 1, 2001, pages 3161
KOMPELLA, A. ET AL., ORG. PROC. RES. DEV., vol. 16, 2012, pages 1794
LIU, H. ET AL., BIOORG. MED. CHEM., vol. 16, 2008, pages 10013
LIU, S. ET AL., SYNTHESIS, vol. 14, 2001, pages 2078

Cited By (134)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020516598A (en) * 2017-04-06 2020-06-11 エフ エム シー コーポレーションＦｍｃ Ｃｏｒｐｏｒａｔｉｏｎ Fungicidal oxadiazole
JP7235672B2 (en) 2017-04-06 2023-03-08 エフ エム シー コーポレーション fungicidal oxadiazole
US11708358B2 (en) 2017-04-06 2023-07-25 Fmc Corporation Fungicidal oxadiazoles
WO2019150219A2 (en) 2018-01-30 2019-08-08 Pi Industries Ltd. Novel oxadiazoles
US11286242B2 (en) 2018-01-30 2022-03-29 Pi Industries Ltd. Oxadiazoles for use in controlling phytopathogenic fungi
WO2020007658A1 (en) * 2018-07-02 2020-01-09 Syngenta Crop Protection Ag 3-(2-thienyl)-5-(trifluoromethyl)-1,2,4-oxadiazole derivatives as agrochemical fungicides
WO2020165403A1 (en) 2019-02-15 2020-08-20 Syngenta Crop Protection Ag Phenyl substituted thiazole derivatives as microbiocidal compounds
WO2020182649A1 (en) 2019-03-08 2020-09-17 Syngenta Crop Protection Ag Pesticidally active azole-amide compounds
WO2020188014A1 (en) 2019-03-20 2020-09-24 Syngenta Crop Protection Ag Pesticidally active azole amide compounds
WO2020188027A1 (en) 2019-03-20 2020-09-24 Syngenta Crop Protection Ag Pesticidally active azole amide compounds
WO2020193341A1 (en) 2019-03-22 2020-10-01 Syngenta Crop Protection Ag N-[1-(5-bromo-2-pyrimidin-2-yl-1,2,4-triazol-3-yl)ethyl]-2-cyclopropyl-6-(trifluoromethyl)pyridine-4-carboxamide derivatives and related compounds as insecticides
WO2020193387A1 (en) 2019-03-22 2020-10-01 Syngenta Crop Protection Ag Fungicidal compounds
WO2020193618A1 (en) 2019-03-27 2020-10-01 Syngenta Crop Protection Ag Microbiocidal thiazole derivatives
WO2020201079A1 (en) 2019-03-29 2020-10-08 Syngenta Crop Protection Ag Pesticidally active diazine-amide compounds
WO2020201398A1 (en) 2019-04-05 2020-10-08 Syngenta Crop Protection Ag Pesticidally active diazine-amide compounds
WO2020208096A1 (en) 2019-04-10 2020-10-15 Syngenta Crop Protection Ag Fungicidal compositions
WO2020208095A1 (en) 2019-04-10 2020-10-15 Syngenta Crop Protection Ag Microbiocidal picolinamide derivatives
WO2020208036A1 (en) 2019-04-11 2020-10-15 Syngenta Crop Protection Ag Pesticidally active diazine-amide compounds
WO2020239853A1 (en) 2019-05-29 2020-12-03 Syngenta Crop Protection Ag Microbiocidal derivatives
WO2020239856A1 (en) 2019-05-29 2020-12-03 Syngenta Crop Protection Ag Microbiocidal derivatives
WO2020239855A1 (en) 2019-05-29 2020-12-03 Syngenta Crop Protection Ag Microbiocidal derivatives
WO2020239854A1 (en) 2019-05-29 2020-12-03 Syngenta Crop Protection Ag Microbiocidal derivatives
WO2021004968A1 (en) 2019-07-05 2021-01-14 Syngenta Crop Protection Ag Microbiocidal picolinamide derivatives
WO2021009026A1 (en) 2019-07-12 2021-01-21 Syngenta Crop Protection Ag Methyl 2-[(4-methoxyimino-tetralin-6-yl]prop-2-enoate derivatives, chromane, isochromane, 6,7,8,9-tetrahydrobenzo[7]annulene, 1h-isobenzofurane and indane analogues thereof, and similar compounds, as agrochemical fungicides
WO2021033133A1 (en) 2019-08-19 2021-02-25 Pi Industries Ltd. Novel oxadiazole compounds containing 5- membered heteroaromatic ring for controlling or preventing phytopathogenic fungi
WO2021037614A1 (en) 2019-08-23 2021-03-04 Syngenta Crop Protection Ag Pesticidally active pyrazine-amide compounds
WO2021043616A1 (en) 2019-09-02 2021-03-11 Syngenta Crop Protection Ag Strigolactone derivatives as plant growth regulator compounds
WO2021053110A1 (en) 2019-09-20 2021-03-25 Syngenta Crop Protection Ag Pesticidally active heterocyclic derivatives with sulfur and sulfoximine containing substituents
WO2021053161A1 (en) 2019-09-20 2021-03-25 Syngenta Crop Protection Ag Pesticidally active cyclic amine compounds
WO2021083936A1 (en) 2019-11-01 2021-05-06 Syngenta Crop Protection Ag Pesticidally active fused bicyclic heteroaromatic compounds
WO2021090865A1 (en) * 2019-11-07 2021-05-14 日本農薬株式会社 Oxadiazoline compound or salts thereof, agricultural and horticultural bactericide containing said compound, and method for using same
CN114616231A (en) * 2019-11-07 2022-06-10 日本农药株式会社 Oxadiazoline compound or salt thereof, agricultural or horticultural fungicide containing the same, and method for using the same
WO2021110891A1 (en) 2019-12-04 2021-06-10 Syngenta Crop Protection Ag Pesticidally active fused bicyclic heteroaromatic amino compounds
WO2021122645A1 (en) 2019-12-20 2021-06-24 Syngenta Crop Protection Ag Pesticidally active azole-amide compounds
WO2021136722A1 (en) 2019-12-31 2021-07-08 Syngenta Crop Protection Ag Pesticidally active heterocyclic derivatives with sulfur containing substituents
WO2021140122A1 (en) 2020-01-06 2021-07-15 Syngenta Crop Protection Ag Pesticidally active heterocyclic derivatives with sulfur containing substituents
WO2021148639A1 (en) 2020-01-24 2021-07-29 Syngenta Crop Protection Ag Pesticidally active fused bicyclic heteroaromatic compounds
WO2021151926A1 (en) 2020-01-30 2021-08-05 Syngenta Crop Protection Ag Pesticidally active fused bicyclic heteroaromatic amino compounds
WO2021160680A1 (en) 2020-02-11 2021-08-19 Syngenta Crop Protection Ag Pesticidally active cyclic amine compounds
WO2021170881A1 (en) 2020-02-27 2021-09-02 Syngenta Crop Protection Ag Pesticidally active diazine-bisamide compounds
WO2021175822A1 (en) 2020-03-02 2021-09-10 Syngenta Crop Protection Ag Pesticidally amidine-substituted benzoic acid amide compounds
WO2021176007A1 (en) 2020-03-05 2021-09-10 Syngenta Crop Protection Ag Fungicidal compositions
WO2021176057A1 (en) 2020-03-05 2021-09-10 Syngenta Crop Protection Ag Fungicidal compositions
WO2021180596A1 (en) 2020-03-13 2021-09-16 Syngenta Crop Protection Ag Methods of controlling or preventing infestation of plants by the phytopathogenic microorganism corynespora cassiicola
WO2021180598A1 (en) 2020-03-13 2021-09-16 Syngenta Crop Protection Ag Methods of controlling or preventing infestation of plants by the phytopathogenic microorganism corynespora cassiicola
WO2021180592A1 (en) 2020-03-13 2021-09-16 Syngenta Crop Protection Ag Methods of controlling or preventing infestation of plants by the phytopathogenic microorganism corynespora cassiicola
WO2021204857A1 (en) 2020-04-08 2021-10-14 Syngenta Crop Protection Ag Microbiocidal quinoline dihydro-(thiazine)oxazine derivatives
WO2021204822A1 (en) 2020-04-08 2021-10-14 Syngenta Crop Protection Ag Microbiocidal quinoline dihydro-(thiazine)oxazine derivatives
WO2021204855A1 (en) 2020-04-08 2021-10-14 Syngenta Crop Protection Ag Microbiocidal quinoline dihydropyrrolopyrazine derivatives
WO2021213929A1 (en) 2020-04-20 2021-10-28 Syngenta Crop Protection Ag Pesticidally active substituted 1,3-dihydro-2h-imidazo[4,5-c]pyridin-2-one derivatives with sulfur containing substituents
WO2021219775A1 (en) 2020-04-30 2021-11-04 Syngenta Crop Protection Ag Microbiocidal compounds
WO2021219810A1 (en) 2020-04-30 2021-11-04 Syngenta Crop Protection Ag Pesticidally active heterocyclic derivatives with sulfur containing substituents
WO2021219778A1 (en) 2020-04-30 2021-11-04 Syngenta Crop Protection Ag Microbiocidal compounds
WO2021219780A1 (en) 2020-05-01 2021-11-04 Syngenta Crop Protection Ag Microbiocidal compounds
WO2021224102A1 (en) 2020-05-05 2021-11-11 Syngenta Crop Protection Ag Microbiocidal compounds
WO2021224409A1 (en) 2020-05-06 2021-11-11 Syngenta Crop Protection Ag Pesticidally active heterocyclic derivatives with sulfur containing substituents
WO2021244952A1 (en) 2020-06-03 2021-12-09 Syngenta Crop Protection Ag Microbiocidal derivatives
WO2021244950A1 (en) 2020-06-03 2021-12-09 Syngenta Crop Protection Ag Fungicidal compositions
WO2021244951A1 (en) 2020-06-03 2021-12-09 Syngenta Crop Protection Ag Fungicidal compositions
WO2022013417A1 (en) 2020-07-17 2022-01-20 Syngenta Crop Protection Ag Pesticidally active heterocyclic derivatives with sulfur containing substituents
WO2022017975A1 (en) 2020-07-18 2022-01-27 Syngenta Crop Protection Ag Pesticidally active heterocyclic derivatives with sulfur containing substituents
WO2022043576A2 (en) 2020-08-31 2022-03-03 Syngenta Crop Protection Ag Pesticidally active heterocyclic derivatives with sulfur containing substituents
WO2022049141A1 (en) 2020-09-01 2022-03-10 Syngenta Crop Protection Ag Pesticidally active heterocyclic derivatives with sulfur containing substituents
WO2022048988A1 (en) 2020-09-02 2022-03-10 Syngenta Participations Ag Plant growth regulator compounds
WO2022049144A1 (en) 2020-09-02 2022-03-10 Syngenta Crop Protection Ag Pesticidally active heterocyclic derivatives with sulfur containing substituents
WO2022049146A1 (en) 2020-09-02 2022-03-10 Syngenta Crop Protection Ag Pesticidally active heterocyclic derivatives with sulfur containing substituents
WO2022053567A1 (en) 2020-09-09 2022-03-17 Syngenta Crop Protection Ag Pesticidally active heterocyclic derivatives with sulfur containing substituents
WO2022058580A1 (en) 2020-09-21 2022-03-24 Syngenta Crop Protection Ag Microbiocidal compounds
WO2022084346A1 (en) 2020-10-22 2022-04-28 Syngenta Crop Protection Ag Zealactone derivatives as plant growth regulators
WO2022101265A1 (en) 2020-11-13 2022-05-19 Syngenta Crop Protection Ag Pesticidally active fused bicyclic heteroaromatic compounds
WO2022117650A1 (en) 2020-12-02 2022-06-09 Syngenta Crop Protection Ag Fungicidal compositions
WO2022117653A1 (en) 2020-12-02 2022-06-09 Syngenta Crop Protection Ag Fungicidal compositions
WO2022157334A1 (en) 2021-01-21 2022-07-28 Syngenta Crop Protection Ag Pesticidally active heterocyclic derivatives with sulfur containing substituents
WO2022157122A1 (en) 2021-01-22 2022-07-28 Syngenta Crop Protection Ag Method for the control or suppression of phytopathogenic bacteria
WO2022157188A2 (en) 2021-01-23 2022-07-28 Syngenta Crop Protection Ag Pesticidally active heteroaromatic compounds
WO2022207479A1 (en) 2021-03-27 2022-10-06 Syngenta Crop Protection Ag Microbiocidal isonicotinic amide derivatives
WO2022207462A1 (en) 2021-03-30 2022-10-06 Syngenta Crop Protection Ag Pesticidally active cyclic amine compounds
WO2022207665A1 (en) 2021-03-31 2022-10-06 Syngenta Crop Protection Ag Microbiocidal quinoline/quinoxaline benzothiazine derivatives
WO2022219146A2 (en) 2021-04-16 2022-10-20 Syngenta Crop Protection Ag Pesticidally active cyclic amine compounds
WO2022223376A1 (en) 2021-04-20 2022-10-27 Syngenta Crop Protection Ag Microbiocidal quinoline/quinoxaline isoquinoline derivatives
WO2022233869A1 (en) 2021-05-04 2022-11-10 Syngenta Crop Protection Ag Use of clethodim for insect control
WO2022253645A1 (en) 2021-06-01 2022-12-08 Syngenta Crop Protection Ag Microbiocidal tetrahydroisoquinoline derivatives
WO2022253841A1 (en) 2021-06-02 2022-12-08 Syngenta Crop Protection Ag Pesticidally active heterocyclic derivatives with sulfoximine containing substituents
WO2022258481A1 (en) 2021-06-09 2022-12-15 Syngenta Crop Protection Ag Pesticidally active diazine-amide compounds
WO2022268648A1 (en) 2021-06-24 2022-12-29 Syngenta Crop Protection Ag 2-[3-[1 [(quinazolin-4-yl)amino]ethyl]pyrazin-2-yl]thiazole-5-carbonitrile derivatives and similar compounds as pesticides
WO2023275116A1 (en) 2021-07-02 2023-01-05 Syngenta Crop Protection Ag Use of fluazifop-p-butyl for insect control
WO2023006634A1 (en) 2021-07-27 2023-02-02 Syngenta Crop Protection Ag Method for controlling diamide resistant pests & compounds therefor
WO2023006789A1 (en) 2021-07-29 2023-02-02 Syngenta Crop Protection Ag Pesticidally active fused bicyclic heteroaromatic compounds
WO2023012044A1 (en) 2021-08-02 2023-02-09 Syngenta Crop Protection Ag Microbiocidal pyrazole derivatives
WO2023012081A1 (en) 2021-08-05 2023-02-09 Syngenta Crop Protection Ag Method for controlling diamide resistant pests & compounds therefor
WO2023017094A1 (en) 2021-08-10 2023-02-16 Syngenta Crop Protection Ag 2,2-difluoro-5h-[1,3]dioxolo[4,5-f]isoindol-7-one derivatives as pesticides
WO2023017016A1 (en) 2021-08-10 2023-02-16 Syngenta Crop Protection Ag Fungicide mixture
WO2023021020A1 (en) 2021-08-19 2023-02-23 Syngenta Crop Protection Ag Method for controlling diamide resistant pests & compounds therefor
WO2023061838A1 (en) 2021-10-14 2023-04-20 Syngenta Crop Protection Ag Imidazo[1,2-a]pyridine derivatives
WO2023072945A1 (en) 2021-10-25 2023-05-04 Syngenta Crop Protection Ag Pesticidally active heterocyclic derivatives with sulfur containing substituents
WO2023072849A1 (en) 2021-10-27 2023-05-04 Syngenta Crop Protection Ag Pesticidally active pyridazinone compounds
WO2023072785A1 (en) 2021-10-29 2023-05-04 Syngenta Crop Protection Ag Fungicidal compositions
WO2023072784A1 (en) 2021-10-29 2023-05-04 Syngenta Crop Protection Ag Fungicidal compositions comprising fludioxonil
WO2023089049A2 (en) 2021-11-19 2023-05-25 Syngenta Crop Protection Ag Microbiocidal isonicotinic amide derivatives
WO2023094303A1 (en) 2021-11-25 2023-06-01 Syngenta Crop Protection Ag Microbiocidal heterobiaryl amide derivatives
WO2023094304A1 (en) 2021-11-25 2023-06-01 Syngenta Crop Protection Ag Microbiocidal heterobiaryl amide derivatives
WO2023099460A1 (en) 2021-12-02 2023-06-08 Syngenta Crop Protection Ag Fungicidal compositions
WO2023104714A1 (en) 2021-12-10 2023-06-15 Syngenta Crop Protection Ag Pesticidally active pyridazinone compounds
WO2023110710A1 (en) 2021-12-13 2023-06-22 Syngenta Crop Protection Ag Method for controlling diamide resistant pests & compounds therefor
EP4197333A1 (en) 2021-12-15 2023-06-21 Syngenta Crop Protection AG Method for controlling diamide resistant pests & compounds therefor
WO2023110869A1 (en) 2021-12-15 2023-06-22 Syngenta Crop Protection Ag Microbiocidal bicycle heterocyclic derivatives
WO2023110871A1 (en) 2021-12-17 2023-06-22 Syngenta Crop Protection Ag Microbiocidal pyrazole derivatives
WO2023111215A1 (en) 2021-12-17 2023-06-22 Syngenta Crop Protection Ag Microbiocidal pyridine-substituted benzothiazine derivatives
WO2023110928A1 (en) 2021-12-17 2023-06-22 Syngenta Crop Protection Ag Fungicidal compositions
WO2023118434A1 (en) 2021-12-22 2023-06-29 Globachem Nv Pesticidally active amide compounds
WO2023117625A1 (en) 2021-12-22 2023-06-29 Syngenta Crop Protection Ag Fungicidal compositions
WO2023118011A1 (en) 2021-12-22 2023-06-29 Syngenta Crop Protection Ag Microbiocidal aza-heterobiaryl derivatives
WO2023139166A1 (en) 2022-01-19 2023-07-27 Syngenta Crop Protection Ag Methods for controlling plant pathogens
WO2023148206A1 (en) 2022-02-02 2023-08-10 Syngenta Crop Protection Ag Microbiocidal n-amide derivatives
WO2023148369A1 (en) 2022-02-07 2023-08-10 Syngenta Crop Protection Ag Pesticidally active heterocyclic derivatives with sulfur containing substituents
WO2023148368A1 (en) 2022-02-07 2023-08-10 Syngenta Crop Protection Ag Pesticidally active heterocyclic derivatives with sulfur containing substituents
WO2023166067A1 (en) 2022-03-02 2023-09-07 Syngenta Crop Protection Ag Microbiocidal pyridazinone amide derivatives
WO2023187191A1 (en) 2022-04-01 2023-10-05 Syngenta Crop Protection Ag Pesticidally active heterocyclic derivatives with sulfur containing substituents
WO2023209238A1 (en) 2022-04-29 2023-11-02 Syngenta Crop Protection Ag Fungicidal compositions
WO2023217989A1 (en) 2022-05-12 2023-11-16 Syngenta Crop Protection Ag Alkoxy heteroaryl- carboxamide or thioamide compounds
WO2023247552A1 (en) 2022-06-21 2023-12-28 Syngenta Crop Protection Ag Microbiocidal bicyclic heterocyclic carboxamide derivatives
WO2023247360A1 (en) 2022-06-21 2023-12-28 Syngenta Crop Protection Ag Pesticidally active fused bicyclic heteroaromatic compounds
WO2024008567A1 (en) 2022-07-07 2024-01-11 Syngenta Crop Protection Ag Precision application devices and compositions
WO2024018016A1 (en) 2022-07-21 2024-01-25 Syngenta Crop Protection Ag Crystalline forms of 1,2,4-oxadiazole fungicides
WO2024017788A1 (en) 2022-07-22 2024-01-25 Syngenta Crop Protection Ag Solid form of a heterocyclic amide derivative
WO2024022910A1 (en) 2022-07-26 2024-02-01 Syngenta Crop Protection Ag 1-[1-[2-(pyrimidin-4-yl)-1,2,4-triazol-3-yl]ethyl]-3-[2,4-dichloro-5-phenyl]urea derivatives and similar compounds as pesticides
WO2024033374A1 (en) 2022-08-11 2024-02-15 Syngenta Crop Protection Ag Novel arylcarboxamide or arylthioamide compounds
WO2024038053A1 (en) 2022-08-16 2024-02-22 Syngenta Crop Protection Ag New use of pydiflumetofen
WO2024056732A1 (en) 2022-09-16 2024-03-21 Syngenta Crop Protection Ag Pesticidally active cyclic amine compounds
WO2024068655A1 (en) 2022-09-28 2024-04-04 Syngenta Crop Protection Ag Fungicidal compositions
WO2024068656A1 (en) 2022-09-28 2024-04-04 Syngenta Crop Protection Ag Fungicidal compositions
WO2024068838A1 (en) 2022-09-28 2024-04-04 Syngenta Crop Protection Ag Fungicidal compositions
WO2024068950A1 (en) 2022-09-30 2024-04-04 Syngenta Crop Protection Ag Microbiocidal pyrazole derivatives
WO2024068947A1 (en) 2022-09-30 2024-04-04 Syngenta Crop Protection Ag Microbiocidal pyrazole derivatives

Also Published As

Publication number Publication date
MX2019010261A (en) 2019-10-21
IL269023A (en) 2019-10-31
CL2019002512A1 (en) 2019-11-29
JP2020510670A (en) 2020-04-09
US20200277287A1 (en) 2020-09-03
BR112019018238A2 (en) 2020-06-23
CO2019009262A2 (en) 2019-08-30
CN110382492A (en) 2019-10-25
US11358957B2 (en) 2022-06-14
IL269023B (en) 2021-12-01
CN110382492B (en) 2023-07-14
EP3589629A1 (en) 2020-01-08
BR112019018238B1 (en) 2023-11-07
UY37623A (en) 2018-09-28

Similar Documents

Publication Publication Date Title
US11358957B2 (en) Microbiocidal oxadiazole derivatives
EP3522715B1 (en) Microbiocidal oxadiazole derivatives
WO2017220485A1 (en) Microbiocidal oxadiazole derivatives
EP3515908A1 (en) Microbiocidal oxadiazole derivatives
EP3442969A1 (en) Microbiocidal oxadiazole derivatives
EP3458446A1 (en) Microbiocidal oxadiazole derivatives
EP3464251A1 (en) Microbiocidal oxadiazole derivatives
EP3487842A1 (en) Microbiocidal oxadiazole derivatives
WO2018162643A1 (en) Microbiocidal oxadiazole derivatives
EP3487855A1 (en) Microbiocidal oxadiazole derivatives
WO2019097054A1 (en) Microbiocidal oxadiazole derivatives
WO2019012011A1 (en) Microbiocidal oxadiazole derivatives
WO2019012003A1 (en) Microbiocidal oxadiazole derivatives
WO2019011923A1 (en) Microbiocidal oxadiazole derivatives
WO2018029242A1 (en) Microbiocidal oxadiazole derivatives
US11447481B2 (en) Microbiocidal oxadiazole derivatives
EP3606913B1 (en) Microbiocidal oxadiazole derivatives
WO2019011929A1 (en) Microbiocidal oxadiazole derivatives
WO2019011926A1 (en) Microbiocidal oxadiazole derivatives
WO2019011928A1 (en) Microbiocidal oxadiazole derivatives
WO2019012001A1 (en) Microbiocidal oxadiazole derivatives
WO2018184985A1 (en) Microbiocidal oxadiazole derivatives
WO2018184982A1 (en) Microbiocidal oxadiazole derivatives
WO2019207058A1 (en) Microbiocidal oxadiazole derivatives
WO2018185211A1 (en) Microbiocidal oxadiazole derivatives

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18708404

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2019547632

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112019018238

Country of ref document: BR

WWE Wipo information: entry into national phase

Ref document number: 2018708404

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 112019018238

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20190902